PT J
AU Haddock, CK
   Poston, WSC
   LaGrotte, C
   Klotz, AA
   Oliver, TL
   Vander Veur, SS
   Foster, GD
   Jebb, SA
   Moore, C
   Roberts, SA
   Reeves, RS
   Bolton, MP
   Foreyt, JP
AF Haddock, C. Keith
   Poston, Walker S. C.
   LaGrotte, Caitlin
   Klotz, Alicia A.
   Oliver, Tracy L.
   Vander Veur, Stephanie S.
   Foster, Gary D.
   Jebb, Susan A.
   Moore, Carmel
   Roberts, Susan A.
   Reeves, Rebecca S.
   Bolton, Mary Pat
   Foreyt, John P.
TI Findings from an online behavioural weight management programme provided with or without a fortified diet beverage
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Internet; Obesity; Weight loss; Online behavioural modification programmes
ID green tea; energy-expenditure; fat oxidation; primary-care; body-weight; internet; maintenance; web; caffeine; adults
AB The present multi-centre randomised weight-loss trial evaluated the efficacy of a low-intensity 12-week online behavioural modification programme, with or without a fortified diet beverage using a 2x2 factorial design. A total of 572 participants were randomised to: (1) an online basic lifestyle information (OBLI) intervention, consisting of one online informational class about tips for weight management; (2) an online behavioural weight management (OBWM) intervention, entailing 12 weekly online classes focused on weight-loss behaviour modification; (3) an OBLI intervention plus a fortified diet cola beverage (BEV) containing green tea extract (total catechin 167mg), soluble fibre dextrin (10g) and caffeine (100mg) (OBLI+BEV); (4) OBWM+BEV. Assessments included height, weight, dual-energy X-ray absorptiometry-derived body composition, and waist circumference (WC). Attrition was 15 center dot 7%. Intention-to-treat (ITT) models demonstrated a main effect for type of Internet programme, with those assigned to the OBWM condition losing significantly more weight (F=7 center dot 174; P=0 center dot 008) and fat mass (F=4 center dot 491; P=0 center dot 035) than those assigned to the OBLI condition. However, there was no significant main effect for the OBWM condition on body fat percentage (F=2 center dot 906; P=0 center dot 089) or WC (F=3 center dot 351; P=0 center dot 068), and no significant main effect for beverage use or significant interactions between factors in ITT models. A 12-week, low-intensity behaviourally based online programme produced a greater weight loss than a basic information website. The addition of a fortified diet beverage had no additional impact.
C1 [Haddock, C. Keith; Poston, Walker S. C.] Natl Dev & Res Inst Inc, Inst Biobehav Hlth Res, Leawood, KS 66224 USA.
   [LaGrotte, Caitlin; Klotz, Alicia A.; Oliver, Tracy L.; Vander Veur, Stephanie S.; Foster, Gary D.] Temple Univ, Philadelphia, PA 19122 USA.
   [Jebb, Susan A.; Moore, Carmel] Elsie Widdowson Lab, MRC Human Nutr Res, Cambridge, England.
   [Roberts, Susan A.] Coca Cola Co, Global Sci & Regulatory Affairs, Atlanta, GA USA.
   [Reeves, Rebecca S.; Bolton, Mary Pat; Foreyt, John P.] Baylor Coll Med, Behav Med Res Ctr, Houston, TX 77030 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; The Coca-Cola Company; Baylor College of Medicine
RP Poston, WSC (corresponding author), Natl Dev & Res Inst Inc, Inst Biobehav Hlth Res, 1920 West 143rd St,Suite 120, Leawood, KS 66224 USA.
EM carlosposton@hopehri.com
FU Coca-Cola Company; MRC [MC_U105960389] Funding Source: UKRI
CR Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x
   Unknown -, 2009, OPEN MED-WARSAW, V0, P0
   Arem H, 2011, OBES REV, V12, Pe236, DOI 10.1111/j.1467-789X.2010.00787.x
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   Bennett GG, 2010, OBESITY, V18, P308, DOI 10.1038/oby.2009.242
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   Gold B, 2007, ANN BEHAV MED, V33, P49, DOI 10.1207/s15324796abm3301_6
   Gold BC, 2007, OBESITY, V15, P155, DOI 10.1038/oby.2007.520
   Gu√©rin-Deremaux L, 2011, NUTR RES, V31, P665, DOI 10.1016/j.nutres.2011.09.004
   Guerin-Deremaux L, 2011, INT J FOOD SCI NUTR, V62, P628, DOI 10.3109/09637486.2011.569492
   Harvey-Berino J, 2002, BEHAV MODIF, V26, P103, DOI 10.1177/0145445502026001006
   Hase T, 2001, JOURNAL OF OLEO SCIENCE, V50, P599, DOI 10.5650/jos.50.599
   Hunter CM, 2008, AM J PREV MED, V34, P119, DOI 10.1016/j.amepre.2007.09.026
   Hursel R, 2011, OBES REV, V12, PE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Jebb SA, 2011, LANCET, V378, P1485, DOI 10.1016/S0140-6736(11)61344-5
   MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2001, JOURNAL OF OLEO SCIENCE, V50, P717
   Organisation for Economic Co-operation and Development (OECD), 2011, OECD HLTH DAT 2010 F, V0, P0
   Pasman W, 2006, EUR J CLIN NUTR, V60, P1024, DOI 10.1038/sj.ejcn.1602418
   Pritchard JE, 1997, J AM DIET ASSOC, V97, P37, DOI 10.1016/S0002-8223(97)00015-1
   Rothert K, 2006, OBESITY, V14, P266, DOI 10.1038/oby.2006.34
   Rowe S, 2009, AM J CLIN NUTR, V89, P1285, DOI 10.3945/ajcn.2009.27604
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   Smith CE, 2011, NUTR RES REV, V24, P118, DOI 10.1017/S0954422411000023
   Tate DF, 2001, JAMA-J AM MED ASSOC, V285, P1172, DOI 10.1001/jama.285.9.1172
   Tate DF, 2003, JAMA-J AM MED ASSOC, V289, P1833, DOI 10.1001/jama.289.14.1833
   Ware JH, 2003, NEW ENGL J MED, V348, P2136, DOI 10.1056/NEJMe030054
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Williamson D A, 2005, EAT WEIGHT DISORD, V10, P193
   Wing RR, 2006, NEW ENGL J MED, V355, P1563, DOI 10.1056/NEJMoa061883
   Womble LG, 2004, OBES RES, V12, P1011, DOI 10.1038/oby.2004.124
NR 36
TC 9
Z9 10
U1 0
U2 12
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD JAN 28
PY 2014
VL 111
IS 2
BP 372
EP 379
DI 10.1017/S0007114513002377
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA AD0UX
UT WOS:000332950700022
PM 23920353
DA 2025-04-28
ER

PT J
AU Kobayashi, S
   Asakura, K
   Suga, H
   Sasaki, S
AF Kobayashi, S.
   Asakura, K.
   Suga, H.
   Sasaki, S.
TI Inverse association between dietary habits with high total antioxidant capacity and prevalence of frailty among elderly Japanese women: A multicenter cross-sectional study
SO JOURNAL OF NUTRITION HEALTH & AGING
LA English
DT Article
DE Frailty; dietary total antioxidant capacity; brief-type self-administered diet history questionnaire; elderly Japanese women
ID food-frequency questionnaire; sf-36 health survey; c-reactive protein; older-adults; history questionnaires; abdominal obesity; oxidative stress; predict frailty; redox status; aged 65
AB To examine the association of dietary habits with high total antioxidant capacity (TAC) with frailty among elderly Japanese women. Cross-sectional multicenter study. Thirty-five of 47 prefectures in Japan. 2121 grandmothers or acquaintances of dietetic students aged 65 and older. Dietary TAC and food intakes were calculated using a validated brief-type self-administered diet history questionnaire. The TAC value of each food was assigned using four different assays, ferric reducing ability of plasma (FRAP), oxygen radical absorbance capacity (ORAC), Trolox equivalent antioxidant capacity (TEAC), and total radical-trapping antioxidant parameter (TRAP). Frailty was defined as the presence three or more of the following four components: slowness and weakness (two points), exhaustion, low physical activity, and unintentional weight loss. The number of subjects with frailty was 486 (23%). Multivariate adjusted ORs (95% CI) for frailty in the highest compared to the lowest quintile were 0.35 (0.24, 0.53) for FRAP, 0.35 (0.23, 0.52) for ORAC, 0.40 (0.27, 0.60) for TEAC, and 0.41 (0.28, 0.62) for TRAP. The intakes of green tea, coffee, vegetables, and fruits which contribute to dietary TAC were also associated with lower odds of frailty (the range of multivariate adjusted OR: 0.47 for vegetables to 0.77 for green tea), although the odds ratios were less marked than those of dietary TAC. Dietary habits with high TAC showed a stronger inverse association with frailty in elderly Japanese women than the individual foods examined.
C1 [Kobayashi, S.; Suga, H.; Sasaki, S.] Univ Tokyo, Dept Social & Prevent Epidemiol, Grad Sch Med, Tokyo 1130033, Japan.
   [Asakura, K.; Sasaki, S.] Univ Tokyo, Dept Social & Prevent Epidemiol, Sch Publ Hlth, Tokyo 1130033, Japan.
   [Asakura, K.] Univ Tokyo, Interfac Initiat Informat Studies, Tokyo, Japan.
C3 University of Tokyo; University of Tokyo; University of Tokyo
RP Sasaki, S (corresponding author), Univ Tokyo, Dept Social & Prevent Epidemiol, Sch Publ Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.
EM stssasak@m.u-tokyo.ac.jp
FU JSPS KAKENHI Grant from the Japan Society for the Promotion of Science [22240077]; Grants-in-Aid for Scientific Research [24500837, 26305027, 22240077] Funding Source: KAKEN
CR Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12
   Bartali B, 2006, J GERONTOL A-BIOL, V61, P589, DOI 10.1093/gerona/61.6.589
   Ble A, 2006, J GERONTOL A-BIOL, V61, P278, DOI 10.1093/gerona/61.3.278
   Bollwein J, 2013, J GERONTOL A-BIOL, V68, P483, DOI 10.1093/gerona/gls204
   Brighenti F, 2005, BRIT J NUTR, V93, P619, DOI 10.1079/BJN20051400
   Carlsen MH, 2010, NUTR J, V9, P0, DOI 10.1186/1475-2891-9-3
   Chan DCD, 2012, BMC GERIATR, V12, P0, DOI 10.1186/1471-2318-12-58
   Chen XL, 2010, J CLIN ONCOL, V28, P991, DOI 10.1200/JCO.2009.23.0565
   Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x
   Dent E, 2012, J NUTR HEALTH AGING, V16, P764, DOI 10.1007/s12603-012-0405-5
   Detopoulou P, 2010, EUR J CLIN NUTR, V64, P161, DOI 10.1038/ejcn.2009.130
   Devore EE, 2010, AM J CLIN NUTR, V92, P1157, DOI 10.3945/ajcn.2010.29634
   Doba N, 2012, EXP GERONTOL, V47, P638, DOI 10.1016/j.exger.2012.05.016
   Fried LP, 2001, J GERONTOL A-BIOL, V56, PM146, DOI 10.1093/gerona/56.3.M146
   Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X
   Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1
   Fukuhara S, 2004, MANUAL SF 36V2 JAPAN, V0, P0
   Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4
   Hermsdorff HHM, 2010, NUTR METAB, V7, P0, DOI 10.1186/1743-7075-7-42
   Hsiao PY, 2013, J NUTR HEALTH AGING, V17, P19, DOI 10.1007/s12603-012-0082-4
   Hubbard RE, 2010, J GERONTOL A-BIOL, V65, P377, DOI 10.1093/gerona/glp186
   Kaiser MJ, 2009, AGING MALE, V12, P87, DOI 10.3109/13685530903296706
   Kobayashi S, 2012, NUTR J, V11, P0, DOI 10.1186/1475-2891-11-91
   Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI 10.2188/jea.JE20110075
   Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504
   Kolomvotsou AI, 2013, EUR J NUTR, V52, P37, DOI 10.1007/s00394-011-0283-3
   La Vecchia C, 2013, INT J CANCER, V133, P1447, DOI 10.1002/ijc.28133
   Lakey SL, 2012, J AM GERIATR SOC, V60, P854, DOI 10.1111/j.1532-5415.2012.03940.x
   Lee PH, 2012, J CLIN GERONTOL GERI, V3, P47, DOI 10.1016/j.jcgg.2012.04.001
   Michelon E, 2006, J GERONTOL A-BIOL, V61, P600, DOI 10.1093/gerona/61.6.600
   Ministry of Education Culture Sports and Technology, 2012, GEN SURV SCH, V0, P0
   Ministry of Health Labour and Welfare, 2009, DIET REF INT JAP 201, V0, P0
   Mulero J, 2011, J NUTR HEALTH AGING, V15, P756, DOI 10.1007/s12603-011-0130-5
   Murayama H, 2012, J EPIDEMIOL, V22, P551, DOI 10.2188/jea.JE20120015
   Nemoto M, 2012, ARCH GERONTOL GERIAT, V55, P385, DOI 10.1016/j.archger.2011.10.004
   Niu KJ, 2009, AM J CLIN NUTR, V90, P1615, DOI 10.3945/ajcn.2009.28216
   Pellegrini N, 2003, J NUTR, V133, P2812, DOI 10.1093/jn/133.9.2812
   Pellegrini N, 2007, J NUTR, V137, P93, DOI 10.1093/jn/137.1.93
   RADLOFF L S, 1977, APPLIED PSYCHOLOGICAL MEASUREMENT, V1, P385, DOI 10.1177/014662167700100306
   Raji MA, 2010, J GERONTOL A-BIOL, V65, P1228, DOI 10.1093/gerona/glq121
   Rautiainen S, 2008, AM J CLIN NUTR, V87, P1247, DOI 10.1093/ajcn/87.5.1247
   Science and Technology Agency, 2010, STAND TABL FOOD COMP, V0, P0
   Semba RD, 2006, J GERONTOL A-BIOL, V61, P594, DOI 10.1093/gerona/61.6.594
   Serafini M, 2004, REDOX REP, V9, P145, DOI 10.1179/135100004225004814
   Stanner SA, 2004, PUBLIC HEALTH NUTR, V7, P407, DOI 10.1079/PHN2003543
   Takebayashi J, 2010, BIOSCI BIOTECH BIOCH, V74, P2137, DOI 10.1271/bbb.100430
   Talegawkar SA, 2012, J NUTR, V142, P2161, DOI 10.3945/jn.112.165498
   Valtuena S, 2008, AM J CLIN NUTR, V87, P1290, DOI 10.1093/ajcn/87.5.1290
   Wada K, 2007, AM J IND MED, V50, P8, DOI 10.1002/ajim.20403
   WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366
   Woods NF, 2005, J AM GERIATR SOC, V53, P1321, DOI 10.1111/j.1532-5415.2005.53405.x
NR 51
TC 60
Z9 62
U1 0
U2 27
PU SPRINGER FRANCE
PI PARIS
PA 22 RUE DE PALESTRO, PARIS, 75002, FRANCE
SN 1279-7707
EI 1760-4788
J9 J NUTR HEALTH AGING
JI J. Nutr. Health Aging
PD DEC 15
PY 2014
VL 18
IS 9
BP 827
EP 836
DI 10.1007/s12603-014-0556-7
PG 10
WC Geriatrics & Gerontology; Nutrition & Dietetics
SC Geriatrics & Gerontology; Nutrition & Dietetics
GA AW3LE
UT WOS:000346187400008
PM 25389961
DA 2025-04-28
ER

PT J
AU Naidoo, P
   Islam, MS
AF Naidoo, Pragalathan
   Islam, Md Shahidul
TI Development of an alternative non-obese non-genetic rat model of type 2 diabetes using caffeine and streptozotocin
SO PHARMACOLOGICAL REPORTS
LA English
DT Article
DE Caffeine; Streptozotocin; Non-obese; Type 2 diabetes; Rat model
ID insulin-secretion; clinical characteristics; rodent models; mellitus; diet; prevention; coffee; overexpression; glibenclamide; consumption
AB Background: The aim of the present study was to develop an alternative non-obese non-genetic rat model of type 2 diabetes (T2D). Methods: Six-week-old male SD rats were randomly divided into six groups, namely: Normal Control (NC), Diabetic Control (DBC), Caffeine 5 mg/kg BW + STZ (CAF5), Caffeine 10 mg/kg BW + STZ (CAF10), Caffeine 20 mg/kg BW + STZ (CAF20) and Caffeine 40 mg/kg BW + STZ (CAF40) and were fed a normal rat pellet diet and drinking water ad libitum throughout the experimental period. After a one week acclimatization period, diabetes was induced in the animals in DBC and all CAF groups with an injection (i.p.) of the respective dosages of caffeine (mg/kg BW) 15 min before the injection of STZ (65 mg/kg BW) when normal saline was injected to the DBC group instead of caffeine. The NC group received normal saline and buffer instead of caffeine and STZ, respectively. One week after the STZ injection, animals with non-fasting blood glucose >300 mg/dl were considered as diabetic. Three weeks after the STZ injection, the animals in the CAF5 and CAF10 groups were eliminated from the study due to the severity of diabetes and the experiment was continued with the remainder groups for a 13 weeks period. Results and conclusion: The data of food and fluid intake, body weight, blood glucose, glucose tolerance test, HOMA-IR, HOMA-beta, serum insulin, fructosamine, lipid profile and organ specific enzymes, antidiabetic drug response tests, and pancreatic histopathology suggest that CAF20 group can be a better alternative non-genetic model of non-obese T2D. (C) 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
C1 [Naidoo, Pragalathan; Islam, Md Shahidul] Univ KwaZulu Natal, Sch Life Sci, Dept Biochem, Durban, South Africa.
C3 University of Kwazulu Natal
RP Islam, MS (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Dept Biochem, Westville Campus, Durban, South Africa.
EM islamd@ukzn.ac.za
FU Competitive Research Grant (UCRG) from the Research Office, University of KwaZulu-Natal Natal (Westville Campus); Incentive Grant for Rated Researchers from the National Research Foundation (NRF), Pretoria, South Africa [IFR2011041000003]; Grant Support for Young Men and Women Researchers from the National Research Foundation (NRF), Pretoria, South Africa [UID 74297]
CR Ainscow EK, 2000, DIABETES, V49, P1149, DOI 10.2337/diabetes.49.7.1149
   Alvarsson M, 2005, DIABETOLOGIA, V48, P2262, DOI 10.1007/s00125-005-1929-6
   American Diabetes Association, 2007, DIABETES CARE, V30 Suppl 1, P0
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   BILLINGHAM MS, 1989, DIABETES RES CLIN EX, V11, P13
   Bonner-Weir S, 1989, J CLIN INVEST, V71, P544
   Chen D, 2005, DIABETES OBES METAB, V7, P307, DOI 10.1111/j.1463-1326.2004.00392.x
   Cho NH, 2007, DIABETES CARE, V30, P2566, DOI 10.2337/dc07-0106
   Daniele SM, 2010, DIABETOL METAB SYNDR, V2, P0, DOI 10.1186/1758-5996-2-15
   De Carvalho JAM, 2011, CLIN CHIM ACTA, V412, P1407, DOI 10.1016/j.cca.2011.04.015
   DeFronzo RA, 1997, DIABETES REV, V5, P177
   Evliyaoglu O, 2011, CELL BIOCHEM FUNCT, V29, P506, DOI 10.1002/cbf.1779
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Harris EH, 2005, CLIN. DIABETES, V23, P115, DOI 10.2337/diaclin.23.3.115
   Hudson OD, 2012, BMC PEDIATR, V12, P0, DOI 10.1186/1471-2431-12-174
   Islam MS, 2007, PHARMACOLOGY, V79, P243, DOI 10.1159/000101989
   Islam MS, 2009, METHOD FIND EXP CLIN, V31, P249, DOI 10.1358/mf.2009.31.4.1362513
   Ito H, 2010, NUTR METAB, V7, P0, DOI 10.1186/1743-7075-7-83
   Judi L, 2010, ANN SAUDI MED, V30, P25, DOI 10.5144/0256-4947.59369
   Kagami K, 2008, J PHARM PHARMACOL, V60, P1161, DOI 10.1211/jpp.60.9.0007
   Kim DJ, 2007, DIABETES RES CLIN PR, V77, PS252, DOI 10.1016/j.diabres.2007.01.067
   Kitahara Y, 2002, METABOLISM, V51, P1452, DOI 10.1053/meta.2002.35195
   LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234
   Masiello P, 1998, DIABETES, V47, P224, DOI 10.2337/diabetes.47.2.224
   Morinaga H, 2008, J VET MED SCI, V70, P1239, DOI 10.1292/jvms.70.1239
   Naramura T, 2006, BIOL PHARM BULL, V29, P1167, DOI 10.1248/bpb.29.1167
   Oka K, 2007, YAKUGAKU ZASSHI, V127, P1825, DOI 10.1248/yakushi.127.1825
   Olatunbosun ST, 2000, J NATL MED ASSOC, V92, P265
   Park S, 2007, METABOLISM, V56, P599, DOI 10.1016/j.metabol.2006.12.004
   PORTHA B, 1989, DIABETES METAB, V15, P61
   Shinohara M, 2000, INT J EXP DIABETES RES, V1, P89, DOI 10.1155/EDR.2000.89
   Shrestha S, 2008, JOURNAL OF NEPAL ASSOCIATION FOR MEDICAL LABORATORY SCIENCES, V0, P11
   Srinivasan K, 2007, INDIAN J MED RES, V125, P451
   Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004
   Steyn NP, 2004, PUBLIC HEALTH NUTR, V7, P147, DOI 10.1079/PHN2003586
   TAKEDA N, 1991, DIABETES RES CLIN PR, V11, P99, DOI 10.1016/0168-8227(91)90098-X
   USDepartment of Agriculture, 1989, AN WELF ENF REP FISC, V0, P0
   Urakami T, 2013, DIABETES RES CLIN PR, V99, P105, DOI 10.1016/j.diabres.2012.11.021
   Vaag A, 2007, APPL PHYSIOL NUTR ME, V32, P912, DOI 10.1139/H07-100
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Ventura-Sobrevilla J, 2011, PROC WEST PHARMACOL SOC, V54, P5
   WEIR G C, 1986, DIABETES METABOLISM REVIEWS, V2, P125
   Whitehead N, 2013, J HUM NUTR DIET, V26, P111, DOI 10.1111/jhn.12033
   Wilson RD, 2012, PHARMACOL REP, V64, P129, DOI 10.1016/S1734-1140(12)70739-9
   Yamamoto Y, 2008, EXP ANIM TOKYO, V57, P385, DOI 10.1538/expanim.57.385
NR 45
TC 8
Z9 8
U1 0
U2 16
PU POLISH ACAD SCIENCES INST PHARMACOLOGY
PI KRAKOW
PA SMETNA 12, 31-343 KRAKOW, POLAND
SN 1734-1140
EI 
J9 PHARMACOL REP
JI Pharmacol. Rep.
PD AUG 15
PY 2014
VL 66
IS 4
BP 585
EP 593
DI 10.1016/j.pharep.2014.02.019
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AK4LG
UT WOS:000338395600009
PM 24948058
DA 2025-04-28
ER

PT J
AU Mielgo-Ayuso, J
   Barrenechea, L
   Alcorta, P
   Larrarte, E
   Margareto, J
   Labayen, I
AF Mielgo-Ayuso, Juan
   Barrenechea, Lurdes
   Alcorta, Pilar
   Larrarte, Eider
   Margareto, Javier
   Labayen, Idoia
TI Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Green tea; Epigallocatechin-3-gallate; Weight loss; Resting energy expenditure; Insulin resistance; Cholesterol
ID green tea-extract; resting metabolic-rate; fat oxidation; substrate oxidation; insulin-resistance; catechins; caffeine; maintenance; expenditure; restriction
AB The aim of the present study was to examine the effects of green tea epigallocatechin-3-gallate (EGCG) on changes in body composition, energy and substrate metabolism, cardiometabolic risk factors and liver function enzymes after an energy-restricted diet intervention in obese women. In the present randomised, double-blind, placebo-controlled study, eighty-three obese (30 kg/m(2) > BMI < 40 kg/m(2)) premenopausal women consumed 300 mg/d of EGCG or placebo (lactose). We measured body weight and adiposity (dual-energy X-ray absorptiometry), energy expenditure and fat oxidation rates (indirect calorimetry), blood lipid levels (TAG, total cholesterol, LDL-cholesterol and HDL-cholesterol), insulin resistance, C-reactive protein and liver function markers (aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, g-glutamyltransferase, urea, bilirubin and 2-keto[1-C-13] isocaproate oxidation) before and after the intervention in the EGCG and control groups. We did not find any significant difference in the changes in body weight (-0.3 kg, 95% CI -5.0, 4.3), fat mass (-0.7 kg, 95% CI -3.5, 2.1), energy (0.3 kJ/kg per d, 95% CI -3.1, 2.7) and fat (-0.1 g/min, 95% CI -0.03, 0.01) metabolism, homeostasis assessment model for insulin resistance (0.2, 95% CI -0.2, 0.7), total cholesterol (-0.21 mmol/l, 95% CI -0.55, 0.13), LDL-cholesterol (-0.15 mmol/l, 95% CI -0.50, 0.20), TAG (-0.14 mmol/l, 95% CI -0.56, 0.29) and liver function markers between the EGCG and control groups. In conclusion, the present results suggest that dietary supplementation with 300 mg/d of EGCG for 12 weeks did not enhance energy-restricted diet-induced adiposity reductions, and did not improve weight-loss-induced changes in cardiometabolic risk factors in obese Caucasian women. The intake of 300 mg/d of EGCG for 12 weeks did not cause any adverse effect on liver function biomarkers.
C1 [Mielgo-Ayuso, Juan; Labayen, Idoia] Univ Basque Country, Dept Nutr & Food Sci, UPV EHU, Vitoria, Spain.
   [Barrenechea, Lurdes] Univ Basque Country, Dept Med, Vitoria, Spain.
   [Alcorta, Pilar] Hosp Santiago Apostol, Dept Nucl Med, UPV EHU, Vitoria, Spain.
   [Larrarte, Eider; Margareto, Javier] Tecnalia, Biomed Res Area, Minano, Spain.
   [Larrarte, Eider] Tecnalia, Hlth & Qual Life Area, Minano, Spain.
C3 University of Basque Country; University of Basque Country; University of Basque Country
RP Labayen, I (corresponding author), Univ Basque Country, Dept Nutr & Food Sci, UPV EHU, Vitoria, Spain.
EM idoia.labayen@ehu.es
FU Department of Industry of the Government of the Basque Country [S-PE06LE04]
CR Amer Diabet Associat, 2008, DIABETES CARE, V31, PS61, DOI 10.2337/dc08-S061
   Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797
   B√©rub√©-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727
   Chan CCW, 2006, J SOC GYNECOL INVEST, V13, P63, DOI 10.1016/j.jsgi.2005.10.006
   Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009
   Davis NJ, 2006, DIABETES EDUCATOR, V32, P557, DOI 10.1177/0145721706290437
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x
   Frank J, 2009, J NUTR, V139, P58, DOI 10.3945/jn.108.096412
   Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806
   Grattagliano I, 2010, EUR J CLIN INVEST, V40, P843, DOI 10.1111/j.1365-2362.2010.02331.x
   Gregersen NT, 2009, BRIT J NUTR, V102, P1187, DOI 10.1017/S0007114509371779
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hsu Chung-Hua, 2011, ALTERN MED REV, V16, P157
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Krishna YR, 2011, CAN J GASTROENTEROL, V25, P157
   Labayen I, 1999, EUR J NUTR, V38, P158, DOI 10.1007/s003940050057
   Labayen I, 2004, CLIN NUTR, V23, P571, DOI 10.1016/j.clnu.2003.10.004
   Martin CK, 2007, OBESITY, V15, P2964, DOI 10.1038/oby.2007.354
   Mazzanti G, 2009, EUR J CLIN PHARMACOL, V65, P331, DOI 10.1007/s00228-008-0610-7
   Moore RJ, 2009, BRIT J NUTR, V102, P1790, DOI 10.1017/S0007114509991218
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Parra D, 2003, METABOLISM, V52, P463, DOI 10.1053/meta.2003.50075
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Ruiz JR, 2012, NUTR METAB CARDIOVAS, V22, PE1, DOI 10.1016/j.numecd.2011.03.003
   Ruiz JR, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0023759
   Ryu OH, 2006, DIABETES RES CLIN PR, V71, P356, DOI 10.1016/j.diabres.2005.08.001
   Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013
   Sarma DN, 2008, DRUG SAFETY, V31, P469, DOI 10.2165/00002018-200831060-00003
   Suliburska J, 2012, BIOL TRACE ELEM RES, V149, P315, DOI 10.1007/s12011-012-9448-z
   Temme EHM, 2002, EUR J CLIN NUTR, V56, P379, DOI 10.1038/sj.ejcn.1601309
   Thielecke F, 2010, EUR J CLIN NUTR, V64, P704, DOI 10.1038/ejcn.2010.47
   Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Wylie-Rosett J, 2007, J AM DIET ASSOC, V107, P1296, DOI 10.1016/j.jada.2007.05.009
   Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309
   Yang HY, 2012, BRIT J NUTR, V107, P749, DOI 10.1017/S0007114511005095
NR 45
TC 124
Z9 133
U1 1
U2 47
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD APR 14
PY 2014
VL 111
IS 7
BP 1263
EP 1271
DI 10.1017/S0007114513003784
PG 9
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA AZ2CJ
UT WOS:000348041900014
PM 24299662
DA 2025-04-28
ER

PT J
AU Fardet, A
   Boirie, Y
AF Fardet, Anthony
   Boirie, Yves
TI Associations between food and beverage groups and major diet-related chronic diseases: an exhaustive review of pooled/meta-analyses and systematic reviews
SO NUTRITION REVIEWS
LA English
DT Review
DE association analysis; food groups; beverages; diet-related chronic diseases; meta-analyses; systematic reviews; dairy; meats; fruits; vegetables; grains
ID coronary-heart-disease; plant-based foods; mediterranean diet; cancer-risk; cardiovascular-disease; vegetable consumption; caffeine consumption; lipotropic capacity; coffee consumption; fish consumption
AB Associations between food and beverage groups and the risk of diet-related chronic disease (DRCD) have been the subject of intensive research in preventive nutrition. Pooled/meta-analyses and systematic reviews (PMASRs) aim to better characterize these associations. To date, however, there has been no attempt to synthesize all PMASRs that have assessed the relationship between food and beverage groups and DRCDs. The objectives of this review were to aggregate PMASRs to obtain an overview of the associations between food and beverage groups (n = 17) and DRCDs (n = 10) and to establish new directions for future research needs. The present review of 304 PMASRs published between 1950 and 2013 confirmed that plant food groups are more protective than animal food groups against DRCDs. Within plant food groups, grain products are more protective than fruits and vegetables. Among animal food groups, dairy/milk products have a neutral effect on the risk of DRCDs, while red/processed meats tend to increase the risk. Among beverages, tea was the most protective and soft drinks the least protective against DRCDs. For two of the DRCDs examined, sarcopenia and kidney disease, no PMASR was found. Overweight/obesity, type 2 diabetes, and various types of cardiovascular disease and cancer accounted for 289 of the PMASRs. There is a crucial need to further study the associations between food and beverage groups and mental health, skeletal health, digestive diseases, liver diseases, kidney diseases, obesity, and type 2 diabetes. (C) 2014 International Life Sciences Institute
C1 [Fardet, Anthony; Boirie, Yves] INRA, Unite Nutr Humaine, F-63122 St Genes Champanelle, France.
   [Fardet, Anthony; Boirie, Yves] Univ Auvergne, F-63122 St Genes Champanelle, France.
C3 INRAE; Universite Clermont Auvergne (UCA)
RP Fardet, A (corresponding author), INRA, UMR 1019, Unite Nutr Humaine, F-63122 St Genes Champanelle, France.
EM anthony.fardet@clermont.inra.fr
CR Arab L, 2013, ADV NUTR, V4, P115, DOI 10.3945/an.112.002717
   Arab L, 2009, STROKE, V40, P1786, DOI 10.1161/STROKEAHA.108.538470
   ASTRUP A, 1993, INT J OBESITY, V17, P0
   Aune D, 2012, BREAST CANCER RES TR, V134, P479, DOI 10.1007/s10549-012-2118-1
   Quintana JLB, 2007, NEUROL RES, V29, P91, DOI 10.1179/174313206X152546
   Cassady BA, 2009, AM J CLIN NUTR, V89, P794, DOI 10.3945/ajcn.2008.26669
   Chan DSM, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0020456
   Chowdhury R, 2012, BMJ-BRIT MED J, V345, P0, DOI 10.1136/bmj.e6698
   Corrao G, 1998, ALCOHOL ALCOHOLISM, V33, P381
   Costanzo S, 2011, EUR J EPIDEMIOL, V26, P833, DOI 10.1007/s10654-011-9631-0
   Crookes PF, 1999, GASTROENTEROLOGY, V116, P0
   De Caterina R, 2000, AM J CLIN NUTR, V71, P213S, DOI 10.1093/ajcn/71.1.213S
   DICKERSIN K, 1993, ANN NY ACAD SCI, V703, P135, DOI 10.1111/j.1749-6632.1993.tb26343.x
   Djouss√© L, 2012, CLIN NUTR, V31, P846, DOI 10.1016/j.clnu.2012.05.010
   Dong JY, 2011, DIABETES CARE, V34, P2116, DOI 10.2337/dc11-0518
   Eilat-Adar S, 2010, NUTR METAB CARDIOVAS, V20, P459, DOI 10.1016/j.numecd.2010.01.011
   Esposito K, 2011, METAB SYNDR RELAT D, V9, P1, DOI 10.1089/met.2010.0031
   Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528
   Fardet A, 2013, NUTR REV, V71, P643, DOI 10.1111/nure.12052
   Fardet A, 2012, J FOOD COMPOS ANAL, V28, P135, DOI 10.1016/j.jfca.2012.07.011
   Fardet A, 2013, CRIT REV FOOD SCI, V53, P535, DOI 10.1080/10408398.2010.549596
   Fardet A, 2011, J FOOD COMPOS ANAL, V24, P895, DOI 10.1016/j.jfca.2011.03.013
   Fardet A, 2011, FOOD FUNCT, V2, P483, DOI 10.1039/c1fo10041f
   Fardet A, 2010, NUTR RES REV, V23, P65, DOI 10.1017/S0954422410000041
   Flight I, 2006, EUR J CLIN NUTR, V60, P1145, DOI 10.1038/sj.ejcn.1602435
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6
   HARRIS WS, 1989, J LIPID RES, V30, P785
   He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212
   Hern√°n MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277
   Islami F, 2009, INT J CANCER, V125, P491, DOI 10.1002/ijc.24445
   Jacobson KA, 1996, TRENDS PHARMACOL SCI, V17, P108, DOI 10.1016/0165-6147(96)10002-X
   Jenab M, 2004, CANCER EPIDEM BIOMAR, V13, P1595
   Jensdottir T, 2004, CLIN ORAL INVESTIG, V8, P91
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073
   KAWACHI I, 1994, BRIT HEART J, V72, P269
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Kelley GA, 2011, BMC MED, V9, P0, DOI 10.1186/1741-7015-9-74
   Kim HJ, 2010, CANCER SCI, V101, P508, DOI 10.1111/j.1349-7006.2009.01374.x
   Kong FB, 2009, FOOD BIOPHYS, V4, P365, DOI 10.1007/s11483-009-9135-6
   KOREN G, 1991, JAMA-J AM MED ASSOC, V266, P1824, DOI 10.1001/jama.266.13.1824
   Larsson SC, 2012, BRIT J CANCER, V106, P603, DOI 10.1038/bjc.2011.585
   Ledoux TA, 2011, OBES REV, V12, Pe143, DOI 10.1111/j.1467-789X.2010.00786.x
   Lee JE, 2009, CANCER EPIDEM BIOMAR, V18, P1730, DOI 10.1158/1055-9965.EPI-09-0045
   Li TY, 2009, J NUTR, V139, P1333, DOI 10.3945/jn.108.103622
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Little JP, 2009, APPL PHYSIOL NUTR ME, V34, P817, DOI 10.1139/H09-093
   Mallath MK, 2004, GASTROENTEROLOGY, V126, P0
   Meyer KA, 2000, AM J CLIN NUTR, V71, P921
   Millward DJ, 2012, P NUTR SOC, V71, P566, DOI 10.1017/S0029665112000201
   Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805
   Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1
   Nettleton JA, 2008, J AM DIET ASSOC, V108, P1881, DOI 10.1016/j.jada.2008.08.015
   Nordmann AJ, 2011, AM J MED, V124, P841, DOI 10.1016/j.amjmed.2011.04.024
   Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102
   Phillips SM, 2012, MEAT SCI, V92, P174, DOI 10.1016/j.meatsci.2012.04.027
   Priebe MG, 2008, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD006061.pub2
   Ras RT, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0016974
   Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x
   Robinson S, 2016, CLINICAL NUTRITION AND AGING: SARCOPENIA AND MUSCLE METABOLISM, V0, PP3, DOI 10.1155/2012/510801
   Rolls BJ, 2004, NUTR REV, V62, P1, DOI 10.1301/nr.2004.jan.1‚Äì17
   Ruhl CE, 2005, GASTROENTEROLOGY, V128, P24, DOI 10.1053/j.gastro.2004.09.075
   Scargle JD, 2000, JOURNAL OF SCIENTIFIC EXPLORATION, V14, P91, DOI 10.48550/ARXIV.PHYSICS/9909033
   Shen L, 2012, J ZHEJIANG UNIV-SC B, V13, P652, DOI 10.1631/jzus.B1201001
   Smith-Warner SA, 2003, INT J CANCER, V107, P1001, DOI 10.1002/ijc.11490
   Sofi F, 2007, NUTR METAB CARDIOVAS, V17, P209, DOI 10.1016/j.numecd.2006.07.013
   Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673
   Sohn W, 2006, J DENT RES, V85, P262, DOI 10.1177/154405910608500311
   SPRIET LL, 1992, AM J PHYSIOL, V262, PE891, DOI 10.1152/ajpendo.1992.262.6.E891
   STEINMETZ KA, 1991, CANCER CAUSE CONTROL, V2, P325, DOI 10.1007/BF00051672
   Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8
   Sun Q, 2010, ARCH INTERN MED, V170, P961, DOI 10.1001/archinternmed.2010.109
   Svilaas A, 2004, J NUTR, V134, P562, DOI 10.1093/jn/134.3.562
   Urgert R, 2000, AM J CLIN NUTR, V72, P1107
   Venn BJ, 2004, EUR J CLIN NUTR, V58, P1443, DOI 10.1038/sj.ejcn.1601995
   von Schacky C, 2000, AM J CLIN NUTR, V71, P224S, DOI 10.1093/ajcn/71.1.224s
   Wang CJ, 2012, MED ONCOL, V29, P848, DOI 10.1007/s12032-011-9985-x
   Wang ZM, 2011, AM J CLIN NUTR, V93, P506, DOI 10.3945/ajcn.110.005363
   Wien M, 2011, AGRO FOOD IND HI TEC, V22, P36
   Wien M, 2010, J AM COLL NUTR, V29, P189, DOI 10.1080/07315724.2010.10719833
   Willcox DC, 2009, J AM COLL NUTR, V28, P500S, DOI 10.1080/07315724.2009.10718117
   Xun P, 2012, EUR J CLIN NUTR, V66, P1199, DOI 10.1038/ejcn.2012.133
   Zheng JS, 2012, PUBLIC HEALTH NUTR, V15, P725, DOI 10.1017/S1368980011002254
NR 85
TC 154
Z9 172
U1 3
U2 133
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0029-6643
EI 1753-4887
J9 NUTR REV
JI Nutr. Rev.
PD DEC 15
PY 2014
VL 72
IS 12
BP 741
EP 762
DI 10.1111/nure.12153
PG 22
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA AX8PP
UT WOS:000347171400002
PM 25406801
DA 2025-04-28
ER

PT J
AU Flanagan, J
   Bily, A
   Rolland, Y
   Roller, M
AF Flanagan, John
   Bily, Antoine
   Rolland, Yohan
   Roller, Marc
TI Lipolytic Activity of Svetol¬Æ, a Decaffeinated Green Coffee Bean Extract
SO PHYTOTHERAPY RESEARCH
LA English
DT Article
DE chlorogenic acid; adipocyte; weight loss; diabetes
ID chlorogenic acids; in-vitro; inhibition; volunteers; overweight; mass
AB The beneficial health effects of chlorogenic acids (CGAs), major components of coffee beans, are well known and have been attributed to multiple mechanisms of action. However, the lipolytic activity of CGAs does not appear to have been reported. We studied the effects of varying concentrations of Svetol (R), a decaffeinated green coffee bean extract enriched in CGAs, on the liberation of free fatty acids from human adipocytes following short-term (2h) and long-term (192h) exposure. The results showed that although lipolytic activity observed following short-term incubation could be tentatively linked to residual caffeine traces in the sample, longer-term exposure clearly showed the effects of Svetol (R) on release of free fatty acids, and this effect was not due to caffeine. The results of this study provide a further mechanism by which to explain the long-term health benefits of CGAs and Svetol (R). Copyright (c) 2013 John Wiley & Sons, Ltd.
C1 [Flanagan, John; Bily, Antoine; Rolland, Yohan; Roller, Marc] Naturex SA, F-84911 Avignon 9, France.
RP Bily, A (corresponding author), Naturex SA, Site Agroparc BP 1218, F-84911 Avignon 9, France.
EM a.bily@naturex.com
FU Naturex
CR Blum J, 2007, NUTRAFOODS, V6, P13
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Dallas C, 2008, PHYTOMEDICINE, V15, P783, DOI 10.1016/j.phymed.2008.05.006
   Dellalibera O, 2006, PHYTOTHERAPIE (PARIS), V4, P194, DOI 10.1007/s10298-006-0181-7
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Henry-Vitrac C, 2010, J AGR FOOD CHEM, V58, P4141, DOI 10.1021/jf9044827
   Kamitani Y, 2009, J JPN SOC FOOD SCI, V56, P336, DOI 10.3136/nskkk.56.336
   RODBELL M, 1964, J BIOL CHEM, V239, P375
   Tanaka K, 2009, FOOD SCI TECHNOL RES, V15, P147, DOI 10.3136/fstr.15.147
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
NR 11
TC 31
Z9 33
U1 1
U2 38
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD JUN 15
PY 2014
VL 28
IS 6
BP 946
EP 948
DI 10.1002/ptr.5085
PG 3
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AJ3OE
UT WOS:000337575400021
PM 24338784
DA 2025-04-28
ER

PT J
AU Pham, NM
   Nanri, A
   Kochi, T
   Kuwahara, K
   Tsuruoka, H
   Kurotani, K
   Akter, S
   Kabe, I
   Sato, M
   Hayabuchi, H
   Mizoue, T
AF Ngoc Minh Pham
   Nanri, Akiko
   Kochi, Takeshi
   Kuwahara, Keisuke
   Tsuruoka, Hiroko
   Kurotani, Kayo
   Akter, Shamima
   Kabe, Isamu
   Sato, Masao
   Hayabuchi, Hitomi
   Mizoue, Tetsuya
TI Coffee and green tea consumption is associated with insulin resistance in Japanese adults
SO METABOLISM-CLINICAL AND EXPERIMENTAL
LA English
DT Article
DE Beverage; Diabetes; Glucose metabolism; Japanese
ID impaired glucose-tolerance; decaffeinated coffee; caffeinated coffee; blood-glucose; acid-derivatives; in-vitro; inflammation; sensitivity; risk; healthy
AB Objective. Higher coffee and green tea consumption has been suggested to decrease risk of type 2 diabetes, but their roles in insulin resistance (IR) and insulin secretion remain unclear. This study examined the association between habitual consumption of these beverages and markers of glucose metabolism in a Japanese working population. Materials/Methods. Participants were 1440 Japanese employees (1151 men and 289 women) aged 18-69 years. Consumption of coffee and green tea was ascertained via a validated brief diet history questionnaire. Multilevel linear regression was used to estimate means (95% confidence intervals) of fasting insulin, fasting plasma glucose, homeostatic model assessment of IR (HOMA-IR), homeostatic model assessment of 3-cell function (HOMA-beta) and glycated hemoglobin (HbA1c) with adjustment for potential confounding variables. Results. Coffee consumption was significantly, inversely associated with HOMA-IR (P for trend = 0.03), and the association appeared to be confined to overweight subjects (BMI >= 25 kg/m(2)) (P for trend = 0.01, P for interaction = 0.08). Unexpectedly, green tea consumption was positively associated with HOMA-IR (P for trend = 0.02), though there was no dose-response relationship among daily consumers of green tea. Neither coffee nor green tea consumption was associated with HOMA-beta and HbA1c. Conclusions. Our findings indicate that coffee consumption may be associated with decreased IR, but not with insulin secretion. The positive association between green tea consumption and IR warrants further investigation. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Ngoc Minh Pham; Nanri, Akiko; Kuwahara, Keisuke; Kurotani, Kayo; Akter, Shamima; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan.
   [Kochi, Takeshi; Tsuruoka, Hiroko; Kabe, Isamu] Furukawa Elect Corp, Dept Hlth Adm, Tokyo, Japan.
   [Sato, Masao] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Appl Biol Chem, Fukuoka 812, Japan.
   [Hayabuchi, Hitomi] Fukuoka Womens Univ, Grad Sch Nutr & Hlth Sci, Fukuoka, Japan.
C3 Japan Institute for Health Security (JIHS); National Center for Global Health & Medicine - Japan; Furukawa Electric; Kyushu University
RP Pham, NM (corresponding author), Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Shinjuku Ku, Toyama 1-21-1, Tokyo 1628655, Japan.
EM minh.pn@tnu.edu.vn
FU Japan Society for the Promotion of Science [21390213]; Ministry of Education, Culture, Sports, Science and Technology [21790598]; National Center for Global Health and Medicine; Grants-in-Aid for Scientific Research [21790598] Funding Source: KAKEN
CR Adisakwattana S, 2008, J AGR FOOD CHEM, V56, P7838, DOI 10.1021/jf801208t
   Agardh EE, 2004, J INTERN MED, V255, P645, DOI 10.1111/j.1365-2796.2004.01331.x
   √Ñrnl√∂v J, 2004, JAMA-J AM MED ASSOC, V291, P1199, DOI 10.1001/jama.291.10.1199-b
   Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518
   Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002
   Da Cunha FM, 2004, FREE RADICAL RES, V38, P1241, DOI 10.1080/10715760400016139
   Gavrieli A, 2013, METABOLISM, V62, P1099, DOI 10.1016/j.metabol.2013.02.003
   Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Hu G, 2006, INT J OBESITY, V30, P1742, DOI 10.1038/sj.ijo.0803341
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI 10.1007/s13340-012-0069-8
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Kim DJ, 2010, DIABETES CARE, V33, P2604, DOI 10.2337/dc10-0994
   Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504
   Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235
   Krebs JD, 2012, METABOLISM, V61, P1231, DOI 10.1016/j.metabol.2012.01.021
   Kurotani K, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0064758
   Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003
   Liu K, 2013, AM J CLIN NUTR, V98, P340, DOI 10.3945/ajcn.112.052746
   Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   Mackenzie T, 2006, ANN EPIDEMIOL, V16, P688, DOI 10.1016/j.annepidem.2005.11.009
   Maki T, 2010, DIABETES METAB SYND, V4, P69, DOI 10.1016/j.dsx.2010.01.001
   Maruyama K, 2009, J CLIN BIOCHEM NUTR, V44, P41, DOI 10.3164/jcbn.08-13
   McKay DL, 2002, J AM COLL NUTR, V21, P1
   Moisey LL, 2008, AM J CLIN NUTR, V87, P1254, DOI 10.1093/ajcn/87.5.1254
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   Natella F, 2002, J AGR FOOD CHEM, V50, P6211, DOI 10.1021/jf025768c
   Pham NM, 2013, METABOLISM, V62, P561, DOI 10.1016/j.metabol.2012.07.025
   Ohnaka K, 2012, J NUTR METAB, V2012, P0, DOI 10.1155/2012/207426
   Orts√§ter H, 2012, NUTR METAB, V9, P0, DOI 10.1186/1743-7075-9-11
   Rebello SA, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-61
   Science and Technology Agency, 2005, STAND TABL FOOD COMP, V0, P0
   Shearer J, 2003, J NUTR, V133, P3529, DOI 10.1093/jn/133.11.3529
   Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059
   Stote Kim S, 2008, J NUTR, V138, P0
   Takaya J, 2004, MAGNESIUM RES, V17, P126
   Trikudanathan S, 2013, METABOLISM, V62, P1448, DOI 10.1016/j.metabol.2013.05.016
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   van Dam RM, 2004, DIABETOLOGIA, V47, P2152, DOI 10.1007/s00125-004-1573-6
   Van Dam RM, 2004, DIABETES CARE, V27, P2990, DOI 10.2337/diacare.27.12.2990
   van Dam RM, 2003, ANN NUTR METAB, V47, P627
   Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487
   Wedick NM, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-93
   Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654
   Wu TY, 2005, DIABETES CARE, V28, P1390, DOI 10.2337/diacare.28.6.1390
   Yamaji T, 2004, DIABETOLOGIA, V47, P2145, DOI 10.1007/s00125-004-1590-5
   Yamashita K, 2012, NUTR DIABETES, V2, P0, DOI 10.1038/nutd.2012.6
   Zheng XX, 2013, AM J CLIN NUTR, V97, P750, DOI 10.3945/ajcn.111.032573
NR 53
TC 45
Z9 49
U1 0
U2 22
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0026-0495
EI 1532-8600
J9 METABOLISM
JI Metab.-Clin. Exp.
PD MAR 15
PY 2014
VL 63
IS 3
BP 400
EP 408
DI 10.1016/j.metabol.2013.11.008
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AB7RT
UT WOS:000331989100011
PM 24342074
DA 2025-04-28
ER

PT J
AU Grasser, EK
   Yepuri, G
   Dulloo, AG
   Montani, JP
AF Grasser, Erik K.
   Yepuri, Gayathri
   Dulloo, Abdul G.
   Montani, Jean-Pierre
TI Cardio- and cerebrovascular responses to the energy drink Red Bull in young adults: a randomized cross-over study
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Energy drink; Blood pressure; Cerebral blood flow velocity; Microvascular endothelial dysfunction; Hemodynamics; Risk factor
ID blood-flow; consumption; caffeine; parameters; taurine; bioimpedance
AB Energy drinks are beverages containing vasoactive metabolites, usually a combination of caffeine, taurine, glucuronolactone and sugars. There are concerns about the safety of energy drinks with some countries banning their sales. We determined the acute effects of a popular energy drink, Red Bull, on cardiovascular and hemodynamic variables, cerebrovascular parameters and microvascular endothelial function. Twenty-five young non-obese and healthy subjects attended two experimental sessions on separate days according to a randomized crossover study design. During each session, primary measurements included beat-to-beat blood pressure measurements, impedance cardiography and transcranial Doppler measurements for at least 20 min baseline and for 2 h following the ingestion of either 355 mL of the energy drink or 355 mL of tap water; the endothelial function test was performed before and two hours after either drink. Unlike the water control load, Red Bull consumption led to increases in both systolic and diastolic blood pressure (p < 0.005), associated with increased heart rate and cardiac output (p < 0.05), with no significant changes in total peripheral resistance and without diminished endothelial response to acetylcholine; consequently, double product (reflecting myocardial load) was increased (p < 0.005). Red Bull consumption also led to increases in cerebrovascular resistance and breathing frequency (p < 0.005), as well as to decreases in cerebral blood flow velocity (p < 0.005) and end-tidal carbon dioxide (p < 0.005). Our results show an overall negative hemodynamic profile in response to ingestion of the energy drink Red Bull, in particular an elevated blood pressure and double product and a lower cerebral blood flow velocity.
C1 [Grasser, Erik K.; Yepuri, Gayathri; Dulloo, Abdul G.; Montani, Jean-Pierre] Univ Fribourg, Div Physiol, Dept Med, Lab Integrat Cardiovasc & Metab Physiol, CH-1700 Fribourg, Switzerland.
C3 University of Fribourg
RP Grasser, EK (corresponding author), Univ Fribourg, Div Physiol, Dept Med, Lab Integrat Cardiovasc & Metab Physiol, Chemin Musee 5, CH-1700 Fribourg, Switzerland.
EM erikkonrad.grasser@unifr.ch
FU Swiss National Science Foundation [3200B0-122554]
CR Alford C, 2001, AMINO ACIDS, V21, P139, DOI 10.1007/s007260170021
   Baum M, 2001, AMINO ACIDS, V20, P75, DOI 10.1007/s007260170067
   Berger AJ, 2009, MED J AUSTRALIA, V190, P41, DOI 10.5694/j.1326-5377.2009.tb02263.x
   Bichler A, 2006, AMINO ACIDS, V31, P471, DOI 10.1007/s00726-005-0302-x
   Brown CM, 2005, AM J PHYSIOL-REG I, V289, PR1687, DOI 10.1152/ajpregu.00205.2005
   de Jongh RT, 2004, DIABETOLOGIA, V47, P978, DOI 10.1007/s00125-004-1412-9
   Fennessy FM, 2003, CIRCULATION, V107, P410, DOI 10.1161/01.CIR.0000046447.72402.47
   Fortin J, 2006, COMPUT BIOL MED, V36, P1185, DOI 10.1016/j.compbiomed.2005.06.001
   Franks AM, 2012, ANN PHARMACOTHER, V46, P192, DOI 10.1345/aph.1Q555
   Grasser EK, 2009, PHYSIOL RES, V58, P817, DOI 10.33549/physiolres.931591
   Gratze G, 1998, COMPUT BIOL MED, V28, P121, DOI 10.1016/S0010-4825(98)00005-5
   Heckman MA, 2010, COMPR REV FOOD SCI F, V9, P303, DOI 10.1111/j.1541-4337.2010.00111.x
   Higgins JP, 2013, INT J CARDIOL, V168, PE47, DOI 10.1016/j.ijcard.2013.06.114
   Higgins JP, 2013, AM J MED, V126, P0, DOI 10.1016/j.amjmed.2012.12.023
   Higgins JP, 2010, MAYO CLIN PROC, V85, P1033, DOI 10.4065/mcp.2010.0381
   KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995
   KUBICEK WG, 1970, ANN NY ACAD SCI, V170, P724, DOI 10.1111/j.1749-6632.1970.tb17735.x
   Lal GG, 2007, FOOD TECHNOL-CHICAGO, V61, P24
   MATHEW RJ, 1985, STROKE, V16, P814, DOI 10.1161/01.STR.16.5.814
   Morris SJ, 1996, J PHYSIOL-LONDON, V496, P531, DOI 10.1113/jphysiol.1996.sp021704
   Nienhueser J, 2011, INT J EXERC SCI, V4, P321
   Ragsdale FR, 2010, AMINO ACIDS, V38, P1193, DOI 10.1007/s00726-009-0330-z
   Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001
   REIVICH M, 1964, AM J PHYSIOL, V206, P25, DOI 10.1152/ajplegacy.1964.206.1.25
   Rottlaender D, 2011, INT J CARDIOL, V158, P51
   Steinke L, 2009, ANN PHARMACOTHER, V43, P596, DOI 10.1345/aph.1L614
   Trabulo D, 2011, EMERG MED J, V28, P712, DOI 10.1136/emj.09.2010.3322rep
   Umemura T, 2006, AM J CARDIOL, V98, P1538, DOI 10.1016/j.amjcard.2006.06.058
   Van Vliet BN, 1999, AM J PHYSIOL-HEART C, V277, PH1679, DOI 10.1152/ajpheart.1999.277.5.H1679
   WEINHOLD C, 1993, J HEART LUNG TRANSPL, V12, P832
   Worthley MI, 2010, AM J MED, V123, P184, DOI 10.1016/j.amjmed.2009.09.013
NR 31
TC 93
Z9 102
U1 2
U2 109
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD OCT 15
PY 2014
VL 53
IS 7
BP 1561
EP 1571
DI 10.1007/s00394-014-0661-8
PG 11
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA AP9UV
UT WOS:000342426800012
PM 24474552
DA 2025-04-28
ER

PT J
AU Schinella, G
   Neyret, E
   C√≥nsole, G
   Tournier, H
   Prieto, JM
   R√≠os, JL
   Giner, RM
AF Schinella, Guillermo
   Neyret, Elisa
   Console, Gloria
   Tournier, Horacio
   Prieto, Jose M.
   Rios, Jose-Luis
   Maria Giner, Rosa
TI An Aqueous Extract of Ilex paraguariensis Reduces Carrageenan-Induced Edema and Inhibits the Expression of Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in Animal Models of Inflammation
SO PLANTA MEDICA
LA English
DT Article
DE Ilex paraguariensis; Aquifoliaceae; mate; anti-inflammatory effects; in vivo
ID skin inflammation; laggera-alata; mate; leaves; constituents; obesity; mice; diet
AB Mate (Ilex paraguariensis) is a highly popular herbal beverage in South America due to its high content of caffeine. Its hypolipidemic and antioxidant properties are of increasing interest in the treatment of cardiovascular disorders and for weight control. In the present study, we show for the first time both the local and systemic anti-inflammatory effects of an aqueous extract of mate in three classic in vivo models, namely acute and chronic 12-O-tetradecanoylphorbol 13-acetateinduced mouse ear edema and acute carrageenan-induced mouse paw edema. Caffeine, rutin, chlorogenic acid, 3,5-dicafeoyl quinic acid, and 4,5-dicafeoyl quinic acid, accompanied by a complex mixture of other simple phenolic acids, were identified in the extract by HPLC-UV analyses. In the acute edema model, mate extract applied topically (1mg/ear) halved the 12-O-tetradecanoylphorbol 13-acetate-induced acute edema (50%) and almost suppressed neutrophil infiltration (93%), while in the 12-O-tetradecanoylphorbol 13-acetate-induced subchronic inflammation, the edema was significantly reduced by 62% (1mg/ear/day x seven doses). The oral administration of the mate extract (250 mg/kg) significantly reduced the carrageenan-induced edema at all time points, an effect which was accompanied by a 43% and 53% reduction of the expression of cyclooxygenase-2 and inducible nitric oxide synthase, respectively. Histological analyses confirmed a reduction of epithelium thickness, dermis with mild inflammation, hair follicles with some secretory cells of sebaceous glands, and hypodermic adipocytes. In conclusion, mate is endowed with in vivo preventative or therapeutic anti-inflammatory effects in both local and systemic inflammatory processes.
C1 [Schinella, Guillermo; Tournier, Horacio] Univ Nacl La Plata, Catedra Farmacol Basica, Fac Ciencias Med, RA-1900 La Plata, Argentina.
   [Neyret, Elisa; Rios, Jose-Luis; Maria Giner, Rosa] Univ Valencia, Dept Farmacol, E-46100 Burjassot, Spain.
   [Console, Gloria] Univ Nacl La Plata, Catedra Citol Histol & Embriol B, Fac Ciencias Med, RA-1900 La Plata, Argentina.
   [Schinella, Guillermo; Console, Gloria; Tournier, Horacio] CIC, La Plata, Buenos Aires, Argentina.
   [Prieto, Jose M.] UCL, Sch Pharm, Ctr Pharmacognosy & Phytotherapy, Dept Pharmaceut & Biol Chem, London, England.
C3 National University of La Plata; University of Valencia; National University of La Plata; University of London; University College London; University of London School of Pharmacy
RP Schinella, G (corresponding author), Univ Nacl La Plata, Catedra Farmacol Basica, Fac Ciencias Med, Av 60 & 120, RA-1900 La Plata, Argentina.
EM schinell@uv.es
CR Akkol EK, 2012, J ETHNOPHARMACOL, V140, P261, DOI 10.1016/j.jep.2012.01.015
   Andersen T, 2001, J HUM NUTR DIET, V14, P243, DOI 10.1046/j.1365-277X.2001.00290.x
   Ar√ßari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   Bastos DHM, 2007, MED AROMAT PLANT SCI BIOTECHNOL, V1, P37
   Bracesco N, 2011, J ETHNOPHARMACOL, V136, P378, DOI 10.1016/j.jep.2010.06.032
   Bravo L, 2007, FOOD RES INT, V40, P393, DOI 10.1016/j.foodres.2006.10.016
   Chattopadhyay C, 2012, INT J NUTR PHARM NEU, V2, P20
   Chen BT, 2012, OXID MED CELL LONGEV, V2012, P0, DOI 10.1155/2012/537923
   Chua LS, 2013, J ETHNOPHARMACOL, V150, P805, DOI 10.1016/j.jep.2013.10.036
   de Morais EC, 2009, J AGR FOOD CHEM, V57, P8316, DOI 10.1021/jf901660g
   Dickel ML, 2007, J ETHNOPHARMACOL, V109, P60, DOI 10.1016/j.jep.2006.07.003
   Dufresne CJ, 2001, J NUTR BIOCHEM, V12, P404, DOI 10.1016/S0955-2863(01)00155-3
   Escandell JM, 2007, J PHARMACOL EXP THER, V320, P581, DOI 10.1124/jpet.106.107003
   Francisco V, 2013, J ETHNOPHARMACOL, V148, P126, DOI 10.1016/j.jep.2013.03.077
   Giner RM, 2000, EUR J PHARMACOL, V389, P243, DOI 10.1016/S0014-2999(99)00846-8
   Hao BJ, 2012, J ETHNOPHARMACOL, V144, P190, DOI 10.1016/j.jep.2012.09.003
   Heck CI, 2007, J FOOD SCI, V72, PR138, DOI 10.1111/j.1750-3841.2007.00535.x
   Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011
   Kwon OS, 2011, ARCH PHARM RES, V34, P1561, DOI 10.1007/s12272-011-0919-0
   Lang R, 2013, ANAL BIOANAL CHEM, V405, P8487, DOI 10.1007/s00216-013-7288-0
   Lanzetti M, 2008, NUTRITION, V24, P375, DOI 10.1016/j.nut.2008.01.002
   Lee R, 2007, HARV HLTH LETT, V18, P8
   Martinet A, 1999, PHYTOMEDICINE, V6, P231, DOI 10.1016/S0944-7113(99)80014-2
   Martins F, 2010, OBESITY, V18, P42, DOI 10.1038/oby.2009.189
   Matsumoto RLT, 2009, J AGR FOOD CHEM, V57, P1775, DOI 10.1021/jf803096g
   Mosimann ALP, 2006, BIOFACTORS, V26, P59, DOI 10.1002/biof.5520260106
   Oliveira DM, 2008, J AGR FOOD CHEM, V56, P10527, DOI 10.1021/jf8021404
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   Pimentel GD, 2013, J NUTR BIOCHEM, V24, P809, DOI 10.1016/j.jnutbio.2012.04.016
   Pittler MH, 2005, OBES REV, V6, P93, DOI 10.1111/j.1467-789X.2005.00169.x
   Posadas I, 2004, BRIT J PHARMACOL, V142, P331, DOI 10.1038/sj.bjp.0705650
   Schinella GR, 2000, BIOCHEM BIOPH RES CO, V269, P357, DOI 10.1006/bbrc.2000.2293
   Schinella G, 2009, FOOD RES INT, V42, P1403, DOI 10.1016/j.foodres.2009.07.004
   Slomiany BL, 2002, J PHYSIOL PHARMACOL, V53, P325
   STANLEY PL, 1991, SKIN PHARMACOL, V4, P262, DOI 10.1159/000210960
   Sugimoto S, 2009, CHEM PHARM BULL, V57, P257, DOI 10.1248/cpb.57.257
   SUGISHITA E, 1981, J PHARMACOBIO-DYNAM, V4, P565, DOI 10.1248/bpb1978.4.565
   SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2
   Wu YH, 2006, J ETHNOPHARMACOL, V108, P243, DOI 10.1016/j.jep.2006.05.017
   Xu GH, 2009, ARCH PHARM RES, V32, P1215, DOI 10.1007/s12272-009-1905-7
NR 40
TC 18
Z9 18
U1 1
U2 11
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0032-0943
EI 1439-0221
J9 PLANTA MED
JI Planta Med.
PD AUG 15
PY 2014
VL 80
IS 12
BP 961
EP 968
DI 10.1055/s-0034-1382876
PG 8
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine
GA AN9CT
UT WOS:000340904300001
PM 25089736
DA 2025-04-28
ER

PT J
AU Kim, J
   Jang, JY
   Cai, J
   Kim, Y
   Shin, K
   Choi, EK
   Lee, SP
   Kim, JC
   Kim, TS
   Jeong, HS
   Kim, YB
AF Kim, Jihyun
   Jang, Ja Young
   Cai, Jingmei
   Kim, Youngeun
   Shin, Kyungha
   Choi, Ehn-Kyoung
   Lee, Sung-Pyo
   Kim, Jong-Choon
   Kim, Tae-Su
   Jeong, Heon-Sang
   Kim, Yun-Bae
TI Ethanol extracts of unroasted Coffea canephora robusta beans suppress adipogenesis in preadipocytes and fat accumulation in rats fed a high-fat diet
SO FOOD SCIENCE AND BIOTECHNOLOGY
LA English
DT Article
DE green coffee bean extract; adiopogenesis; obesity; hyperlipidemia
ID weight-gain; body-fat; obesity; mortality; leptin
AB Anti-adipogenic and anti-obesity effects of a green coffee been extract (GCE) from unroasted Coffea canephora Robusta beans were investigated in vitro and in vivo. Insulin-induced adipogenesis in 3T3-L1 preadipocytes was inhibited by 25.6 and 87.9% following treatment with 100 and 500 mu g/mL GCE, respectively. Expression of adipogenesis-specific genes was down-regulated. Body weight gains of C57BL/6 mice fed a high-fat diet (HFD) were suppressed in a concentration-dependent manner using GCE (0.3 or 1% in the diet), exhibiting a marked lower gain in 1% GCE-fed mice than in normal diet-fed animals. Decreases in body fat weights and the size of adipocytes were confirmed. GCE supplementation reduced concentrations of blood lipids and leptin, and attenuated hepatic steatosis. GCE inhibits adipogenesis by modulating cell signaling and improves dietary obesity by reducing lipid accumulation and the size of adipocytes.
C1 [Kim, Jihyun; Jang, Ja Young; Cai, Jingmei; Kim, Youngeun; Shin, Kyungha; Choi, Ehn-Kyoung; Kim, Yun-Bae] Chungbuk Natl Univ, Coll Vet Med, Cheongju 362763, Chungbuk, South Korea.
   [Lee, Sung-Pyo; Kim, Tae-Su] Misuba RTech Co Ltd, Asan 336795, Chungnam, South Korea.
   [Kim, Jong-Choon] Chonnam Natl Univ, Coll Vet Med, Kwangju 500757, South Korea.
   [Jeong, Heon-Sang] Chungbuk Natl Univ, Dept Food Sci & Biotechnol, Cheongju 362763, Chungbuk, South Korea.
C3 Chungbuk National University; Chonnam National University; Chungbuk National University
RP Kim, YB (corresponding author), Chungbuk Natl Univ, Coll Vet Med, Cheongju 362763, Chungbuk, South Korea.
EM solar93@cbu.ac.kr
FU Province of Chungcheongnam-do; Chungcheong Institute for Regional Program Evaluation (CIRPE) through Research and Development fund for Regional Industry
CR Ahr√©n B, 1998, EUR J ENDOCRINOL, V139, P461, DOI 10.1530/eje.0.1390461
   Unknown -, 2006, BMC COMPLEM ALTERN M, V0, P0
   BELLET S, 1968, METABOLISM, V17, P702, DOI 10.1016/0026-0495(68)90054-1
   BEUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001
   del Castillo MD, 2002, J AGR FOOD CHEM, V50, P3698, DOI 10.1021/jf011702q
   Despres J P, 1998, OBES RES, V6 Suppl 1, P0
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   HART RW, 1995, FUND APPL TOXICOL, V25, P184, DOI 10.1006/faat.1995.1054
   Hill JO, 2007, CLIN PHARMACOL THER, V81, P772, DOI 10.1038/sj.clpt.6100107
   Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Lee Myung-Yul, 2006, JOURNAL OF THE KOREAN SOCIETY OF FOOD SCIENCE AND NUTRITION ÌïúÍµ≠ÏãùÌíàÏòÅÏñëÍ≥ºÌïôÌöåÏßÄ, V35, P335
   Lee SH, 2012, EUR J NUTR, V51, P1011, DOI 10.1007/s00394-011-0280-6
   Levy JR, 2000, AM J PHYSIOL-ENDOC M, V279, PE1088, DOI 10.1152/ajpendo.2000.279.5.E1088
   MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101
   Mercer JG, 2000, CNS DRUGS, V14, P413, DOI 10.2165/00023210-200014060-00001
   Milagro FI, 2006, OBESITY, V14, P1118, DOI 10.1038/oby.2006.128
   Morrison RF, 2000, J NUTR, V130, P3116S, DOI 10.1093/jn/130.12.3116S
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   Nicklas BJ, 2003, DIABETES CARE, V26, P1413, DOI 10.2337/diacare.26.5.1413
   Ntambi JM, 2000, J NUTR, V130, P3122S, DOI 10.1093/jn/130.12.3122S
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Prineas R J, 1993, ANN EPIDEMIOL, V3, P35, DOI 10.1016/1047-2797(93)90007-Q
   ROTHWELL NJ, 1984, CLIN ENDOCRINOL META, V13, P437, DOI 10.1016/S0300-595X(84)80032-8
   ÏµúÏö©ÎØº, 2010, JOURNAL OF THE KOREAN SOCIETY OF FOOD SCIENCE AND NUTRITION ÌïúÍµ≠ÏãùÌíàÏòÅÏñëÍ≥ºÌïôÌöåÏßÄ, V39, P927
   Tanaka K, 2009, FOOD SCI TECHNOL RES, V15, P147, DOI 10.3136/fstr.15.147
   Vasselli JR, 2005, OBES RES, V13, P693, DOI 10.1038/oby.2005.78
   Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355
   Woods SC, 2003, J NUTR, V133, P1081, DOI 10.1093/jn/133.4.1081
   Yang G, 2011, FOOD SCI BIOTECHNOL, V20, P1649, DOI 10.1007/s10068-011-0227-y
NR 33
TC 8
Z9 8
U1 0
U2 12
PU KOREAN SOCIETY FOOD SCIENCE & TECHNOLOGY-KOSFOST
PI SEOUL
PA #605, KOREA SCI TECHNOL CENT, 635-4 YEOKSAM-DONG, KANGNAM-GU, SEOUL, 135-703, SOUTH KOREA
SN 1226-7708
EI 2092-6456
J9 FOOD SCI BIOTECHNOL
JI Food Sci. Biotechnol.
PD DEC 15
PY 2014
VL 23
IS 6
BP 2029
EP 2035
DI 10.1007/s10068-014-0276-0
PG 7
WC Food Science & Technology
SC Food Science & Technology
GA AS5RE
UT WOS:000344326600040
DA 2025-04-28
ER

PT J
AU Fujii, TMD
   Jacob, PS
   Yamada, M
   Borges, MC
   Norde, MM
   Pantaleao, LC
   de Oliveira, DM
   Tirapegui, J
   de Castro, IA
   Borelli, P
   Fock, RA
   Rogero, MM
AF de Meneses Fujii, Tatiane Mieko
   Jacob, Patricia Silva
   Yamada, Monica
   Borges, Maria Carolina
   Norde, Marina Maintinguer
   Pantaleao, Lucas Carminatti
   de Oliveira, Daniela Moura
   Tirapegui, Julio
   de Castro, Inar Alves
   Borelli, Primavera
   Fock, Ricardo Ambrosio
   Rogero, Marcelo Macedo
TI Yerba Mate (Ilex paraguariensis) modulates NF-kappaB pathway and AKT expression in the liver of rats fed on a high-fat diet
SO INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
LA English
DT Article
DE High-fat diet; inflammation; insulin resistance; tea extract
ID insulin-resistance; chlorogenic acid; aqueous extract; intestinal-absorption; metabolic-disorders; induced obesity; caffeic acid; glucose; plasma; cholesterol
AB To investigate the effect of Yerba Mate (YM) aqueous extract intake on the NF-kB pathway and AKT expression in the liver, muscle, and adipose tissue of rats submitted to a high-fat diet (HFD). Male Wistar rats were fed a control (CON) (n = 24) or a HFD (n = 24) for 12 weeks. Afterwards, rats received YM daily (1 g/kg body weight) for 4 weeks. Intake of YM aqueous extract reduced body weight gain (p<0.05) and total blood cholesterol (p<0.05) in the HFD group in comparison to the non-treated HFD group. HFD group demonstrated an increased glycemic response at 5 and 10 min after insulin injection. YM decreased the ratio between phosphorylated and total kinase inhibitor of kappa B (IKK), increased the ratio of phosphorylated to total form of protein kinase B (AKT) and reduced NF-kappa B phosphorylation in the liver of the HFD group. Our data suggest a beneficial role of YM in improving metabolic dysfunctions induced by HFD.
C1 [de Meneses Fujii, Tatiane Mieko; Jacob, Patricia Silva; Yamada, Monica; Borges, Maria Carolina; Norde, Marina Maintinguer; de Oliveira, Daniela Moura; Rogero, Marcelo Macedo] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, BR-01246904 Sao Paulo, Brazil.
   [Pantaleao, Lucas Carminatti] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol, BR-01246904 Sao Paulo, Brazil.
   [Tirapegui, Julio; de Castro, Inar Alves] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Food & Expt Nutr, BR-01246904 Sao Paulo, Brazil.
   [Borelli, Primavera; Fock, Ricardo Ambrosio] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Analyzes, BR-01246904 Sao Paulo, Brazil.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo
RP Rogero, MM (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Av Doutor Arnaldo 715, BR-01246904 Sao Paulo, Brazil.
EM mmrogero@usp.br
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/54395-0]; FAPESP [2010/14609-9, 2009/12790-0, 2010/14164-7]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [09/12790-0, 10/14164-7, 10/14609-9] Funding Source: FAPESP
CR Ar√ßari DP, 2011, MOL CELL ENDOCRINOL, V335, P110, DOI 10.1016/j.mce.2011.01.003
   Ar√ßari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   Azuma K, 2000, J AGR FOOD CHEM, V48, P5496, DOI 10.1021/jf000483q
   Bastos DHM, 2007, MOLECULES, V12, P423, DOI 10.3390/12030423
   Bastos DHM, 2007, MED AROMAT PLANT SCI BIOTECHNOL, V1, P37
   Ble-Castillo JL, 2012, INT J ENV RES PUB HE, V9, P1663, DOI 10.3390/ijerph9051663
   Bok SH, 2002, INT J VITAM NUTR RES, V72, P161, DOI 10.1024/0300-9831.72.3.161
   BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374
   BONORA E, 1987, DIABETES METAB, V13, P116
   Borges MC, 2013, INT J FOOD SCI NUTR, V64, P561, DOI 10.3109/09637486.2012.759188
   Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608
   Capurso C, 2012, VASC PHARMACOL, V57, P91, DOI 10.1016/j.vph.2012.05.003
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Crozier A, 2010, MOL ASPECTS MED, V31, P446, DOI 10.1016/j.mam.2010.09.007
   de Resende PE, 2012, J ETHNOPHARMACOL, V144, P735, DOI 10.1016/j.jep.2012.10.023
   Ferreira F, 1997, PHYTOTHER RES, V11, P79, DOI 10.1002/(SICI)1099-1573(199702)11:1<79::AID-PTR34>3.3.CO;2-I
   Gao HL, 2013, EXP GERONTOL, V48, P572, DOI 10.1016/j.exger.2013.03.008
   Gosmann G, 2012, PLANT FOOD HUM NUTR, V67, P156, DOI 10.1007/s11130-012-0289-x
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Gugliucci A, 2009, FITOTERAPIA, V80, P339, DOI 10.1016/j.fitote.2009.04.007
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   Hotamisligil GS, 2003, INT J OBESITY, V27, PS53, DOI 10.1038/sj.ijo.0802502
   Hussein GME, 2011, BIOL PHARM BULL, V34, P1849, DOI 10.1248/bpb.34.1849
   IKEDA I, 1992, BIOCHIM BIOPHYS ACTA, V1127, P141, DOI 10.1016/0005-2760(92)90269-2
   Jacob PS, 2013, CELL BIOCHEM FUNCT, V31, P244, DOI 10.1002/cbf.2894
   Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402
   Kishino E, 2006, J NUTR, V136, P433, DOI 10.1093/jn/136.2.433
   Konishi Y, 2006, J AGR FOOD CHEM, V54, P7539, DOI 10.1021/jf061554+
   Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007
   Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192
   Lima ND, 2014, EUR J NUTR, V53, P73, DOI 10.1007/s00394-013-0500-3
   Martins F, 2010, OBESITY, V18, P42, DOI 10.1038/oby.2009.189
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Michalany J, 1979, AMB REV ASSOC MED BRAS, V25, P44
   Miranda DDC, 2008, MUTAGENESIS, V23, P261, DOI 10.1093/mutage/gen011
   Oliveira DM, 2008, J AGR FOOD CHEM, V56, P10527, DOI 10.1021/jf8021404
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   Pearse AGE, 1968, HISTOCHEMISTRY: THEORETICAL AND APPLIED, VI., P0
   Perez-Echarri N, 2007, J PHYSIOL BIOCHEM, V63, P317, DOI 10.1007/BF03165763
   Pimentel GD, 2013, J NUTR BIOCHEM, V24, P809, DOI 10.1016/j.jnutbio.2012.04.016
   Puangpraphant S, 2009, J AGR FOOD CHEM, V57, P8873, DOI 10.1021/jf902255h
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Rivelli DP, 2011, J AGR FOOD CHEM, V59, P8901, DOI 10.1021/jf201665t
   Rogero MM, 2008, J NUTR, V138, P1343, DOI 10.1093/jn/138.7.1343
   Safwat GM, 2009, NUTRITION, V25, P1157, DOI 10.1016/j.nut.2009.02.009
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Schinella G, 2005, CLIN NUTR, V24, P360, DOI 10.1016/j.clnu.2004.11.013
   Schinella GR, 2000, BIOCHEM BIOPH RES CO, V269, P357, DOI 10.1006/bbrc.2000.2293
   Shirai N, 2005, ANAL BIOCHEM, V343, P48, DOI 10.1016/j.ab.2005.04.037
   Silva RD, 2011, FITOTERAPIA, V82, P818, DOI 10.1016/j.fitote.2011.04.011
   Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340
   Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641
   Vallerie SN, 2010, SCI TRANSL MED, V2, P0, DOI 10.1126/scitranslmed.3001007
   Wang S, 2006, J NUTR, V136, P2791, DOI 10.1093/jn/136.11.2791
NR 55
TC 6
Z9 11
U1 0
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-7486
EI 1465-3478
J9 INT J FOOD SCI NUTR
JI Int. J. Food Sci. Nutr.
PD DEC 15
PY 2014
VL 65
IS 8
BP 967
EP 976
DI 10.3109/09637486.2014.945153
PG 10
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA AU0YB
UT WOS:000345347000008
PM 25088791
DA 2025-04-28
ER

PT J
AU Friis, K
   Lyng, JI
   Lasgaard, M
   Larsen, FB
AF Friis, Karina
   Lyng, Jeppe I.
   Lasgaard, Mathias
   Larsen, Finn B.
TI Energy drink consumption and the relation to socio-demographic factors and health behaviour among young adults in Denmark. A population-based study
SO EUROPEAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
ID sweetened beverage consumption; jock identity; alcohol; risk; patterns; masculinity; association; caffeine; weight; sports
AB Background: The objective of this study is to estimate the prevalence of energy drink consumption and examine the associations of socio-demographic factors and health behaviour with energy drink consumption among young adults in Denmark. Methods: The study is based on a public health survey from 2010 (n= 3923). Multiple logistic regression analyses were used to analyse the association between weekly consumption of energy drink and the potential explanatory factors of interest. Results: In total, 15.8 % of the young adults drink energy drinks on a weekly basis. Men have higher odds of weekly energy drink consumption than women. The study also shows that young age, being employed and having a low educational level are associated with weekly energy drink consumption. According to health behaviour, daily smoking, high amounts of alcohol consumption, alcoholic binge drinking and being overweight are associated with weekly energy drink consumption. Conclusion: Compared with other European countries the prevalence of energy drink consumption is relatively low in Denmark. In Denmark energy drink consumption is typically a male phenomenon and there is a clear social gradient in the prevalence of energy drink consumption where the intake is far more common among people with low levels of education than among people with higher levels of education. This study also shows that there is some kind of 'add on' effect of energy drinks, meaning that people who also use other stimulants-such as alcohol and cigarettes-are more inclined to consume energy drinks.
C1 [Friis, Karina; Lasgaard, Mathias; Larsen, Finn B.] Cent Denmark Reg, Publ Hlth & Qual Improvement, Aarhus, Denmark.
   [Lyng, Jeppe I.] Ctr Sociol Anal, Aalborg, Denmark.
   [Lasgaard, Mathias] Univ Southern Denmark, Odense, Denmark.
C3 University of Southern Denmark
RP Friis, K (corresponding author), Reg House Aarhus, Olof Palmes Alle 15, DK-8200 Aarhus N, Denmark.
EM karina.friis@stab.rm.dk
FU Central Denmark Region
CR Arria AM, 2011, ALCOHOL CLIN EXP RES, V35, P365, DOI 10.1111/j.1530-0277.2010.01352.x
   Arria AM, 2010, J ADDICT MED, V4, P74, DOI 10.1097/ADM.0b013e3181aa8dd4
   Attila S, 2011, NUTRITION, V27, P316, DOI 10.1016/j.nut.2010.02.008
   Ballistreri MC, 2008, REV LAT-AM ENFERM, V16, P558, DOI 10.1590/S0104-11692008000700009
   Berger LK, 2011, ADDICT BEHAV, V36, P516, DOI 10.1016/j.addbeh.2010.12.027
   Brache K, 2011, ADDICT BEHAV, V36, P1133, DOI 10.1016/j.addbeh.2011.07.003
   Brasel SA, 2011, J CONSUM PSYCHOL, V21, P57, DOI 10.1016/j.jcps.2010.09.008
   Burrows T, 2013, NUTR REV, V71, P135, DOI 10.1111/nure.12005
   Burt BA, 2006, CARIES RES, V40, P473, DOI 10.1159/000095645
   Carrillo JA, 2000, CLIN PHARMACOKINET, V39, P127, DOI 10.2165/00003088-200039020-00004
   Christensen AI, 2012, SCAND J PUBLIC HEALT, V40, P391, DOI 10.1177/1403494812451412
   Clauson KA, 2008, J AM PHARM ASSOC, V48, PE55, DOI 10.1331/JAPhA.2008.07055
   Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1
   Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107
   de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922
   Duffey KJ, 2010, AM J CLIN NUTR, V92, P954, DOI 10.3945/ajcn.2010.29478
   Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983
   Higgins JP, 2010, MAYO CLIN PROC, V85, P1033, DOI 10.4065/mcp.2010.0381
   Iyadurai SJP, 2007, EPILEPSY BEHAV, V10, P504, DOI 10.1016/j.yebeh.2007.01.009
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malinauskas BM, 2007, NUTR J, V6, P0, DOI 10.1186/1475-2891-6-35
   Marczinski CA, 2013, ALCOHOL CLIN EXP RES, V37, P276, DOI 10.1111/j.1530-0277.2012.01868.x
   Marczinski CA, 2011, INT J ENV RES PUB HE, V8, P3232, DOI 10.3390/ijerph8083232
   Miller KE, 2008, J ADOLESCENT HEALTH, V43, P490, DOI 10.1016/j.jadohealth.2008.03.003
   Miller KE, 2008, J AM COLL HEALTH, V56, P481, DOI 10.3200/JACH.56.5.481-490
   Miller K, 2009, AM PHILOS QUART, V46, P1
   OBrien MC, 2008, ACAD EMERG MED, V15, P453, DOI 10.1111/j.1553-2712.2008.00085.x
   Park S, 2013, J ACAD NUTR DIET, V113, P112, DOI 10.1016/j.jand.2012.09.019
   Peacock A, 2013, APPETITE, V64, P1, DOI 10.1016/j.appet.2012.12.021
   Price SR, 2010, DRUG ALCOHOL REV, V29, P331, DOI 10.1111/j.1465-3362.2009.00163.x
   R√≠os JL, 2013, P R HEALTH SCI J, V32, P95
   SARNDAL CE, 2005, WILEY, V0, P1
   Sindal H, 2013, POLITIKKEN 0125, V0, P0
   Venables MC, 2005, MED SCI SPORT EXER, V37, P39, DOI 10.1249/01.MSS.0000150017.74892.F5
   Wimer DJ, 2013, AM J MENS HEALTH, V7, P317, DOI 10.1177/1557988312474034
   Worthley MI, 2010, AM J MED, V123, P184, DOI 10.1016/j.amjmed.2009.09.013
   Zucconi S, 2013, GATHERING CONSUMPTION DATA ON SPECIFIC CONSUMER GROUPS OF ENERGY DRINKS, V0, P0, DOI DOI 10.2903/sp.efsa.2013.EN-394
NR 37
TC 32
Z9 34
U1 1
U2 15
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1101-1262
EI 1464-360X
J9 EUR J PUBLIC HEALTH
JI Eur. J. Public Health
PD OCT 15
PY 2014
VL 24
IS 5
BP 840
EP 844
DI 10.1093/eurpub/cku003
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AR1EQ
UT WOS:000343326900025
PM 24532566
DA 2025-04-28
ER

PT J
AU Cheong, JDLK
   Croft, KD
   Henry, PD
   Matthews, V
   Hodgson, JM
   Ward, NC
AF Cheong, J. D. Li Kwok
   Croft, K. D.
   Henry, P. D.
   Matthews, V.
   Hodgson, J. M.
   Ward, N. C.
TI Green coffee polyphenols do not attenuate features of the metabolic syndrome and improve endothelial function in mice fed a high fat diet
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Chlorogenic acid; Atherosclerosis; Metabolic syndrome; Endothelial dysfunction; Coffee
ID e-knockout mice; chlorogenic acid; oxidative stress; phenolic-compounds; tea consumption; dysfunction; obesity; plasma; atherosclerosis; carbohydrate
AB We have investigated the effects of the major polyphenol in coffee, chlorogenic acid (CGA), on obesity, glucose intolerance, insulin resistance, systemic oxidative stress and endothelial dysfunction in a mouse model of the metabolic syndrome. Thirty C57BL6 mice were randomly divided into (n = 10/group) (i) normal diet (ND), (ii) high fat diet (HFD), or (iii) high fat diet supplemented with 0.5% w/w green coffee bean extract (GCE) rich in chlorogenic acid (HFD + GCE). The high fat diet consisted of 28% fat and all animals were maintained on their diets for 12 weeks. The mice fed a HFD and HFD + GCE displayed symptoms of the metabolic syndrome compared to their normal fed counterparts, although no endothelial dysfunction was detected in the abdominal aortas after 12 weeks. GCE did not attenuate HFD-induced obesity, glucose intolerance, insulin resistance or systemic oxidative stress. Furthermore, GCE did not protect against ex vivo oxidant (hypochlorous acid)-induced endothelial dysfunction. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Cheong, J. D. Li Kwok; Croft, K. D.; Henry, P. D.; Hodgson, J. M.; Ward, N. C.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6847, Australia.
   [Matthews, V.] Harry Perkins Inst Med Res, UWA Ctr Med Res, Lab Metab Dysfunct, Perth, WA, Australia.
C3 University of Western Australia; Harry Perkins Institute of Medical Research
RP Ward, NC (corresponding author), Univ Western Australia, Sch Med & Pharmacol, GPO Box X2213, Perth, WA 6847, Australia.
EM natalie.ward@uwa.edu.au
FU Raine Medical Research Foundation; MRF/UWA Postdoctoral Fellowship; NHMRC
CR Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Bohn SK, 2012, FOOD FUNCT, V3, P575, DOI 10.1039/c2fo10288a
   Bondonno CP, 2012, FREE RADICAL BIO MED, V52, P95, DOI 10.1016/j.freeradbiomed.2011.09.028
   Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Crozier TWM, 2012, FOOD FUNCT, V3, P30, DOI 10.1039/c1fo10240k
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Deckert V, 1999, CIRCULATION, V100, P1230, DOI 10.1161/01.CIR.100.11.1230
   Deedwania Prakash C, 2003, CURR DIAB REP, V3, P289, DOI 10.1007/s11892-003-0019-8
   DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013
   Del Rio D, 2004, J AGR FOOD CHEM, V52, P2807, DOI 10.1021/jf0354848
   Esper RJ, 2006, CARDIOVASC DIABETOL, V5, P0, DOI 10.1186/1475-2840-5-4
   Gallou-Kabani C, 2007, OBESITY, V15, P1996, DOI 10.1038/oby.2007.238
   Gonthier MP, 2003, J NUTR, V133, P1853, DOI 10.1093/jn/133.6.1853
   Hollman PCH, 2011, J NUTR, V141, P989S, DOI 10.3945/jn.110.131490
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Jaiswal R, 2012, FOOD FUNCT, V3, P976, DOI 10.1039/c2fo10260a
   Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11
   Kobayasi R, 2010, J HYPERTENS, V28, P2111, DOI 10.1097/HJH.0b013e32833ca68c
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Liu J, 2013, MAYO CLIN P, V88, P10
   Loke WM, 2010, ARTERIOSCL THROM VAS, V30, P749, DOI 10.1161/ATVBAHA.109.199687
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   Mori TA, 1999, ANAL BIOCHEM, V268, P117, DOI 10.1006/abio.1998.3037
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Perticone F, 2001, DIABETES, V50, P159, DOI 10.2337/diabetes.50.1.159
   Roberts CK, 2005, J APPL PHYSIOL, V98, P203, DOI 10.1152/japplphysiol.00463.2004
   Ruhl CE, 2005, GASTROENTEROLOGY, V129, P1928, DOI 10.1053/j.gastro.2005.08.056
   Shen Y, 2013, FREE RADICAL BIO MED, V65, P908, DOI 10.1016/j.freeradbiomed.2013.08.185
   Shen Y, 2012, BIOCHEM PHARMACOL, V84, P1036, DOI 10.1016/j.bcp.2012.07.016
   Stalmach Ang√©lique, 2006, BRAZ. J. PLANT PHYSIOL., V18, P253, DOI 10.1590/S1677-04202006000100018
   Stocker R, 2004, ARTERIOSCL THROM VAS, V24, P2028, DOI 10.1161/01.ATV.0000143388.20994.fa
   Suzuki A, 2006, J HYPERTENS, V24, P1065, DOI 10.1097/01.hjh.0000226196.67052.c0
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Zhao YY, 2012, HYPERTENS RES, V35, P370, DOI 10.1038/hr.2011.195
NR 39
TC 30
Z9 31
U1 0
U2 60
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2014
VL 559
IS 
BP 46
EP 52
DI 10.1016/j.abb.2014.02.005
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AO1LH
UT WOS:000341073100008
PM 24583266
DA 2025-04-28
ER

PT J
AU Fisman, EZ
   Tenenbaum, A
AF Fisman, Enrique Z.
   Tenenbaum, Alexander
TI Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?
SO CARDIOVASCULAR DIABETOLOGY
LA English
DT Review
DE Adipokines; Adiponectin; Atherosclerosis; Coronary artery disease; Diabetes mellitus; Metabolic syndrome; Obesity; T-cadherin
ID cardiovascular risk-factors; adipose-specific protein; progenitor-cell function; life-style intervention; insulin-resistance; artery-disease; t-cadherin; plasma-protein; inflammatory markers; serum-levels
AB Adiponectin is the most abundant peptide secreted by adipocytes, being a key component in the interrelationship between adiposity, insulin resistance and inflammation. Central obesity accompanied by insulin resistance is a key factor in the development of metabolic syndrome (MS) and future macrovascular complications. Moreover, the remarkable correlation between coronary artery disease (CAD) and alterations in glucose metabolism has raised the likelihood that atherosclerosis and type 2 diabetes mellitus (T2DM) may share a common biological background. We summarize here the current knowledge about the influence of adiponectin on insulin sensitivity and endothelial function, discussing its forthcoming prospects and potential role as a therapeutic target for MS, T2DM, and cardiovascular disease. Adiponectin is present in the circulation as a dimer, trimer or protein complex of high molecular weight hexamers, >400 kDa. AdipoR1 and AdipoR2 are its major receptors in vivo mediating the metabolic actions. Adiponectin stimulates phosphorylation and AMP (adenosin mono phosphate) kinase activation, exerting direct effects on vascular endothelium, diminishing the inflammatory response to mechanical injury and enhancing endothelium protection in cases of apolipoprotein E deficiency. Hypoadiponectinemia is consistently associated with obesity, MS, atherosclerosis, CAD, T2DM. Lifestyle correction helps to favorably modify plasma adiponectin levels. Low adiponectinemia in obese patients is raised via continued weight loss programs in both diabetic and nondiabetic individuals and is also accompanied by reductions in pro-inflammatory factors. Diet modifications, like intake of fish, omega-3 supplementation, adherence to a Mediterranean dietary pattern and coffee consumption also increase adiponectin levels. Antidiabetic and cardiovascular pharmacological agents, like glitazones, glimepiride, angiotensin converting enzyme inhibitors and angiotensin receptor blockers are also able to improve adiponectin concentration. Fibric acid derivatives, like bezafibrate and fenofibrate, have been reported to enhance adiponectin levels as well. T-cadherin, a membrane-associated adiponectin-binding protein lacking intracellular domain seems to be a main mediator of the antiatherogenic adiponectin actions. The finding of novel pharmacologic agents proficient to improve adiponectin plasma levels should be target of exhaustive research. Interesting future approaches could be the development of adiponectin-targeted drugs chemically designed to induce the activaton of its receptors and/or postreceptor signaling pathways, or the development of specific adiponectin agonists.
C1 [Fisman, Enrique Z.; Tenenbaum, Alexander] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel.
   [Fisman, Enrique Z.; Tenenbaum, Alexander] Cardiovasc Diabetol Res Fdn, IL-58484 Holon, Israel.
   [Tenenbaum, Alexander] Chaim Sheba Med Ctr, Cardiac Rehabil Inst, IL-52621 Tel Hashomer, Israel.
C3 Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center
RP Fisman, EZ (corresponding author), Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel.
EM zfisman@post.tau.ac.il
FU Cardiovascular Diabetology Research Foundation, Holon, Israel [RA 58-040-684-1]
CR Abdelgadir M, 2013, DIABETOL METAB SYNDR, V5, P0, DOI 10.1186/1758-5996-5-15
   Al-Attas OS, 2013, J ATHEROSCLER THROMB, V20, P313, DOI 10.5551/jat.14837
   Apte RN, 2008, IMMUNOL REV, V222, P222, DOI 10.1111/j.1600-065X.2008.00615.x
   Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255
   Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010
   Baars T, 2013, CARDIOVASC DIABETOL, V12, P0, DOI 10.1186/1475-2840-12-12
   Balagopal P, 2005, J CLIN ENDOCR METAB, V90, P6192, DOI 10.1210/jc.2004-2427
   Baldasseroni S, 2012, CARDIOVASC DIABETOL, V11, P0, DOI 10.1186/1475-2840-11-151
   Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992
   Boe AE, 2013, CIRCULATION, V128, P2318, DOI 10.1161/CIRCULATIONAHA.113.003192
   Brooks NL, 2007, DIABETES OBES METAB, V9, P246, DOI 10.1111/j.1463-1326.2006.00596.x
   Caselli C, 2012, CARDIOVASC DIABETOL, V11, P0, DOI 10.1186/1475-2840-11-143
   Cesari M, 2007, J CLIN ENDOCR METAB, V92, P3082, DOI 10.1210/jc.2007-0403
   Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z
   Comuzzie AG, 2001, J CLIN ENDOCR METAB, V86, P4321, DOI 10.1210/jc.86.9.4321
   Curti MLR, 2012, DIABETOL METAB SYNDR, V4, P0, DOI 10.1186/1758-5996-4-49
   Dastani Z, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1002607
   Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464
   D√≠ez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293
   Dominguez Reyes C, 2007, REV ENDOCRINOLOGIA N, V15, P149
   Elkayam A, 2013, ISR MED ASSOC J, V15, P170
   Fava C, 2011, AM J CARDIOL, V108, P1432, DOI 10.1016/j.amjcard.2011.06.068
   Fisman EZ, 2008, ADV CARDIOL, V45, P44, DOI 10.1159/000115187
   Fisman EZ, 2006, AM J CARDIOL, V98, P14, DOI 10.1016/j.amjcard.2006.01.045
   Fisman EZ, 2003, CARDIOVASC DIABETOL, V2, P0, DOI 10.1186/1475-2840-2-11
   Furuhashi M, 2003, HYPERTENSION, V42, P76, DOI 10.1161/01.HYP.0000078490.59735.6E
   Gallagher AM, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0028157
   Ghaffari S, 2013, CARDIOL J, V20, P261, DOI 10.5603/CJ.2013.0071
   Gil JS, 2013, CLINICS, V68, P1495, DOI 10.6061/clinics/2013(12)04
   Grundy SM, 2002, CIRCULATION, V105, P2696, DOI 10.1161/01.CIR.0000020650.86137.84
   Guo ZX, 2012, CARDIOVASC DIABETOL, V11, P0, DOI 10.1186/1475-2840-11-94
   Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387
   Hamdy O, 2006, CURR DIABETES REV, V2, P367, DOI 10.2174/1573399810602040367
   Han SH, 2007, J AM COLL CARDIOL, V49, P531, DOI 10.1016/j.jacc.2006.08.061
   Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536
   Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801
   Hiuge A, 2007, ARTERIOSCL THROM VAS, V27, P635, DOI 10.1161/01.ATV.0000256469.06782.d5
   Hoffstedt J, 2004, J CLIN ENDOCR METAB, V89, P1391, DOI 10.1210/jc.2003-031458
   Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595
   Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697
   Huang PH, 2011, J MOL CELL CARDIOL, V51, P109, DOI 10.1016/j.yjmcc.2011.03.008
   Hug C, 2005, SCIENCE, V307, P366, DOI 10.1126/science.1106933
   Hui XY, 2012, BRIT J PHARMACOL, V165, P574, DOI 10.1111/j.1476-5381.2011.01395.x
   Issan Y, 2012, CAN J CARDIOL, V28, P728, DOI 10.1016/j.cjca.2012.01.013
   Iwashima Y, 2004, HYPERTENSION, V43, P1318, DOI 10.1161/01.HYP.0000129281.03801.4b
   Jeon WS, 2013, CARDIOVASC DIABETOL, V12, P0, DOI 10.1186/1475-2840-12-137
   Jung CH, 2012, CARDIOVASC DIABETOL, V11, P0, DOI 10.1186/1475-2840-11-24
   Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126
   Kaser S, 2008, EUR J CLIN INVEST, V38, P827, DOI 10.1111/j.1365-2362.2008.02028.x
   KATO M, 1985, LANCET, V2, P270
   Kawano Jordan, 2009, J CARDIOMETAB SYNDR, V4, P44, DOI 10.1111/j.1559-4572.2008.00030.x
   Kharroubi I, 2003, BIOCHEM BIOPH RES CO, V312, P1118, DOI 10.1016/j.bbrc.2003.11.042
   Kim JY, 2013, CARDIOVASC DIABETOL, V12, P0, DOI 10.1186/1475-2840-12-140
   Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478
   Koh KK, 2006, INT J CARDIOL, V108, P96, DOI 10.1016/j.ijcard.2005.07.040
   Kolattukudy PE, 1998, AM J PATHOL, V152, P101
   Kostopoulos CG, 2014, CARDIOVASC PATHOL, V23, P131, DOI 10.1016/j.carpath.2014.02.003
   Kriketos AD, 2004, DIABETES CARE, V27, P629, DOI 10.2337/diacare.27.2.629
   Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200
   Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50
   Lacquemant C, 2004, DIABETIC MED, V21, P776, DOI 10.1111/j.1464-5491.2004.01224.x
   Leguisamo NM, 2012, CARDIOVASC DIABETOL, V11, P0, DOI 10.1186/1475-2840-11-100
   Lima Marcos Miguel, 2009, REV. VENEZ. ENDOCRINOL. METAB., V7, P3
   Lin HV, 2007, DIABETES, V56, P1969, DOI 10.2337/db07-0127
   Liu PH, 2008, TWIN RES HUM GENET, V11, P495, DOI 10.1375/twin.11.5.495
   Liu Y, 2014, DIABETOL METAB SYNDR, V6, P0, DOI 10.1186/1758-5996-6-25
   Lu CJ, 2013, CEREBROVASC DIS, V36, P145, DOI 10.1159/000353679
   Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587
   Maia-Fernandes Teresa, 2008, REV PORT CARDIOL, V27, P1431
   Mamali I, 2012, PEPTIDES, V33, P120, DOI 10.1016/j.peptides.2011.11.007
   Mantzoros CS, 2006, AM J CLIN NUTR, V84, P328
   Matsubara M, 2004, ENDOCR J, V51, P587, DOI 10.1507/endocrj.51.587
   Matsuzawa Y, 2003, HORM RES, V60, P56, DOI 10.1159/000074502
   Milewicz A, 2005, GYNECOL ENDOCRINOL, V20, P68, DOI 10.1080/09513590400020989
   Monzillo LU, 2003, OBES RES, V11, P1048, DOI 10.1038/oby.2003.144
   Moreno-Aliaga MJ, 2008, REV ESP OBES, V6, P205
   Morisaki H, 2012, HUM MUTAT, V33, P402, DOI 10.1002/humu.21652
   Ogawa Y, 2005, HYPERTENS RES, V28, P51, DOI 10.1291/hypres.28.51
   Ohashi K, 2004, J AM COLL CARDIOL, V43, P1195, DOI 10.1016/j.jacc.2003.10.049
   Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656
   Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19
   Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182
   Okamoto Y, 2000, HORM METAB RES, V32, P47, DOI 10.1055/s-2007-978586
   Oranskiy SP, 2012, CROAT MED J, V53, P350, DOI 10.3325/cmj.2012.53.350
   Ouchi N, 2003, HYPERTENSION, V42, P231, DOI 10.1161/01.HYP.0000083488.67550.B8
   Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296
   Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057
   Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473
   Ozeki N, 2009, METABOLISM, V58, P1470, DOI 10.1016/j.metabol.2009.04.042
   Parker-Duffen JL, 2014, BEST PRACT RES CL EN, V28, P81, DOI 10.1016/j.beem.2013.09.001
   Parker-Duffen JL, 2013, J BIOL CHEM, V288, P24886, DOI 10.1074/jbc.M113.454835
   Peake PW, 2005, EUR J ENDOCRINOL, V153, P409, DOI 10.1530/eje.1.01978
   Philippova M, 2012, CARDIOVASC RES, V93, P498, DOI 10.1093/cvr/cvs004
   Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730
   Ranheim T, 2004, ACTA OBSTET GYN SCAN, V83, P341, DOI 10.1111/j.0001-6349.2004.00413.x
   Robinson K, 2011, CRIT CARE, V15, P0, DOI 10.1186/cc10021
   Sahebkar A, 2013, ATHEROSCLEROSIS, V230, P110, DOI 10.1016/j.atherosclerosis.2013.06.026
   Sarkanen JR, 2012, TISSUE ENG PT A, V18, P17, DOI 10.1089/ten.tea.2010.0712
   SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746
   Schmid PM, 2013, CARDIOVASC DIABETOL, V12, P0, DOI 10.1186/1475-2840-12-46
   Schupp M, 2004, CIRCULATION, V109, P2054, DOI 10.1161/01.CIR.0000127955.36250.65
   Shargorodsky M, 2012, CARDIOVASC DIABETOL, V11, P0, DOI 10.1186/1475-2840-11-61
   Sharma AM, 2002, HYPERTENSION, V40, P609, DOI 10.1161/01.HYP.0000036448.44066.53
   Shuldiner AR, 2001, NEW ENGL J MED, V345, P1345, DOI 10.1056/NEJM200111013451814
   Silva FM, 2011, NUTR REV, V69, P599, DOI 10.1111/j.1753-4887.2011.00414.x
   Silva TE, 2014, DIABETES METAB, V40, P95, DOI 10.1016/j.diabet.2013.11.004
   Silva-Nunes J, 2013, OBESITY FACTS, V6, P124, DOI 10.1159/000350664
   STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369
   Stumvoll M, 2002, DIABETES, V51, P37, DOI 10.2337/diabetes.51.1.37
   Sulistyoningrum DC, 2013, CARDIOVASC DIABETOL, V12, P0, DOI 10.1186/1475-2840-12-170
   Suzuki H, 2013, CARDIOVASC DIABETOL, V12, P0, DOI 10.1186/1475-2840-12-71
   Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69
   Tenenbaum A, 2006, ARCH INTERN MED, V166, P737, DOI 10.1001/archinte.166.7.737
   Tenenbaum A, 2004, INT J CARDIOL, V97, P167, DOI 10.1016/j.ijcard.2003.07.033
   Tenenbaum H, 2007, ATHEROSCLEROSIS, V194, P265, DOI 10.1016/j.atherosclerosis.2006.08.005
   Thanakun S, 2013, PEPTIDES, V47, P60, DOI 10.1016/j.peptides.2013.06.010
   Tiraby C, 2003, TRENDS ENDOCRIN MET, V14, P439, DOI 10.1016/j.tem.2003.10.001
   Toldo S, 2014, AM J PHYSIOL-HEART C, V306, PH1025, DOI 10.1152/ajpheart.00795.2013
   Tong GX, 2013, CARDIOVASC DIABETOL, V12, P0, DOI 10.1186/1475-2840-12-67
   Tremblay M, 2012, DIABETOL METAB SYNDR, V4, P0, DOI 10.1186/1758-5996-4-4
   Tripathy D, 2014, DIABETES CARE, V0, P0
   Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x
   Tschritter O, 2003, DIABETES, V52, P239, DOI 10.2337/diabetes.52.2.239
   Tsunekawa T, 2003, DIABETES CARE, V26, P285, DOI 10.2337/diacare.26.2.285
   Tu√±√≥n J, 2014, AM J CARDIOL, V113, P434, DOI 10.1016/j.amjcard.2013.10.012
   Tvarijonaviciute A, 2010, CAN J VET RES, V74, P279
   Tyrberg B, 2011, ISLETS, V3, P327, DOI 10.4161/isl.3.6.17705
   Valsamakis G, 2003, DIABETES OBES METAB, V5, P131, DOI 10.1046/j.1463-1326.2003.00254.x
   Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607
   Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200
   Weiss R, 2003, J CLIN ENDOCR METAB, V88, P2014, DOI 10.1210/jc.2002-021711
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Xu AM, 2010, ADV PHARMACOL, V60, P229, DOI 10.1016/S1054-3589(10)60002-6
   Xu AM, 2009, ENDOCRINOLOGY, V150, P625, DOI 10.1210/en.2008-0999
   Yamauchi T, 2008, INT J OBESITY, V32, PS13, DOI 10.1038/ijo.2008.233
   Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788
   Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557
   Yamauchi T, 2014, BEST PRACT RES CL EN, V28, P15, DOI 10.1016/j.beem.2013.09.003
   Yu JG, 2002, DIABETES, V51, P2968, DOI 10.2337/diabetes.51.10.2968
   Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081
NR 140
TC 181
Z9 194
U1 2
U2 40
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1475-2840
J9 CARDIOVASC DIABETOL
JI Cardiovasc. Diabetol.
PD JUN 23
PY 2014
VL 13
IS 
BP 
EP 
DI 10.1186/1475-2840-13-103
PG 10
WC Cardiac & Cardiovascular Systems; Endocrinology & Metabolism
SC Cardiovascular System & Cardiology; Endocrinology & Metabolism
GA AO2AV
UT WOS:000341118200001
PM 24957699
DA 2025-04-28
ER

PT J
AU Nugara, RN
   Inafuku, M
   Takara, K
   Iwasaki, H
   Oku, H
AF Nugara, Ruwani N.
   Inafuku, Masashi
   Takara, Kensaku
   Iwasaki, Hironori
   Oku, Hirosuke
TI Pteryxin: A coumarin in Peucedanum japonicum Thunb leaves exerts antiobesity activity through modulation of adipogenic gene network
SO NUTRITION
LA English
DT Article
DE Lipid metabolism; Obesity; Peucedanum japonicum Thunb; Pteryxin; 3T3-L1 adipocytes; HepG2 hepatocytes
ID proliferator-activated receptor; 3t3-l1 adipocytes; chlorogenic acid; protein-kinase; 4 expression; obesity; white; fat; accumulation; adiponectin
AB Objectives: Partially purified hexane phase (HP) of Peucedanum japonicum Thunb (PJT) was identified as an antiobesity candidate. However, the compound responsible for the antiobesity activity remained unknown. Thus, in this study we isolated the active compound, to determine the mechanisms related to antiobesity activity in vitro. Methods: The HP was fractionated, and the effect on the triacylglycerol (TG) content was evaluated in 3T3-L1 preadipocytes and HepG2 hepatocytes. On the basis of comprehensive spectroscopic analyses, the structure of the active compound was identified as pteryxin, a known compound in PJT. However, to our knowledge, its biological activities against obesity have not been reported previously. The dose-dependent effect on the TG content, and the gene expressions related to adipogenesis, fatty acid catabolism, energy expenditure, lipolysis, and lipogenesis due to pteryxin (10, 15, and 20 mu g/mL) were examined in vitro. Results: Pteryxin dose dependently suppressed TG content in both 3T3-L1 adipocytes (by 52.7%, 53.8%, and 57.4%, respectively; P < 0.05) and HepG2 hepatocytes (by 25.2%, 34.1%, and 27.4%, respectively; P < 0.05). Sterol regulatory element-binding protein-1 (SREBP-1c), fatty acid synthase (FASN), and acetyl-coenzyme A carboxylase-1 (ACC1) were down-regulated in pteryxin-treated 3T3-L1 adipocytes (by 18%, 36.1%, and 38.2%, P < 0.05) and HepG2 hepatocytes (by 72.3%, 62.9%, and 38.8%, respectively; P < 0.05). The adipocyte size marker gene, paternally expressed genel/ mesoderm specific transcript (MEST) was down-regulated (by 42.8%; P < 0.05), and hormone-sensitive lipase, a lipid catabolizing gene was up-regulated (by 15.1%; P < 0.05) in pteryxin-treated adipocytes. The uncoupling protein 2 (by 77.5%; P < 0.05) and adiponectin (by 76.3%; P > 0.05) were up-regulated due to pteryxin. Conclusion: Our study demonstrated that pteryxin in PJT plays the key role in regulating the lipid metabolism-related gene network and improving energy production in vitro. Thus, the results suggest pteryxin as a new natural compound to be used as an antiobesity drug in the pharmaceutical industry. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Nugara, Ruwani N.] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan.
   [Nugara, Ruwani N.; Inafuku, Masashi; Iwasaki, Hironori; Oku, Hirosuke] Univ Ryukyus, Trop Biosphere Res Ctr, Ctr Mol Biosci, Okinawa, Japan.
   [Takara, Kensaku] Univ Ryukyus, Fac Agr, Dept Biosci & Biotechnol, Okinawa, Japan.
C3 Kagoshima University; University of the Ryukyus; University of the Ryukyus
RP Oku, H (corresponding author), Univ Ryukyus, Trop Biosphere Res Ctr, Ctr Mol Biosci, Okinawa, Japan.
EM Okuhiros@comb.u-ryukyu.ac.jp
CR Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100
   Adams M, 2009, J ETHNOPHARMACOL, V121, P343, DOI 10.1016/j.jep.2008.11.010
   Akihisa T, 2003, CANCER LETT, V201, P133, DOI 10.1016/S0304-3835(03)00466-X
   Alappat L, 2010, NUTR REV, V68, P729, DOI 10.1111/j.1753-4887.2010.00341.x
   Unknown -, 2013, OB OV, V0, P0
   Unknown -, 2006, BMC COMPLEM ALTERN M, V0, P0
   Bandyopadhyay GK, 2012, J BIOL CHEM, V287, P23141, DOI 10.1074/jbc.M111.335877
   Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200
   Cerejeira J, 2012, FRONT NEUROL, V3, P73, DOI 10.3389/fneur.2012.00073
   Chang YC, 2012, BIOCHEM BIOPH RES CO, V422, P423, DOI 10.1016/j.bbrc.2012.05.008
   Chen IS, 1996, PHYTOCHEMISTRY, V41, P525, DOI 10.1016/0031-9422(95)00625-7
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966
   Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111
   Flowers MT, 2006, J CLIN INVEST, V116, P1478, DOI 10.1172/JCI28774
   Frank J, 2003, J AGR FOOD CHEM, V51, P2526, DOI 10.1021/jf026127k
   Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539
   Genome Research Center, 2002, MEPHAS, V0, P0
   Havel PJ, 2002, CURR OPIN LIPIDOL, V13, P51, DOI 10.1097/00041433-200202000-00008
   Hisamoto M, 2003, J AGR FOOD CHEM, V51, P5255, DOI 10.1021/jf0262458
   Holness MJ, 2012, FEBS OPEN BIO, V2, P32, DOI 10.1016/j.fob.2012.02.003
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Jeong YS, 2012, NUTR RES, V32, P514, DOI 10.1016/j.nutres.2012.06.001
   Jin LN, 2012, MOL CELL ENDOCRINOL, V358, P81, DOI 10.1016/j.mce.2012.02.025
   Alonso-Castro AJ, 2008, J ETHNOPHARMACOL, V120, P458, DOI 10.1016/j.jep.2008.09.019
   Lii CK, 2012, FOOD CHEM TOXICOL, V50, P478, DOI 10.1016/j.fct.2011.11.020
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   Nishino Naonobu, 2007, KOBE J MED SCI, V53, P99
   Nishiyama T, 2005, J AGR FOOD CHEM, V53, P959, DOI 10.1021/jf0483873
   Nugara RN, 2014, NUTRITION, V30, P575, DOI 10.1016/j.nut.2013.09.017
   Nukitrangsan N, 2012, LSMR, V22, P28
   Nukitrangsan N, 2012, J OLEO SCI, V61, P89, DOI 10.5650/jos.61.89
   Ohara K, 2009, PHYTOMEDICINE, V16, P130, DOI 10.1016/j.phymed.2008.09.012
   Raichur S, 2007, J MOL ENDOCRINOL, V39, P29, DOI 10.1677/jme.1.00010
   Schrauwen P, 2002, J EXP BIOL, V205, P2275
   Shan TZ, 2013, FASEB J, V27, P277, DOI 10.1096/fj.12-211516
   Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665
   Takahashi M, 2005, AM J PHYSIOL-ENDOC M, V288, PE117, DOI 10.1152/ajpendo.00244.2004
   TAKEUCHI N, 1991, CHEM PHARM BULL, V39, P1415, DOI 10.1248/cpb.39.1415
   Tan BE, 2012, FRONT BIOSCI-LANDMRK, V17, P2237, DOI 10.2741/4047
   Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011
   Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a
   Yahagi T, 2012, CHEM PHARM BULL, V60, P129, DOI 10.1248/cpb.60.129
   Yang LH, 2007, PHARMACOL RES, V56, P202, DOI 10.1016/j.phrs.2007.05.007
   Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200
   Zhang XH, 2012, NUTR RES PRACT, V6, P286
NR 46
TC 34
Z9 35
U1 0
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD OCT 15
PY 2014
VL 30
IS 10
BP 1177
EP 1184
DI 10.1016/j.nut.2014.01.015
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA AP5KB
UT WOS:000342117000013
PM 24993752
DA 2025-04-28
ER

PT J
AU Bohn, SK
   Croft, KD
   Burrows, S
   Puddey, IB
   Mulder, TPJ
   Fuchs, D
   Woodmand, RJ
   Hodgson, JM
AF Bohn, Siv K.
   Croft, Kevin D.
   Burrows, Sally
   Puddey, Ian B.
   Mulder, Theo P. J.
   Fuchs, Dagmar
   Woodmand, Richard J.
   Hodgson, Jonathan M.
TI Effects of black tea on body composition and metabolic outcomes related to cardiovascular disease risk: a randomized controlled trial
SO FOOD & FUNCTION
LA English
DT Article
ID green tea; insulin concentrations; lipoprotein oxidation; plasma-glucose; blood-pressure; obese women; consumption; supplementation; overweight; resistance
AB There is increasing evidence that tea and its non-caffeine components (primarily flavonoids)contribute to cardiovascular health. Randomized controlled trials have shown that tea can improve cardiovascular disease risk factors. We have previously reported a non-caffeine associated beneficial effect of regular black tea consumption on blood pressure and its variation. Objective: To explore the non-caffeine associated effects of black tea on body weight and body fat distribution, and cardiovascular disease related metabolic outcomes. Design: regular tea-drinking men and women (n = 111; BMI 20-35 kg m(-2)) were recruited to a randomized controlled double-blind 6 month parallel-designed trial. Participants consumed 3 cups per day of either powdered black tea solids (tea) or a flavonoid-free flavour-and caffeine-matched placebo (control). Body weight, waist-and hip-circumference, endothelial function and plasma biomarkers were assessed at baseline, 3 months and 6 months. Results: Compared to control, regular ingestion of black tea over 3 months inhibited weight gain (-0.64 kg, p = 0.047) and reduced waist circumference (-1.88 cm, P = 0.035) and waist-to-hip ratio (-0.03, P = 0.005). These effects were no longer significant at 6 months. There were no significant effects observed on fasting glucose, insulin, plasma lipids or endothelial function. Conclusion: Our study suggests that short-term regular ingestion of black tea over 3 months can improve body weight and body fat distribution, compared to a caffeine-matched control beverage. However, there was no evidence that these effects were sustained beyond 3 months.
C1 [Bohn, Siv K.] Univ Oslo, Fac Med, Inst Basic Med Sci, Dept Nutr, N-0316 Oslo, Norway.
   [Croft, Kevin D.; Burrows, Sally; Puddey, Ian B.; Hodgson, Jonathan M.] Univ Western Australia, Western Australian Inst Med Res, Sch Med & Pharmacol, Ctr Food & Genom Med, Perth, WA 6009, Australia.
   [Mulder, Theo P. J.; Fuchs, Dagmar] Unilever Res Labs, Vlaardingen, Netherlands.
   [Woodmand, Richard J.] Flinders Univ S Australia, Discipline Gen Practice, Adelaide, SA 5001, Australia.
C3 University of Oslo; University of Western Australia; Unilever; Flinders University South Australia
RP Bohn, SK (corresponding author), Univ Oslo, Fac Med, Inst Basic Med Sci, Dept Nutr, N-0316 Oslo, Norway.
EM s.k.bohn@medisin.uio.no
FU National Health and Medical Research Council of Australia [513744]; Unilever Research and Development; National Health and Medical Research Council Fellowship; Unilever Research and Development, Vlaardingen, the Netherlands; Henning ock Throne-Holst stiftelse (Sweden); NH&MRC Senior Research Fellowship
CR Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Bahorun T, 2012, PREV MED, V54, PS98, DOI 10.1016/j.ypmed.2011.12.009
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Bohn SK, 2012, FOOD FUNCT, V3, P575, DOI 10.1039/c2fo10288a
   Brown AL, 2011, BRIT J NUTR, V106, P1880, DOI 10.1017/S0007114511002376
   Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727
   Bryans JA, 2007, J AM COLL NUTR, V26, P471, DOI 10.1080/07315724.2007.10719638
   Cardoso GA, 2013, J MED FOOD, V16, P120, DOI 10.1089/jmf.2012.0062
   Corella D, 2009, CIRC-CARDIOVASC GENE, V2, P637, DOI 10.1161/CIRCGENETICS.109.891366
   Davies MJ, 2003, J NUTR, V133, P3298S, DOI 10.1093/jn/133.10.3298S
   Deka A, 2011, PHARMACOL RES, V64, P136, DOI 10.1016/j.phrs.2011.03.009
   Dogra G, 2001, DIABETOLOGIA, V44, P593, DOI 10.1007/s001250051665
   Duffy SJ, 2001, CIRCULATION, V104, P151, DOI 10.1161/01.CIR.104.2.151
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Grassi D, 2009, J HYPERTENS, V27, P774, DOI 10.1097/HJH.0b013e328326066c
   Hodgson JM, 1999, J SCI FOOD AGR, V79, P561, DOI 10.1002/(SICI)1097-0010(19990315)79:4<561::AID-JSFA218>3.0.CO;2-X
   Hodgson JM, 2000, AM J CLIN NUTR, V71, P1103
   Hodgson JM, 2002, CLIN SCI, V102, P195, DOI 10.1042/CS20010120
   Hodgson JM, 2008, ASIA PAC J CLIN NUTR, V17, P288
   Hodgson JM, 2013, AM J CLIN NUTR, V97, P943, DOI 10.3945/ajcn.112.051375
   Hodgson JM, 2012, ARCH INTERN MED, V172, P186, DOI 10.1001/archinte.172.2.186
   Hosoda K, 2003, DIABETES CARE, V26, P1714, DOI 10.2337/diacare.26.6.1714
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Kubot K, 2011, NUTR RES, V31, P421, DOI 10.1016/j.nutres.2011.05.004
   KUHR S, 1991, Z LEBENSM UNTERS FOR, V192, P526, DOI 10.1007/BF01202507
   Li SH, 2010, AM J CLIN NUTR, V91, P480, DOI 10.3945/ajcn.2009.28203
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Princen HMG, 1998, ARTERIOSCL THROM VAS, V18, P833, DOI 10.1161/01.ATV.18.5.833
   Ras RT, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0016974
   Ribeiro FF, 2003, OBES RES, V11, P1488, DOI 10.1038/oby.2003.199
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   Ueda M, 2008, BIOCHEM BIOPH RES CO, V377, P286, DOI 10.1016/j.bbrc.2008.09.128
   Senger AEV, 2012, J NUTR HEALTH AGING, V16, P738, DOI 10.1007/s12603-012-0081-5
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Woodman RJ, 2001, J APPL PHYSIOL, V91, P929, DOI 10.1152/jappl.2001.91.2.929
NR 37
TC 36
Z9 37
U1 0
U2 36
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD JUL 15
PY 2014
VL 5
IS 7
BP 1613
EP 1620
DI 10.1039/c4fo00209a
PG 8
WC Biochemistry & Molecular Biology; Food Science & Technology
SC Biochemistry & Molecular Biology; Food Science & Technology
GA AK3BL
UT WOS:000338297500034
PM 24889137
DA 2025-04-28
ER

PT J
AU Ormsbee, MJ
   Rawal, SR
   Baur, DA
   Kinsey, AW
   Elam, ML
   Spicer, MT
   Fischer, NT
   Madzima, TA
   Thomas, DD
AF Ormsbee, Michael J.
   Rawal, Shweta R.
   Baur, Daniel A.
   Kinsey, Amber W.
   Elam, Marcus L.
   Spicer, Maria T.
   Fischer, Nicholas T.
   Madzima, Takudzwa A.
   Thomas, D. David
TI The effects of a multi-ingredient dietary supplement on body composition, adipokines, blood lipids, and metabolic health in overweight and obese men and women: a randomized controlled trial
SO JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION
LA English
DT Article
DE Green tea; Caffeine; Conjugated linoleic acid; Branched chain amino acids; Body composition; Obesity
ID conjugated linoleic-acid; green tea extract; insulin sensitivity; weight-loss; double-blind; lipoprotein cholesterol; leucine supplementation; energy-expenditure; gene-expression; plasma-glucose
AB Background: The present study investigated the effects of a multi-ingredient dietary supplement (MIDS) containing caffeine, conjugated linoleic acid (CLA), green tea, and branched-chain amino acids (BCAA) taken for 8 weeks on body composition, blood lipid profile, glucose, insulin, adiponectin, leptin, and high-sensitivity C-reactive protein (hs-CRP) in overweight and obese men and women. Methods: Twenty-two participants completed the study (PL, n = 11; 7 women, 4 men; age, 34 +/- 3.5 years; height, 169.2 +/- 3.3 cm; body mass, 96.9 +/- 6.8 kg; BMI, 34.1 +/- 1.8 kg/m(2); MIDS, n = 11; 9 women, 2 men; age, 36 +/- 3.4 years; height, 173.2 +/- 2.9 cm; body mass, 91.9 +/- 5.6 kg; BMI, 30.0 +/- 1.5 kg/m(2)). Participants were randomly assigned and stratified by body fat percentage to two groups: 1) a soybean oil placebo (PL) or 2) MIDS. Each group consumed two pills with breakfast and two pills with lunch. Body composition and android fat, waist and hip circumferences, blood pressure and heart rate were measured at baseline and after 8 weeks of supplementation. Results: There were no significant changes for any of the variables of body composition. Feelings of hunger were significantly higher in MIDS versus PL with no changes observed in satiety or desire to eat. Heart rate and blood pressure were unaltered in MIDS after 8 weeks of supplementation. Furthermore, lipid profile, food intake, mood state variables, fasting blood glucose, and endocrine markers did not significantly change regardless of group. Conclusion: MIDS intake does not appear to alter body composition or markers of cardiovascular health versus PL. Moreover, MIDS may actually increase feelings of hunger versus PL.
C1 [Ormsbee, Michael J.; Rawal, Shweta R.; Baur, Daniel A.; Kinsey, Amber W.; Elam, Marcus L.; Spicer, Maria T.; Fischer, Nicholas T.; Madzima, Takudzwa A.; Thomas, D. David] Florida State Univ, Dept Nutr Food & Exercise Sci, Tallahassee, FL 32306 USA.
   [Ormsbee, Michael J.] Univ KwaZulu Natal, Durban, South Africa.
   [Ormsbee, Michael J.] Florida State Univ, Inst Sports Sci & Med, Tallahassee, FL 32306 USA.
C3 State University System of Florida; Florida State University; University of Kwazulu Natal; State University System of Florida; Florida State University
RP Ormsbee, MJ (corresponding author), Florida State Univ, Dept Nutr Food & Exercise Sci, Tallahassee, FL 32306 USA.
EM mormsbee@fsu.edu
FU International Society of Sports Nutrition
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Arciero PJ, 2008, METABOLISM, V57, P757, DOI 10.1016/j.metabol.2008.01.015
   Arciero PJ, 2006, INT J SPORT NUTR EXE, V16, P373, DOI 10.1123/ijsnem.16.4.373
   ASTRUP A, 1992, INT J OBESITY, V16, P269
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Barte JCM, 2010, OBES REV, V11, P899, DOI 10.1111/j.1467-789X.2010.00740.x
   Blankson H, 2000, J NUTR, V130, P2943, DOI 10.1093/jn/130.12.2943
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Chiou WB, 2011, PSYCHOL SCI, V22, P1081, DOI 10.1177/0956797611416253
   Choi YJ, 2000, J NUTR, V130, P1920, DOI 10.1093/jn/130.8.1920
   Donato J, 2006, NUTRITION, V22, P520, DOI 10.1016/j.nut.2005.12.008
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Evans M, 2002, J NUTR, V132, P450, DOI 10.1093/jn/132.3.450
   GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8
   Granlund L, 2003, J LIPID RES, V44, P1441, DOI 10.1194/jlr.M300120-JLR200
   House RL, 2005, OBES REV, V6, P247, DOI 10.1111/j.1467-789X.2005.00198.x
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hursel R, 2011, OBES REV, V12, PE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Kamphuis MMJW, 2003, INT J OBESITY, V27, P840, DOI 10.1038/sj.ijo.0802304
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Kernan WN, 2000, NEW ENGL J MED, V343, P1826, DOI 10.1056/NEJM200012213432501
   Lopez HL, 2013, J INT SOC SPORT NUTR, V10, P0, DOI 10.1186/1550-2783-10-22
   Manders RJF, 2005, AM J CLIN NUTR, V82, P76, DOI 10.1093/ajcn/82.1.76
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McEwen LN, 2010, OBES SURG, V20, P919, DOI 10.1007/s11695-010-0169-0
   Moloney F, 2004, AM J CLIN NUTR, V80, P887
   Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nazare JA, 2007, BRIT J NUTR, V97, P273, DOI 10.1017/S0007114507191911
   Ogden Cynthia L, 2012, NCHS DATA BRIEF, V0, P1
   Outlaw J, 2013, J INT SOC SPORT NUTR, V10, P0, DOI 10.1186/1550-2783-10-25
   Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0
   Park Y, 1997, LIPIDS, V32, P853, DOI 10.1007/s11745-997-0109-x
   Poirier H, 2005, DIABETOLOGIA, V48, P1059, DOI 10.1007/s00125-005-1765-8
   Qin LQ, 2011, J NUTR, V141, P249, DOI 10.3945/jn.110.128520
   Rieu I, 2006, J PHYSIOL-LONDON, V575, P305, DOI 10.1113/jphysiol.2006.110742
   ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124
   Smedman A, 2001, LIPIDS, V36, P773, DOI 10.1007/s11745-001-0784-7
   SUPERKO HR, 1991, AM J CLIN NUTR, V54, P599, DOI 10.1093/ajcn/54.3.599
   Thrush AB, 2007, APPL PHYSIOL NUTR ME, V32, P372, DOI 10.1139/H06-116
   TREMBLAY A, 1988, NUTR RES, V8, P553, DOI 10.1016/S0271-5317(88)80077-0
   Tricon S, 2004, AM J CLIN NUTR, V80, P614
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   West DB, 1998, AM J PHYSIOL-REG I, V275, P0
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Womack CJ, 2012, J INT SOC SPORT NUTR, V9, P0, DOI 10.1186/1550-2783-9-7
   Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123
NR 49
TC 19
Z9 20
U1 0
U2 30
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1550-2783
EI 
J9 J INT SOC SPORT NUTR
JI J. Int. Soc. Sport Nutr.
PD JUL 26
PY 2014
VL 11
IS 
BP 
EP 
DI 10.1186/1550-2783-11-37
PG 10
WC Nutrition & Dietetics; Sport Sciences
SC Nutrition & Dietetics; Sport Sciences
GA AM5SG
UT WOS:000339919900001
PM 25093015
DA 2025-04-28
ER

PT J
AU Lima, TP
   Nicoletti, CF
   Marchini, JS
   Salgado, W
   Nonino, CB
AF Lima, Tatiana Pereira
   Nicoletti, Carolina Ferreira
   Marchini, Julio Sergio
   Salgado Junior, Wilson
   Nonino, Carla Barbosa
TI Effect of Weight Loss on Bone Mineral Density Determined by Ultrasound of Phalanges in Obese Women After Roux-en-y Gastric Bypass: Conflicting Results With Dual-Energy X-ray Absorptiometry
SO JOURNAL OF CLINICAL DENSITOMETRY
LA English
DT Article
DE Bariatric surgery; bone mass; DXA; obesity; utrasonography
ID bariatric surgery; body-composition; calcium-metabolism; life-style; turnover; disease; markers
AB The rapid weight loss that occurs in obese patients submitted to Roux-en-y gastric bypass (RYGB) as well as the changes in dietary pattern and the intestinal malabsorption result in changes in bone mineral density (BMD). The objective of the present study was to assess the changes in BMD after the weight loss induced by RYGB using ultrasound of the phalanges and compare the results with those obtained by dual-energy X-ray absorptiometry (DXA). We conducted a 1-yr prospective longitudinal study on women with grade III obesity submitted to RYGB. Anthropometric (weight, height, body mass index, and abdominal circumference) and body composition measurements by electrical bioimpedance, assessment of food consumption by 24-h recall, biochemical evaluation, and assessment of BMD by ultrasonography of the phalanges and DXA (BMD values are from the 33% radius site) were performed during the preoperative period and 3, 6, and 12 mo after surgery. The mixed-effects linear regression model was used to analyze the effect of postoperative time on the variable of interest, and the kappa coefficient (p < 0.05) was used to compare the concordance of the methods used for BMD evaluation. Twenty-nine patients were included in the study. During the 1-yr follow-up, a reduction of 39 +/- 8 kg (71 +/- 15% of excess weight) and -29 +/- 7 kg of fat mass was observed. Calcium and zinc concentrations were reduced after 12 mo. No difference in caffeine, calcium, or sodium consumption was observed between the preoperative and postoperative periods. Analysis of BMD by ultrasonography of the phalanges 1 yr after surgery showed increased values of amplitude-dependent speed of sound (2064.6 +/- 59.4 vs 2154.7 +/- 63 m/s; p < 0.001) and ultrasound bone profile index (0.73 +/- 0.13 vs 0.76 +/- 0.14; p < 0.001). Analysis of BMD by DXA showed a reduction of BMD values (0.6 +/- 0.04 vs 0.57 +/- 0.05 g/cm(3); p < 0.001) in the sixth month and maintenance of the values from the sixth to the 12th month. At the end of the study, there was no concordance between the methods for BMD analysis. This study showed improvement in bone quality and quantity assessed by ultrasonography. However, the MCA results showed a reduction in BMD after 12 mo of RYGB. Thus, the BMD measurement methods were discordant.
C1 [Lima, Tatiana Pereira; Nicoletti, Carolina Ferreira; Marchini, Julio Sergio; Nonino, Carla Barbosa] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Internal Med, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Salgado Junior, Wilson] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Surgely & Anat, BR-14049900 Ribeirao Preto, SP, Brazil.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo
RP Nonino, CB (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Internal Med, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM carla@fmrp.usp.br
CR Binkley N, 2003, J CLIN DENSITOM, V6, P199, DOI 10.1385/JCD:6:3:199
   Bruno C, 2010, J CLIN ENDOCR METAB, V95, P159, DOI 10.1210/jc.2009-0265
   Brzozowska MM, 2013, OBES REV, V14, P52, DOI 10.1111/j.1467-789X.2012.01050.x
   Carrasco F, 2009, OBES SURG, V19, P41, DOI 10.1007/s11695-008-9638-0
   Casagrande DS, 2012, OBES SURG, V22, P1287, DOI 10.1007/s11695-012-0687-z
   Coates PS, 2004, J CLIN ENDOCR METAB, V89, P1061, DOI 10.1210/jc.2003-031756
   Cohen HJ, 2000, FOOD CHEM TOXICOL, V38, P237, DOI 10.1016/S0278-6915(99)00145-3
   De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y
   De Prisco C, 2005, AM J MED SCI, V329, P57, DOI 10.1097/00000441-200502000-00001
   Dib L, 2005, BONE, V36, P736, DOI 10.1016/j.bone.2005.01.009
   Drozdzowska B, 2005, J CLIN DENSITOM, V8, P216, DOI 10.1385/JCD:8:2:216
   El-Kadre LJ, 2004, OBES SURG, V14, P1062, DOI 10.1381/0960892041975505
   Fleischer J, 2008, J CLIN ENDOCR METAB, V93, P3735, DOI 10.1210/jc.2008-0481
   De Carvalho FG, 2012, NUTR HOSP, V27, P612, DOI 10.3305/nh.2012.27.2.5625
   Hypp√∂nen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860
   Iannetta O, 2006, OSTEOPOROSE EXENFERM, V0, P237
   Jakicic JM, 1998, INT J OBESITY, V22, P243, DOI 10.1038/sj.ijo.0800576
   Mahdy T, 2008, OBES SURG, V18, P1526, DOI 10.1007/s11695-008-9653-1
   Mann Tandip S, 2008, MCGILL J MED, V11, P132
   *MLF, 1983, HEIGHT WEIGHT TABL M, V0, P0
   Nicoletti CF, 2013, SURG OBES RELAT DIS, V9, P1008, DOI 10.1016/j.soard.2013.07.004
   Ricci TA, 2001, AM J CLIN NUTR, V73, P347
   Rico H, 2002, NUTRITION, V18, P189, DOI 10.1016/S0899-9007(01)00718-3
   Schweitzer DH, 2007, OBES SURG, V17, P1510, DOI 10.1007/s11695-008-9431-0
   Scibora LM, 2012, OBES SURG, V22, P654, DOI 10.1007/s11695-012-0596-1
   Sinha N, 2011, OBESITY, V19, P2388, DOI 10.1038/oby.2011.133
   Slater GH, 2004, J GASTROINTEST SURG, V8, P48, DOI 10.1016/j.gassur.2003.09.020
   Soleymani T, 2011, CURR OPIN RHEUMATOL, V23, P396, DOI 10.1097/BOR.0b013e328346f832
   Tsukiyama K, 2006, MOL ENDOCRINOL, V20, P1644, DOI 10.1210/me.2005-0187
   Viegas M, 2010, ARQ BRAS ENDOCRINOL, V54, P158, DOI 10.1590/S0004-27302010000200011
   Vilarrasa N, 2011, OBES SURG, V21, P465, DOI 10.1007/s11695-010-0338-1
   Wucher H, 2008, OBES SURG, V18, P58, DOI 10.1007/s11695-007-9258-0
   Yu EW, 2014, J BONE MINER RES, V29, P542, DOI 10.1002/jbmr.2063
NR 33
TC 9
Z9 10
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1094-6950
EI 1559-0747
J9 J CLIN DENSITOM
JI J. Clin. Densitom.
PD OCT-DEC 15
PY 2014
VL 17
IS 4
BP 473
EP 478
DI 10.1016/j.jocd.2014.08.002
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AT3MS
UT WOS:000344839500006
PM 25443227
DA 2025-04-28
ER

PT J
AU Worsztynowicz, P
   Napierala, M
   Bialas, W
   Grajek, W
   Olkowicz, M
AF Worsztynowicz, Paulina
   Napierala, Marta
   Bialas, Wojciech
   Grajek, Wlodzimierz
   Olkowicz, Mariola
TI Pancreatic Œ±-amylase and lipase inhibitory activity of polyphenolic compounds present in the extract of black chokeberry (Aronia melanocarpa L.)
SO PROCESS BIOCHEMISTRY
LA English
DT Article
DE Chokeberry; Obesity; Amylase; Lipase; Enzyme inhibition
ID tea polyphenols; anthocyanins; glucosidase; obesity; metabolism; absorption; cyanidin; enzymes
AB The aim of this study was to investigate the effect of black chokeberry (Aronia melanoccopa L.) extract on the activity of porcine pancreatic alpha-amylase and lipase. An in vitro study demonstrated that three kinds of chokeberry extracts: methanolic, water and acetic caused inhibition of alpha-amylase and lipase. The methanolic and acetic extracts exhibited the highest inhibitory activities against alpha-amylase with the IC50 values of 10.31 +/- 0.04 mg/ml and pancreatic lipase 83.45 +/- 0.50 mg/ml, respectively. In order to identify the compounds which may be the potential inhibitors of alpha-amylase and lipase, chokeberry extract was analyzed by preparative reverse phase chromatography and high performance liquid chromatography-mass spectrometry (HPLC-MS). These studies have shown that both anthocyanins and phenolic acids are compounds which inhibit the ability of the reaction catalyzed by alpha-amylase and lipase. The most effective inhibitor of pancreatic alpha-amylase was chlorogenic acid (IC50= 0.57 +/- 0.16 mg/ml). In the group of anthocyanins the most potent inhibitor of alpha-amylase was cyanidin-3-glucoside (IC50= 1.74 +/- 0.04 mg/ml), which also showed an ability to inhibit the reaction catalyzed by pancreatic lipase(IC50 = 1.17 +/- 0.05 mg/ml). These findings seem to indicate the use of chokeberry as a functional food component, contributing to its anti-obesity activities. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Worsztynowicz, Paulina; Napierala, Marta; Bialas, Wojciech; Grajek, Wlodzimierz; Olkowicz, Mariola] Poznan Univ Life Sci, Dept Biotechnol & Food Microbiol, PL-60627 Poznan, Poland.
   [Napierala, Marta] Poznan Univ Med Sci, Environm Res Lab, Dept Toxicol, PL-60631 Poznan, Poland.
C3 Poznan University of Life Sciences; Poznan University of Medical Sciences
RP Worsztynowicz, P (corresponding author), Poznan Univ Life Sci, Dept Biotechnol & Food Microbiol, Wojska Polskiego 48, PL-60627 Poznan, Poland.
EM paulina.worsztynowicz@up.poznan.pl; martan@ump.edu.pl; wbialas@up.poznan.pl; grajek@up.poznan.pl; mariola.olkowicz@up.poznan.pl
FU [POIG 01.01.02-00-061/09]
CR Akkarachiyasit S, 2010, INT J MOL SCI, V11, P3387, DOI 10.3390/ijms11093387
   Unknown -, 2006, BMC COMPLEM ALTERN M, V0, P0
   Asai A, 2014, AM J PHYSL GASTROINT, V0, P0
   Barrett ML, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-24
   Br√§unlich M, 2013, NUTRIENTS, V5, P663, DOI 10.3390/nu5030663
   Cai ZJ, 1999, WHO TECH REP SER, V887, P1
   Griffiths D W, 1986, ADV EXP MED BIOL, V199, P509
   Grussu D, 2011, J AGR FOOD CHEM, V59, P2324, DOI 10.1021/jf1045359
   Gu YY, 2011, J AGR FOOD CHEM, V59, P5305, DOI 10.1021/jf200180n
   Han LK, 2001, INT J OBESITY, V25, P1459, DOI 10.1038/sj.ijo.0801747
   Huang JB, 2013, J AGR FOOD CHEM, V61, P8565, DOI 10.1021/jf402004x
   Hung PF, 2005, AM J PHYSIOL-CELL PH, V288, PC1094, DOI 10.1152/ajpcell.00569.2004
   Kim HK, 2012, NUTR RES, V32, P770, DOI 10.1016/j.nutres.2012.06.008
   de la Garza AL, 2013, J AGR FOOD CHEM, V61, P12012, DOI 10.1021/jf4021569
   Matsui T, 2004, BIOSCI BIOTECH BIOCH, V68, P2239, DOI 10.1271/bbb.68.2239
   Matsui T, 2001, J AGR FOOD CHEM, V49, P1948, DOI 10.1021/jf001251u
   McDougall GJ, 2008, BIOFACTORS, V34, P73, DOI 10.1002/biof.5520340108
   Moreno DA, 2003, NUTRITION, V19, P876, DOI 10.1016/S0899-9007(03)00167-9
   Moreno DA, 2006, LIFE SCI, V78, P2797, DOI 10.1016/j.lfs.2005.11.012
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   Narita Y, 2011, FOOD CHEM, V127, P1532, DOI 10.1016/j.foodchem.2011.02.013
   Narita Y, 2009, J AGR FOOD CHEM, V57, P9218, DOI 10.1021/jf9017383
   Ono Y, 2006, J ETHNOPHARMACOL, V106, P238, DOI 10.1016/j.jep.2005.12.036
   Qin BL, 2012, BRIT J NUTR, V108, P581, DOI 10.1017/S000711451100599X
   SATOUCHI K, 1974, AGR BIOL CHEM TOKYO, V38, P97, DOI 10.1080/00021369.1974.10861113
   Sikora J, 2012, EUR J NUTR, V51, P549, DOI 10.1007/s00394-011-0238-8
   Slimestad R, 2005, J FOOD COMPOS ANAL, V18, P61, DOI 10.1016/j.jfca.2003.12.003
   Somogyi M, 1952, J BIOL CHEM, V200, P245
   Sousa BA, 2012, BRAZ J CHEM ENG, V29, P25, DOI 10.1590/S0104-66322012000100003
   TANI H, 1995, J AGR FOOD CHEM, V43, P2796, DOI 10.1021/jf00059a003
   Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   WINKLER UK, 1979, J BACTERIOL, V138, P663, DOI 10.1128/JB.138.3.663-670.1979
   Wu XL, 2004, J AGR FOOD CHEM, V52, P7846, DOI 10.1021/jf0486850
   Yao SL, 2013, FOOD FUNCT, V4, P1602, DOI 10.1039/c3fo60196j
   You Q, 2011, J AGR FOOD CHEM, V59, P9506, DOI 10.1021/jf201452v
   Zielinska-Przyjemska M, 2009, PHYTOTHER RES, V23, P49, DOI 10.1002/ptr.2535
NR 37
TC 84
Z9 96
U1 3
U2 110
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-5113
EI 1873-3298
J9 PROCESS BIOCHEM
JI Process Biochem.
PD SEP 15
PY 2014
VL 49
IS 9
BP 1457
EP 1463
DI 10.1016/j.procbio.2014.06.002
PG 7
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Engineering
GA AO7RF
UT WOS:000341549600011
DA 2025-04-28
ER

PT J
AU Chong, PW
   Beah, ZM
   Grube, B
   Riede, L
AF Chong, Pee-Win
   Beah, Zhi-Ming
   Grube, Barbara
   Riede, Linda
TI IQP-GC-101 Reduces Body Weight and Body Fat Mass: A Randomized, Double-Blind, Placebo-Controlled Study
SO PHYTOTHERAPY RESEARCH
LA English
DT Article
DE herbal extracts; weight management; overweight; body fat; obesity
ID hydroxycitric acid; green tea; overweight; orlistat; caffeine; obese
AB IQP-GC-101 is a patented blend of the standardized extracts of Garcinia cambogia, Camellia sinensis, unroasted Coffea arabica, and Lagerstroemia speciosa. These individual ingredients of IQP-GC-101 have each shown promise in promoting weight loss; however, the efficacy of the blend has not been established. This randomized, placebo-controlled, double-blind, parallel group study conducted over 14weeks (including a 2-week run-in phase) aimed to investigate the efficacy and safety of IQP-GC-101 in reducing body weight and body fat mass in overweight Caucasian adults. Subjects took three IQP-GC-101 or placebo tablets, twice a day, 30min before main meals. All subjects also adhered to a 500kcal/day energy deficit diet with 30% of energy from fat. Ninety-one overweight and mildly obese subjects (46 in the IQP-GC-101 group, 45 in the placebo group) completed the study. After 12-week intervention, IQP-GC-101 resulted in a mean (+/- SD) weight loss of 2.26 +/- 2.37kg compared with 0.56 +/- 2.34kg for placebo (p(U)=0.002). There was also significantly more reduction in body fat mass, waist circumference, and hip circumference in the IQP-GC-101 group. No serious adverse events were reported. The use of IQP-GC-101 has been shown to result in body weight and body fat reduction in the current study, with good tolerability. (c) 2014 InQpharm Group Sdn Bhd. Phytotherapy Research published by John Wiley & Sons, Ltd.
C1 [Chong, Pee-Win; Beah, Zhi-Ming] InQpharm Europe Ltd, Hitchin SG4 0TY, Herts, England.
   [Riede, Linda] Anal & Realize GmbH, D-13467 Berlin, Germany.
RP Chong, PW (corresponding author), InQpharm Europe Ltd, Invis House,Wilbury Way, Hitchin SG4 0TY, Herts, England.
EM pwchong@inqpharm.com
FU InQpharm Europe Ltd
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Agostoni C, 2012, EFSA J, V10, P0, DOI 10.2903/j.efsa.2012.2604
   Anderson JW, 2006, ANN PHARMACOTHER, V40, P1717, DOI 10.1345/aph.1H234
   Unknown -, 1987, PERENNIAL EDIBLE FRUITS OF THE TROPICS: AN INVENTORY, V0, P0
   Unknown -, 2006, BMC COMPLEM ALTERN M, V0, P0
   Unknown -, 2005, J. APPL. SCI. RES., V0, P0
   Unknown -, 2003, J OLEO SCI, V0, P0, DOI DOI 10.5650/JOS.52.499
   Bloch KV, 2003, J HYPERTENS, V21, P2159, DOI 10.1097/00004872-200311000-00026
   Chuah LO, 2012, EVID-BASED COMPL ALT, V2012, P0, DOI 10.1155/2012/197920
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Greenway FL, 2010, LANCET, V376, P595, DOI 10.1016/S0140-6736(10)60888-4
   Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560
   Heymsfield SB, 1998, JAMA-J AM MED ASSOC, V280, P1596, DOI 10.1001/jama.280.18.1596
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Jayaprakasha GK, 1998, J CHROMATOGR A, V806, P337, DOI 10.1016/S0021-9673(98)00054-5
   Klein G, 2007, EVID-BASED COMPL ALT, V4, P401, DOI 10.1093/ecam/nem013
   Kopelman P, 2007, OBES REV, V8, P13, DOI 10.1111/j.1467-789X.2007.00311.x
   Liu F, 2001, J NUTR, V131, P2242, DOI 10.1093/jn/131.9.2242
   Mattes RD, 2000, PHYSIOL BEHAV, V71, P87, DOI 10.1016/S0031-9384(00)00321-8
   Ohia SE, 2002, MOL CELL BIOCHEM, V238, P89, DOI 10.1023/A:1019911205672
   Onakpoya I, 2011, J OBES, V2011, P0, DOI 10.1155/2011/509038
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, P0, DOI 10.1155/2011/382852
   Razak F, 2005, INT J OBESITY, V29, P656, DOI 10.1038/sj.ijo.0802937
   Schwartz MW, 2003, DIABETES, V52, P232, DOI 10.2337/diabetes.52.2.232
   Stohs SJ, 2012, PHYTOTHER RES, V26, P317, DOI 10.1002/ptr.3664
   SULLIVAN AC, 1974, LIPIDS, V9, P129, DOI 10.1007/BF02532137
   SULLIVAN AC, 1977, J BIOL CHEM, V252, P7583
   Fayh APT, 2013, EUR J NUTR, V52, P1443, DOI 10.1007/s00394-012-0450-1
   Tsuchibe S, 2006, J. INTEGR. STUDY DIET HABITS, V17, P255, DOI 10.2740/jisdh.17.255
NR 29
TC 25
Z9 25
U1 0
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD OCT 15
PY 2014
VL 28
IS 10
BP 1520
EP 1526
DI 10.1002/ptr.5158
PG 7
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AQ4VP
UT WOS:000342798700012
PM 24797657
DA 2025-04-28
ER

PT J
AU da Silva, LA
   Pereira, RA
   T√∫rmina, JA
   Kerppers, II
   Osiecki, R
   Altimari, LR
   Malfatti, CRM
AF da Silva, Luiz Augusto
   Pereira, Ricardo Aparecido
   Turmina, Janaina Angela
   Kerppers, Ivo Ilvan
   Osiecki, Raul
   Altimari, Leandro Ricardo
   Maneck Malfatti, Carlos Ricardo
TI Sulfonylurea induction of caffeine-enhanced insulin secretion and reduction of glycemic levels in diabetic rats
SO PHARMACEUTICAL BIOLOGY
LA English
DT Article
DE Blood glucose; diabetes mellitus; exercise; streptozotocin
ID glucose-homeostasis; blood-pressure; coffee; exercise; resistance; endurance; obesity
AB Context: Caffeine can stimulate insulin secretion by attenuating hyperglycemia in diabetes models with significant reduction of pancreatic functional beta cells. Knowledge of these mechanisms could contribute to new strategies for treating diabetes. Objective: This study evaluated the effects of caffeine and physical exercise on glycemic and insulin responses in diabetic rats. Materials and methods: The diabetes model was induced by intraperitoneal administration of 60 mg/kg of streptozotocin (STZ). Animals were divided into six groups: control, caffeine, STZ control, STZ caffeine, STZ sulfonylurea, and STZ caffeine + sulfonylurea. Acutely, control animals received 6 mg of caffeine and 10 mg/kg sulfonylurea or 10 mg/kg saline. Animals were sacrificed after physical exercise; blood samples were collected for glucose, glycerol, lactate, and insulin analyses. Cardiovascular responses were recorded before and after treatments. A one-way ANOVA and the post hoc Student-Newman-Keuls test were used to analyze statistical differences between treatments (p < 0.05). Results: About 6 mg/kg of caffeine did not alter cardiovascular responses, but promoted blood glucose reduction after 60 min of exercise when compared to animals in the control groups (387-187 mg/dL; p < 0.05). Insulin levels increased significantly (0.6-10 mu U/mL; p < 0.05) in rats that received acute caffeine treatment associated with sulfonylurea compared to rats in the other groups. Discussion and conclusion: Acute caffeine intake with exercise can increase glucose uptake enhancing insulin secretion stimulated by sulfonylurea in b cells-deficient pancreas. The results indicate the potential use of caffeine as a strategy for glycemic and insulin control in diabetes.
C1 [da Silva, Luiz Augusto; Pereira, Ricardo Aparecido; Turmina, Janaina Angela; Kerppers, Ivo Ilvan; Maneck Malfatti, Carlos Ricardo] Midwest State Univ Parana, Dept Physiotherapy, BR-85040080 Guarapuava, Parana, Brazil.
   [Osiecki, Raul] Univ Fed Parana, Dept Phys Educ, BR-80060000 Curitiba, Parana, Brazil.
   [Altimari, Leandro Ricardo] Univ Estadual Londrina, Dept Phys Educ, Londrina, Parana, Brazil.
C3 Universidade Federal do Parana; Universidade Estadual de Londrina
RP Malfatti, CRM (corresponding author), Midwest State Univ Parana, Dept Physiotherapy, R Simeao Camargo Varela de Sa 03, BR-85040080 Guarapuava, Parana, Brazil.
EM crmalfatti@gmail.com
FU CAPES (Brazil); Fundacao Araucaria of Parana (Brazil)
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   Chu YF, 2011, FOOD CHEM, V124, P914, DOI 10.1016/j.foodchem.2010.07.019
   Colberg SR, 2010, MED SCI SPORT EXER, V42, P2282, DOI 10.1249/MSS.0b013e3181eeb61c
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013
   Egawa T, 2009, METABOLISM, V58, P1609, DOI 10.1016/j.metabol.2009.05.013
   Gallagher EJ, 2008, ENDOCRIN METAB CLIN, V37, P559, DOI 10.1016/j.ecl.2008.05.002
   Gobatto CA, 2001, COMP BIOCHEM PHYS A, V130, P21, DOI 10.1016/S1095-6433(01)00362-2
   Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Helmy, 2012, J NUTR FOOD SCI, V2, P1
   Larsen JJ, 1999, DIABETES CARE, V22, P1647, DOI 10.2337/diacare.22.10.1647
   Lee S, 2005, DIABETES CARE, V28, P566, DOI 10.2337/diacare.28.3.566
   Luciano E, 2002, EUR J ENDOCRINOL, V147, P149, DOI 10.1530/eje.0.1470149
   Mougios V, 2003, J APPL PHYSIOL, V94, P476, DOI 10.1152/japplphysiol.00624.2002
   Murosaki S, 2007, J NUTR, V137, P2252, DOI 10.1093/jn/137.10.2252
   Noordzij M, 2005, J HYPERTENS, V23, P921, DOI 10.1097/01.hjh.0000166828.94699.1d
   Nurminen ML, 1999, EUR J CLIN NUTR, V53, P831, DOI 10.1038/sj.ejcn.1600899
   Paluska Scott A, 2003, CURR SPORTS MED REP, V2, P213, DOI 10.1249/00149619-200308000-00008
   Park S, 2009, AM J PHYSIOL-CELL PH, V296, PC106, DOI 10.1152/ajpcell.00114.2008
   Park S, 2007, METABOLISM, V56, P599, DOI 10.1016/j.metabol.2006.12.004
   Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910
   Szkudelski T, 2012, EXP BIOL MED, V237, P481, DOI 10.1258/ebm.2012.011372
   Takada J, 2007, METABOLISM, V56, P977, DOI 10.1016/j.metabol.2006.05.021
   Alves-Wagner ABT, 2009, MUSCLE NERVE, V40, P847, DOI 10.1002/mus.21359
   Wang L, 2013, TOXICOL LETT, V0378-4274, P1397
   Yasuda N, 2003, EUR J PHARMACOL, V459, P159, DOI 10.1016/S0014-2999(02)02832-7
   Zheng G, 2008, IN VIVO, V18, P55
NR 28
TC 3
Z9 3
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1388-0209
EI 1744-5116
J9 PHARM BIOL
JI Pharm. Biol.
PD AUG 15
PY 2014
VL 52
IS 8
BP 956
EP 960
DI 10.3109/13880209.2013.874462
PG 5
WC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
SC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
GA AM8GF
UT WOS:000340109700004
PM 24601939
DA 2025-04-28
ER

PT J
AU Yamashita, Y
   Wang, LQ
   Wang, LH
   Tanaka, Y
   Zhang, TS
   Ashida, H
AF Yamashita, Yoko
   Wang, Liuqing
   Wang, Lihua
   Tanaka, Yuki
   Zhang, Tianshun
   Ashida, Hitoshi
TI Oolong, black and pu-erh tea suppresses adiposity in mice via activation of AMP-activated protein kinase
SO FOOD & FUNCTION
LA English
DT Article
ID factor-binding protein-1; green tea; glucose-intolerance; gene-expression; uncoupling proteins; cardiovascular risk; lipid-accumulation; prevents obesity; adipocytes; caffeine
AB It is well known that tea has a variety of beneficial impacts on human health, including anti-obesity effects. It is well documented that green tea and its constituent catechins suppress obesity, but the effects of other types of tea on obesity and the potential mechanisms involved are not yet fully understood. In this study, we investigated the suppression of adiposity by oolong, black and pu-erh tea and characterized the underlying molecular mechanism in vivo. We found that the consumption of oolong, black or pu-erh tea for a period of one week significantly decreased visceral fat without affecting body weight in male ICR mice. On a mechanistic level, the consumption of tea enhanced the phosphorylation of AMP-activated protein kinase (AMPK) in white adipose tissue (WAT). This was accompanied by the induction of WAT protein levels of uncoupling protein 1 and insulin-like growth factor binding protein 1. Our results indicate that oolong, black and pu-erh tea, and in particular, black tea, suppresses adiposity via phosphorylation of the key metabolic regulator AMPK and increases browning of WAT.
C1 [Yamashita, Yoko; Wang, Liuqing; Wang, Lihua; Tanaka, Yuki; Zhang, Tianshun; Ashida, Hitoshi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Nada Ku, Kobe, Hyogo 6578501, Japan.
C3 Kobe University
RP Yamashita, Y (corresponding author), Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Nada Ku, Kobe, Hyogo 6578501, Japan.
EM ashida@kobe-u.ac.jp
FU Social Coordination Funds for Promoting Science and Technology and Creation of Innovation Centers for Advanced Interdisciplinary Research Area (Innovative Bioproduction Kobe), MEXT, Japan
CR Bonet ML, 2013, BBA-MOL CELL BIOL L, V1831, P969, DOI 10.1016/j.bbalip.2012.12.002
   Boss O, 1998, EUR J ENDOCRINOL, V139, P1, DOI 10.1530/eje.0.1390001
   Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003
   Chow HHS, 2011, PHARMACOL RES, V64, P105, DOI 10.1016/j.phrs.2011.05.007
   Egawa T, 2011, ACTA PHYSIOL, V201, P227, DOI 10.1111/j.1748-1716.2010.02169.x
   Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966
   Fuster A, 2009, COMP BIOCHEM PHYS A, V153, P106, DOI 10.1016/j.cbpa.2009.01.007
   Gao Y, 2008, BIOL PHARM BULL, V31, P1716, DOI 10.1248/bpb.31.1716
   GREENBERG AS, 1991, J BIOL CHEM, V266, P11341
   Gruzman Arie, 2009, REV DIABET STUD, V6, P13, DOI 10.1900/RDS.2009.6.13
   Hardie DG, 2006, J PHYSL, V574, P5747
   Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982
   Heald AH, 2001, DIABETOLOGIA, V44, P333, DOI 10.1007/s001250051623
   Hilding A, 2003, BIOCHEM BIOPH RES CO, V303, P693, DOI 10.1016/S0006-291X(03)00403-0
   Hodgson JM, 2010, MOL ASPECTS MED, V31, P495, DOI 10.1016/j.mam.2010.09.004
   Huang HC, 2012, FOOD FUNCT, V3, P170, DOI 10.1039/c1fo10157a
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kalme T, 2005, J CLIN ENDOCR METAB, V90, P1550, DOI 10.1210/jc.2004-0762
   Kanamoto Y, 2011, J AGR FOOD CHEM, V59, P8985, DOI 10.1021/jf201471p
   Klaus S, 2012, GENES NUTR, V7, P369, DOI 10.1007/s12263-011-0260-8
   Kogure A, 2002, CLIN EXP PHARMACOL P, V29, P391, DOI 10.1046/j.1440-1681.2002.03675.x
   Lewitt MS, 2001, BIOCHEM BIOPH RES CO, V282, P1126, DOI 10.1006/bbrc.2001.4702
   Lin CL, 2007, J LIPID RES, V48, P2334, DOI 10.1194/jlr.M700128-JLR200
   Lin YL, 1996, J AGR FOOD CHEM, V44, P1387, DOI 10.1021/jf950652k
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maeda H, 2005, BIOCHEM BIOPH RES CO, V332, P392, DOI 10.1016/j.bbrc.2005.05.002
   Murase T, 2009, BIOCHEM PHARMACOL, V78, P78, DOI 10.1016/j.bcp.2009.03.021
   Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074
   Nakabayashi H, 2008, BIOFACTORS, V34, P293, DOI 10.3233/BIO-2009-1083
   Nomura S, 2008, J NUTR BIOCHEM, V19, P840, DOI 10.1016/j.jnutbio.2007.11.005
   Ostrowska Lucyna, 2013, ROCZ PANSTW ZAKL HIG, V64, P61
   Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Rajkumar K, 1999, J ENDOCRINOL, V162, P457, DOI 10.1677/joe.0.1620457
   Rajpathak SN, 2008, GROWTH HORM IGF RES, V18, P166, DOI 10.1016/j.ghir.2007.08.004
   Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161
   Sanderson M, 2014, PHYTOMEDICINE, V21, P109, DOI 10.1016/j.phymed.2013.08.011
   Sawada T, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0014006
   Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001
   Tiraby C, 2007, DIABETOLOGIA, V50, P2190, DOI 10.1007/s00125-007-0765-2
   Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259
   Ueda M, 2012, J AGR FOOD CHEM, V60, P8917, DOI 10.1021/jf2053788
   UNTERMAN TG, 1991, ENDOCRINOLOGY, V128, P2693, DOI 10.1210/endo-128-6-2693
   Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08
   Weisburger JH, 2002, FOOD CHEM TOXICOL, V40, P1145, DOI 10.1016/S0278-6915(02)00044-3
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Yamashita Y, 2012, J AGR FOOD CHEM, V60, P11366, DOI 10.1021/jf303597c
   Yamashita Y, 2012, ARCH BIOCHEM BIOPHYS, V527, P95, DOI 10.1016/j.abb.2012.03.018
NR 48
TC 67
Z9 76
U1 0
U2 58
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD OCT 15
PY 2014
VL 5
IS 10
BP 2420
EP 2429
DI 10.1039/c4fo00095a
PG 10
WC Biochemistry & Molecular Biology; Food Science & Technology
SC Biochemistry & Molecular Biology; Food Science & Technology
GA AQ7TY
UT WOS:000343023300004
PM 25098399
DA 2025-04-28
ER

PT J
AU Caria, CREP
   de Oliveira, CC
   Gotardo, √âFM
   de Souza, VT
   Rocha, T
   Macedo, JA
   Carvalho, PD
   Ribeiro, ML
   Gambero, A
AF Caria, Cintia Rabelo e Paiva
   de Oliveira, Caroline Candida
   Martins Gotardo, Erica Ferreira
   de Souza, Veronica Tricoli
   Rocha, Thalita
   Macedo, Juliana Alves
   Carvalho, Patricia de Oliveira
   Ribeiro, Marcelo Lima
   Gambero, Alessandra
TI Caffeinated and decaffeinated instant coffee consumption partially reverses high-fat diet-induced metabolic alterations in mice
SO FOOD RESEARCH INTERNATIONAL
LA English
DT Article
DE Obesity; Adiponectin; Leptin; Adipose tissue; TNF-alpha; Fatty acids
ID gene-expression; chemical-characterization; insulin-resistance; serum adiponectin; tea consumption; habitual coffee; liver-enzymes; association; risk; receptor
AB Epidemiological data has associated coffee consumption with a lower prevalence of type 2 diabetes, metabolic syndrome and chronic liver disease. However, the mechanisms and coffee substances responsible for these effects remain unclear. In the present study, mice received caffeinated or decaffeinated instant coffee ad libitum during a two week period after inducing obesity by introducing a high-fat diet over a 10 week period. Body weight, glucose homeostasis, and liver and visceral adipose tissue inflammation were assessed. In addition, AKT signaling, the fatty acid profile and liver histopathological analyses were performed. Ingestion of caffeinated or decaffeinated coffee for 2 weeks resulted in reductions in glucose and insulin blood levels, and insulin tolerance was improved without reductions in final body weight or adiposity. Only caffeinated coffee modified the adipokine profile in visceral adipose tissue, resulting in a restoration of adiponectin levels. However, deleterious liver alterations, which manifested as reductions in steatosis, inhibition of iNOS expression and restoration of insulin inducing-AKT phosphorylation, were reversed by the ingestion of both caffeinated and decaffeinated coffee. Serum AST and ALT levels were also improved in mice after coffee ingestion, while the fatty add profile in the liver and the cytokine profiles in adipose and liver tissues were not altered by coffee ingestion. Thus, instant coffee consumption reverses obesity-induced alterations in mice, and our results corroborate those of epidemiological studies that associated coffee consumption with a lower prevalence of obesity-related pathologies. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Caria, Cintia Rabelo e Paiva; de Oliveira, Caroline Candida; Martins Gotardo, Erica Ferreira; de Souza, Veronica Tricoli; Rocha, Thalita; Macedo, Juliana Alves; Carvalho, Patricia de Oliveira; Ribeiro, Marcelo Lima; Gambero, Alessandra] Univ Sao Francisco, Sch Med, Clin Pharmacol & Gastroenterol Unit, BR-12916900 Braganca Paulista, SP, Brazil.
C3 Universidade Sao Francisco
RP Gambero, A (corresponding author), Univ Sao Francisco, Sch Med, Clin Pharmacol & Gastroenterol Unit, Ave Sao Francisco de Assis 218, BR-12916900 Braganca Paulista, SP, Brazil.
EM alessandra.gambero@usf.edu.br
CR AOCS, 1993, OFFICIAL METHODS AND RECOMMENDED PRACTICES, V0, P0
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   BONORA E, 1987, DIABETES METAB, V13, P116
   Caridi D, 2007, FOOD CHEM, V105, P691, DOI 10.1016/j.foodchem.2006.12.063
   Carrieri MP, 2014, J HEPATOL, V60, P46, DOI 10.1016/j.jhep.2013.08.014
   Chatterjee S, 2013, J HEPATOL, V58, P778, DOI 10.1016/j.jhep.2012.11.035
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Danielsson J, 2013, ALCOHOL ALCOHOLISM, V48, P303, DOI 10.1093/alcalc/agt017
   DeOliveira CC, 2012, MOL CELL ENDOCRINOL, V361, P92, DOI 10.1016/j.mce.2012.03.016
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P11100, DOI 10.1021/jf901278u
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Ikeda M, 2010, SCAND J CLIN LAB INV, V70, P171, DOI 10.3109/00365511003650165
   Kersten S, 2002, P NUTR SOC, V61, P371, DOI 10.1079/PNS2002169
   Kogure A, 2002, CLIN EXP PHARMACOL P, V29, P391, DOI 10.1046/j.1440-1681.2002.03675.x
   Liao CC, 2013, J AGR FOOD CHEM, V61, P11082, DOI 10.1021/jf4026647
   Matsuda Y, 2011, BIOSCI BIOTECH BIOCH, V75, P2309, DOI 10.1271/bbb.110452
   Matsuzaka T, 2002, J LIPID RES, V43, P107
   Molloy JW, 2012, HEPATOLOGY, V55, P429, DOI 10.1002/hep.24731
   Murakami K, 2013, NUTRITION, V29, P1315, DOI 10.1016/j.nut.2013.04.012
   Mure K, 2013, NUTRITION, V29, P982, DOI 10.1016/j.nut.2013.01.011
   Nakamura MT, 2000, J NUTR, V130, P1561, DOI 10.1093/jn/130.6.1561
   Nunes FM, 2007, J AGR FOOD CHEM, V55, P3967, DOI 10.1021/jf063735h
   Nunes FM, 2001, J AGR FOOD CHEM, V49, P1773, DOI 10.1021/jf0012953
   Ostrowska Lucyna, 2013, ROCZ PANSTW ZAKL HIG, V64, P61
   Pauli JR, 2008, J PHYSIOL-LONDON, V586, P659, DOI 10.1113/jphysiol.2007.142414
   Ramirez-Coronel MAN, 2004, J AGR FOOD CHEM, V52, P1344, DOI 10.1021/jf035208t
   Shearer J, 2007, CAN J PHYSIOL PHARM, V85, P823, DOI 10.1139/Y07-070
   Shin JW, 2010, J SCI FOOD AGR, V90, P450, DOI 10.1002/jsfa.3838
   Sinha RA, 2013, HEPATOLOGY, V0, P0
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Wedick NM, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-93
   Yamashita K, 2012, NUTR DIABETES, V2, P0, DOI 10.1038/nutd.2012.6
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
NR 38
TC 2
Z9 2
U1 1
U2 30
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0963-9969
EI 1873-7145
J9 FOOD RES INT
JI Food Res. Int.
PD JUL 15
PY 2014
VL 61
IS 
BP 120
EP 126
DI 10.1016/j.foodres.2014.02.025
PG 7
WC Food Science & Technology
SC Food Science & Technology
GA AK4IX
UT WOS:000338389500015
DA 2025-04-28
ER

PT J
AU Merlotti, C
   Morabito, A
   Pontiroli, AE
AF Merlotti, C.
   Morabito, A.
   Pontiroli, A. E.
TI Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies
SO DIABETES OBESITY & METABOLISM
LA English
DT Article
DE bariatric surgery; lifestyle modifications; meta-analysis; prevention; type 2 diabetes
ID impaired glucose-tolerance; life-style intervention; renin-angiotensin system; lipid-lowering treatment; beta-cell function; cardiovascular-disease; bariatric surgery; fasting glucose; double-blind; alcohol-consumption
AB Aim: Different intervention strategies can prevent type 2 diabetes (T2DM). Aim of the present systematic review and meta-analysis was to evaluate the effectiveness of different strategies. Methods: Studies were grouped into 15 different strategies: 1: diet plus physical activity; 2: physical activity; 3-6: anti-diabetic drugs [glitazones, metformin, beta-cell stimulating drugs (sulphanylureas, glinides), alfa-glucosidase inhibitors]; 7-8: cardiovascular drugs (ACE inhibitors, ARB, calcium antagonists); 9-14 [diets, lipid-affecting drugs (orlistat, bezafibrate), vitamins, micronutrients, estrogens, alcohol, coffee]; 15: bariatric surgery. Only controlled studies were included in the analysis, whether randomized, non-randomized, observational studies, whether primarily designed to assess incident cases of diabetes, or performed with other purposes, such as control of hypertension, of ischemic heart disease or prevention of cardiovascular events. Appropriate methodology [preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement] was used. Seventy-one studies (490 813 subjects), published as full papers, were analysed to identify predictors of new cases of T2DM, and were included in a meta-analysis (random-effects model) to study the effect of different strategies. Intervention effect (new cases of diabetes) was expressed as odds ratio (OR), with 95% confidence intervals (C. I. s). Publication bias was formally assessed. Results: Body mass index was in the overweight range for 13 groups, obese or morbidly obese in lipid-affecting drugs and in bariatric surgery. Non-surgical strategies, except for beta-cell stimulating drugs, estrogens and vitamins, were able to prevent T2DM, with different effectiveness, from 0.37 (C. I. 0.26-0.52) to 0.85 (C. I. 0.77-0.93); the most effective strategy was bariatric surgery in morbidly obese subjects [0.16 (C. I. 0.11,0.24)]. At meta-regression analysis, age of subjects and amount of weight lost were associated with effectiveness of intervention. Conclusions: These data indicate that several strategies prevent T2DM, making it possible to make a choice for the individual subject.
C1 Univ Milan, Cattedra Med Interna, Dipartimento Sci Salute, I-20142 Milan, Italy.
   Univ Milan, Cattedra Stat Med & Biometria, Dipartimento Sci Salute, I-20142 Milan, Italy.
   Dipartimento Sci Clin & Comunita, Milan, Italy.
C3 University of Milan; University of Milan
RP Pontiroli, AE (corresponding author), Univ Milan, Osped San Paolo, Dipartimento Sci Salute, Via Antonio di Rudini 8, I-20142 Milan, Italy.
EM antonio.pontiroli@unimi.it
CR Abuissa H, 2005, J AM COLL CARDIOL, V46, P821, DOI 10.1016/j.jacc.2005.05.051
   Abuissa H, 2008, DIABETES OBES METAB, V10, P1157, DOI 10.1111/j.1463-1326.2008.00898.x
   Anderson DC Jr, 2005, ANN PHARMACOTHER, V39, P102, DOI 10.1345/aph.1E081
   Andraws R, 2007, AM J CARDIOL, V99, P1006, DOI 10.1016/j.amjcard.2006.10.068
   Unknown -, 1900, DOI 10.2337/DC10-S011, V0, P0
   Arterburn DE, 2013, OBES SURG, V23, P93, DOI 10.1007/s11695-012-0802-1
   Barzilay JI, 2006, ARCH INTERN MED, V166, P2191, DOI 10.1001/archinte.166.20.2191
   Bennett SMA, 2004, DIABETIC MED, V21, P415, DOI 10.1111/j.1464-5491.2004.01155.x
   Black HR, 2008, DIABETES CARE, V31, P353, DOI 10.2337/dc07-1452
   Bo S, 2007, J GEN INTERN MED, V22, P1695, DOI 10.1007/s11606-007-0399-6
   Bonds DE, 2006, DIABETOLOGIA, V49, P459, DOI 10.1007/s00125-005-0096-0
   Bosch J, 2005, CIRCULATION, V112, P1339, DOI 10.1161/CIRCULATIONAHA.105.548461
   Bosch J, 2006, NEW ENGL J MED, V355, P1551
   Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4
   Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796
   Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041
   Carlsson LMS, 2012, NEW ENGL J MED, V367, P695, DOI 10.1056/NEJMoa1112082
   Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5
   Cooper-DeHoff R, 2006, AM J CARDIOL, V98, P890, DOI 10.1016/j.amjcard.2006.04.030
   Dahl√∂f B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3
   Dahl√∂f B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1
   de Boer IH, 2008, DIABETES CARE, V31, P701, DOI 10.2337/dc07-1829
   de Vegt F, 2002, DIABETES RES CLIN PR, V57, P53, DOI 10.1016/S0168-8227(02)00013-X
   DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Diabetes Prevention Progam, 2005, DIABETES, V54, P1150
   Djouss√© L, 2007, OBESITY, V15, P1758, DOI 10.1038/oby.2007.209
   Durbin RJ, 2004, DIABETES OBES METAB, V6, P280, DOI 10.1111/j.1462-8902.2004.0348.x
   EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y
   Eriksson JG, 2006, J INTERN MED, V259, P553, DOI 10.1111/j.1365-2796.2006.01633.x
   ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196
   Flory JH, 2009, DIABETES CARE, V32, P547, DOI 10.2337/dc08-1809
   Fossum E, 2007, J INTERN MED, V262, P439, DOI 10.1111/j.1365-2796.2007.01808.x
   Garber Alan J, 2008, ENDOCR PRACT, V14, P933
   Gerstein HC, 2011, DIABETOLOGIA, V54, P487, DOI 10.1007/s00125-010-1985-4
   Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8
   Haffner SM, 2000, CIRCULATION, V101, P975, DOI 10.1161/01.CIR.101.9.975
   Harbord RM, 2009, STATA J, V9, P197, DOI 10.1177/1536867X0900900202
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hirai FE, 2008, DIABETES CARE, V31, P493, DOI 10.2337/dc07-1161
   Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122
   Hu FB, 2002, DIABETES CARE, V25, P1129, DOI 10.2337/diacare.25.7.1129
   Hu G, 2006, INT J OBESITY, V30, P1742, DOI 10.1038/sj.ijo.0803341
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   JARRETT RJ, 1979, DIABETOLOGIA, V16, P25, DOI 10.1007/BF00423146
   Kanaya AM, 2003, ANN INTERN MED, V138, P1, DOI 10.7326/0003-4819-138-1-200301070-00005
   Kataja-Tuomola M, 2008, DIABETOLOGIA, V51, P47, DOI 10.1007/s00125-007-0864-0
   Kawahara T, 2008, DIABETES CARE, V31, P1949, DOI 10.2337/dc07-2272
   Kawamori R, 2009, LANCET, V373, P1607, DOI 10.1016/S0140-6736(09)60222-1
   Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006
   Kjeldsen SE, 2006, J HYPERTENS, V24, P1405, DOI 10.1097/01.hjh.0000234122.55895.5b
   Knowler WC, 2003, DIABETES CARE, V26, P977
   Knowler William C, 2002, N ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512
   Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010
   Li CL, 1999, DIABETIC MED, V16, P477, DOI 10.1046/j.1464-5491.1999.00090.x
   Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7
   Liao D, 2002, DIABETES CARE, V25, P1504, DOI 10.2337/diacare.25.9.1504
   Liu SM, 2006, DIABETES, V55, P2856, DOI 10.2337/db06-0456
   Lloret-Linares C, 2008, DIABETIC MED, V25, P1142, DOI 10.1111/j.1464-5491.2008.02550.x
   LONG SD, 1994, DIABETES CARE, V17, P372, DOI 10.2337/diacare.17.5.372
   Mancia G, 2003, HYPERTENSION, V41, P431, DOI 10.1161/01.HYP.0000057420.27692.AD
   Mayer-Davis EJ, 2002, DIABETES CARE, V25, P2172, DOI 10.2337/diacare.25.12.2172
   McMurray JJ, 2010, NEW ENGL J MED, V362, P1477, DOI 10.1056/NEJMoa1001121
   Moher D, 2009, BMJ-BRIT MED J, V339, P0, DOI 10.1136/bmj.i4086
   Norris SL, 2005, AM J PREV MED, V28, P126, DOI 10.1016/j.amepre.2004.08.006
   Oldroyd JC, 2006, DIABETES RES CLIN PR, V72, P117, DOI 10.1016/j.diabres.2005.09.018
   Padwal R, 2005, DIABETES CARE, V28, P736, DOI 10.2337/diacare.28.3.736
   Pan CY, 2003, DIABETES RES CLIN PR, V61, P183, DOI 10.1016/S0168-8227(03)00117-7
   Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537
   Penn L, 2009, BMC PUBLIC HEALTH, V9, P0, DOI 10.1186/1471-2458-9-342
   Phung OJ, 2011, DIABETIC MED, V28, P948, DOI 10.1111/j.1464-5491.2011.03303.x
   Pontiroli AE, 2012, NUTR METAB CARDIOVAS, V22, PE24, DOI 10.1016/j.numecd.2012.05.012
   Pontiroli AE, 2005, DIABETES CARE, V28, P2703, DOI 10.2337/diacare.28.11.2703
   Qiao Q, 2003, DIABETES CARE, V26, P688
   Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z
   Ramachandran A, 2009, DIABETOLOGIA, V52, P1019, DOI 10.1007/s00125-009-1315-x
   Ratner RE, 2008, J CLIN ENDOCR METAB, V93, P4774, DOI 10.1210/jc.2008-0772
   Rossi R, 2004, DIABETES CARE, V27, P645, DOI 10.2337/diacare.27.3.645
   Roumen C, 2008, DIABETIC MED, V25, P597, DOI 10.1111/j.1464-5491.2008.02417.x
   Saito T, 2011, ARCH INTERN MED, V171, P1352, DOI 10.1001/archinternmed.2011.275
   Salas-Salvad√≥ J, 2011, DIABETES CARE, V34, P14, DOI 10.2337/dc10-1288
   SARTOR G, 1980, DIABETES, V29, P41, DOI 10.2337/diabetes.29.1.41
   Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6
   Scheen AJ, 2007, DIABETES METAB, V33, P3, DOI 10.1016/j.diabet.2006.11.005
   Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007
   Simmons D, 2004, DIABETIC MED, V21, P122, DOI 10.1111/j.1464-5491.2004.01020.x
   Sj√∂str√∂m L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622
   Smith GD, 2005, ANN INTERN MED, V142, P313, DOI 10.7326/0003-4819-142-5-200503010-00006
   Southwood RL, 2010, AM J THER, V17, P201, DOI 10.1097/MJT.0b013e3181b64aa1
   Stranges S, 2007, ANN INTERN MED, V147, P217, DOI 10.7326/0003-4819-147-4-200708210-00175
   Tenenbaum A, 2005, EUR HEART J, V26, P2032, DOI 10.1093/eurheartj/ehi310
   Tenenbaum A, 2004, CIRCULATION, V109, P2197, DOI 10.1161/01.CIR.0000126824.12785.B6
   Tenenbaum A, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0035298
   Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155
   Tuomilehto Jaakko, 2001, NEW ENGLAND JOURNAL OF MEDICINE, V344, P1343, DOI 10.1056/NEJM200105033441801
   Wein P, 1999, AUST NZ J OBSTET GYN, V39, P162, DOI 10.1111/j.1479-828X.1999.tb03363.x
   Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029
   Xiang AH, 2006, DIABETES, V55, P517, DOI 10.2337/diabetes.55.02.06.db05-1066
   Yamaoka K, 2005, DIABETES CARE, V28, P2780, DOI 10.2337/diacare.28.11.2780
   Yates T, 2007, DIABETOLOGIA, V50, P1116, DOI 10.1007/s00125-007-0638-8
   Yusuf S, 2005, CIRCULATION, V112, P48, DOI 10.1161/CIRCULATIONAHA.104.528166
   Yusuf S, 2001, JAMA-J AM MED ASSOC, V286, P1882, DOI 10.1001/jama.286.15.1882
   Zanolla L, 2007, J CARDIOVASC MED, V8, P473, DOI 10.2459/01.JCM.0000278445.04613.27
   Zinman B, 2010, LANCET, V376, P103, DOI 10.1016/S0140-6736(10)60746-5
NR 107
TC 113
Z9 122
U1 2
U2 57
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-8902
EI 1463-1326
J9 DIABETES OBES METAB
JI Diabetes Obes. Metab.
PD AUG 15
PY 2014
VL 16
IS 8
BP 719
EP 727
DI 10.1111/dom.12270
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AN5EH
UT WOS:000340612400006
PM 24476122
DA 2025-04-28
ER

PT J
AU Aoyagi, R
   Funakoshi-Tago, M
   Fujiwara, Y
   Tamura, H
AF Aoyagi, Ryohei
   Funakoshi-Tago, Megumi
   Fujiwara, Yosuke
   Tamura, Hiroomi
TI Coffee Inhibits Adipocyte Differentiation via Inactivation of PPARŒ≥
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE 3T3-L1; adipocyte; coffee; differentiation; obesity; peroxisome proliferator-activated receptor gamma (PPAR gamma)
ID nf-kappa-b; gene-expression; 3t3-l1 adipocytes; antioxidant; consumption; metabolism; obesity; cells; nrf2; mice
AB Recent epidemiological studies showed that coffee consumption is associated with a lower risk of type 2 diabetes, presumably due to suppression of excess fat accumulation in adipocytes. However, the mechanism underlying the effect of coffee on adipocyte differentiation has not been well documented. To elucidate the mechanism, we investigated the effect of coffee on the differentiation of mouse preadipocyte 3T3-L1 cells. Coffee reduced the accumulation of lipids during adipocytic differentiation of 3T3-L1 cells. At 5% coffee, the accumulation of lipids decreased to half that of the control. Coffee also inhibited the expression of the peroxisome proliferator-activated receptor gamma (PPAR gamma), a transcription factor controlling the differentiation of adipocytes. Furthermore, coffee reduced the expression of other differentiation marker genes, aP2, adiponectin, CCAAT-enhancer-binding protein alpha (C/EBP alpha), glucose transporter 4 (GLUT4), and lipoprotein lipase (LPL), during adipocyte differentiation. Major bioactive constituents in coffee extracts, such as caffeine, trigonelline, chlorogenic acid, and caffeic acid, showed no effect on PPAR gamma gene expression. The inhibitory activity was produced by the roasting of the coffee beans.
C1 [Aoyagi, Ryohei; Funakoshi-Tago, Megumi; Fujiwara, Yosuke; Tamura, Hiroomi] Keio Univ, Grad Sch Pharmaceut Sci, Minato Ku, Tokyo 1058512, Japan.
C3 Keio University
RP Tamura, H (corresponding author), Keio Univ, Grad Sch Pharmaceut Sci, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.
EM tamura-hr@pha.keio.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Grants-in-Aid for Scientific Research [24500996] Funding Source: KAKEN
CR Daglia M, 2000, J AGR FOOD CHEM, V48, P1449, DOI 10.1021/jf990510g
   del Castillo MD, 2002, J AGR FOOD CHEM, V50, P3698, DOI 10.1021/jf011702q
   Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649
   Floyd ZE, 2012, BBA-MOL BASIS DIS, V1822, P1090, DOI 10.1016/j.bbadis.2012.03.014
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Hemati N, 1997, J BIOL CHEM, V272, P25913, DOI 10.1074/jbc.272.41.25913
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Huang JS, 2010, AM J PHYSIOL-GASTR L, V299, PG1211, DOI 10.1152/ajpgi.00322.2010
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Isshiki M, 2011, BIOL PHARM BULL, V34, P1624, DOI 10.1248/bpb.34.1624
   Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395
   Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285
   Nakabayashi H, 2008, BIOFACTORS, V34, P293, DOI 10.3233/BIO-2009-1083
   Nicoli MC, 1997, CANCER LETT, V114, P71, DOI 10.1016/S0304-3835(97)04628-4
   Paur I, 2010, CANCER PREV RES, V3, P653, DOI 10.1158/1940-6207.CAPR-09-0089
   Paur I, 2010, FREE RADICAL BIO MED, V48, P1218, DOI 10.1016/j.freeradbiomed.2010.02.005
   Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066
   Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8
   Takahashi S, 2014, J FUNCT FOODS, V6, P157, DOI 10.1016/j.jff.2013.10.002
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Wahli W, 2008, J INTERN MED, V263, P613, DOI 10.1111/j.1365-2796.2008.01951.x
   White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
   Zhan LJ, 2012, FREE RADICAL BIO MED, V53, P758, DOI 10.1016/j.freeradbiomed.2012.05.041
NR 24
TC 33
Z9 37
U1 0
U2 25
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
EI 
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD NOV 15
PY 2014
VL 37
IS 11
BP 1820
EP 1825
DI 10.1248/bpb.b14-00378
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AS0JW
UT WOS:000343964500017
PM 25212747
DA 2025-04-28
ER

PT J
AU Bezerra, IN
   Goldman, J
   Rhodes, DG
   Hoy, MK
   Souza, AD
   Chester, DN
   Martin, CL
   Sebastian, RS
   Ahuja, JK
   Sichieri, R
   Moshfegh, AJ
AF Bezerra, Ilana Nogueira
   Goldman, Joseph
   Rhodes, Donna G.
   Hoy, Mary Katherine
   Souza, Amanda de Moura
   Chester, Deirdra N.
   Martin, Carrie L.
   Sebastian, Rhonda S.
   Ahuja, Jaspreet K.
   Sichieri, Rosely
   Moshfegh, Alanna J.
TI Difference in adult food group intake by sex and age groups comparing Brazil and United States nationwide surveys
SO NUTRITION JOURNAL
LA English
DT Article
DE Diet; Food groups; Dietary surveys; Brazilian and American diet; Food habits
ID dietary patterns; energy-intake; nutritional-status; consumption; trends; us; availability; variety; obesity; sugar
AB Background: International comparisons of dietary intake are an important source of information to better understand food habits and their relationship to nutrition related diseases. The objective of this study is to compare food intake of Brazilian adults with American adults identifying possible dietary factors associated with the increase in obesity in Brazil. Methods: This research used cross-national analyses between the United States and Brazil, including 5,420 adults in the 2007-2008 What We Eat In America, National Health and Nutrition Examination Survey and 26,390 adults in the 2008-2009 Brazilian Household Budget Survey, Individual Food Intake. Dietary data were collected through 24 h recalls in the U. S. and through food records in Brazil. Foods and beverages were combined into 25 food categories. Food intake means and percentage of energy contribution by food categories to the population's total energy intake were compared between the countries. Results: Higher frequencies of intake were reported in the United States compared to Brazil for the majority of food categories except for meat, rice and rice dishes; beans and legumes; spreads; and coffee and tea. In either country, young adults (20-39 yrs) had greater reports of meat, poultry and fish mixed dishes; pizza and pasta; and soft drinks compared to older adults (60 + yrs). Meat, poultry and fish mixed dishes (13%), breads (11%), sweets and confections (8%), pizza and pasta (7%), and dairy products (6%) were the top five food category sources of energy intake among American adults. The top five food categories in Brazil were rice and rice dishes (13%), meat (11%), beans and legumes (10%), breads (10%), and coffee and tea (6%). Thus, traditional plant-based foods such as rice and beans were important contributors in the Brazilian diet. Conclusion: Although young adults had higher reports of high-calorie and nutrient-poor foods than older adults in both countries, Brazilian young adults did not consume a diet similar to Americans, indicating that it is still possible to reverse the current trends of incorporating Western dietary habits in Brazil.
C1 [Bezerra, Ilana Nogueira] Univ Fortaleza UNIFOR, Curso Nutr, Ctr Ciencias Saude, Fortaleza, Ceara, Brazil.
   [Goldman, Joseph; Rhodes, Donna G.; Hoy, Mary Katherine; Martin, Carrie L.; Sebastian, Rhonda S.; Ahuja, Jaspreet K.; Moshfegh, Alanna J.] ARS, Food Surveys Res Grp, Beltsville Human Nutr Res Ctr, USDA,BARC West, Beltsville, MD 20705 USA.
   [Souza, Amanda de Moura; Sichieri, Rosely] Univ Estado Rio De Janeiro, Inst Social Med, Dept Epidemiol, BR-20550012 Rio De Janeiro, RJ, Brazil.
   [Chester, Deirdra N.] USDA, Natl Inst Food & Agr, Washington, DC 20250 USA.
C3 Universidade Fortaleza; United States Department of Agriculture (USDA); Universidade do Estado do Rio de Janeiro; United States Department of Agriculture (USDA)
RP Bezerra, IN (corresponding author), Univ Fortaleza UNIFOR, Curso Nutr, Ctr Ciencias Saude, Av Washington Soares 1321,Sala C04 Edson Queiroz, Fortaleza, Ceara, Brazil.
EM ilana.bezerra@yahoo.com.br
FU Brazilian Ministry of Health; Brazilian Federal Agency for the Improvement of Higher Education (CAPES) [6748-10-4]
CR Araujo MC, 2013, PUBLIC HLTH NUTR, V0, P0
   Bezerra IN, 2011, INT J BEHAV NUTR PHY, V8, P0, DOI 10.1186/1479-5868-8-22
   Block G, 2004, J FOOD COMPOS ANAL, V17, P439, DOI 10.1016/j.jfca.2004.02.007
   Martins APB, 2013, REV SAUDE PUBL, V47, P656, DOI 10.1590/S0034-8910.2013047004968
   BrazilMinistry of Health:, 2013, VIG BRAS 2012 VIG FA, V0, P0
   Canella DS, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0092752
   Chun OK, 2010, NUTRIENTS, V2, P834, DOI 10.3390/nu2080834
   Cuevas Ada, 2009, EXPERT REV CARDIOVASC THER, V7, P281, DOI 10.1586/14779072.7.3.281
   Cunha DB, 2010, BRIT J NUTR, V104, P908, DOI 10.1017/S0007114510001479
   Demory-Luce D, 2004, J AM DIET ASSOC, V104, P1684, DOI 10.1016/j.jada.2004.07.026
   Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   Foote JA, 2004, J NUTR, V134, P1779
   Hatloy A, 2000, PUBLIC HEALTH NUTR, V3, P57, DOI 10.1017/S1368980000000628
   Heidemann C, 2008, CIRCULATION, V118, P230, DOI 10.1161/CIRCULATIONAHA.108.771881
   IBGE, 2004, NAT HOUS BUDG SURV 2, V0, P0
   IBGE, 2010, CONS EXP SURV 2008 2, V0, P0
   Kim S, 2003, J NUTR, V133, P3476, DOI 10.1093/jn/133.11.3476
   Levy-Costa RB, 2005, REV SAUDE PUBL, V39, P530, DOI 10.1590/S0034-89102005000400003
   Marchioni DM, 2011, PUBLIC HEALTH NUTR, V14, P1586, DOI 10.1017/S1368980011000486
   McCrory MA, 2000, J NUTR, V130, P276S, DOI 10.1093/jn/130.2.276S
   Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241
   Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324
   Nascimento S, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-79
   National Diabetes Fact Sheet, 2011, DIAGN UND DIAB US AG, V0, P0
   Nelson MC, 2008, OBESITY, V16, P2205, DOI 10.1038/oby.2008.365
   Olinto MTA, 2012, EUR J NUTR, V51, P281, DOI 10.1007/s00394-011-0213-4
   Olinto MTA, 2011, PUBLIC HEALTH NUTR, V14, P150, DOI 10.1017/S136898001000162X
   Pereira RA, 2014, PUBLIC HEALTH NUTR, V17, P113, DOI 10.1017/S1368980012004892
   Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9
   Sichieri R, 2002, OBES RES, V10, P42, DOI 10.1038/oby.2002.6
   Sichieri R, 2010, CAD SAUDE PUBLICA, V26, P2050, DOI 10.1590/S0102-311X2010001100006
   Sun J, 2004, INT J ENV RES PUB HE, V11, P3956
   WHO, 2011, WHO FOR TECHN M IT W, V0, P0
   Willett WC, 1998, NUTR EPIDEMIOLOGY, V0, P0
NR 36
TC 49
Z9 51
U1 0
U2 24
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-2891
EI 
J9 NUTR J
JI Nutr. J.
PD JUL 21
PY 2014
VL 13
IS 
BP 
EP 
DI 10.1186/1475-2891-13-74
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA AM2HJ
UT WOS:000339670900001
PM 25047421
DA 2025-04-28
ER

PT J
AU Settle, PJ
   Cameron, AJ
   Thornton, LE
AF Settle, Philippa J.
   Cameron, Adrian J.
   Thornton, Lukar E.
TI Socioeconomic differences in outdoor food advertising at public transit stops across Melbourne suburbs
SO AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE food advertising; area-level disadvantage; public transport
ID obesity; disadvantage; environments; consumption; extent; audit; fat
AB Objective: To assess and compare the number and type of outdoor food advertisements at public transit stops within suburbs of varying levels of socioeconomic disadvantage. Method: An observational audit tool was developed and implemented to assess the number and type of food advertisements at public transit stops within Melbourne, Victoria. A total of 20 Melbourne neighbourhoods (suburbs) from across the least and the most socioeconomically disadvantaged areas were selected. All public transit stops, including train stations and bus and tram stops with a shelter were audited. Results: A similar proportion of transit stops in the least and most-disadvantaged suburbs displayed food advertisements (total n= 203). However, some differences in the type of advertisements across suburbs were noted with advertisements for fast food restaurants, flavoured milk and fruit juice more common in the most-disadvantaged neighbourhoods (all p< 0.05) and advertisements for diet soft drink, tea, coffee and convenience stores more common in the least-disadvantaged neighbourhoods (all p< 0.05). Conclusion: This exploration of outdoor food advertising at Melbourne transit stops found 30% displayed food advertisements, with those in more disadvantaged suburbs more frequently promoting chain-brand fast food and less frequently promoting diet varieties of soft drinks. These findings may help raise awareness of unhealthy environmental exposures.
C1 [Settle, Philippa J.; Thornton, Lukar E.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, Burwood, Vic 3125, Australia.
   [Cameron, Adrian J.] World Hlth Org Collaborating Ctr Obes Prevent, Deakin Populat Hlth, Melbourne, Vic, Australia.
C3 Deakin University; World Health Organization; World Health Organization (WHO) Australia
RP Thornton, LE (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, 221 Burwood Highway, Burwood, Vic 3125, Australia.
EM lukar.thornton@deakin.edu.au
FU Deakin University; Deakin University Alfred Deakin Postdoctoral Research Fellowship; National Health and Medical Research Council [1013313]
CR Adams J, 2011, PUBLIC HEALTH NUTR, V14, P945, DOI 10.1017/S1368980010003332
   Unknown -, 2012, 4364 0 055 001 AUSTR, V0, P0
   Australian Bureau of Statistics, 2013, CENS POP HOUS 2011, V0, P0
   Australian Bureau of Statistics, 2013, WHAT IS SEIFA, V0, P0
   Cairns G, 2013, APPETITE, V62, P209, DOI 10.1016/j.appet.2012.04.017
   Cameron AJ, 2013, PUBLIC HEALTH NUTR, V16, P1178, DOI 10.1017/S1368980012002649
   Chandon P, 2012, NUTR REV, V70, P571, DOI 10.1111/j.1753-4887.2012.00518.x
   Fraser LK, 2010, INT J ENV RES PUB HE, V7, P2290, DOI 10.3390/ijerph7052290
   Glanz K, 2005, AM J HEALTH PROMOT, V19, P330, DOI 10.4278/0890-1171-19.5.330
   Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399
   Henderson VR, 2005, J NUTR EDUC BEHAV, V37, P191, DOI 10.1016/S1499-4046(06)60245-5
   Hillier A, 2009, HEALTH PLACE, V15, P935, DOI 10.1016/j.healthplace.2009.02.014
   House of Representatives Standing Committee on Social Policy and Legal Affairs, 2011, RECL PUBL SPAC INQ R, V0, P0
   Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149
   Kelly B, 2008, AUST NZ J PUBL HEAL, V32, P522, DOI 10.1111/j.1753-6405.2008.00303.x
   Kelly B, 2012, HEALTH PROMOT J AUST, V23, P73, DOI 10.1071/HE12073
   King T, 2006, INT J OBESITY, V30, P281, DOI 10.1038/sj.ijo.0803176
   Kwate NOA, 2007, J URBAN HEALTH, V84, P21, DOI 10.1007/s11524-006-9127-5
   Lesser LI, 2013, BMC PUBLIC HEALTH, V13, P0, DOI 10.1186/1471-2458-13-20
   Lobstein T, 2005, OBES REV, V6, P203, DOI 10.1111/j.1467-789X.2005.00191.x
   Maher A, 2005, NEW ZEALAND MEDICAL JOURNAL, V118, P1556
   Melway, 2012, GREATER MELBOURNE ST, V0, P0
   Mhurchu CN, 2013, OBES REV, V14, P108, DOI 10.1111/obr.12080
   Papas MA, 2007, EPIDEMIOL REV, V29, P129, DOI 10.1093/epirev/mxm009
   Pierce HL, 2013, MED J AUSTRALIA, V198, P478, DOI 10.5694/mja13.10317
   STATA, 2013, STATA STAT SOFTW COM, V0, P0
   Story M, 2008, ANNU REV PUBL HEALTH, V29, P253, DOI 10.1146/annurev.publhealth.29.020907.090926
   Thornton LE, 2012, BMC PUBLIC HEALTH, V12, P0, DOI 10.1186/1471-2458-12-194
   Village Well, 2006, TRAIN STAT PLAC COMM, V0, P0
   Walton M, 2009, HEALTH PLACE, V15, P841, DOI 10.1016/j.healthplace.2009.02.003
   WHO, 2003, WHO TECHN REP SER, V0, P0
   Yancey AK, 2009, MILBANK Q, V87, P155, DOI 10.1111/j.1468-0009.2009.00551.x
   Zimmerman FJ, 2011, ANNU REV PUBL HEALTH, V32, P285, DOI 10.1146/annurev-publhealth-090810-182502
NR 33
TC 26
Z9 27
U1 3
U2 37
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1326-0200
EI 1753-6405
J9 AUST NZ J PUBL HEAL
JI Aust. N. Z. Publ. Health
PD OCT 15
PY 2014
VL 38
IS 5
BP 414
EP 418
DI 10.1111/1753-6405.12257
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AQ4KL
UT WOS:000342765100006
PM 25269979
DA 2025-04-28
ER

PT J
AU Colon, M
   Nerin, C
AF Colon, Marta
   Nerin, Cristina
TI Molecular Interactions between Caffeine and Catechins in Green Tea
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE caffeine; (+)-catechin; (-)-epicatechin; intermolecular interactions; simulation; migration; active packaging
ID gallocatechin gallate; antioxidant capacity; crystal-structure; complexes; polyphenol; films; reduction; coatings; obesity
AB Migration of green tea components from an active packaging material containing green tea extract was performed in water and 3% acetic acid in water. The migration values for acid simulant were much higher than the values obtained in water. The influence of the acidic media in solutions of catechin standards and green tea extract was evaluated by liquid chromatography. Catechin, epicatechin, and caffeine from the green tea extract exhibited major variation in their concentrations values, with increases of 29.90, 20.75, and 15.95%, respectively, in acidic medium. The results suggested that catechins and caffeine form complexes through intermolecular interactions in neutral media and that these interactions are broken in acidic media. The continuous variation method was also performed to confirm the stoichiometry of the complexes between catechins and caffeine. Finally, a computer simulation was applied by Chem Pro 12.0, and the energies involved were calculated to confirm the experimental results obtained.
C1 [Colon, Marta; Nerin, Cristina] CPS Univ Zaragoza, Aragon Inst Engn Res I3A, Dept Analyt Chem, E-50018 Zaragoza, Spain.
C3 University of Zaragoza
RP Nerin, C (corresponding author), CPS Univ Zaragoza, Aragon Inst Engn Res I3A, Dept Analyt Chem, Torres Quevedo Bldg,Maria de Luna St 3, E-50018 Zaragoza, Spain.
EM cnerin@unizar.es
FU MICINN, Ministerio de Ciencia e Innovacion, Spain [INNPACTO 2010/0486]; Project Gobierno de Aragon; European Social Funds [GUIA-T-10]
CR Aznar M, 2012, ANAL BIOANAL CHEM, V404, P1945, DOI 10.1007/s00216-012-6247-5
   Bahrami H, 2013, CHEM PHYS, V415, P222, DOI 10.1016/j.chemphys.2013.01.022
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   CAI Y, 1990, J CHEM SOC PERK T 2, V0, PP2197, DOI 10.1039/p29900002197
   Colon M, 2012, J AGR FOOD CHEM, V60, P9842, DOI 10.1021/jf302477y
   Frei B, 2003, J NUTR, V133, P3275S, DOI 10.1093/jn/133.10.3275S
   GAFFNEY SH, 1986, J CHEM SOC CHEM COMM, V0, PP107, DOI 10.1039/c39860000107
   Garces O, 2004, ANTIOXIDANT ACTIVE VARNISH PATENT, V0, Patent No. [1477519, EP1477519]
   Glade MJ, 2010, NUTRITION, V26, P932, DOI 10.1016/j.nut.2010.08.004
   Hayashi N, 2004, BIOSCI BIOTECH BIOCH, V68, P2512, DOI 10.1271/bbb.68.2512
   HORMAN I, 1972, J FOOD SCI, V37, P925, DOI 10.1111/j.1365-2621.1972.tb03705.x
   Ishizu T, 2011, PLANTA MED, V77, P1099, DOI 10.1055/s-0030-1270982
   Ishizu T, 2010, CHEM LETT, V39, P607, DOI 10.1246/cl.2010.607
   Ishizu T, 2009, CHEM LETT, V38, P230, DOI 10.1246/cl.2009.230
   Ishizu T, 2009, TETRAHEDRON LETT, V50, P4121, DOI 10.1016/j.tetlet.2009.04.113
   Job P, 1928, ANN CHIM FRANCE, V9, P113
   de Dicastillo CL, 2011, J AGR FOOD CHEM, V59, P7832, DOI 10.1021/jf201246g
   MARTIN R, 1987, PHYTOCHEMISTRY, V26, P273, DOI 10.1016/S0031-9422(00)81527-7
   MARUYAMA N, 1991, PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON TEA SCIENCE, V0, P145
   Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135
   NATHANSON JA, 1984, SCIENCE, V226, P184, DOI 10.1126/science.6207592
   Office C., 2005, CHEM 3D US MAN, V0, P0
   Peng Y, 2013, INT J BIOL MACROMOL, V59, P282, DOI 10.1016/j.ijbiomac.2013.04.019
   Perva-Uzunalic A, 2006, FOOD CHEM, V96, P597, DOI 10.1016/j.foodchem.2005.03.015
   Roy MK, 2010, INT J FOOD SCI NUTR, V61, P109, DOI 10.3109/09637480903292601
   Sharma A, 2012, FOOD CHEM, V135, P672, DOI 10.1016/j.foodchem.2012.04.143
   Shin HS, 2003, FOOD SCI BIOTECHNOL, V12, P737
   Shiota S, 1999, BIOL PHARM BULL, V22, P1388, DOI 10.1248/bpb.22.1388
   Silva-Weiss A, 2013, FOOD ENG REV, V5, P200, DOI 10.1007/s12393-013-9072-5
   Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093
   Stan TC, 2002, INTRO COMPUTATIONAL, V14, P285
   Tsutsumi H, 2011, CHEM PHARM BULL, V59, P1008, DOI 10.1248/cpb.59.1008
   Vargas M, 2008, CRIT REV FOOD SCI, V48, P496, DOI 10.1080/10408390701537344
   Yang CS, 2010, NUTR CANCER, V62, P931, DOI 10.1080/01635581.2010.509536
   Yuan JM, 2011, PHARMACOL RES, V64, P123, DOI 10.1016/j.phrs.2011.03.002
NR 35
TC 20
Z9 21
U1 4
U2 73
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD JUL 16
PY 2014
VL 62
IS 28
BP 6777
EP 6783
DI 10.1021/jf5011287
PG 7
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology
SC Agriculture; Chemistry; Food Science & Technology
GA AL6EZ
UT WOS:000339226700033
PM 24980214
DA 2025-04-28
ER

PT J
AU Lee, HS
   Park, S
   Kim, MH
AF Lee, Haeng-Shin
   Park, Sohyun
   Kim, Mi-Hyun
TI Factors associated with low water intake among South Korean adolescents - Korea National Health and Nutrition Examination Survey, 2007-2010
SO NUTRITION RESEARCH AND PRACTICE
LA English
DT Article
DE Plain water; adolescents; behaviors; demographics; beverages
ID sugar-sweetened beverages; youth physical-activity; drinking-water; energy-intake; weight; consumption; children; impact; trial
AB Water is essential for life and plain water instead of sugar-sweetened beverages is one approach for decreasing energy intake. Due to limited data on characteristics associated with water intake among Korean adolescents, this study examined associations of demographic and behavioral characteristics with plain water intake by using nationally representative sample of South Korean adolescents. The data (2007-2010 Korea National Health and Nutrition Examination Survey) for 1,288 high school-aged adolescents (15-18 years) were used. Multivariable logistic regression was used to calculate adjusted odds ratios (OR) for factors associated with low water intake (<4 cups/day) and very low water intake (<2.5 cups/day). Nationwide, 38.4% and 19.0% of adolescents reported drinking water <4.0 cups/day and <2.5 cups/day, respectively. The mean plain water intake was 5.7 cups/day for males and 4.1 cups/day for females. Females had significantly higher odds for drinking water <2.5 cups/day (OR = 2.2) than males, whereas adolescents with low milk consumption had significantly lower odds for drinking water <2.5 cups/day (OR = 0.7). Factors significantly associated with a greater odds for drinking water <4 cups/daywere being female (OR = 2.8) and not meeting physical activity recommendations 20 min/day on <3 days/week) (OR = 1.6). Being underweight, overweight, and obese were significantly associated with reduced odds for drinking water <4 cups/day (OR = 0.7, 0.4 and 0.5, respectively). However, intake of soda, coffee drinks, fruits, vegetables, and sodium and eating out were not significantly associated with low or very low water intake. These findings may be used to target intervention efforts to increase plain water intake as part of a healty lifestyle.
C1 [Lee, Haeng-Shin] Korea Hlth Ind Dev Inst, Nutr Management Serv & Policy Team, Chungbuk 363700, South Korea.
   [Park, Sohyun] Ctr Dis Control & Prevent, Div Nutr Phys Activ & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA.
   [Kim, Mi-Hyun] Korea Natl Univ Transportat, Dept Food & Nutr, Chungbuk 368701, South Korea.
C3 Centers for Disease Control & Prevention - USA; Korea National University of Transportation
RP Kim, MH (corresponding author), Korea Natl Univ Transportat, Dept Food & Nutr, 61 Daehak Ro, Chungbuk 368701, South Korea.
EM mhkim1129@ut.ac.kr
CR Unknown -, 2007, KOREAN J PEDIAT, V0, P0, DOI DOI 10.3345/KJP.2008.51.1.1
   Unknown -, 2011, REV UPD CURR WHO REC, V0, P0
   Armfield JM, 2013, AM J PUBLIC HEALTH, V103, P494, DOI 10.2105/AJPH.2012.300889
   Brener Nancy D, 2011, MORBIDITY AND MORTALITY WEEKLY REPORT, V60, P778
   Daniels MC, 2010, NUTR REV, V68, P505, DOI 10.1111/j.1753-4887.2010.00311.x
   de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034
   Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388
   Isasi CR, 2006, DIABETES EDUCATOR, V32, P415, DOI 10.1177/0145721706288763
   Kant AK, 2010, AM J CLIN NUTR, V92, P887, DOI 10.3945/ajcn.2010.29708
   Korea Centers for Disease Control and Prevention; Korean Pediatric Society; Establishing Commission for Growth Curve of Children and Adolescents, 2007, 2007 KOR NAT GROWTH, V0, P0
   Korea Centers for Disease Control & Prevention, 2011, KOREA NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (KNHANES VII1), V2, P0
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Ministry of Health and Welfare Korea Centers for Disease Control and Prevention, 2011, AN GUID KOR NAT HLTH, V0, P0
   Muckelbauer R, 2009, PEDIATRICS, V123, PE661, DOI 10.1542/peds.2008-2186
   Park MK, 2009, SPORT SCI, V9, P2
   Park S, 2012, J ACAD NUTR DIET, V112, P1421, DOI 10.1016/j.jand.2012.04.014
   Park S, 2012, J ACAD NUTR DIET, V112, P125, DOI 10.1016/j.jada.2011.08.045
   Park S, 2012, J NUTR, V142, P306, DOI 10.3945/jn.111.148536
   Park S, 2011, J AM DIET ASSOC, V111, P1211, DOI 10.1016/j.jada.2011.05.006
   Rural Development Administration (KR), 2006, FOOD COMP TABL KOR, V0, P0
   Schneider MB, 2011, PEDIATRICS, V127, P1182, DOI 10.1542/peds.2011-0965
   Sebastian RS, 2011, DRINKING WATER INTAKE IN THE UNITED STATES, V0, P0
   Tate DF, 2012, AM J CLIN NUTR, V95, P555, DOI 10.3945/ajcn.111.026278
   The Korean Nutrition Society, 2010, DIEAT REF INT KOR 20, V0, P0
   Wang YC, 2009, ARCH PEDIAT ADOL MED, V163, P336, DOI 10.1001/archpediatrics.2009.23
   WHO, 2003, WHO TECHN REP SER, V0, P0
NR 28
TC 6
Z9 7
U1 1
U2 12
PU KOREAN NUTRITION SOC
PI SEOUL
PA 804 KST CTR, 635-4 YEOGSAM-SONG KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA
SN 1976-1457
EI 2005-6168
J9 NUTR RES PRACT
JI Nutr. Res. Pract.
PD FEB 15
PY 2014
VL 8
IS 1
BP 74
EP 80
DI 10.4162/nrp.2014.8.1.74
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA AA0WW
UT WOS:000330819100011
PM 24611109
DA 2025-04-28
ER

PT J
AU Cheng, DM
   Pogrebnyak, N
   Kuhn, P
   Poulev, A
   Waterman, C
   Rojas-Silva, P
   Johnson, WD
   Raskin, I
AF Cheng, Diana M.
   Pogrebnyak, Natalia
   Kuhn, Peter
   Poulev, Alexander
   Waterman, Carrie
   Rojas-Silva, Patricio
   Johnson, William D.
   Raskin, Ilya
TI Polyphenol-rich Rutgers Scarlet Lettuce improves glucose metabolism and liver lipid accumulation in diet-induced obese C57BL/6 mice
SO NUTRITION
LA English
DT Article
DE Red lettuce; Anthocyanins; Flavonols; Chlorogenic acid; Metabolic syndrome
ID high-fat diet; chlorogenic acid; insulin-resistance; cardiovascular-disease; antioxidant status; vegetable intake; lactuca-sativa; in-vivo; cholesterol; quercetin
AB Objective: The aims of the following experiments were to characterize antidiabetic in vitro and in vivo activity of the polyphenol-rich aqueous extract of Rutgers Scarlet Lettuce (RSL). Methods: RSL extract (RSLE) and isolated compounds were evaluated for inhibitory effects on glucose production as well as tumor necrosis factor alpha-dependent inhibition of insulin activity in H4IIE rat hepatoma cells. Additionally, high-fat diet-induced obese mice were treated with RSLE (100 or 300 mg/kg), metformin (250 mg/kg), or vehicle (water) for 28 d by oral administration and insulin and oral glucose tolerance tests were conducted. Tissues were harvested at the end of the study and evaluated for biochemical and physiological improvements in metabolic syndrome conditions. Results: A polyphenol-rich RSLE, containing chlorogenic acid, cyanidin malonyl-glucoside, and quercetin malonyl-glucoside, was produced by simple boiling water extraction at pH 2.0. In vitro, RSLE and chlorogenic acid demonstrated dose-dependent inhibition of glucose production. In vivo, RSLE treatment improved glucose metabolism measured by oral glucose tolerance tests, but not insulin tolerance tests. RSLE treated groups had a lower ratio of liver weight to body weight as well as decreased total liver lipids compared with the control group after 28 d of treatment. No significant differences in plasma glucose, insulin, cholesterol, and triglycerides were observed with RSLE-treated groups compared with vehicle control. Conclusion: RSLE demonstrated antidiabetic effects in vitro and in vivo and may improve metabolic syndrome conditions of fatty liver and glucose metabolism. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Cheng, Diana M.; Pogrebnyak, Natalia; Kuhn, Peter; Poulev, Alexander; Waterman, Carrie; Rojas-Silva, Patricio; Raskin, Ilya] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA.
   [Johnson, William D.] Pennington Biomed Res Ctr, Dept Biostat, Baton Rouge, LA 70808 USA.
C3 Rutgers University System; Rutgers University New Brunswick; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center
RP Cheng, DM (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA.
EM Cheng@aesop.rutgers.edu
FU National Center for Complementary and Alternative Medicine (NCCAM) [P50 AT002776]; Office of Dietary Supplements (ODS); Botanical Research Center and Botanical Research Center Pilot Program [5 P50 AT002776, 08 S12 to 50318]; NIH [T32: 5 132 AT004094 to 04]; SENESCYT-2011 Ecuadorian fellowship
CR AOKI H, 2002, FOODS AND FOOD INGREDIENTS JOURNAL OF JAPAN, V0, P41
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Bazzano LA, 2002, AM J CLIN NUTR, V76, P93
   Bumgarner NR, 2012, PLANT FOOD HUM NUTR, V67, P215, DOI 10.1007/s11130-012-0306-0
   Cheng DM, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0091571
   Cheng DM, 2012, FOOD CHEM, V135, P2994, DOI 10.1016/j.foodchem.2012.06.117
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Chuang CC, 2010, AM J CLIN NUTR, V92, P1511, DOI 10.3945/ajcn.2010.29807
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127
   Ferreres F, 1997, J AGR FOOD CHEM, V45, P4249, DOI 10.1021/jf970399j
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P11100, DOI 10.1021/jf901278u
   Grace MH, 2009, PHYTOMEDICINE, V16, P406, DOI 10.1016/j.phymed.2009.02.018
   Guo HH, 2012, J NUTR BIOCHEM, V23, P349, DOI 10.1016/j.jnutbio.2010.12.013
   Held P, 2012, PERFORMING OXGEN RAD, V0, P0
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296
   Ioannou I, 2012, J FOOD ENG, V111, P208, DOI 10.1016/j.jfoodeng.2012.02.006
   Iwai K, 2012, FOOD SCI TECHNOL RES, V18, P849, DOI 10.3136/fstr.18.849
   Lee J, 2005, J AOAC INT, V88, P1269
   Lee JH, 2009, BRIT J NUTR, V101, P1246, DOI 10.1017/S0007114508073650
   Lumeng CN, 2013, MOL ASPECTS MED, V34, P12, DOI 10.1016/j.mam.2012.10.002
   MORISHITA H, 1984, J CHROMATOGR, V315, P253, DOI 10.1016/S0021-9673(01)90742-3
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Muraki I, 2013, BMJ-BRIT MED J, V347, P0, DOI 10.1136/bmj.f5001
   Murase T, 2012, BRIT J NUTR, V107, P1757, DOI 10.1017/S0007114511005083
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   Nicolle C, 2004, J SCI FOOD AGR, V84, P2061, DOI 10.1002/jsfa.1916
   Nicolle C, 2004, CLIN NUTR, V23, P605, DOI 10.1016/j.clnu.2003.10.009
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Prior RL, 2003, J AGR FOOD CHEM, V51, P3273, DOI 10.1021/jf0262256
   Qin Bolin, 2010, J DIABETES SCI TECHNOL, V4, P685
   Rivera L, 2008, OBESITY, V16, P2081, DOI 10.1038/oby.2008.315
   Roopchand DE, 2013, PHARMACOL RES, V68, P59, DOI 10.1016/j.phrs.2012.11.008
   Roopchand DE, 2012, J AGR FOOD CHEM, V60, P8860, DOI 10.1021/jf300232h
   Rie S, 2007, BIOCHEM PHARMACOL, V74, P1619, DOI 10.1016/j.bcp.2007.08.008
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   Stull AJ, 2010, J NUTR, V140, P1764, DOI 10.3945/jn.110.125336
   SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X
   van Dam RM, 2013, CURR OPIN LIPIDOL, V24, P25, DOI 10.1097/MOL.0b013e32835bcdff
   Vitaglione P, 2010, HEPATOLOGY, V52, P1652, DOI 10.1002/hep.23902
   WALD B, 1989, PHYTOCHEMISTRY, V28, P663, DOI 10.1016/0031-9422(89)80083-4
   Wu XL, 2004, J AGR FOOD CHEM, V52, P7846, DOI 10.1021/jf0486850
NR 45
TC 56
Z9 59
U1 0
U2 37
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD JUL-AUG 15
PY 2014
VL 30
IS 7-8
BP S52
EP S58
DI 10.1016/j.nut.2014.02.022
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA AL7ID
UT WOS:000339306500010
PM 24985107
DA 2025-04-28
ER

PT J
AU Marrelli, M
   Loizzo, MR
   Nicoletti, M
   Menichini, F
   Conforti, F
AF Marrelli, Mariangela
   Loizzo, Monica Rosa
   Nicoletti, Marcello
   Menichini, Francesco
   Conforti, Filomena
TI In vitro investigation of the potential health benefits of wild Mediterranean dietary plants as anti-obesity agents with Œ±-amylase and pancreatic lipase inhibitory activities
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article
DE wild edible plants; pancreatic lipase; alpha-amylase; inhibitors; chemical composition
ID obesity; glucosidase; antioxidant; prevalence; flavonoids; saponin
AB BACKGROUND: Inhibition of digestive enzymes is one of the most widely studied mechanisms used to determine the potential efficacy of natural products as anti-obesity agents. In vitro studies reported here were performed to evaluate the inhibitory activity of formulations of edible plants from Italy on amylase and lipase by monitoring the hydrolysis of nitrophenyl caprilate and the hydrolysis of glycoside bonds in digestible carbohydrate foods. RESULTS: The formulation obtained from Capparis sicula exhibited the strongest inhibitory effect on pancreatic lipase (IC50 = 0.53 mg mL(-1)) while the Borago officinalis formulation exhibited the strongest inhibitory effect on alpha-amylase (IC50 = 31.61 mu g mL(-1)). In order to characterise the extracts, high-performance thin-layer chromatography analysis of the formulations was performed, revealing the predominance of (+/-)-catechin in Mentha aquatica formulation, rutin in C. sicula, and caffeic acid and chlorogenic acid in Echium vulgare. CONCLUSION: The results obtained indicated that the extracts of C. sicula and B. officinalis could be good candidates for further studies to isolate pancreatic lipase and alpha-amylase inhibitors, respectively. (C) 2013 Society of Chemical Industry
C1 [Marrelli, Mariangela; Loizzo, Monica Rosa; Menichini, Francesco; Conforti, Filomena] Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87036 Arcavacata Di Rende, CS, Italy.
   [Nicoletti, Marcello] Univ Roma La Sapienza, Dept Environm Biol, Rome, Italy.
C3 University of Calabria; Sapienza University Rome
RP Conforti, F (corresponding author), Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87036 Arcavacata Di Rende, CS, Italy.
EM filomena.conforti@unical.it
CR Birari RB, 2007, DRUG DISCOV TODAY, V12, P879, DOI 10.1016/j.drudis.2007.07.024
   Bustanji Y, 2011, J ENZYM INHIB MED CH, V26, P453, DOI 10.3109/14756366.2010.525509
   Carek PJ, 1999, DRUGS, V57, P883, DOI 10.2165/00003495-199957060-00005
   Chen PN, 2006, CANCER LETT, V235, P248, DOI 10.1016/j.canlet.2005.04.033
   Chiasson Jean-Louis, 2006, ENDOCR PRACT, V12 Suppl 1, P25
   Conforti F, 2008, FOOD CHEM TOXICOL, V46, P3325, DOI 10.1016/j.fct.2008.08.004
   Conforti F, 2012, PHYTOTHER RES, V26, P600, DOI 10.1002/ptr.3603
   de Sales PM, 2012, J PHARM PHARM SCI, V15, P141
   Elkhayat ES, 2008, J ASIAN NAT PROD RES, V10, P1039, DOI 10.1080/10286020802320590
   Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39
   Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861
   Funke I, 2005, PHARMAZIE, V60, P796
   Galhardo J, 2010, ARCH DIS CHILD, V95, P856, DOI 10.1136/adc.2010.190959
   Glensk M, 1999, J NAT PROD, V62, P717, DOI 10.1021/np980505r
   Grussu D, 2011, J AGR FOOD CHEM, V59, P2324, DOI 10.1021/jf1045359
   Karu N, 2007, J AGR FOOD CHEM, V55, P2824, DOI 10.1021/jf0628025
   Kim YS, 2010, J ETHNOPHARMACOL, V130, P621, DOI 10.1016/j.jep.2010.05.053
   de la Garza AL, 2011, PLANTA MED, V77, P773, DOI 10.1055/s-0030-1270924
   Lee YM, 2012, PHYTOTHER RES, V26, P778, DOI 10.1002/ptr.3644
   Li MF, 2009, BRIT J CLIN PHARMACO, V68, P804, DOI 10.1111/j.1365-2125.2009.03453.x
   Loizzo MR, 2008, J MED FOOD, V11, P184, DOI 10.1089/jmf.2007.638
   LOWE ME, 1994, GASTROENTEROLOGY, V107, P1524, DOI 10.1016/0016-5085(94)90559-2
   Marrelli M, 2013, PLANT FOOD HUM NUTR, V68, P340, DOI 10.1007/s11130-013-0390-9
   Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76
   Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238
   Morikawa T, 2010, YAKUGAKU ZASSHI, V130, P673, DOI 10.1248/yakushi.130.673
   Nagai T, 2012, FOOD AND NUTRITION SCIENCES, V3, P614, DOI 10.4236/fns.2012.35084
   Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s
   Nicoletti M, 2012, STUD NAT PROD CHEM, V37, P217, DOI 10.1016/B978-0-444-59514-0.00008-0
   Nicoletti M, 2011, REV BRAS FARMACOGN, V21, P818, DOI 10.1590/S0102-695X2011005000131
   Piccin A, 2012, NUTRAFOODS, V11, P29
   Qian JY, 2004, FOOD CHEM, V87, P283, DOI 10.1016/j.foodchem.2003.11.008
   Sales PMD, 2012, JOURNAL OF PHARMACOLOGY AND PHARMACEUTICAL SCIENCES, V15, P141, DOI 10.18433/J35S3K
   Schnee DM, 2006, CURR MED RES OPIN, V22, P1463, DOI 10.1185/030079906X115496
   Soobrattee MA, 2005, MUTAT RES-FUND MOL M, V579, P200, DOI 10.1016/j.mrfmmm.2005.03.023
   Sreerama YN, 2012, J FOOD SCI, V77, PC927, DOI 10.1111/j.1750-3841.2012.02848.x
   Tundis R, 2010, MINI-REV MED CHEM, V10, P315, DOI 10.2174/138955710791331007
   Vetter ML, 2010, NAT REV ENDOCRINOL, V6, P578, DOI 10.1038/nrendo.2010.121
   Wang HY, 2013, ADV FOOD NUTR RES, V70, P103, DOI 10.1016/B978-0-12-416555-7.00003-5
   Youdim KA, 2002, J NUTR BIOCHEM, V13, P282, DOI 10.1016/S0955-2863(01)00221-2
   Yuda N, 2012, J FOOD SCI, V77, PH254, DOI 10.1111/j.1750-3841.2012.02967.x
   Zia-Ul-Haq M, 2011, INT J MOL SCI, V12, P8846, DOI 10.3390/ijms12128846
NR 42
TC 65
Z9 69
U1 1
U2 78
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD AUG 15
PY 2014
VL 94
IS 11
BP 2217
EP 2224
DI 10.1002/jsfa.6544
PG 8
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology
SC Agriculture; Chemistry; Food Science & Technology
GA AL3BA
UT WOS:000338998700010
PM 24535986
DA 2025-04-28
ER

PT J
AU Takahashi, S
   Egashira, K
   Saito, K
   Jia, HJ
   Abe, K
   Kato, H
AF Takahashi, Shoko
   Egashira, Kenji
   Saito, Kenji
   Jia, Huijuan
   Abe, Keiko
   Kato, Hisanori
TI Coffee intake down-regulates the hepatic gene expression of peroxisome proliferator-activated receptor gamma in C57BL/6J mice fed a high-fat diet
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE DNA microarray; Anti-obesity; Adipogenic hepatic steatosis; Chlorogenic acid; Lipid metabolism
ID ppar-gamma; transcriptional regulation; glucose-tolerance; chlorogenic acid; mouse-liver; consumption; humans; risk; steatosis
AB Several lines of evidence, including those from epidemiological studies, have suggested that coffee intake reduces the risks of diabetes and obesity, although the detailed mechanisms of such effects are not clearly understood. The present study was conducted to examine the effects of three types of coffee (caffeinated, decaffeinated, and green unroasted coffee) on the livers of C57BL/6J mice fed a high-fat diet, and to elucidate the detailed physiological responses to coffee intake by analysing the data obtained from a transcriptomic analysis using DNA microarrays. The results showed that the three types of coffee suppressed the weight gain and fat accumulation induced by a high-fat diet. A remarkable finding was a down-regulation of PPAR gamma and related molecules. Furthermore, the protein levels of hepatic peroxisome proliferator-activated receptor gamma (PPAR gamma) were revealed by Western blot analysis to be lower in all of the coffee-fed groups compared to the high-fat group. Since overexpression of PPAR gamma in the liver has been implicated in adipogenic hepatic steatosis, we hypothesised that the alterations in PPAR gamma and its target molecules, which play pivotal roles in adipogenic hepatic steatosis, might be involved in the anti-obesity effect of coffee. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Takahashi, Shoko; Egashira, Kenji; Abe, Keiko] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan.
   [Takahashi, Shoko; Egashira, Kenji; Saito, Kenji; Jia, Huijuan; Kato, Hisanori] Univ Tokyo, Org Interdisciplinary Res Projects, Bunkyo Ku, Tokyo 1138657, Japan.
C3 University of Tokyo; University of Tokyo
RP Kato, H (corresponding author), Univ Tokyo, Org Interdisciplinary Res Projects, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.
EM akatoq@mail.ecc.u-tokyo.ac.jp
FU All Japan Coffee Association
CR Unknown -, 2006, BMC COMPLEM ALTERN M, V0, P0
   Bai LA, 2011, HEPATOLOGY, V53, P1164, DOI 10.1002/hep.24155
   Bidel S, 2006, HORM METAB RES, V38, P38, DOI 10.1055/s-2006-924982
   Boelsterli UA, 2002, BIOCHEM PHARMACOL, V63, P1, DOI 10.1016/S0006-2952(01)00817-6
   Carlsson S, 2004, INT J EPIDEMIOL, V33, P616, DOI 10.1093/ije/dyh185
   Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P11100, DOI 10.1021/jf901278u
   Hoelzl C, 2010, MOL NUTR FOOD RES, V54, P1722, DOI 10.1002/mnfr.201000048
   Hong SH, 2001, J BIOL CHEM, V276, P28098, DOI 10.1074/jbc.M010912200
   Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Jia HJ, 2013, J FUNCT FOODS, V5, P1611, DOI 10.1016/j.jff.2013.07.003
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kadota K, 2008, ALGORITHM MOL BIOL, V3, P0, DOI 10.1186/1748-7188-3-8
   Kato H, 2005, CURR OPIN CLIN NUTR, V8, P516, DOI 10.1097/01.mco.0000179166.33323.c3
   Kreppenhofer S, 2011, FOOD CHEM, V126, P441, DOI 10.1016/j.foodchem.2010.11.008
   Lim HJ, 2006, PROSTAG OTH LIPID M, V80, P165, DOI 10.1016/j.prostaglandins.2006.06.006
   Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   Pimentel GD, 2009, DIABETOL METAB SYNDR, V1, P0, DOI 10.1186/1758-5996-1-6
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Viswakarma N, 2007, J BIOL CHEM, V282, P18613, DOI 10.1074/jbc.M701983200
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Williamson G, 2011, MOL NUTR FOOD RES, V55, P864, DOI 10.1002/mnfr.201000631
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
   Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200
NR 32
TC 9
Z9 9
U1 1
U2 23
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JAN 15
PY 2014
VL 6
IS 
BP 157
EP 167
DI 10.1016/j.jff.2013.10.002
PG 11
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA AA9OO
UT WOS:000331423000015
DA 2025-04-28
ER

PT J
AU Nakamura, R
   Pechey, R
   Suhrcke, M
   Jebb, SA
   Marteau, TM
AF Nakamura, Ryota
   Pechey, Rachel
   Suhrcke, Marc
   Jebb, Susan A.
   Marteau, Theresa M.
TI Sales impact of displaying alcoholic and non-alcoholic beverages in end-of-aisle locations: An observational study
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE United Kingdom; Alcohol; Non-alcoholic beverages; End-of-aisle display; Grocery store; Primary prevention
ID supermarket; behavior; obesity; foods
AB In-store product placement is perceived to be a factor underpinning impulsive food purchasing but empirical evidence is limited. In this study we present the first in-depth estimate of the effect of end-of-aisle display on sales, focussing on alcohol. Data on store layout and product-level sales during 2010-11 were obtained for one UK grocery store, comprising detailed information on shelf space, price, price promotion and weekly sales volume in three alcohol categories (beer, wine, spirits) and three non-alcohol categories (carbonated drinks, coffee, tea). Multiple regression techniques were used to estimate the effect of end-of-aisle display on sales, controlling for price, price promotion, and the number of display locations for each product. End-of-aisle display increased sales volumes in all three alcohol categories: by 23.2% (p = 0.005) for beer, 33.6% (p < 0.001) for wine, and 46.1% (p < 0.001) for spirits, and for three non-alcohol beverage categories: by 51.7% (p < 0.001) for carbonated drinks, 73.5% (p < 0.001) for coffee, and 113.8% (p < 0.001) for tea. The effect size was equivalent to a decrease in price of between 4% and 9% per volume for alcohol categories, and a decrease in price of between 22% and 62% per volume for non-alcohol categories. End-of-aisle displays appear to have a large impact on sales of alcohol and non-alcoholic beverages. Restricting the use of aisle ends for alcohol and other less healthy products might be a promising option to encourage healthier in-store purchases, without affecting availability or cost of products. (c) 2014 The Authors. Published by Elsevier Ltd.
C1 [Nakamura, Ryota; Pechey, Rachel; Suhrcke, Marc; Jebb, Susan A.; Marteau, Theresa M.] Univ Cambridge, Inst Publ Hlth, Behav & Hlth Res Unit, Cambridge CB2 1TN, England.
   [Nakamura, Ryota; Suhrcke, Marc] Univ E Anglia, Norwich Med Sch, Hlth Econ Grp, Norwich NR4 7TJ, Norfolk, England.
   [Jebb, Susan A.] Elsie Widdowson Lab, MRC Human Nutr Res, Cambridge, England.
C3 University of Cambridge; University of East Anglia; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research
RP Marteau, TM (corresponding author), Univ Cambridge, Inst Publ Hlth, Behav & Hlth Res Unit, Cambridge CB2 1TN, England.
EM tm388@cam.ac.uk
FU MRC [MC_U105960389] Funding Source: UKRI
CR BEMMAOR AC, 1991, J MARKETING RES, V28, P202, DOI 10.2307/3172808
   CHEVALIER M, 1975, J MARKETING RES, V12, P426, DOI 10.2307/3151091
   Chintagunta P, 2005, MANAGE SCI, V51, P832, DOI 10.1287/mnsc.1040.0323
   Cohen DA, 2012, OBES REV, V13, P766, DOI 10.1111/j.1467-789X.2012.01001.x
   Cohen DA, 2012, NEW ENGL J MED, V367, P1381, DOI 10.1056/NEJMp1209443
   Competition Commission, 2000, BACKGR CHAPT, V2, P0
   CURHAN RC, 1974, J MARKETING RES, V11, P286, DOI 10.2307/3151144
   Erdem T, 1999, J ECONOMETRICS, V89, P177
   FRANK RE, 1970, J MARKETING RES, V7, P59, DOI 10.2307/3149508
   Glanz K, 2012, AM J PREV MED, V42, P503, DOI 10.1016/j.amepre.2012.01.013
   HONORE BE, 1992, ECONOMETRICA, V60, P533, DOI 10.2307/2951583
   Klein B, 2007, J LAW ECON, V50, P421, DOI 10.1086/524125
   Lee A, 2013, OBES REV, V14, P82, DOI 10.1111/obr.12078
   Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918
   Mhurchu CN, 2013, OBES REV, V14, P108, DOI 10.1111/obr.12080
   Nevo A, 2001, ECONOMETRICA, V69, P307, DOI 10.1111/1468-0262.00194
   PARK CW, 1989, J CONSUM RES, V15, P422, DOI 10.1086/209182
   Sigurdsson V, 2011, SERV IND J, V31, P2543, DOI 10.1080/02642069.2011.531127
   Sorensen H, 2003, MARK RES, V15, P30
   Sorensen H, 2008, J ADVERTISING RES, V48, P329, DOI 10.2501/S0021849908080380
   Stuckler D, 2012, PLOS MED, V9, P0, DOI 10.1371/journal.pmed.1001235
   USDA Foreign Agricultural Service, 2011, UK SUP CHAIN PROF GA, V0, P0
   Waterlander WE, 2011, BMC PUBLIC HEALTH, V11, P0, DOI 10.1186/1471-2458-11-589
   Wilkie WL, 2002, J PUBLIC POLICY MARK, V21, P275, DOI 10.1509/jppm.21.2.275.17591
   WILKINSON JB, 1982, J MARKETING RES, V19, P72, DOI 10.2307/3151532
NR 25
TC 58
Z9 65
U1 3
U2 34
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
EI 1873-5347
J9 SOC SCI MED
JI Soc. Sci. Med.
PD MAY 15
PY 2014
VL 108
IS 
BP 68
EP 73
DI 10.1016/j.socscimed.2014.02.032
PG 6
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA AH4PE
UT WOS:000336109700008
PM 24632050
DA 2025-04-28
ER

PT J
AU Szewczyk, K
   Zidorn, C
AF Szewczyk, Katarzyna
   Zidorn, Christian
TI Ethnobotany, phytochemistry, and bioactivity of the genus Turnera (Passifloraceae) with a focus on damiana-Turnera diffusa
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Review
DE Passifloraceae; Chemosystematics; Aphrodisiacs; Ethnomedicine; Pharmacology
ID mexican medicinal-plants; anti-aromatase activity; ulmifolia l turneraceae; willd. ex schult.; essential oil; antioxidant activity; quality-control; nutritional supplement; cyanohydrin glucosides; antibacterial activity
AB Ethnopharmacological relevance: Half a dozen of the currently accepted 135 Turnera species are used in traditional medicine, most notably Turnera diffusa Willd. ex Schult. which is one of the most highly appreciated plant aphrodisiacs. Other traditional uses of Turnera L species include the treatment of anaemia, bronchitis, cough, diabetes, fever, fungal disease, gastrointestinal complaints, pain, pulmonary and respiratory diseases, skin disorders, and women's health problems. Additionally, Turnera species are used as abortives, expectorants, and laxatives. Phytochemistiy: Flavonoids (22 different compounds), maltol glucoside, phenolics, cyanogenic glycosides (7 different compounds), monoterpenoids, sesquiterpenoids, triterpenoids, the polyterpene ficaprenol-11, fatty acids, and caffeine have been found in the genus Turnera. Bioactivity: Bioactivities experimentally proven for members of the genus Tumera encompass antianxiety, antiaromatase, antibacterial including antimycobacterial, antidiabetic, antioxidant, adapatogenic, antiobesity, antispasmodic, cytotoxic, gastroprotective, hepatoprotective, and aphrodisiac activities. Most of these activities have so far been investigated only in chemical, cell based, or animal assays. In contrast, the antiobesity activity was also investigated in a study on healthy human subjects and with a herbal preparation containing among other ingredients Tumera diffusa leaves. Moreover, the enhancement of female sexual function was assessed in humans; again the product contained besides Turnera diffusa other potentially bioactive ingredients. However, with only few exceptions, most of the traditional uses and the experimentally verified bioactivities can currently not be related to a particular compound or compound class. A notable exception is the flavonoid apigenin, which was identified animal experiments as the antinociceptive principle of Tumera diffusa. Conclusion: In this review, the current knowledge on ethnobotanical uses of members of the genus Turnera, the secondary metabolites reported from Tumera, and experimentally documented bioactivities from Tumera extracts and pure compounds derived from Tumera extracts are compiled. Moreover, some of the most interesting avenues for future research projects are being discussed briefly. These include in particular the aphrodisiac activity of Tumera diffusa and the antibiotic activity potentiating effect of Tumera ulmifolia L. against aminoglycoside resistant bacteria. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
C1 [Szewczyk, Katarzyna] Med Univ Lublin, Chair & Dept Pharmaceut Bot, PL-20093 Lublin, Poland.
   [Zidorn, Christian] Univ Innsbruck, Inst Pharm, Abt Pharmakognosie, A-6020 Innsbruck, Austria.
C3 Medical University of Lublin; University of Innsbruck
RP Zidorn, C (corresponding author), Univ Innsbruck, Inst Pharm, Abt Pharmakognosie, Innrain 80-82, A-6020 Innsbruck, Austria.
EM Christian.H.Zidorn@uibk.ac.at
CR Abedi A, 2013, ADV SEX MED, V3, P28, DOI 10.4236/asm.2013.31006
   Adak M, 2008, J I MED, V30, P23
   Agra MF, 2007, J ETHNOPHARMACOL, V111, P383, DOI 10.1016/j.jep.2006.12.007
   Aguilar A, 1994, FLORA MED INDIGENA M, V1-3, P0
   Aguilera-Carbo AF, 2008, CHEM PAP, V62, P440, DOI 10.2478/s11696-008-0042-y
   Alarcon-Aguilar FJ, 2002, PHYTOTHER RES, V16, P383, DOI 10.1002/ptr.914
   Alarcon-Aguilara FJ, 1998, J ETHNOPHARMACOL, V61, P101, DOI 10.1016/S0378-8741(98)00020-8
   Alcaraz-Mel√©ndez L, 2004, FITOTERAPIA, V75, P696, DOI 10.1016/j.fitote.2004.09.001
   Alcaraz-Mel√©ndez L, 2007, J PLANT BIOL, V50, P378, DOI 10.1007/BF03030671
   Soriano-Melgar LDA, 2012, IND CROP PROD, V37, P321, DOI 10.1016/j.indcrop.2011.12.017
   Almir de Aradjo F, 2011, REV VERDE AGROECOLOG, V6, P149
   Alves IC, 2009, 4 C PESQ IN RED NORT, V0, P0
   Andersen T, 2001, J HUM NUTR DIET, V14, P243, DOI 10.1046/j.1365-277X.2001.00290.x
   Andrade-Cetto A, 2005, J ETHNOPHARMACOL, V99, P325, DOI 10.1016/j.jep.2005.04.019
   Ankli A, 1999, ECON BOT, V53, P144, DOI 10.1007/BF02866493
   Unknown -, 2009, IRAN J PHARM THER, V0, P0
   Unknown -, 2011, BIOFAR REV BIOL FARM, V0, P0
   Unknown -, 1994, HERBARIO MED I MEXIC, V0, P0
   Antonio MA, 1998, J ETHNOPHARMACOL, V61, P215, DOI 10.1016/S0378-8741(98)00049-X
   Arbo MM, 2011, SYST BIODIVERS, V9, P203, DOI 10.1080/14772000.2011.603382
   Argueta VA, 1994, ATLAS PLANTAS MEDICI, V0, P1786
   Arletti R, 1999, PSYCHOPHARMACOLOGY, V143, P15, DOI 10.1007/s002130050913
   Aung HH, 2004, AM J CHINESE MED, V32, P161, DOI 10.1142/S0192415X04001837
   AUTERHOFF H, 1968, ARCH PHARM, V301, P537, DOI 10.1002/ardp.19683010710
   Barbosa Danila de Ara√∫jo, 2007, REV. BRAS. FARMACOGN., V17, P396, DOI 10.1590/S0102-695X2007000300016
   Bezerra AG, 2011, REV BRAS FARMACOGN, V21, P121, DOI 10.1590/S0102-695X2011005000019
   Bicchi C, 2003, FLAVOUR FRAG J, V18, P59, DOI 10.1002/ffj.1155
   Brito NJN, 2012, FOOD CHEM TOXICOL, V50, P4340, DOI 10.1016/j.fct.2012.08.003
   Bueno J, 2011, NAT PROD COMMUN, V6, P1743
   Bueno-Sanchez JG, 2010, REV SALUD PUBLICA S2, V12, P53
   Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385
   Camargo EES, 2010, REV BRAS FARMACOGN, V20, P228, DOI 10.1590/S0102-695X2010000200015
   Canales M, 2005, J ETHNOPHARMACOL, V97, P429, DOI 10.1016/j.jep.2004.11.013
   Cartaxo SL, 2010, J ETHNOPHARMACOL, V131, P326, DOI 10.1016/j.jep.2010.07.003
   Chai TsunThai Chai TsunThai, 2012, JOURNAL OF MEDICINAL PLANTS RESEARCH, V6, P1730, DOI 10.5897/JMPR11.1541
   Chang R, 2011, REV BRAS FARMACOGN, V21, P392, DOI 10.1590/S0102-695X2011005000042
   Chen S, 2006, CANCER RES, V66, P12026, DOI 10.1158/0008-5472.CAN-06-2206
   Coe FG, 1999, ECON BOT, V53, P363, DOI 10.1007/BF02866715
   Coelho-Ferreira M, 2009, J ETHNOPHARMACOL, V126, P159, DOI 10.1016/j.jep.2009.07.016
   Cornara L, 2013, INT J LEGAL MED, V127, P1109, DOI 10.1007/s00414-013-0893-9
   Correa MPio, 1984, DICIONARIO DAS PLANTAS UTEIS DO BRASIL, V0, P0
   Coutinho HDM, 2009, BMC COMPLEM ALTERN M, V9, P0, DOI 10.1186/1472-6882-9-13
   Cruz MD, 1991, LIBELLUS DE MEDICINALIBUS INDORUM HERBIS, V0, P0
   De Albuquerque UP, 2007, J ETHNOPHARMACOL, V114, P325, DOI 10.1016/j.jep.2007.08.017
   Mota KSD, 2009, MOLECULES, V14, P979, DOI 10.3390/molecules14030979
   de Salvatierra JM, 1699, NUEVAS CARTAS CALIFO, V0, P0
   DOMINGUEZ XA, 1976, PLANTA MED, V30, P68, DOI 10.1055/s-0028-1097695
   Dragendorff G, 1898, HEILPFLANZEN VERSCHI, V0, P0
   Estrada-Castill√≥n E, 2012, J ETHNOBIOL ETHNOMED, V8, P0, DOI 10.1186/1746-4269-8-45
   Estrada-Reyes R, 2013, J ETHNOPHARMACOL, V146, P164, DOI 10.1016/j.jep.2012.12.025
   Estrada-Reyes R, 2009, J ETHNOPHARMACOL, V123, P423, DOI 10.1016/j.jep.2009.03.032
   Falcao HS, 2008, PHYTOMEDICINE, V15, P132, DOI 10.1016/j.phymed.2007.07.057
   Feistel B, 2010, PLANTA MED, V76, P1193
   FOSTER S, 1999, TYLERS HONEST HERBAL: A SENSIBLE GUIDE TO THE USE OF HERBS AND RELATED REMEDIES, VFOURTH, P0
   Franco EAP, 2006, REVISTA BRASILEIRA DE PLANTAS MEDICINAIS, V8, P78
   Frei B, 1998, J ETHNOPHARMACOL, V62, P149, DOI 10.1016/S0378-8741(98)00051-8
   Galvez J, 2006, FITOTERAPIA, V77, P515, DOI 10.1016/j.fitote.2006.05.029
   Garza-Ju√°rez A, 2011, PLANTA MED, V77, P958, DOI 10.1055/s-0030-1250684
   Gawlik-Dziki U, 2008, FOOD CHEM, V109, P393, DOI 10.1016/j.foodchem.2007.12.058
   Giron LM, 1996, PLANTAS DE USO MEDICINAL EN GUATEMALA, V0, P0
   Godoi AFL, 2004, J CHROMATOGR A, V1027, P127, DOI 10.1016/j.chroma.2003.08.079
   Gonzalez-Stuart AE, 2010, NOTULAE SCIENTIA BIOLOGICAE, V2, P7
   Gracioso JD, 2002, BIOL PHARM BULL, V25, P487, DOI 10.1248/bpb.25.487
   Halberstein R A, 1997, J ALTERN COMPLEMENT MED, V3, P227, DOI 10.1089/acm.1997.3.227
   Halberstein RA, 2005, ANN EPIDEMIOL, V15, P686, DOI 10.1016/j.annepidem.2005.02.004
   Halberstein RA, 2012, STUD NAT PROD CHEM, V37, P1, DOI 10.1016/B978-0-444-59514-0.00001-8
   Harrold JA, 2013, APPETITE, V62, P84, DOI 10.1016/j.appet.2012.11.018
   Heinrich M, 2006, CURR DRUG TARGETS, V7, P239, DOI 10.2174/138945006776054988
   Heinrich M, 1998, SOC SCI MED, V47, P1859, DOI 10.1016/S0277-9536(98)00181-6
   Heinrich M, 2006, J ETHNOPHARMACOL, V107, P157, DOI 10.1016/j.jep.2006.05.035
   Hern√°ndez T, 2005, INTERCIENCIA, V30, P529
   Hern√°ndez T, 2003, J ETHNOPHARMACOL, V88, P181, DOI 10.1016/S0378-8741(03)00213-7
   Hernandez-Galicia E, 2002, P W PHARMACOL SOC, V45, P118
   Hnatyszyn O, 2003, PHYTOMEDICINE, V10, P669, DOI 10.1078/0944-7113-00261
   HOSAMANI KM, 1993, PHYTOCHEMISTRY, V34, P1363, DOI 10.1016/0031-9422(91)80030-5
   HUANG ZJ, 1982, J PHARM SCI, V71, P270, DOI 10.1002/jps.2600710235
   Hughes G, 2011, APPETITE, V57, P550
   Israel D, 1997, PHARMACOTHERAPY, V17, P970
   Ito TY, 2006, J SEX MARITAL THER, V32, P369, DOI 10.1080/00926230600834901
   Ito TY, 2001, J SEX MARITAL THER, V27, P541, DOI 10.1080/713846828
   Jang M, 2013, FOOD SCI BIOTECHNOL, V22, P213, DOI 10.1007/s10068-013-0069-x
   Jaroszewski JW, 1996, PHYTOCHEMISTRY, V42, P649, DOI 10.1016/0031-9422(96)00065-9
   KELLIS JT, 1984, SCIENCE, V225, P1032, DOI 10.1126/science.6474163
   Kikuchi H, 2010, FORENSIC TOXICOL, V28, P77, DOI 10.1007/s11419-010-0091-0
   Kumar D, 2012, J ETHNOPHARMACOL, V140, P1, DOI 10.1016/j.jep.2011.12.039
   Kumar S, 2007, NIGERIAN JOURNAL OF NATURAL PRODUCTS AND MEDICINE, V11, P5
   Kumar S, 2006, PHARM BIOL, V44, P84, DOI 10.1080/13880200600591758
   Kumar S, 2005, PHARM BIOL, V43, P383, DOI 10.1080/13880200590962926
   Kumar S, 2005, EVID-BASED COMPL ALT, V2, P117, DOI 10.1093/ecam/neh069
   Kumar S, 2008, INDIAN J PHARM SCI, V70, P740, DOI 10.4103/0250-474X.49095
   Kumar S, 2009, INT J PHARMACOGN PHY, V1, P1
   Kumar Suresh, 2005, JOURNAL OF HERBAL PHARMACOTHERAPY, V5, P13, DOI 10.1080/J157v05n04_02
   Kumar S, 2006, J MED FOOD, V9, P254, DOI 10.1089/jmf.2006.9.254
   Li HB, 2008, LWT-FOOD SCI TECHNOL, V41, P385, DOI 10.1016/j.lwt.2007.03.011
   Linares E, 1999, PLANTAS MED MEXICO U, V0, P102
   Mabberley DJ, 2008, MABBERLEYS PLANT BOO, VThird, P0
   Makheswari MU, 2012, INT J PHARMA SCI RES, V3, P287
   Martinez M, 1969, LAS PLANTAS MEDICINALES DE MEXICO, V0, P0
   Mart√≠nez MR, 2004, J ETHNOPHARMACOL, V95, P317, DOI 10.1016/j.jep.2004.07.018
   Mendes FR, 2011, REV BRAS FARMACOGN, V21, P754, DOI 10.1590/S0102-695X2011005000097
   Mendes FR, 2007, J ETHNOPHARMACOL, V109, P493, DOI 10.1016/j.jep.2006.08.024
   Arbo MM, 2009, TAXON, V58, P457
   Mitchell SA, 2011, FOCUS ON ALTERNATIVE AND COMPLEMENTARY THERAPIES, V16, P271, DOI 10.1111/j.2042-7166.2011.01124.x
   Morais SM, 1994, JOURNAL OF ESSENTIAL OIL RESEARCH, V6, P429
   Murugan T, 2011, INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND BIOLOGICAL ARCHIVES, V2, P1456
   NAKANISHI K, 1965, CHEM PHARM BULL, V13, P882
   Nascimento MA, 2006, BIORESOURCE TECHNOL, V97, P1387, DOI 10.1016/j.biortech.2005.07.009
   NASCIMENTO S C, 1990, FITOTERAPIA, V61, P353
   Neffa VGS, 2003, BOT J LINN SOC, V141, P85
   Neven MM, 2012, NY SCI J, V5, P50
   OLAFSDOTTIR ES, 1992, PHYTOCHEMISTRY, V31, P4129, DOI 10.1016/0031-9422(92)80427-G
   OLAFSDOTTIR ES, 1990, BIOCHEM SYST ECOL, V18, P435, DOI 10.1016/0305-1978(90)90089-X
   ORTIZDEMONTELLANO B, 1975, SCIENCE, V188, P215, DOI 10.1126/science.1090996
   Ososki AL, 2002, J ETHNOPHARMACOL, V79, P285, DOI 10.1016/S0378-8741(01)00376-2
   Otsuka Rafaela Denise, 2010, CENTRAL NERVOUS SYSTEM AGENTS IN MEDICINAL CHEMISTRY, V10, P218
   Paredes-Flores M, 2007, ACTA BOT MEX, V79, P13
   Patel DK, 2011, ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE, V1, PS131, DOI 10.1016/S2221-1691(11)60140-8
   PEREZ RM, 1984, J ETHNOPHARMACOL, V12, P253, DOI 10.1016/0378-8741(84)90054-0
   P√©rez-Meseguer J, 2010, J AOAC INT, V93, P1161
   Piacente S, 2002, Z NATURFORSCH C, V57, P983
   Pino JA, 2010, NAT PROD COMMUN, V5, P1829
   Presser AM, 2000, PHARM GUIDE MED HERB, V0, P0
   Ram√≠rez-Dur√≥n R, 2007, J AOAC INT, V90, P920
   Ratsch C, 1997, PFLANZEN LIEBE, V0, P0
   Reiser C, 2000, J UNDERGRAD RES, V3, P109
   Lucio-Guti√©rrez JR, 2012, J CHROMATOGR A, V1235, P68, DOI 10.1016/j.chroma.2012.02.042
   RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2
   Roque AA, 2010, REV. BRAS. PLANTAS MED., V12, P31, DOI 10.1590/S1516-05722010000100006
   Rybakowski J, 2001, PSYCHIAT PRAKT OGOLN, V1, P11
   Saetung A, 2005, J. SCI. TECHNOL, V27, P469, DOI 10.1186/1472-6882-10-55
   Saini NK, 2010, THE PHARMA RESEARCH, V4, P206
   Salazar Aranda R, 2008, PHARM BIOL, V46, P166, DOI 10.1080/13880200701498952
   Sanderson JT, 2004, TOXICOL SCI, V82, P70, DOI 10.1093/toxsci/kfh257
   Santos KKA, 2012, J MED FOOD, V15, P322, DOI 10.1089/jmf.2011.0128
   Camargo EES, 2008, REV BRAS FARMACOGN, V18, P356, DOI 10.1590/S0102-695X2008000300008
   Sch√§ffer M, 2013, FORENSIC TOXICOL, V31, P251, DOI 10.1007/s11419-013-0186-5
   Schappert PJ, 1999, J CHEM ECOL, V25, P1455, DOI 10.1023/A:1020995329980
   Schappert PJ, 2000, EVOL ECOL RES, V2, P337
   SCHAPPERT PJ, 1995, HEREDITY, V74, P392, DOI 10.1038/hdy.1995.57
   Schneider G, 1999, ARZNEIDROGEN, V0, P0
   SEIGLER DS, 1989, PHYTOCHEMISTRY, V28, P931, DOI 10.1016/0031-9422(89)80146-3
   Sethi P, 2011, ADVANCE RESEARCH IN PHARMACEUTICALS AND BIOLOGICALS, V1, P101
   Sethi P, 2012, INT J PHARM SCI RES, V3, P225, DOI 10.13040/IJPSR.0975-8232.3(1).224-26
   Shaban A, 2012, ASIAN J. PHARM. CLIN. RES, V5, P271
   SHORE JS, 1992, BIOCHEM SYST ECOL, V20, P9, DOI 10.1016/0305-1978(92)90066-M
   Siegmund F, 1874, ALLGEMEINE ILLUSTRIR, V0, P0
   Singh H, 2010, REP. OPIN, V2, P22
   Sinha SD, 2008, INDIAN J PHARMACOL, V40, P93
   SPENCER KC, 1981, PLANTA MED, V43, P175, DOI 10.1055/s-2007-971495
   SPENCER KC, 1985, BIOCHEM SYST ECOL, V13, P433, DOI 10.1016/0305-1978(85)90088-2
   SPENCER KC, 1980, PHYTOCHEMISTRY, V19, P1863, DOI 10.1016/S0031-9422(00)83836-4
   Svetaz L, 2010, J ETHNOPHARMACOL, V127, P137, DOI 10.1016/j.jep.2009.09.034
   Taafaki I, 2006, TRADITIONAL MED MARS, V0, P0
   Taha MME, 2012, J ETHNOPHARMACOL, V141, P273, DOI 10.1016/j.jep.2012.02.030
   TARAR J L, 1979, INDIAN JOURNAL OF BOTANY, V2, P118
   Thulin M, 2012, TAXON, V61, P308, DOI 10.1002/tax.612003
   TOBER I, 1985, PHYTOCHEMISTRY, V24, P1215, DOI 10.1016/S0031-9422(00)81104-8
   Torres-Gon√°lez L, 2011, ANN HEPATOL, V10, P73, DOI 10.1016/S1665-2681(19)31590-X
   TROTTER RT, 1981, SOC SCI MED-MED ANTH, V15, P107, DOI 10.1016/0160-7987(81)90033-8
   van Andel T, 2012, J ETHNOPHARMACOL, V143, P840, DOI 10.1016/j.jep.2012.08.008
   Vikas Gupta Vikas Gupta, 2010, INTERNATIONAL JOURNAL OF PHARMTECH RESEARCH, V2, P1655
   Wagh SS, 2010, ADV STU BIOL, V2, P105
   Wagner H, 1994, PHYTOMEDICINE, V1, P63, DOI 10.1016/S0944-7113(11)80025-5
   Wang WQ, 1999, NUTR RES, V19, P191, DOI 10.1016/S0271-5317(98)00183-3
   Warburton D, 1986, A Z APHRODISIA, V0, P0
   Winer EP, 2002, J CLIN ONCOL, V20, P3317, DOI 10.1200/JCO.2002.06.020
   Winkelman M, 1989, MED ANTHROPOL, V11, P255
   Wong SP, 2006, FOOD CHEM, V99, P775, DOI 10.1016/j.foodchem.2005.07.058
   Wyk van B, 2004, HDB ARZNEIPFLANZEN, V0, P0
   Zhao JP, 2007, J NAT PROD, V70, P289, DOI 10.1021/np060253r
   Zhao JP, 2008, J ETHNOPHARMACOL, V120, P387, DOI 10.1016/j.jep.2008.09.016
NR 172
TC 56
Z9 59
U1 4
U2 106
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD MAR 28
PY 2014
VL 152
IS 3
BP 424
EP 443
DI 10.1016/j.jep.2014.01.019
PG 20
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine
GA AF6IK
UT WOS:000334818100005
PM 24468305
DA 2025-04-28
ER

PT J
AU Winkler, S
   Dieminger, N
   Blust, V
   Riedel, A
   Bakuradze, T
   Montoya, G
   Hassmann, U
   Lang, R
   Hofmann, T
   Somoza, V
   Richling, E
   Bytof, G
   Stiebitz, H
   Lantz, I
   Schipp, D
   Raedle, J
   Marko, D
AF Winkler, Swantje
   Dieminger, Natalie
   Blust, Volker
   Riedel, Annett
   Bakuradze, Tamara
   Montoya, Gina
   Hassmann, Ute
   Lang, Roman
   Hofmann, Thomas
   Somoza, Veronika
   Richling, Elke
   Bytof, Gerhard
   Stiebitz, Herbert
   Lantz, Ingo
   Schipp, Dorothea
   Raedle, Jochen
   Marko, Doris
TI Modulation of inflammatory gene transcription after long-term coffee consumption
SO FOOD RESEARCH INTERNATIONAL
LA English
DT Article; Proceedings Paper
DE Nrf2; Inflammation; Obesity; Coffee; Chlorogenic acid; Polymorphism
ID type-2 diabetes-mellitus; pathway in-vitro; high-fat diet; chlorogenic acid; pro12ala polymorphism; decaffeinated coffee; insulin-resistance; oxidative stress; lipid-metabolism; adipose-tissue
AB Scope: Obesity has been found to be associated with low grade inflammation accompanied by chronic oxidative stress. The transcription factor Nrf2 is likely involved in lipid metabolism and inflammation processes, possibly mediated by an antioxidant response element (ARE)-similar region located in the promoter of lipogenic genes like peroxisome-proliferator activated receptor gamma (PPAR gamma) and pro-inflammatory interleukin 6 (IL6). The present study investigates the influence of coffee consumption on the transcription of obesity-associated genes in human peripheral blood lymphocytes (PBL). Two different coffee blends with comparable caffeine concentrations were provided, rich either in chlorogenic acids and trigonelline (market blend, MB) or in N-methylpyridinium (NMP, study blend, SB). Methods and results: In a cross-over randomized double blind intervention study 84 volunteers (male and female, 25.6 +/- 5.8 years, BMI 22.9 +/- 1.9 kg/m(2), healthy, nonsmokers, regular coffee drinker) daily consumed 750 mL of the respective coffee over a period of 4 weeks, respectively. Transcription of IL6 in PBL was found to be positively associated with body fat. In the first intervention period consumption of MB decreased significantly the transcription of Nrf2, PPAR gamma and IL6 while concomitantly an enhanced level of PPAR alpha mRNA was found. Due to carry-over effects for Nrf2 and PPAR alpha, data of both intervention periods could only be pooled for PPAR gamma and IL6. Pooled data from both intervention periods showed a significant decrease of IL6 transcripts for SB consumption only. The changes in gene transcription appear to correlate with the level of different CGA metabolites in the plasma of the volunteers. Initial results further indicate a potential contribution of genetic polymorphisms in the nrf2 promoter and the ppar gamma-gene to the influence of coffee consumption on PPAR gamma transcription. Conclusion: Regular coffee consumption affects the transcription of genes associated with obesity and/or inflammation. Metabolites of chlorogenic acids as well as genetic polymorphisms may be relevant influencing factors. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Winkler, Swantje; Blust, Volker; Hassmann, Ute; Marko, Doris] Univ Vienna, Dept Food Chem & Toxicol, A-1090 Vienna, Austria.
   [Dieminger, Natalie; Lang, Roman; Hofmann, Thomas] Tech Univ Munich, Chair Food Chem & Mol Sensory Sci, D-85354 Freising Weihenstephan, Germany.
   [Riedel, Annett; Somoza, Veronika] Univ Vienna, Dept Physiol Chem & Nutr, A-1090 Vienna, Austria.
   [Bakuradze, Tamara; Montoya, Gina; Richling, Elke] Univ Kaiserslautern, Dept Chem, Div Food Chem & Toxicol, D-67663 Kaiserslautern, Germany.
   [Bytof, Gerhard; Stiebitz, Herbert; Lantz, Ingo] Tchibo GmbH, D-22297 Hamburg, Germany.
   [Raedle, Jochen] Westpfalzklinikum, Innere Med 3, Kaiserslautern, Germany.
C3 University of Vienna; Technical University of Munich; University of Vienna; University of Kaiserslautern
RP Marko, D (corresponding author), Univ Vienna, Dept Food Chem & Toxicol, Wahringerstr 38, A-1090 Vienna, Austria.
EM doris.marko@univie.ac.at
FU German Federal Ministry of Education and Research (BMBF) [01EA1365]; Tchibo GmbH
CR Bakuradze T, 2014, FOOD RES INT, V63, P420, DOI 10.1016/j.foodres.2014.05.032
   Bakuradze T, 2011, MOL NUTR FOOD RES, V55, P793, DOI 10.1002/mnfr.201100093
   Barbarroja N, 2010, BIOCHEM J, V430, P141, DOI 10.1042/BJ20100285
   Berhouma R, 2013, BIOCHEM GENET, V51, P256, DOI 10.1007/s10528-012-9560-y
   Boettler U, 2012, MOL BIOL REP, V39, P7155, DOI 10.1007/s11033-012-1547-6
   Boettler U, 2011, MOL NUTR FOOD RES, V55, P798, DOI 10.1002/mnfr.201100115
   Boettler U, 2011, J NUTR BIOCHEM, V22, P426, DOI 10.1016/j.jnutbio.2010.03.011
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Di Paola R, 2010, FREE RADICAL RES, V44, P74, DOI 10.3109/10715760903300709
   Ek J, 1999, DIABETOLOGIA, V42, P892, DOI 10.1007/s001250051243
   Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200
   Fujioka K, 2002, OBES RES, V10, P116S, DOI 10.1038/oby.2002.204
   Gouda HN, 2010, AM J EPIDEMIOL, V171, P645, DOI 10.1093/aje/kwp450
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Higdon JV, 2003, ARTERIOSCL THROM VAS, V23, P365, DOI 10.1161/01.ATV.0000063608.43095.E2
   Hou YY, 2012, FREE RADICAL BIO MED, V52, P462, DOI 10.1016/j.freeradbiomed.2011.10.453
   Huang JS, 2010, AM J PHYSIOL-GASTR L, V299, PG1211, DOI 10.1152/ajpgi.00322.2010
   ICO, 2011, MONTHL COFF MARK REP, V0, P0
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Jones B, 1988, DESIGN ANAL CROSS OV, V0, P0
   Kang JG, 2012, DIABETES METAB J, V36, P13, DOI 10.4093/dmj.2012.36.1.13
   Kang NJ, 2009, CARCINOGENESIS, V30, P321, DOI 10.1093/carcin/bgn282
   Kempf K, 2010, MED KLIN, V105, P910, DOI 10.1007/s00063-010-1156-x
   Kesh SB, 2013, LIFE SCI, V92, P938, DOI 10.1016/j.lfs.2013.03.015
   Lang R, 2012, RECENT ADVANCES IN THE ANALYSIS OF FOOD AND FLAVORS, VVolume 1098, P13
   Lang R, 2013, J AGR FOOD CHEM, V61, P12123, DOI 10.1021/jf403846g
   Lang R, 2013, ANAL BIOANAL CHEM, V405, P8487, DOI 10.1007/s00216-013-7288-0
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   L√≥pez-Alarc√≥n M, 2012, GENE, V511, P404, DOI 10.1016/j.gene.2012.09.057
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com
   Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201
   Olthof MR, 2011, NUTR METAB, V8, P0, DOI 10.1186/1743-7075-8-10
   Pi JB, 2010, J BIOL CHEM, V285, P9292, DOI 10.1074/jbc.M109.093955
   Poulsen LL, 2012, SEMIN CELL DEV BIOL, V23, P631, DOI 10.1016/j.semcdb.2012.01.003
   Prabhakar PK, 2011, J AGR FOOD CHEM, V59, P9835, DOI 10.1021/jf2015717
   Riedel A, 2014, FOOD RES INT, V63, P409, DOI 10.1016/j.foodres.2014.04.002
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Shi HT, 2013, INFLAMM RES, V62, P581, DOI 10.1007/s00011-013-0610-7
   Somoza V, 2003, J AGR FOOD CHEM, V51, P6861, DOI 10.1021/jf034750e
   Son MJ, 2010, J CLIN BIOCHEM NUTR, V46, P150, DOI 10.3164/jcbn.09-98
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   Stienstra R, 2007, PPAR RES, V2007, P0, DOI 10.1155/2007/95974
   Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355
   Vitaglione P, 2010, HEPATOLOGY, V52, P1652, DOI 10.1002/hep.23902
   Volz N, 2012, J AGR FOOD CHEM, V60, P9631, DOI 10.1021/jf302258u
   Wang SX, 2012, CHIN J INTEGR MED, V18, P437, DOI 10.1007/s11655-012-1114-y
   Wedick NM, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-93
   Weiss C, 2010, J AGR FOOD CHEM, V58, P1976, DOI 10.1021/jf903614d
   Wruck CJ, 2011, J BIOL CHEM, V286, P4493, DOI 10.1074/jbc.M110.162008
   Xu JL, 2012, DIABETES, V61, P3208, DOI 10.2337/db11-1716
NR 57
TC 6
Z9 6
U1 0
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0963-9969
EI 1873-7145
J9 FOOD RES INT
JI Food Res. Int.
PD SEP 15
PY 2014
VL 63
IS 
BP 428
EP 438
DI 10.1016/j.foodres.2014.05.073
PG 11
WC Food Science & Technology
SC Food Science & Technology
GA AQ1PE
UT WOS:000342552500020
DA 2025-04-28
ER

PT J
AU Rustenbeck, I
   Lier-Glaubitz, V
   Willenborg, M
   Eggert, F
   Engelhardt, U
   J√∂rns, A
AF Rustenbeck, I.
   Lier-Glaubitz, V.
   Willenborg, M.
   Eggert, F.
   Engelhardt, U.
   Joerns, A.
TI Effect of chronic coffee consumption on weight gain and glycaemia in a mouse model of obesity and type 2 diabetes
SO NUTRITION & DIABETES
LA English
DT Article
ID impaired glucose-tolerance; diet-induced obesity; decaffeinated coffee; insulin sensitivity; risk; caffeine; mice; fat; mechanisms; homeostasis
AB OBJECTIVE: Epidemiological evidence shows that chronic coffee consumption in humans is correlated with a lower incidence of type 2 diabetes mellitus. For the experimental exploration of the underlying mechanisms, this effect needs to be replicated in an animal model of type 2 diabetes with a short lifespan. DESIGN: Male C57BL/6 mice consumed regular coffee or water ad libitum and the development of obesity and diabetes caused by high-fat diet (55% lipids, HFD) was observed from week 10 on for 35 weeks in comparison with mice feeding on a defined normal diet (9% lipids, ND). RESULTS: The massive weight gain in HFD mice was dose-dependently retarded (P = 0.034), the moderate weight gain in ND mice was abolished (P<0.001) by coffee consumption, probably because of a lower feeding efficiency. The consumption of fluid (water or coffee) was significantly diminished by HFD (P<0.001), resulting in a higher coffee exposure of ND mice. On week 21 intraperitoneal glucose tolerance tests (IPGTT) showed a dose-dependent faster decline of elevated glucose levels in coffee-consuming HFD mice (P = 0.016), but not in ND mice. Remarkably, a spontaneous decrease in non-fasting glycaemia occurred after week 21 in all treatment groups (P<0.001). On week 39 the IPGTT showed diminished peak of glucose levels in coffee-consuming HFD mice (P<0.05). HFD mice were hyperinsulinaemic and had significantly (P<0.001) enlarged islets. Coffee consumption did not affect islet size or parameters of beta-cell apoptosis, proliferation and insulin granule content. CONCLUSION: Coffee consumption retarded weight gain and improved glucose tolerance in a mouse model of type 2 diabetes and corresponding controls. This gives rise to the expectation that further insight into the mechanism of the diabetes-preventive effect of coffee consumption in humans may be gained by this approach.
C1 [Rustenbeck, I.; Lier-Glaubitz, V.; Willenborg, M.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmacol & Toxicol, D-38106 Braunschweig, Germany.
   [Eggert, F.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Psychol, D-38106 Braunschweig, Germany.
   [Engelhardt, U.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Food Chem, D-38106 Braunschweig, Germany.
   [Joerns, A.] Hannover Med Sch, Dept Anat, Hannover, Germany.
C3 Braunschweig University of Technology; Braunschweig University of Technology; Braunschweig University of Technology; Hannover Medical School
RP Rustenbeck, I (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmacol & Toxicol, Mendelssohnstr 1, D-38106 Braunschweig, Germany.
EM i.rustenbeck@tu-bs.de
FU ISIC (Institute for Scientific Information on Coffee)
CR Anderson J, 1967, DIABETOLOGIA, V3, P50, DOI 10.1007/BF01269911
   Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, PE1323, DOI 10.1152/ajpendo.90617.2008
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   Bidel S, 2006, DIABETOLOGIA, V49, P2618, DOI 10.1007/s00125-006-0435-9
   Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, PE251, DOI 10.1152/ajpendo.00401.2007
   Brownlow BS, 1996, PHYSIOL BEHAV, V60, P37, DOI 10.1016/0031-9384(95)02210-4
   Carnethon MR, 2007, DIABETOLOGIA, V50, P1113, DOI 10.1007/s00125-007-0673-5
   DENARO CP, 1991, EUR J CLIN PHARMACOL, V40, P273, DOI 10.1007/BF00315208
   Feduccia AA, 2012, PHARMACOL BIOCHEM BE, V102, P241, DOI 10.1016/j.pbb.2012.04.014
   FEINBERG LJ, 1968, METABOLISM, V17, P916, DOI 10.1016/0026-0495(68)90158-3
   Floegel A, 2012, AM J CLIN NUTR, V95, P901, DOI 10.3945/ajcn.111.023648
   Gerber DA, 2004, ANN INTERN MED, V141, P323, DOI 10.7326/0003-4819-141-4-200408170-00019
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Ilanne-Parikka P, 2010, DIABETES CARE, V33, P1610, DOI 10.2337/dc09-2155
   J√∂rns A, 2010, ENDOCRINOLOGY, V151, P3555, DOI 10.1210/en.2010-0202
   Kluth O, 2011, DIABETOLOGIA, V54, P605, DOI 10.1007/s00125-010-1973-8
   Laaksonen DE, 2007, DIABETOLOGIA, V50, P2607, DOI 10.1007/s00125-007-0805-y
   LEITER EH, 1988, FASEB J, V2, P2807, DOI 10.1096/fasebj.2.12.3044905
   Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8
   Lopez-Garcia E, 2008, ANN INTERN MED, V148, P904, DOI 10.7326/0003-4819-148-12-200806170-00003
   Matsuda Y, 2011, BIOSCI BIOTECH BIOCH, V75, P2309, DOI 10.1271/bbb.110452
   Mekada K, 2009, EXP ANIM TOKYO, V58, P141, DOI 10.1538/expanim.58.141
   Montanya E, 2009, METHODS MOL BIOL, V560, P137, DOI 10.1007/978-1-59745-448-3_11
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x
   Petrie HJ, 2004, AM J CLIN NUTR, V80, P22
   Petro AE, 2004, METABOLISM, V53, P454, DOI 10.1016/j.metabol.2003.11.018
   Peyot ML, 2010, DIABETES, V59, P2178, DOI 10.2337/db09-1452
   Ranheim T, 2005, MOL NUTR FOOD RES, V49, P274, DOI 10.1002/mnfr.200400109
   Reunanen A, 2003, LANCET, V361, P702, DOI 10.1016/S0140-6736(03)12583-4
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Saremi A, 2003, DIABETES CARE, V26, P2211, DOI 10.2337/diacare.26.7.2211
   Schaefer B, 2004, ANN INTERN MED, V141, P321, DOI 10.7326/0003-4819-141-4-200408170-00016
   Srinivasan K, 2007, INDIAN J MED RES, V125, P451
   Starr ME, 2012, J GERONTOL A-BIOL, V67, P1043, DOI 10.1093/gerona/gls009
   SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
   van Dam RM, 2004, DIABETOLOGIA, V47, P2152, DOI 10.1007/s00125-004-1573-6
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Watanabe M, 2010, J FOOD SCI, V75, PH294, DOI 10.1111/j.1750-3841.2010.01853.x
   Winzell MS, 2004, DIABETES, V53, PS215, DOI 10.2337/diabetes.53.suppl_3.S215
   Yamaji T, 2004, DIABETOLOGIA, V47, P2145, DOI 10.1007/s00125-004-1590-5
   Yang JN, 2009, AM J PHYSIOL-HEART C, V296, PH1141, DOI 10.1152/ajpheart.00754.2008
NR 45
TC 18
Z9 19
U1 0
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2044-4052
EI 
J9 NUTR DIABETES
JI Nutr. Diabetes
PD JUN 15
PY 2014
VL 4
IS 
BP 
EP 
DI 10.1038/nutd.2014.19
PG 9
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA AO9DO
UT WOS:000341656100007
PM 24979152
DA 2025-04-28
ER

PT J
AU Rondanelli, M
   Opizzi, A
   Faliva, M
   Sala, P
   Perna, S
   Riva, A
   Morazzoni, P
   Bombardelli, E
   Giacosa, A
AF Rondanelli, Mariangela
   Opizzi, Annalisa
   Faliva, Milena
   Sala, Patrizio
   Perna, Simone
   Riva, Antonella
   Morazzoni, Paolo
   Bombardelli, Ezio
   Giacosa, Attilio
TI Metabolic Management in Overweight Subjects with Naive Impaired Fasting Glycaemia by Means of a Highly Standardized Extract From Cynara scolymus: A Double-blind, Placebo-controlled, Randomized Clinical Trial
SO PHYTOTHERAPY RESEARCH
LA English
DT Article
DE dietary supplement; overweight; impaired fasting glycaemia; Cynara scolymus
ID chlorogenic acid; phenolic-compounds; glucose-tolerance; glucose-6-phosphatase; inhibitor; weight
AB The aim of this study is to evaluate the efficacy of a dietary supplementation with an extract from Cynara scolymus (Cs) on the glucose pattern in a group of patients with naive impaired fasting glycaemia (IFG). A randomized, double-blind, placebo-controlled trial has been performed in 55 overweight subjects with IFG (fasting blood glucose [FBG]: 6.11 +/- 0.56mmol/l). These subjects were randomly assigned to supplement their diet with either an extract from Cs (600mg/d) (26 subjects) or placebo (29 matched subjects) for 8 weeks. The decrease of FBG was the primary endpoint. The assessment of Homeostatic Metabolic Assessment (HOMA), glycosylated haemoglobin, A1c-Derived Average Glucose (ADAG), lipidic pattern and anthropometric parameters were the secondary endpoints. The within groups and percent changes from baseline were analyzed by the signed rank test. The comparison between groups was performed by Wilcoxon's two sample test. The supplemented group had significant decreases of: FBG (-9.6%), HOMA (-11.7%), glycosylated haemoglobin (-2.3%), ADAG (-3.1%) and lipidic pattern. The placebo group did not show any significant difference. Compared with the placebo, the supplemented group showed a significant difference in FBG, HOMA and lipidic pattern. These data demonstrate the efficacy of Cs extract on the reduction of glycometabolic parameters in overweight subjects with IFG. Copyright (c) 2013 John Wiley & Sons, Ltd.
C1 [Rondanelli, Mariangela; Opizzi, Annalisa; Faliva, Milena; Sala, Patrizio; Perna, Simone] Univ Pavia, Azienda Serv Persona, Sect Human Nutr, Dept Hlth Sci, I-27100 Pavia, Italy.
   [Riva, Antonella; Morazzoni, Paolo; Bombardelli, Ezio] Indena SpA, Milan, Italy.
   [Giacosa, Attilio] Policlin Monza, Dept Gastroenterol, Milan, Italy.
C3 University of Pavia
RP Rondanelli, M (corresponding author), Univ Pavia, Azienda Serv Persona Pavia, Sect Human Nutr & Dietet, Dept Appl Hlth Sci,Fac Med,Endocrinol & Nutr Unit, Via Emilia 12, I-27100 Pavia, Italy.
EM mariangela.rondanelli@unipv.it
CR Unknown -, 1985, WHO TECHN REP SER, V0, P0
   ARION WJ, 1965, BIOCHEM BIOPH RES CO, V20, P606, DOI 10.1016/0006-291X(65)90442-0
   Arion WJ, 1998, ARCH BIOCHEM BIOPHYS, V351, P279, DOI 10.1006/abbi.1997.0563
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Azzini E, 2007, BRIT J NUTR, V97, P963, DOI 10.1017/S0007114507617218
   Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397
   Coon JST, 2003, J FAM PRACTICE, V52, P470
   Dickel ML, 2007, J ETHNOPHARMACOL, V109, P60, DOI 10.1016/j.jep.2006.07.003
   Eastman RC, 1997, DIABETES CARE, V20, P127, DOI 10.2337/diacare.20.2.127
   Fantini N, 2011, PHYTOTHER RES, V25, P463, DOI 10.1002/ptr.3285
   FRISANCHO AR, 1984, AM J CLIN NUTR, V40, P808, DOI 10.1093/ajcn/40.4.808
   Garber Alan J, 2008, J FAM PRACT, V57, P0
   Gl√ºmer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335
   HABER GB, 1977, LANCET, V2, P679
   Haffner SM, 1996, DIABETES CARE, V19, P1138, DOI 10.2337/diacare.19.10.1138
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   Herling AW, 1998, AM J PHYSIOL-GASTR L, V274, PG1087, DOI 10.1152/ajpgi.1998.274.6.G1087
   Hernandez-Galicia E, 2002, P W PHARMACOL SOC, V45, P118
   Hui Hongxiang, 2009, CHIN MED, V4, P11, DOI 10.1186/1749-8546-4-11
   Hui HX, 2005, DIABETES-METAB RES, V21, P313, DOI 10.1002/dmrr.553
   Karthikesan K, 2010, GEN PHYSIOL BIOPHYS, V29, P23, DOI 10.4149/gpb_2010_01_23
   Lupattelli G, 2004, LIFE SCI, V76, P775, DOI 10.1016/j.lfs.2004.07.018
   Matsui T, 2006, MINI-REV MED CHEM, V6, P349, DOI 10.2174/138955706776073484
   Modi Pankaj, 2007, CURR DRUG DISCOV TECHNOL, V4, P39
   Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545
   Neustadt J, 2008, MOL NUTR FOOD RES, V52, P780, DOI 10.1002/mnfr.200700075
   Rodriguez TS, 2002, PHYTOMEDICINE, V9, P687, DOI 10.1078/094471102321621278
   Rondanelli M, 2011, PHYTOTHER RES, V25, P1275, DOI 10.1002/ptr.3425
   Saydah SH, 2001, DIABETES CARE, V24, P447, DOI 10.2337/diacare.24.3.447
   Sch√ºtz K, 2006, J AGR FOOD CHEM, V54, P8812, DOI 10.1021/jf062009b
   SEGAL HL, 1959, J BIOL CHEM, V234, P1937
   Shan Jacqueline J, 2007, PROC WEST PHARMACOL SOC, V50, P24
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   Sherwin RS, 2002, DIABETES CARE, V25, P742
   Simon C, 2000, ARCH BIOCHEM BIOPHYS, V373, P418, DOI 10.1006/abbi.1999.1560
   Steer RA, 1999, GEN HOSP PSYCHIAT, V21, P106, DOI 10.1016/S0163-8343(98)00070-X
   Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x
   WELSCH CA, 1989, J NUTR, V119, P1698, DOI 10.1093/jn/119.11.1698
NR 38
TC 34
Z9 35
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD JAN 15
PY 2014
VL 28
IS 1
BP 33
EP 41
DI 10.1002/ptr.4950
PG 9
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 287AM
UT WOS:000329510400005
PM 23440660
DA 2025-04-28
ER

PT J
AU Lee, YJ
   Yu, SY
   Lee, JS
   Kim, MD
   Lee, DW
   Kim, KJ
   Lee, OH
AF Lee, Young-Jun
   Yu, Seok-Yeong
   Lee, Jong Seok
   Kim, Myoung-Dong
   Lee, Dae-Won
   Kim, Kui-Jin
   Lee, Ok-Hwan
TI Anti-Adipogenic and Anti-Oxidant Activities of Mugwort and Pine Needles Fermented Using Leuconostoc mesenteroides 1076
SO FOOD BIOTECHNOLOGY
LA English
DT Article
DE fermentation; pine needle; lipid accumulation; mugwort; anti-oxidant activities
ID hypertonic saline; lipid-metabolism; flavonoids; mannitol; differentiation; polyphenols; adipocytes; inhibition; vegetables; receptor
AB In this study, we investigated the antioxidant and anti-adipogenic activities of aqueous extracts of mugwort and pine needles fermented by Leuconostoc mesenteroides 1076. We also evaluated the phenolic composition, total phenolic content and flavonoid contents of both the fermented mugwort extract (FME) and fermented pine needle extract (FPE). The antioxidant potentials of the FME and FPE were assessed using various antioxidant assays, including the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical assay, the 2,2-azino-bis-(3-ethylenebenzothiozoline-6-sulfonic acid) (ABTS) radical scavenging assay, the ferric-reducing antioxidant power (FRAP) assay, and the reducing power assay. In addition, the anti-adipogenic effects of the FME and FPE were investigated during the adipogenesis of 3T3-L1 cells. Our results showed that the total phenolic contents of the FME and FPE were 182 +/- 4 and 116 +/- 5 mg GAE/g, respectively. Among the phenolic compounds, chlorogenic acid was found to be the major phenolic acid in the FPE, whereas hesperetin was found to be the major phenolic acid in the FME. The antioxidant activities of the FME and FPE increased in a dose-dependent manner. The FME exhibited higher antioxidant activities than the FPE. Furthermore, both the FME and FPE inhibited lipid accumulation and reactive oxygen species (ROS) production, which involved the down-regulation of peroxisome proliferator-activated receptor gamma (PPAR gamma), adipocyte protein 2 (aP2) and NADPH oxidase 4 (NOX4) mRNA expression. These results indicated that the FPE and FME could be useful in the treatment of obesity and as natural sources of antioxidants.
C1 [Lee, Young-Jun; Yu, Seok-Yeong; Lee, Jong Seok; Kim, Myoung-Dong; Lee, Ok-Hwan] Kangwon Natl Univ, Dept Food Sci & Biotechnol, Chunchon 200701, South Korea.
   [Lee, Dae-Won] Jeongseon Yaccho Co Ltd, Jeongseon, South Korea.
   [Kim, Kui-Jin] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA.
C3 Kangwon National University; University System of Maryland; University of Maryland College Park
RP Lee, OH (corresponding author), Kangwon Natl Univ, Dept Food Sci & Biotechnol, Chunchon 200701, South Korea.
EM loh99@kangwon.ac.kr
FU Small and Medium Business Administration [C1008390-01-02, C-1008143-01-01]
CR Amro B, 2002, FITOTERAPIA, V73, P456, DOI 10.1016/S0367-326X(02)00173-9
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7
   Blumberg JM, 2006, J BIOL CHEM, V281, P11205, DOI 10.1074/jbc.M510343200
   Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047
   Calzadilla P, 2011, INT J MOL SCI, V12, P6936, DOI 10.3390/ijms12106936
   Cao FL, 2012, POULTRY SCI, V91, P1210, DOI 10.3382/ps.2011-01886
   Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6
   Choi MY, 1997, KOREAN J APPL MICROB, V25, P293
   Chu YH, 2000, J SCI FOOD AGR, V80, P561, DOI 10.1002/(SICI)1097-0010(200004)80:5<561::AID-JSFA574>3.0.CO;2-#
   Dewulf EM, 2011, J NUTR BIOCHEM, V22, P712, DOI 10.1016/j.jnutbio.2010.05.009
   Diao JY, 2005, J BIOL CHEM, V280, P33487, DOI 10.1074/jbc.M506276200
   Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   GUTFINGER T, 1981, J AM OIL CHEM SOC, V58, P966, DOI 10.1007/BF02659771
   HANASAKI Y, 1994, FREE RADICAL BIO MED, V16, P845, DOI 10.1016/0891-5849(94)90202-X
   Hsu CL, 2007, J AGR FOOD CHEM, V55, P8404, DOI 10.1021/jf071695r
   Hunaefi D, 2013, FOOD BIOTECHNOL, V27, P66, DOI 10.1080/08905436.2012.755694
   Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184
   Lee Hyogee, 2002, KOREAN JOURNAL OF FOOD AND COOKERY SCIENCE ÌïúÍµ≠ÏãùÌíàÏ°∞Î¶¨Í≥ºÌïôÌöåÏßÄ, V18, P164
   Lee OH, 2012, PHYTOTHER RES, V26, P403, DOI 10.1002/ptr.3568
   Lee OH, 2011, PHYTOTHER RES, V25, P106, DOI 10.1002/ptr.3236
   Lee YL, 2008, FOOD CHEM, V106, P1128, DOI 10.1016/j.foodchem.2007.07.047
   ÍπÄÏÜåÏú§, 2013, JOURNAL OF THE KOREAN SOCIETY OF FOOD SCIENCE AND NUTRITION ÌïúÍµ≠ÏãùÌíàÏòÅÏñëÍ≥ºÌïôÌöåÏßÄ, V42, P325
   Liu Q, 2011, J ASIAN NAT PROD RES, V13, P714, DOI 10.1080/10286020.2011.586341
   Matsuzawa Y, 1999, ANN NY ACAD SCI, V892, P146, DOI 10.1111/j.1749-6632.1999.tb07793.x
   MCCORD JM, 1988, FREE RADICAL BIO MED, V5, P363, DOI 10.1016/0891-5849(88)90109-8
   MEISTER A, 1988, J BIOL CHEM, V263, P17205
   Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883
   Moreno MIN, 2000, J ETHNOPHARMACOL, V71, P109, DOI 10.1016/S0378-8741(99)00189-0
   Moure A, 2001, FOOD CHEM, V72, P145, DOI 10.1016/S0308-8146(00)00223-5
   Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596
   Ou BX, 2002, J AGR FOOD CHEM, V50, P3122, DOI 10.1021/jf0116606
   OYAIZU M, 1988, J JPN SOC FOOD SCI, V35, P771
   Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9
   Roginsky V, 2005, FOOD CHEM, V92, P235, DOI 10.1016/j.foodchem.2004.08.004
   Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145
   Shafi G, 2012, MOL BIOL REP, V39, P7373, DOI 10.1007/s11033-012-1569-0
   Shi Ham Seung, 2005, ÌïúÍµ≠ÏãùÌíàÏ†ÄÏû•Ïú†ÌÜµÌïôÌöåÏßÄ, V12, P179
   Soetaert W, 1999, METH BIOTEC, V10, P261
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   Tan RX, 1998, PLANTA MED, V64, P295, DOI 10.1055/s-2006-957438
   Tiwari AK, 2001, J AGR FOOD CHEM, V49, P4642, DOI 10.1021/jf010573a
   Toda S, 2004, J MED FOOD, V7, P52, DOI 10.1089/109662004322984707
   TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X
   Wang CY, 2011, J SCI FOOD AGR, V91, P2271, DOI 10.1002/jsfa.4450
   Yamamoto N, 2010, BIOSCI BIOTECH BIOCH, V74, P2036, DOI 10.1271/bbb.100305
   Zeng WC, 2012, INT J FOOD MICROBIOL, V153, P78, DOI 10.1016/j.ijfoodmicro.2011.10.019
NR 50
TC 5
Z9 6
U1 0
U2 16
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0890-5436
EI 1532-4249
J9 FOOD BIOTECHNOL
JI Food Biotechnol.
PD APR 3
PY 2014
VL 28
IS 2
BP 79
EP 95
DI 10.1080/08905436.2014.895945
PG 17
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA AG1SZ
UT WOS:000335197700001
DA 2025-04-28
ER

PT J
AU Heber, D
   Zhang, YJ
   Yang, JP
   Ma, JE
   Henning, SM
   Li, ZP
AF Heber, David
   Zhang, Yanjun
   Yang, Jieping
   Ma, Janice E.
   Henning, Susanne M.
   Li, Zhaoping
TI Green Tea, Black Tea, and Oolong Tea Polyphenols Reduce Visceral Fat and Inflammation in Mice Fed High-Fat, High-Sucrose Obesogenic Diets
SO JOURNAL OF NUTRITION
LA English
DT Article
ID epithelium-derived factor; pu-erh tea; adipose-tissue; metabolic syndrome; induced obesity; gallic acid; in-vitro; camellia-sinensis; expression; extract
AB Green tea (GT) and caffeine in combination were shown to increase energy expenditure and fat oxidation, but less is known about the effects of black tea (BT) and oolong tea (OT). This study investigated whether decaffeinated polyphenol extracts from GT, BT, and OT decrease body fat and inflammation in male C57BL/6J mice fed high-fat/high-sucrose [HF/HS (32% energy from fat, 25% energy from sucrose)] diets. Mice were fed either an HF/HS diet with 0.25% of polyphenol from GT, OT, or BT or a low-fat/high-sucrose [LF/HS (10.6% energy from fat, 25% energy from sucrose)] diet for 20 wk. Monomeric tea polyphenols were found in the liver and adipose tissue of mice fed the HF/HS diet with GT polyphenols (GTPs) and OT polyphenols (OTPs) but not BT polyphenols (BTPs). Treatment with GTPs, OTPs, BTPs, and an LF/HS diet led to significantly lower body weight, total visceral fat volume by MRI, and liver lipid weight compared with mice in the HF/HS control group. Only GTPs reduced food intake significantly by similar to 10%. GTP, BTP, and LF/HS-diet treatments significantly reduced serum monocyte chemotactic protein-1 (MCP-1) compared with HF/HS controls. In mesenteric fat, monocyte chemotactic protein-1 (Mcp1) gene expression was significantly decreased by treatment with GTPs, BTPs, OTPs, and an LF/HS diet and in liver tissue by GTP and BTP treatments. Mcp1 gene expression in epididymal fat was significantly decreased by the BTP and LF/HS diet interventions. In epididymal fat, consistent with an anti-inflammatory effect, adiponectin gene expression was significantly increased by GTPs and OTPs. Angiogenesis during adipose tissue expansion is anti-inflammatory by maintaining adipocyte perfusion. We observed significantly increased gene expression of vascular endothelial growth factor A by GTPs and vascular endothelial growth factor receptor 2 by BTPs and the LF/HS diet and a decrease in pigment epithelium-derived factor gene expression by OTPs and BTPs. In summary, all 3 tea polyphenol extracts induced weight loss and anti-inflammatory and angiogenic effects, although the tissue content of polyphenols differed significantly.
C1 [Heber, David; Zhang, Yanjun; Yang, Jieping; Ma, Janice E.; Henning, Susanne M.; Li, Zhaoping] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Human Nutr, Los Angeles, CA 90095 USA.
C3 University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA
RP Heber, D (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ctr Human Nutr, Los Angeles, CA 90095 USA.
FU Center for Human Nutrition, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles
CR Aprahamian TR, 2013, METABOLISM, V62, P1730, DOI 10.1016/j.metabol.2013.07.010
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Chader GJ, 2001, P NATL ACAD SCI USA, V98, P2122, DOI 10.1073/pnas.061024098
   Chen YK, 2011, J AGR FOOD CHEM, V59, P11862, DOI 10.1021/jf2029016
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Elayappan B, 2011, ANGIOGENESIS, V14, P407, DOI 10.1007/s10456-011-9224-2
   Elayappan B, 2009, ANGIOGENESIS, V12, P313, DOI 10.1007/s10456-009-9153-5
   Elias I, 2012, DIABETES, V61, P1801, DOI 10.2337/db11-0832
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5
   Gray KK, 2012, PLOS NEGLECT TROP D, V6, P0, DOI 10.1371/journal.pntd.0001529
   Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139
   Grove KA, 2010, J NUTR, V140, P446, DOI 10.3945/jn.109.115972
   Han LK, 1999, INT J OBESITY, V23, P98, DOI 10.1038/sj.ijo.0800766
   Hodgson JM, 2000, J AGR FOOD CHEM, V48, P2276, DOI 10.1021/jf000089s
   Huang HC, 2012, FOOD FUNCT, V3, P170, DOI 10.1039/c1fo10157a
   Hursel R, 2011, OBES REV, V12, PE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, AM J CLIN NUTR, V89, P822, DOI 10.3945/ajcn.2008.27043
   Juhel C, 2000, J NUTR BIOCHEM, V11, P45, DOI 10.1016/S0955-2863(99)00070-4
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kuhnert N, 2010, RAPID COMMUN MASS SP, V24, P3387, DOI 10.1002/rcm.4778
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   Lu H, 2003, DRUG METAB DISPOS, V31, P572, DOI 10.1124/dmd.31.5.572
   Lu QY, 2009, J AGR FOOD CHEM, V57, P10408, DOI 10.1021/jf901839h
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055
   Mendoza JA, 2007, DIABETES CARE, V30, P974, DOI 10.2337/dc06-2188
   Meng XF, 2002, CHEM RES TOXICOL, V15, P1042, DOI 10.1021/tx010184a
   Mulder TPJ, 2001, J CHROMATOGR B, V760, P271, DOI 10.1016/S0378-4347(01)00285-7
   Oi Y, 2012, PHYTOTHER RES, V26, P475, DOI 10.1002/ptr.3602
   Pafumi Y, 2002, J BIOL CHEM, V277, P28070, DOI 10.1074/jbc.M202839200
   Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799
   Sharma V, 2009, CRIT REV FOOD SCI, V49, P379, DOI 10.1080/10408390802068066
   Shrestha S, 2009, J NUTR, V139, P640, DOI 10.3945/jn.108.103341
   Singleton V L, 1969, ADV FOOD RES SUPPL, V1, P1
   Subramanian N, 1999, J AGR FOOD CHEM, V47, P2571, DOI 10.1021/jf981042y
   Sun K, 2012, P NATL ACAD SCI USA, V109, P5874, DOI 10.1073/pnas.1200447109
   Sung HK, 2013, CELL METAB, V17, P61, DOI 10.1016/j.cmet.2012.12.010
   Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011
   Uchiyama S, 2011, NUTRITION, V27, P287, DOI 10.1016/j.nut.2010.01.019
   Visioli Francesco, 2006, NUTRITION AND HEALTH (BICESTER), V18, P127
   Wang P, 2008, EUR J ENDOCRINOL, V159, P713, DOI 10.1530/EJE-08-0521
   Wang PW, 2010, CANCER PREV RES, V3, P985, DOI 10.1158/1940-6207.CAPR-09-0210
   Wang YX, 2003, OBES RES, V11, P930, DOI 10.1038/oby.2003.128
   Yamagishi SI, 2007, HORM METAB RES, V39, P233, DOI 10.1055/s-2007-970425
   Yoon CH, 2013, JOINT BONE SPINE, V80, P274, DOI 10.1016/j.jbspin.2012.08.010
   Yuda N, 2012, J FOOD SCI, V77, PH254, DOI 10.1111/j.1750-3841.2012.02967.x
   Zhou AL, 2012, LIPIDS, V47, P1119, DOI 10.1007/s11745-012-3729-3
NR 51
TC 105
Z9 120
U1 3
U2 113
PU AMER SOC NUTRITION-ASN
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD SEP 15
PY 2014
VL 144
IS 9
BP 1385
EP 1393
DI 10.3945/jn.114.191007
PG 9
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA AN6VK
UT WOS:000340736300006
PM 25031332
DA 2025-04-28
ER

PT J
AU Martin, BJ
   Tan, RB
   Gillen, JB
   Percival, ME
   Gibala, MJ
AF Martin, Brian J.
   Tan, Rachel B.
   Gillen, Jenna B.
   Percival, Michael E.
   Gibala, Martin J.
TI No Effect of Short-Term Green Tea Extract Supplementation on Metabolism at Rest or During Exercise in the Fed State
SO INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM
LA English
DT Article
DE GTE; tea catechins; fat oxidation; substrate utilization
ID fat oxidation; catechin-polyphenols; substrate oxidation; endurance capacity; energy-expenditure; caffeine; epigallocatechin-3-gallate; ingestion; obesity; consumption
AB Supplementation with green tea extract (GTE) in animals has been reported to induce numerous metabolic adaptations including increased fat oxidation during exercise and improved performance. However, data regarding the metabolic and physiological effects of GTE during exercise in humans are limited and equivocal. Purpose: To examine the effects of short-term GTE treatment on resting energy expenditure (REE), whole-body substrate utilization during exercise and time trial performance. Methods: Fifteen active men (24 +/- 3 y; VO(2)peak = 48 +/- 7 ml.kg.min(-1); BMI = 26 +/- 3 kg.m(2(-1))) ingested GTE (3x per day = 1,000 mg/d) or placebo (PLA) for 2 day in a double-blind, crossover design (each separated by a 1 week wash-out period). REE was assessed in the fasted state. Subjects then ingested a standardized breakfast (similar to 5.0 kcal.kg(-1)) and 90 min later performed a 60 min cycling bout at an intensity corresponding to individual maximal fat oxidation (44 +/- 11% VO(2)peak), followed by a 250 kJ TT. Results: REE, whole-body oxygen consumption (VO2) and substrate oxidation rates during steady-state exercise were not different between treatments. However, mean heart rate (HR) was lower in GTE vs. PLA (115 +/- 16 vs. 118 +/- 17 beats.min(-1); main effect, p = .049). Mixed venous blood [glycerol] was higher during rest and exercise after GTE vs. PLA (p = .006, main effect for treatment) but glucose, insulin and free-fatty acids were not different. Subsequent time trial performance was not different between treatments (GTE = 25:38 +/- 5:32 vs. PLA = 26:08 +/- 8:13 min; p = .75). Conclusion: GTE had minimal effects on whole-body substrate metabolism but significantly increased plasma glycerol and lowered heart rate during steady-state exercise, suggesting a potential increase in lipolysis and a cardiovascular effect that warrants further investigation.
C1 [Martin, Brian J.; Tan, Rachel B.; Gillen, Jenna B.; Percival, Michael E.; Gibala, Martin J.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.
C3 McMaster University
RP Gibala, MJ (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.
EM gibalam@mcmaster.ca
FU TAIYO International, Inc. Natural Sciences and Engineering Council (NSERC) of Canada
CR Achten J, 2002, MED SCI SPORT EXER, V34, P92, DOI 10.1097/00005768-200201000-00015
   Bell C, 2001, J CLIN ENDOCR METAB, V86, P4440, DOI 10.1210/jc.86.9.4440
   B√©rub√©-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Boschmann M, 2007, J AM COLL NUTR, V26, P389S, DOI 10.1080/07315724.2007.10719627
   Burgomaster KA, 2006, J APPL PHYSIOL, V100, P2041, DOI 10.1152/japplphysiol.01220.2005
   Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518
   Call JA, 2008, J APPL PHYSIOL, V105, P923, DOI 10.1152/japplphysiol.00028.2008
   Chow HHS, 2005, CLIN CANCER RES, V11, P4627, DOI 10.1158/1078-0432.CCR-04-2549
   COYLE EF, 1985, J APPL PHYSIOL, V59, P429, DOI 10.1152/jappl.1985.59.2.429
   Dean S, 2009, INT J SPORT NUTR EXE, V19, P624, DOI 10.1123/ijsnem.19.6.624
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Eichenberger P, 2009, INT J VITAM NUTR RES, V79, P24, DOI 10.1024/0300-9831.79.1.24
   FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628
   HETZLER RK, 1994, J APPL PHYSIOL, V76, P1043, DOI 10.1152/jappl.1994.76.3.1043
   Hodgson AB, 2013, J NUTR BIOCHEM, V24, P325, DOI 10.1016/j.jnutbio.2012.06.017
   Ihm SH, 2012, ATHEROSCLEROSIS, V224, P377, DOI 10.1016/j.atherosclerosis.2012.07.006
   Jeukendrup AE, 2005, INT J SPORTS MED, V26, PS28, DOI 10.1055/s-2004-830512
   Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109
   Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011
   Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025
   Lonac MC, 2011, OBESITY, V19, P298, DOI 10.1038/oby.2010.181
   Lu H, 2003, DRUG METAB DISPOS, V31, P572, DOI 10.1124/dmd.31.5.572
   Meyer T, 2007, APPL PHYSIOL NUTR ME, V32, P249, DOI 10.1139/H06-108
   Murase T, 2006, AM J PHYSIOL-REG I, V290, PR1550, DOI 10.1152/ajpregu.00752.2005
   Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135
   Murase T, 2005, AM J PHYSIOL-REG I, V288, PR708, DOI 10.1152/ajpregu.00693.2004
   Nogueira L, 2011, J PHYSIOL-LONDON, V589, P4615, DOI 10.1113/jphysiol.2011.209924
   Ramirez-Sanchez I, 2010, HYPERTENSION, V55, P1398, DOI 10.1161/HYPERTENSIONAHA.109.147892
   Randell RK, 2013, MED SCI SPORT EXER, V45, P883, DOI 10.1249/MSS.0b013e31827dd9d4
   Richards JC, 2010, MED SCI SPORT EXER, V42, P739, DOI 10.1249/MSS.0b013e3181bcab6c
   Sale DG, 1991, PHYSIOLOGICAL TESTIN, V0, P21
   Schneider C, 2009, AM FAM PHYSICIAN, V79, P591
   Shimotoyodome A, 2005, MED SCI SPORT EXER, V37, P1884, DOI 10.1249/01.mss.0000178062.66981.a8
   Stob NR, 2007, EXP PHYSIOL, V92, P823, DOI 10.1113/expphysiol.2007.038174
   Van Soeren MH, 1998, J APPL PHYSIOL, V85, P1493, DOI 10.1152/jappl.1998.85.4.1493
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
NR 37
TC 13
Z9 15
U1 0
U2 43
PU HUMAN KINETICS PUBL INC
PI CHAMPAIGN
PA 1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA
SN 1526-484X
EI 1543-2742
J9 INT J SPORT NUTR EXE
JI Int. J. Sport Nutr. Exerc. Metab.
PD DEC 15
PY 2014
VL 24
IS 6
BP 656
EP 664
DI 10.1123/ijsnem.2013-0202
PG 9
WC Nutrition & Dietetics; Sport Sciences
SC Nutrition & Dietetics; Sport Sciences
GA AZ4FZ
UT WOS:000348178500007
PM 24903465
DA 2025-04-28
ER

PT J
AU Sheehy, T
   Kolandooz, F
   Roache, C
   Sharma, S
AF Sheehy, Tony
   Kolandooz, Fariba
   Roache, Cindy
   Sharma, Sangita
TI Changing dietary patterns in the Canadian Arctic: Frequency of consumption of foods and beverages by Inuit in three Nunavut communities
SO FOOD AND NUTRITION BULLETIN
LA English
DT Article
DE Food and beverage consumption; food frequency; Inuit; Nunavut
ID impaired glucose-tolerance; nutrition transition; life-style; socioeconomic indicators; intervention program; population; obesity; inuvialuit; health; adults
AB Background. Inuit in Arctic regions are experiencing a rapid diet and lifestyle transition. There are limited data on food consumption patterns among this unique population, raising concerns about assessing the risk for the development of diet-related chronic diseases. Objective. To assess the current frequency of consumption of foods and beverages among Inuit in Nunavut, Arctic Canada. Methods. A cross-sectional dietary study was conducted among randomly selected Inuit adults from three communities in Nunavut using a validated quantitative food frequency questionnaire. The participants were 175 women and 36 men with median (IQR) ages of 41.0(32.5-48.5) and 40.1 (30.0-50.0) years, respectively. The mean and median frequencies of consumption over a 30-day period were computed for 147 individual food items and grouped as foods or beverages. Results. The 30 most frequently consumed foods were identified. Non-nutrient-dense foods (i.e., high-fat and high-sugar foods) were the most frequently consumed food group (median intake, 3.4 times/day), followed by grains (2.0 times/day) and traditional meats (1.7 times/day). The frequency of consumption of fruits (0.7 times/day) and vegetables (0.4 times/day) was low The median values for the three most frequently consumed food items were sugar or honey (once/day), butter (0.71 times/day), and Coffee-mate (0.71 times/day). Apart from water, coffee, and tea, the most frequently consumed beverages were sweetened juices (0.71 times/day) and regular pop (soft drinks) (0.36 times/day).This study showed that non-nutrient-dense foods are consumed most frequently in these Inuit communities. Conclusions. The results have implications for dietary quality and provide useful information on current dietary practices to guide nutritional intervention programs.
C1 [Sheehy, Tony] Natl Univ Ireland Univ Coll Cork, Cork, Ireland.
   [Kolandooz, Fariba; Roache, Cindy; Sharma, Sangita] Univ Alberta, Dept Med, Fac Med & Dent, Aboriginal & Global Hlth Res Grp, Edmonton, AB T6G 2T4, Canada.
C3 University College Cork; University of Alberta
RP Sharma, S (corresponding author), Univ Alberta, Dept Med, Fac Med & Dent, Aboriginal & Global Hlth Res Grp, Unit 5-10 Univ Terrace,8303 112 St, Edmonton, AB T6G 2T4, Canada.
EM gita.sharma@ualberta.ca
FU American Diabetes Association Clinical Research award [1-08-CR-57]; Department of Health and Social Services (HSS) of the Government of Nunavut; Health Canada; Health Canada through the Aboriginal Diabetes Initiative and First Nations; Inuit Health Branch
CR Blanchet C, 2000, CAN J DIET PRACT RES, V61, P50
   CHATEAUDEGAT ML, 2010, CAN J CARDIOL, V26, P190, DOI 10.1016/S0828-282X(10)70398-6
   Deering KN, 2009, CAN J PUBLIC HEALTH, V100, P14, DOI 10.1007/BF03405485
   Drewnowski A, 2010, FAT DETECTION: TASTE, V0, P0
   Ebbesson SOK, 1998, DIABETES CARE, V21, P563, DOI 10.2337/diacare.21.4.563
   Egeland GM, 2011, J NUTR, V141, P1746, DOI 10.3945/jn.111.139006
   Erber E, 2010, J HUM NUTR DIET, V23, P35, DOI 10.1111/j.1365-277X.2010.01098.x
   Erber E, 2010, J HUM NUTR DIET, V23, P59, DOI 10.1111/j.1365-277X.2010.01097.x
   Friborg JT, 2008, LANCET ONCOL, V9, P892, DOI 10.1016/S1470-2045(08)70231-6
   Glanz K, 2005, AM J HEALTH PROMOT, V19, P330, DOI 10.4278/0890-1171-19.5.330
   Healey GK, 2007, INT J CIRCUMPOL HEAL, V66, P199, DOI 10.3402/ijch.v66i3.18256
   Hopping BN, 2010, J HUM NUTR DIET, V23, P51, DOI 10.1111/j.1365-277X.2010.01100.x
   Hopping BN, 2010, J HUM NUTR DIET, V23, P27, DOI 10.1111/j.1365-277X.2010.01099.x
   Huet C, 2012, J NUTR, V142, P541, DOI 10.3945/jn.111.149278
   Jorgensen ME, 2002, DIABETES CARE, V25, P1766, DOI 10.2337/diacare.25.10.1766
   Kuhnlein HV, 2004, J NUTR, V134, P1447, DOI 10.1093/jn/134.6.1447
   LARDINOIS CK, 1987, MED HYPOTHESES, V24, P243, DOI 10.1016/0306-9877(87)90071-5
   McLaughlin J, 2005, ATHEROSCLEROSIS, V181, P353, DOI 10.1016/j.atherosclerosis.2005.01.019
   Mead E, 2010, J HUM NUTR DIET, V23, P18, DOI 10.1111/j.1365-277X.2010.01102.x
   Mendoza JA, 2007, DIABETES CARE, V30, P974, DOI 10.2337/dc06-2188
   Pakseresht M, 2010, J HUM NUTR DIET, V23, P67, DOI 10.1111/j.1365-277X.2010.01104.x
   Popkin BM, 2011, P NUTR SOC, V70, P82, DOI 10.1017/S0029665110003903
   Sharma S, 2010, J HUM NUTR DIET, V23, P120, DOI 10.1111/j.1365-277X.2010.01107.x
   Sharma S, 2010, J HUM NUTR DIET, V23, P5, DOI 10.1111/j.1365-277X.2010.01093.x
   Sharma S, 2010, BRIT J NUTR, V103, P749, DOI 10.1017/S0007114509992224
   Sheikh N, 2011, INT J CIRCUMPOL HEAL, V70, P511, DOI 10.3402/ijch.v70i5.17863
   *STAT CAN, 2006, COMM PROF 2006 CENS, V0, P0
   Statistics Canada, 2012, HLTH IND PROF AG STA, V0, P0
   Varela-Moreiras G, 2006, INT J VITAM NUTR RES, V76, P262, DOI 10.1024/0300-9831.76.4.262
   Young TK, 2007, AM J PUBLIC HEALTH, V97, P691, DOI 10.2105/AJPH.2005.080614
   Zienczuk N, 2012, NUTR J, V11, P0, DOI 10.1186/1475-2891-11-73
NR 34
TC 3
Z9 3
U1 0
U2 28
PU INT NUTRITION FOUNDATION
PI BOSTON
PA 150 HARRISON AVE, BOSTON, MA 02111 USA
SN 0379-5721
EI 1564-8265
J9 FOOD NUTR BULL
JI Food Nutr. Bull.
PD JUN 15
PY 2014
VL 35
IS 2
BP 244
EP 252
DI 10.1177/156482651403500211
PG 9
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA CA7YU
UT WOS:000349134500011
PM 25076772
DA 2025-04-28
ER

PT J
AU Revuelta-Iniesta, R
   Al-Dujaili, EAS
AF Revuelta-Iniesta, R.
   Al-Dujaili, E. A. S.
TI Consumption of Green Coffee Reduces Blood Pressure and Body Composition by Influencing 11Œ≤-HSD1 Enzyme Activity in Healthy Individuals: A Pilot Crossover Study Using Green and Black Coffee
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID chlorogenic acid; bean extract; habitual coffee; caffeine; dehydrogenase; tea; risk
AB Dietary polyphenols may have a protective role against the development of CVD. Thus, we aimed to investigate the effects of green coffee (GC), rich in chlorogenic acid, and black coffee (BC) on cardiovascular markers. A randomised pilot crossover study was performed on healthy subjects who consumed both coffees for 2 weeks. We measured anthropometry, blood pressure, and arterial elasticity after each intervention and collected urine samples to monitor antioxidant capacity. Free cortisol and cortisone levels were obtained from urine and analysed by specific ELISA methods. Systolic blood pressure (P = 0.018) and arterial elasticity (P = 0.001) were significantly reduced after GC. BMI (P = 0.04 for BC; P = 0.01 for GC) and abdominal fat (P = 0.01 for BC; P = 0.009 for GC) were also significantly reduced with no changes in energy intake. Urinary free cortisol was significantly reduced from 125.6 +/- 85.9 nmol/day to 76.0 +/- 54.9 nmol/day following GC and increased to 132.1 +/- 89.1 nmol/day after BC. Urinary free cortisone increased by 18% following BC and 9% following GC (nonsignificant). Cortisol/cortisone ratio (indicating 11 beta-HSD1 activity) was reduced after GC (from 3.5 +/- 1.9 to 1.7 +/- 1.04, P = 0.002). This suggests that GC can play a role in reducing cardiovascular risk factors. Further research including hypertensive and overweight individuals will now be justified to clarify whether GC could have a therapeutic role in CVD.
C1 [Revuelta-Iniesta, R.; Al-Dujaili, E. A. S.] Queen Margaret Univ, Dept Dietet Nutr & Biol Sci, Edinburgh EH21 6UU, Midlothian, Scotland.
C3 Queen Margaret University
RP Al-Dujaili, EAS (corresponding author), Queen Margaret Univ, Dept Dietet Nutr & Biol Sci, Queen Margaret Univ Dr, Edinburgh EH21 6UU, Midlothian, Scotland.
EM ealdujaili@qmu.ac.uk
FU Society for Endocrinology, UK
CR Al Moosawi S, 2010, THESIS QUEEN MARGARE, V0, P0
   Al-Dujaili EAS, 2012, STEROIDS, V77, P703, DOI 10.1016/j.steroids.2012.03.001
   Almoosawi S, 2009, END ABSTR, V19, P122
   Arao T, 2011, J HEALTH SCI, V57, P436, DOI 10.1248/jhs.57.436
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Bland M, 2004, DIRECTORY RANDOMISAT, V0, P0
   Corti R, 2002, CIRCULATION, V106, P2935, DOI 10.1161/01.CIR.0000046228.97025.3A
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Folkow B, 1997, ACTA PHYSIOL SCAND, V161, P34
   Geleijnse JM, 2008, VASC HEALTH RISK MAN, V4, P963
   George SE, 2008, CRIT REV FOOD SCI, V48, P464, DOI 10.1080/10408390701522445
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Griffin JE, 2004, TXB ENDOCRINE PHYSL, V0, P0
   Gropper SA, 2009, ADVANCED NUTRITION AND HUMAN METABOLISM, V0, P0
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   HOFER I, 1994, PHARMACOL BIOCHEM BE, V48, P899, DOI 10.1016/0091-3057(94)90198-8
   Jee SH, 1999, HYPERTENSION, V33, P647, DOI 10.1161/01.HYP.33.2.647
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   JUNG RT, 1981, CLIN SCI, V60, P527, DOI 10.1042/cs0600527
   Kaliora AC, 2006, ATHEROSCLEROSIS, V187, P1, DOI 10.1016/j.atherosclerosis.2005.11.001
   Kirilov G, 2003, EUR J ENDOCRINOL, V149, P549, DOI 10.1530/eje.0.1490549
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Lindsay RS, 2003, J CLIN ENDOCR METAB, V88, P2738, DOI 10.1210/jc.2002-030017
   Lopez-Garcia E, 2006, CIRCULATION, V113, P2045, DOI 10.1161/CIRCULATIONAHA.105.598664
   Mitchell Brett M, 2002, BIOL RES NURS, V4, P16, DOI 10.1177/1099800402004001003
   National Institute for Clinical Excellence (NICE), 2006, HYP CLIN MAN PRIM HY, V34, P0
   Nurminen ML, 1999, EUR J CLIN NUTR, V53, P831, DOI 10.1038/sj.ejcn.1600899
   Ochiai R, 2004, HYPERTENS RES, V27, P731, DOI 10.1291/hypres.27.731
   ROSMARIN PC, 1990, J GEN INTERN MED, V5, P211, DOI 10.1007/BF02600536
   Scalbert A, 2000, J NUTR, V130, P2073S, DOI 10.1093/jn/130.8.2073S
   Singleton VL, 1965, AM J ENOL VITICULT, V16, P144, DOI 10.12691/IJEBB-2-1-5
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Uiterwaal CSPM, 2007, AM J CLIN NUTR, V85, P718, DOI 10.1093/ajcn/85.3.718
   Veilleux A, 2009, J CLIN ENDOCR METAB, V94, P3550, DOI 10.1210/jc.2008-2011
   Vlachopoulos C, 2006, ARTERY RES, V1, PS15, DOI 10.1016/S1872-9312(07)70003-0
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135
   Winkelmayer WC, 2005, JAMA-J AM MED ASSOC, V294, P2330, DOI 10.1001/jama.294.18.2330
   World Health Organisation (WHO 2008), 2011, WAIST CIRC WAIST HIP, V0, P0
   Yamaguchi T, 2008, NUTR METAB CARDIOVAS, V18, P408, DOI 10.1016/j.numecd.2007.03.004
NR 42
TC 43
Z9 44
U1 1
U2 34
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PD JUN 15
PY 2014
VL 2014
IS 
BP 
EP 
DI 10.1155/2014/482704
PG 9
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AM4AA
UT WOS:000339792900001
PM 25133164
DA 2025-04-28
ER

PT J
AU Grandner, MA
   Knutson, KL
   Troxel, W
   Hale, L
   Jean-Louis, G
   Miller, KE
AF Grandner, Michael A.
   Knutson, Kristen L.
   Troxel, Wendy
   Hale, Lauren
   Jean-Louis, Girardin
   Miller, Kathleen E.
TI Implications of sleep and energy drink use for health disparities
SO NUTRITION REVIEWS
LA English
DT Review
DE caffeine; energy drinks; health disparities; sleep; sugar-sweetened beverages
ID protective behavioral strategy; alcohol-related consequences; college-students; socioeconomic-status; drug-use; obesity epidemic; blood-pressure; chronic stress; united-states; risk-taking
AB The popularity of energy drinks has increased rapidly in the past decade. One of the main reasons people use energy drinks is to counteract effects of insufficient sleep or sleepiness. Risks associated with energy drink use, including those related to sleep loss, may be disproportionately borne by racial minorities and those of lower socioeconomic status. In this review, a brief introduction to the issue of health disparities is provided, population-level disparities and inequalities in sleep are described, and the social-ecological model of sleep and health is presented. Social and demographic patterns of energy drink use are then presented, followed by discussion of the potential ways in which energy drink use may contribute to health disparities, including the following: 1) effects of excessive caffeine in energy drinks, 2) effects of energy drinks as sugar-sweetened beverages, 3) association between energy drinks and risk-taking behaviors when mixed with alcohol, 4) association between energy drink use and short sleep duration, and 5) role of energy drinks in cardiometabolic disease. The review concludes with a research agenda of critical unanswered questions. (C) 2014 International Life Sciences Institute
C1 [Grandner, Michael A.] Univ Penn, Perelman Sch Med, Dept Psychiat, Behav Sleep Med Program, Philadelphia, PA 19104 USA.
   [Grandner, Michael A.] Univ Penn, Ctr Sleep & Circadian Neurobiol, Philadelphia, PA 19104 USA.
   [Knutson, Kristen L.] Univ Chicago, Dept Med, Sect Pulm Crit Care, Chicago, IL 60637 USA.
   [Troxel, Wendy] RAND Corp, Pittsburgh, PA USA.
   [Hale, Lauren] SUNY Stony Brook, Program Publ Hlth, Stony Brook, NY 11794 USA.
   [Jean-Louis, Girardin] NYU, Sch Med, Dept Populat Hlth, New York, NY USA.
   [Jean-Louis, Girardin] NYU, Sch Med, Dept Psychiat, New York, NY USA.
   [Miller, Kathleen E.] SUNY Buffalo, Res Inst, Buffalo, NY 14260 USA.
C3 University of Pennsylvania; University of Pennsylvania; University of Chicago; RAND Corporation; State University of New York (SUNY) System; Stony Brook University; New York University; New York University; State University of New York (SUNY) System; University at Buffalo, SUNY
RP Grandner, MA (corresponding author), Behav Sleep Med Program, 3535 Market St,Suite 670, Philadelphia, PA 19104 USA.
EM grandner@upenn.edu
FU National Heart, Lung and Blood Institute [K23HL110216]; National Institute of Environmental Health Science [R21ES022931]; University of Pennsylvania CTSA [UL1RR024134]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK095207, R21DK089414s]; National Heart, Lung, and Blood Institute [K23HL093220]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD073352]; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute on Alcohol Abuse and Alcoholism [R01AA021395]
CR Abbey A, 2004, AGGRESS VIOLENT BEH, V9, P271, DOI 10.1016/S1359-1789(03)00011-9
   Adler NE, 2008, ANNU REV PUBL HEALTH, V29, P235, DOI 10.1146/annurev.publhealth.29.020907.090852
   Andreyeva T, 2004, OBES RES, V12, P1936, DOI 10.1038/oby.2004.243
   Andreyeva T, 2012, AM J PREV MED, V43, P411, DOI 10.1016/j.amepre.2012.06.015
   Unknown -, 2005, MONITORING FUTURE NA, V0, P0
   Arria AM, 2011, ALCOHOL CLIN EXP RES, V35, P365, DOI 10.1111/j.1530-0277.2010.01352.x
   Arria AM, 2010, J ADDICT MED, V4, P74, DOI 10.1097/ADM.0b013e3181aa8dd4
   Bailey RL, 2014, NUTR REV, V72, P9, DOI 10.1111/nure.12138
   Berger LK, 2011, ADDICT BEHAV, V36, P516, DOI 10.1016/j.addbeh.2010.12.027
   Bogle KA, 2008, HOOKING SEX DATING R, V0, P0
   Borden LA, 2011, PSYCHOL ADDICT BEHAV, V25, P346, DOI 10.1037/a0022678
   Brache K, 2011, ADDICT BEHAV, V36, P1133, DOI 10.1016/j.addbeh.2011.07.003
   Calamaro CJ, 2009, PEDIATRICS, V123, PE1005, DOI 10.1542/peds.2008-3641
   Clauson KA, 2008, J AM PHARM ASSOC, V48, PE55, DOI 10.1331/JAPhA.2008.07055
   Cornelius L J, 1991, J HEALTH CARE POOR UNDERSERVED, V2, P374
   Crabtree VM, 2005, SLEEP MED, V6, P319, DOI 10.1016/j.sleep.2005.02.001
   Curry K, 2009, HUM PSYCHOPHARM CLIN, V24, P473, DOI 10.1002/hup.1045
   de Leon CFM, 2005, J GERONTOL B-PSYCHOL, V60, PS263, DOI 10.1093/geronb/60.5.S263
   Fillmore MT, 1996, J STUD ALCOHOL, V57, P598, DOI 10.15288/jsa.1996.57.598
   Finch BK, 2010, HEALTH PLACE, V16, P1058, DOI 10.1016/j.healthplace.2010.05.009
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   French SA, 2003, J AM DIET ASSOC, V103, P1326, DOI 10.1016/S0002-8223(03)01076-9
   Friedman EM, 2005, P NATL ACAD SCI USA, V102, P18757, DOI 10.1073/pnas.0509281102
   Gallimberti L, 2013, EUR J PEDIATR, V172, P1335, DOI 10.1007/s00431-013-2036-1
   Gallo LC, 2003, PSYCHOL BULL, V129, P10, DOI 10.1037//0033-2909.129.1.10
   Gellis LA, 2005, J ABNORM PSYCHOL, V114, P111, DOI 10.1037/0021-843X.114.1.111
   Geroldi C, 1996, GERONTOLOGY, V42, P163
   Grandner MA, 2013, J CLIN SLEEP MED, V9, P897, DOI 10.5664/jcsm.2990
   Grandner MA, 2010, SLEEP MED, V11, P470, DOI 10.1016/j.sleep.2009.10.006
   Gunes A, 2008, PHARMACOGENOMICS, V9, P625, DOI 10.2217/14622416.9.5.625
   Hale L, 2007, SLEEP, V30, P1096, DOI 10.1093/sleep/30.9.1096
   Hall MH, 2009, SLEEP, V32, P73
   Harris JL, 2011, EVALUATING SURG DRIN, V0, P0
   Ishak Waguih William, 2012, INNOV CLIN NEUROSCI, V9, P25
   Jackson JS, 2011, INT HANDB POPUL, V2, P311, DOI 10.1007/978-90-481-9996-9_15
   Jackson JS, 2010, AM J PUBLIC HEALTH, V100, P933, DOI 10.2105/AJPH.2008.143446
   Jean-Louis G, 2000, BIOL PSYCHIAT, V47, P921, DOI 10.1016/S0006-3223(99)00169-9
   Jones SC, 2012, DRUG ALCOHOL REV, V31, P281, DOI 10.1111/j.1465-3362.2011.00319.x
   Killgore WDS, 2012, CHRONOBIOL INT, V29, P43, DOI 10.3109/07420528.2011.635230
   Kozak PJ, 2011, SLEEP, V34, P0
   LaBrie JW, 2011, ADDICT BEHAV, V36, P354, DOI 10.1016/j.addbeh.2010.12.013
   Lauderdale DS, 2006, AM J EPIDEMIOL, V164, P5, DOI 10.1093/aje/kwj199
   Lewis MA, 2010, PSYCHOL ADDICT BEHAV, V24, P229, DOI 10.1037/a0018361
   Locatelli D, 2012, REV BRAS PSIQUIATR, V34, P193, DOI 10.1590/S1516-44462012000200012
   Maia Q, 2013, ACCIDENT ANAL PREV, V59, P618, DOI 10.1016/j.aap.2013.07.028
   Marczinski CA, 2005, PSYCHOPHARMACOLOGY, V181, P337, DOI 10.1007/s00213-005-2269-4
   Marczinski CA, 2011, INT J ENV RES PUB HE, V8, P3232, DOI 10.3390/ijerph8083232
   Marczinski CA, 2011, ALCOHOL CLIN EXP RES, V35, P1282, DOI 10.1111/j.1530-0277.2011.01464.x
   Martens MP, 2004, PSYCHOL ADDICT BEHAV, V18, P390, DOI 10.1037/0893-164X.18.4.390
   Mezick EJ, 2008, PSYCHOSOM MED, V70, P410, DOI 10.1097/PSY.0b013e31816fdf21
   Miller KE, 2008, J ADOLESCENT HEALTH, V43, P490, DOI 10.1016/j.jadohealth.2008.03.003
   Miller KE, 2008, J AM COLL HEALTH, V56, P481, DOI 10.3200/JACH.56.5.481-490
   Miller Kathleen E, 2012, J CAFFEINE RES, V2, P62, DOI 10.1089/jcr.2012.0015
   Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76
   Nolen-Hoeksema S, 2006, J GEN PSYCHOL, V133, P357, DOI 10.3200/GENP.133.4.357-374
   Nomura K, 2010, J PSYCHOSOM RES, V69, P435, DOI 10.1016/j.jpsychores.2010.04.014
   OBrien MC, 2008, ACAD EMERG MED, V15, P453, DOI 10.1111/j.1553-2712.2008.00085.x
   Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549
   Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401
   Ogden Cynthia L, 2011, NCHS DATA BRIEF, V0, P1
   Orbeta RL, 2006, J ADOLESCENT HEALTH, V38, P451, DOI 10.1016/j.jadohealth.2005.05.014
   Oteri A, 2007, ALCOHOL CLIN EXP RES, V31, P1677, DOI 10.1111/j.1530-0277.2007.00464.x
   Park S, 2013, J ACAD NUTR DIET, V113, P112, DOI 10.1016/j.jand.2012.09.019
   Patel NP, 2010, SLEEP, V33, P0
   Peacock A, 2012, ALCOHOL CLIN EXP RES, V36, P2008, DOI 10.1111/j.1530-0277.2012.01820.x
   Pollak CP, 2003, PEDIATRICS, V111, P42, DOI 10.1542/peds.111.1.42
   Pomeranz JL, 2013, J PUBLIC HEALTH POL, V34, P254, DOI 10.1057/jphp.2013.6
   Price SR, 2010, DRUG ALCOHOL REV, V29, P331, DOI 10.1111/j.1465-3362.2009.00163.x
   Putnam JudithJ, 1999, FOOD CONSUMPTION PRI, V0, P0
   Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001
   R√≠os JL, 2013, P R HEALTH SCI J, V32, P95
   Roberts RE, 2000, AM J PSYCHIAT, V157, P81, DOI 10.1176/ajp.157.1.81
   Roehrs T, 2008, SLEEP MED REV, V12, P153, DOI 10.1016/j.smrv.2007.07.004
   Ruiter ME, 2011, SLEEP MED, V12, P209, DOI 10.1016/j.sleep.2010.12.010
   Rush E, 2006, ASIA PAC J CLIN NUTR, V15, P242
   Savoca MR, 2005, AM J HYPERTENS, V18, P116, DOI 10.1016/j.amjhyper.2004.08.011
   Savoca MR, 2004, ARCH PEDIAT ADOL MED, V158, P473, DOI 10.1001/archpedi.158.5.473
   Sharwood LN, 2013, BMJ-BRIT MED J, V346, P0, DOI 10.1136/bmj.f1140
   Smedley BD, 2003, UNEQUAL TREATMENT CO, V0, P0, DOI DOI 10.17226/12875
   Smith G, 2009, INT J SEX HEALTH, V21, P119, DOI 10.1080/19317610902973241
   Snipes DJ, 2013, ADDICT BEHAV, V38, P1418, DOI 10.1016/j.addbeh.2012.07.011
   Stamatakis KA, 2007, ANN EPIDEMIOL, V17, P948, DOI 10.1016/j.annepidem.2007.07.096
   Temple JL, 2009, NEUROSCI BIOBEHAV R, V33, P793, DOI 10.1016/j.neubiorev.2009.01.001
   Thombs DL, 2010, ADDICT BEHAV, V35, P325, DOI 10.1016/j.addbeh.2009.11.004
   Toblin Robin L, 2012, MORBIDITY AND MORTALITY WEEKLY REPORT, V61, P895
   Tomfohr LM, 2010, BEHAV SLEEP MED, V8, P219, DOI 10.1080/15402002.2010.509236
   Velazquez CE, 2012, DRUG ALCOHOL DEPEN, V123, P167, DOI 10.1016/j.drugalcdep.2011.11.006
   Walia HK, 2012, SLEEP BREATH, V16, P543, DOI 10.1007/s11325-011-0540-y
   Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007
   Wells BE, 2013, AM J DRUG ALCOHOL AB, V39, P8, DOI 10.3109/00952990.2012.720320
   Whinnery J, 2014, SLEEP, V37, P601, DOI 10.5665/sleep.3508
   Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979
   Woods D, 2012, J PRIM HEALTH CARE, V4, P163, DOI 10.1071/HC12163
   Worthley MI, 2010, AM J MED, V123, P184, DOI 10.1016/j.amjmed.2009.09.013
NR 95
TC 28
Z9 32
U1 4
U2 53
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0029-6643
EI 1753-4887
J9 NUTR REV
JI Nutr. Rev.
PD OCT 15
PY 2014
VL 72
IS 
BP 14
EP 22
DI 10.1111/nure.12137
PG 9
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CB9PR
UT WOS:000349964500003
PM 25293540
DA 2025-04-28
ER

PT J
AU Jia, HJ
   Aw, WP
   Egashira, K
   Takahashi, S
   Aoyama, S
   Saito, K
   Kishimoto, Y
   Kato, H
AF Jia, Huijuan
   Aw, Wanping
   Egashira, Kenji
   Takahashi, Shoko
   Aoyama, Shinya
   Saito, Kenji
   Kishimoto, Yoshimi
   Kato, Hisanori
TI Coffee intake mitigated inflammation and obesity-induced insulin resistance in skeletal muscle of high-fat diet-induced obese mice
SO GENES AND NUTRITION
LA English
DT Article
DE Coffee intake; Insulin resistance; Inflammation and obesity; Skeletal muscle; Transcriptomic analysis; High-fat diet
ID type-2 diabetes-mellitus; c-reactive protein; caffeic acid; mononuclear-cells; expression; risk; stress; gene; consumption; sensitivity
AB Epidemiologic findings offer the promise that coffee or its many constituents may be useful as a dietary intervention in type 2 diabetes (T2D) prevention. We aimed to elucidate the molecular mechanisms involved in the ameliorative effects of caffeinated coffee (CC), decaffeinated coffee (DC) and unroasted caffeinated green coffee (GC) on skeletal muscle gene expression profiles and their relationships in an obesity animal model. Eight-week-old male C57BL6 mice were raised for 9 weeks ad libitum on a normal diet, a high-fat diet, or high-fat diet containing 2 % freeze-dried CC, or DC, or GC. Total RNA and protein were extracted from skeletal muscle and subjected to microarray (Mouse Genome 430 2.0, Affymetrix) and western blotting analyses, respectively. Coffee intake mitigated the insulin resistance by decreasing plasma glucose levels during an insulin tolerance test and by increasing tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1), p85/IRS-1 complex and pAkt/PKB (protein kinase B). In addition, coffee intake down-regulated the anti-inflammatory genes activating transcription factor 3, FBJ osteosarcoma oncogene, heat shock protein 1A, heat shock protein 1B and synuclein, gamma and the inflammation-associated insulin signaling genes stearoyl-coenzyme A desaturase 1 and secreted phosphoprotein 1. These results provide scientific insight on the probable positive effects of coffee intake on impaired insulin signaling, inflammation and obesity, thereby providing a new perspective on the prevention of obesity and T2D.
C1 [Jia, Huijuan; Saito, Kenji; Kato, Hisanori] Univ Tokyo, Corp Sponsored Res Program Food Life, Org Interdisciplinary Res Projects, Bunkyo Ku, Tokyo 1138657, Japan.
   [Aw, Wanping] Tokyo Med & Dent Univ, Grad Sch Biomed Sci, Bunkyo Ku, Tokyo, Japan.
   [Egashira, Kenji; Takahashi, Shoko; Aoyama, Shinya; Kato, Hisanori] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan.
   [Kishimoto, Yoshimi] Ochanomizu Univ, Inst Environm Sci Human Life, Bunkyo Ku, Tokyo 112, Japan.
C3 University of Tokyo; Institute of Science Tokyo; Tokyo Medical & Dental University (TMDU); University of Tokyo; Ochanomizu University
RP Kato, H (corresponding author), Univ Tokyo, Corp Sponsored Res Program Food Life, Org Interdisciplinary Res Projects, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.
EM akatoq@mail.ecc.u-tokyo.ac.jp
FU All Japan Coffee Association; Grants-in-Aid for Scientific Research [23700901] Funding Source: KAKEN
CR Abebe A, 2013, AM J RES COMMUN, V1, P78
   Aljada A, 2002, J CLIN ENDOCR METAB, V87, P1419, DOI 10.1210/jc.87.3.1419
   Barzilay JI, 2001, DIABETES, V50, P2384, DOI 10.2337/diabetes.50.10.2384
   Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005
   Chao PC, 2009, NUTR METAB, V6, P0, DOI 10.1186/1743-7075-6-33
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Dandona P, 2001, J CLIN ENDOCR METAB, V86, P3257, DOI 10.1210/jc.86.7.3257
   DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318
   Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE
   Gray J, 1998, NUTRITION & FOOD SCIENCE, V0, PP314, DOI 10.1108/00346659810235215
   Halter B, 2010, FREE RADICAL BIO MED, V48, P915, DOI 10.1016/j.freeradbiomed.2010.01.014
   Han TS, 2002, DIABETES CARE, V25, P2016, DOI 10.2337/diacare.25.11.2016
   Hojlund K, 2002, EUR J CLIN INVEST, V32, P918, DOI 10.1046/j.1365-2362.2002.01098.x
   Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492
   Hu G, 2006, INT J OBESITY, V30, P1742, DOI 10.1038/sj.ijo.0803341
   Jia HJ, 2013, J FUNCT FOODS, V5, P1611, DOI 10.1016/j.jff.2013.07.003
   Jia HJ, 2013, MOL NUTR FOOD RES, V57, P291, DOI 10.1002/mnfr.201200538
   Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004
   Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163
   Kiefer FW, 2010, DIABETES, V59, P935, DOI 10.2337/db09-0404
   Kobayashi M, 2012, J NUTR SCI VITAMINOL, V58, P408, DOI 10.3177/jnsv.58.408
   Matsuda Y, 2011, BIOSCI BIOTECH BIOCH, V75, P2309, DOI 10.1271/bbb.110452
   Mohanty P, 2000, J CLIN ENDOCR METAB, V85, P2970, DOI 10.1210/jc.85.8.2970
   MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673
   NARDINI M, 1995, FREE RADICAL BIO MED, V19, P541, DOI 10.1016/0891-5849(95)00052-Y
   Oort PJ, 2008, J NUTR, V138, P841, DOI 10.1093/jn/138.5.841
   Paynter NP, 2006, AM J EPIDEMIOL, V164, P1075, DOI 10.1093/aje/kwj323
   Peter A, 2009, DIABETES, V58, P1757, DOI 10.2337/db09-0188
   Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327
   Pradhan AD, 2003, ARTERIOSCL THROM VAS, V23, P650, DOI 10.1161/01.ATV.0000065636.15310.9C
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   REYNET C, 1993, SCIENCE, V262, P1441, DOI 10.1126/science.8248782
   RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9
   Shan JH, 2009, INT IMMUNOPHARMACOL, V9, P1042, DOI 10.1016/j.intimp.2009.04.011
   Smith RS, 2007, DNA SEQUENCE, V18, P47, DOI 10.1080/10425170601060707
   Stefano P, 2002, WORLD DEV, V30, P1099
   Takahashi S, 2014, J FUNCT FOODS, V6, P157, DOI 10.1016/j.jff.2013.10.002
   Zmuda EJ, 2010, MOL ENDOCRINOL, V24, P1423, DOI 10.1210/me.2009-0463
NR 38
TC 34
Z9 35
U1 0
U2 31
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1555-8932
EI 1865-3499
J9 GENES NUTR
JI Genes Nutr.
PD MAY 15
PY 2014
VL 9
IS 3
BP 
EP 
DI 10.1007/s12263-014-0389-3
PG 10
WC Genetics & Heredity; Nutrition & Dietetics
SC Genetics & Heredity; Nutrition & Dietetics
GA AH8MG
UT WOS:000336391300001
PM 24599575
DA 2025-04-28
ER

PT J
AU Schubert, MM
   Hall, S
   Leveritt, M
   Grant, G
   Sabapathy, S
   Desbrow, B
AF Schubert, Matthew M.
   Hall, Susan
   Leveritt, Michael
   Grant, Gary
   Sabapathy, Surendran
   Desbrow, Ben
TI Caffeine consumption around an exercise bout: effects on energy expenditure, energy intake, and exercise enjoyment
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE exercise; appetite; caffeine; fat oxidation; exercise enjoyment
ID predicting body density; physical-activity; generalized equations; perceived exertion; muscle pain; ingestion; oxidation; responses; brain; time
AB Combining an exercise and nutritional intervention is arguably the optimal method of creating energy imbalance for weight loss. This study sought to determine whether combining exercise and caffeine supplementation was more effective for promoting acute energy deficits and manipulations to substrate metabolism than exercise alone. Fourteen recreationally active participants (mean +/- SD body mass index: 22.7 +/- 2.6 kg/m(2)) completed a resting control trial (CON), a placebo exercise trial (EX), and a caffeine exercise trial (EX + CAF, 2 x 3 mg/kg of caffeine 90 min before and 30 min after exercise) in a randomized, double-blinded design. Trials were 4 h in duration with 1 h of rest, 1 h of cycling at similar to 65% power at maximum O-2 consumption or rest, and a 2-h recovery. Gas exchange, appetite perceptions, and blood samples were obtained periodically. Two hours after exercise, participants were offered an ad libitum test meal where energy and macronutrient intake were recorded. EX + CAF resulted in significantly greater energy expenditure and fat oxidation compared with EX (+ 250 kJ; + 10.4 g) and CON (+ 3,126 kJ; + 29.7 g) (P < 0.05). A trend for reduced energy and fat intake compared with CON (-718 kJ; -8 g) (P = 0.055) was observed. Consequently, EX + CAF created a greater energy deficit (P < 0.05). Caffeine also led to exercise being perceived as less difficult and more enjoyable (P < 0.05). Combining caffeine with exercise creates a greater acute energy deficit, and the implications of this protocol for weight loss or maintenance over longer periods of time in overweight/obese populations should be further investigated.
C1 [Schubert, Matthew M.; Sabapathy, Surendran; Desbrow, Ben] Griffith Univ, Sch Allied Hlth Sci, Gold Coast, Qld 4222, Australia.
   [Hall, Susan; Grant, Gary] Griffith Univ, Sch Pharm, Gold Coast, Qld 4222, Australia.
   [Schubert, Matthew M.; Hall, Susan; Grant, Gary; Sabapathy, Surendran; Desbrow, Ben] Griffith Univ, Griffith Hlth Inst, Gold Coast, Qld 4222, Australia.
   [Leveritt, Michael] Univ Queensland, Sch Human Movement Studies, St Lucia, Qld, Australia.
C3 Griffith University; Griffith University - Gold Coast Campus; Griffith University; Griffith University - Gold Coast Campus; Griffith University; Griffith University - Gold Coast Campus; Menzies Health Institute Queensland; University of Queensland
RP Schubert, MM (corresponding author), Griffith Univ, Sch Allied Hlth Sci, G40 2-59,Parklands Dr, Gold Coast, Qld 4222, Australia.
EM m.schubert@griffith.edu.au
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   ARCIERO PJ, 1995, AM J PHYSIOL-ENDOC M, V268, PE1192, DOI 10.1152/ajpendo.1995.268.6.E1192
   Arciero PJ, 2000, METABOLISM, V49, P101, DOI 10.1016/S0026-0495(00)90888-6
   Backhouse SH, 2011, APPETITE, V57, P247, DOI 10.1016/j.appet.2011.05.304
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012
   Broom DR, 2007, J APPL PHYSIOL, V102, P2165, DOI 10.1152/japplphysiol.00759.2006
   Cadieux S, 2014, PHYSIOL BEHAV, V130, P113, DOI 10.1016/j.physbeh.2014.03.031
   Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009
   Cook DB, 1997, MED SCI SPORT EXER, V29, P999, DOI 10.1097/00005768-199708000-00004
   de Araujo IE, 2012, PHYSIOL BEHAV, V106, P394, DOI 10.1016/j.physbeh.2012.02.026
   Deighton K, 2013, APPL PHYSIOL NUTR ME, V38, P947, DOI 10.1139/apnm-2012-0484
   Desbrow B, 2012, CAFFEINE CALCULATOR, V0, P0
   Desbrow B, 2012, J SPORT SCI, V30, P115, DOI 10.1080/02640414.2011.632431
   Desbrow B, 2009, MED SCI SPORT EXER, V41, P1744, DOI 10.1249/MSS.0b013e3181a16cf7
   Doherty M, 2005, SCAND J MED SCI SPOR, V15, P69, DOI 10.1111/j.1600-0838.2005.00445.x
   DONELLY K, 1992, EUR J APPL PHYSIOL O, V65, P459, DOI 10.1007/BF00243514
   Donnelly JE, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0083498
   Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333
   Ekkekakis P, 2011, SPORTS MED, V41, P641, DOI 10.2165/11590680-000000000-00000
   FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Gavrieli A, 2013, OBESITY SILVER SPRIN, V0, P1
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   Gibson S, 2013, NUTR J, V12, P0, DOI 10.1186/1475-2891-12-9
   Greenberg JA, 2012, J AM COLL NUTR, V31, P160, DOI 10.1080/07315724.2012.10720023
   HARDY CJ, 1989, J SPORT EXERCISE PSY, V11, P304, DOI 10.1123/jsep.11.3.304
   Hursel R, 2011, OBES REV, V12, PE573, DOI 10.1111/j.1467-789X.2011.00862.x
   JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152
   JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175
   J√∫dice PB, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0068936
   J√∫dice PB, 2013, APPL PHYSIOL NUTR ME, V38, P49, DOI 10.1139/apnm-2012-0145
   KENDZIERSKI D, 1991, J SPORT EXERCISE PSY, V13, P50, DOI 10.1123/jsep.13.1.50
   Marosi K, 2014, TRENDS ENDOCRIN MET, V25, P89, DOI 10.1016/j.tem.2013.10.006
   Meeusen R, 2013, NESTLE NUTR WORKS SE, V76, P1, DOI 10.1159/000350223
   Mitchell DC, 2014, FOOD CHEM TOXICOL, V63, P136, DOI 10.1016/j.fct.2013.10.042
   Motl RW, 2003, J PAIN, V4, P316, DOI 10.1016/S1526-5900(03)00635-7
   Moy GA, 2013, PHYSIOL BEHAV, V109, P69, DOI 10.1016/j.physbeh.2012.11.008
   Robergs RA, 2010, SPORTS MED, V40, P95, DOI 10.2165/11319670-000000000-00000
   Schrader P, 2013, NUTR RES, V33, P457, DOI 10.1016/j.nutres.2013.04.003
   Schubert MM, 2013, APPETITE, V63, P92, DOI 10.1016/j.appet.2012.12.010
   Sim AY, 2014, INT J OBESITY, V38, P417, DOI 10.1038/ijo.2013.102
   SIRI W E, 1956, ADV BIOL MED PHYS, V4, P239
   Skelly LE, 2014, APPL PHYSIOL NUTR ME, V39, P845, DOI 10.1139/apnm-2013-0562
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8
   TREMBLAY A, 1988, NUTR RES, V8, P553, DOI 10.1016/S0271-5317(88)80077-0
   Unick JL, 2012, PSYCHOL SPORT EXERC, V13, P528, DOI 10.1016/j.psychsport.2012.02.012
   Wallman KE, 2010, J SPORT SCI MED, V9, P183
   Washburn RA, 2014, CLIN OBES, V4, P1, DOI 10.1111/cob.12040
   ZAHN TP, 1987, INT J PSYCHOPHYSIOL, V5, P33, DOI 10.1016/0167-8760(87)90070-5
NR 51
TC 31
Z9 36
U1 2
U2 85
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD OCT 1
PY 2014
VL 117
IS 7
BP 745
EP 754
DI 10.1152/japplphysiol.00570.2014
PG 10
WC Physiology; Sport Sciences
SC Physiology; Sport Sciences
GA AR0DQ
UT WOS:000343237500009
PM 25123196
DA 2025-04-28
ER

PT J
AU Wong, RHX
   Garg, ML
   Wood, LG
   Howe, PRC
AF Wong, Rachel H. X.
   Garg, Manohar L.
   Wood, Lisa G.
   Howe, Peter R. C.
TI Antihypertensive Potential of Combined Extracts of Olive Leaf, Green Coffee Bean and Beetroot: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial
SO NUTRIENTS
LA English
DT Article
DE ambulatory blood pressure; olive leaf extract; chlorogenic acid; hypertension; cholesterol; insulin sensitivity
ID blood-pressure; chlorogenic acid; metabolism; oleuropein; nitrate
AB Extracts of olive leaf, green coffee bean and beetroot may deliver cardiovascular benefits. This study sought to evaluate the effects of regularly consuming a combination of these extracts on blood pressure (BP), arterial compliance, blood lipids, blood glucose and insulin sensitivity. A double-blind randomised placebo-controlled crossover trial was conducted in adults with untreated high normal or borderline elevated BP. They were randomised to take an active supplement, comprising 500 mg olive leaf extract, 100 mg green coffee bean extract and 150 mg beet powder, or a matching placebo twice daily for six weeks, followed by the alternate supplement for a further six weeks. Assessments of 24-h ambulatory BP (ABP), clinic BP arterial compliance (pulse-wave analysis), blood lipids, blood glucose and insulin were obtained at baseline and at the end of each treatment phase. Baseline clinic BP in 37 overweight middle-aged men and women who completed the trial averaged 145/84 mmHg. There was no significant effect of treatment on ABP or any other outcome measure. The failure to confirm prior evidence of the antihypertensive benefits of these extracts emphasises the importance of placebo control and the value of ABP monitoring. Further dose-response evaluation of olive leaf, green coffee bean or beetroot extracts is required to confirm or refute the purported benefits.
C1 [Howe, Peter R. C.] Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Clin Nutr Res Ctr, Callaghan, NSW 2308, Australia.
   Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Nutraceut Res Grp, Callaghan, NSW 2308, Australia.
C3 University of Newcastle; University of Newcastle
RP Howe, PRC (corresponding author), Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Clin Nutr Res Ctr, Callaghan, NSW 2308, Australia.
EM rachel.wong@newcastle.edu.au; manohar.garg@newcastle.edu.au; lisa.wood@newcastle.edu.au; peter.howe@newcastle.edu.au
FU HealthWorld Ltd.
CR Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843
   Unknown -, 2005, HEART LUNG CIRC, V14, P275
   Unknown -, 2011, EUR YB 2011, V0, P33
   Asmar R, 2001, AM J HYPERTENS, V14, P546, DOI 10.1016/S0895-7061(00)01286-3
   Cassileth BR, 2009, PHARM BIOL, V47, P761, DOI 10.1080/13880200902991581
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Colagiuri S, 2009, NATIONAL EVIDENCE BASED GUIDELINE FOR BLOOD GLUCOSE CONTROL IN TYPE 2 DIABETES, V0, P0
   De Bock M, 2013, PLOS ONE, V8, P1
   de Bock M, 2013, MOL NUTR FOOD RES, V57, P2079, DOI 10.1002/mnfr.201200795
   El SN, 2009, NUTR REV, V67, P632, DOI 10.1111/j.1753-4887.2009.00248.x
   GOULD AL, 1995, CIRCULATION, V91, P2274, DOI 10.1161/01.CIR.91.8.2274
   Hobbs DA, 2012, BRIT J NUTR, V108, P2066, DOI 10.1017/S0007114512000190
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Mubarak A, 2012, J AGR FOOD CHEM, V60, P9130, DOI 10.1021/jf303440j
   Pannala AS, 2003, FREE RADICAL BIO MED, V34, P576, DOI 10.1016/S0891-5849(02)01353-9
   Perrinjaquet-Moccetti T, 2008, PHYTOTHER RES, V22, P1239, DOI 10.1002/ptr.2455
   Susalit E, 2011, PHYTOMEDICINE, V18, P251, DOI 10.1016/j.phymed.2010.08.016
   Suzuki A, 2002, HYPERTENS RES, V25, P99, DOI 10.1291/hypres.25.99
   van Velzen AG, 2008, TOXICOL LETT, V181, P177, DOI 10.1016/j.toxlet.2008.07.019
   Verdecchia P, 2000, HYPERTENSION, V35, P844, DOI 10.1161/01.HYP.35.3.844
   Visioli F, 1998, LIFE SCI, V62, P541, DOI 10.1016/S0024-3205(97)01150-8
   Wainstein J, 2012, J MED FOOD, V15, P605, DOI 10.1089/jmf.2011.0243
   Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Webb A, 2008, FASEB J, V22, P0
   Zhao YY, 2012, HYPERTENS RES, V35, P370, DOI 10.1038/hr.2011.195
NR 26
TC 17
Z9 17
U1 0
U2 37
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD NOV 15
PY 2014
VL 6
IS 11
BP 4881
EP 4894
DI 10.3390/nu6114881
PG 14
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA AU3RM
UT WOS:000345531300017
PM 25379688
DA 2025-04-28
ER

PT J
AU Hutcheon, DA
   Ziegler, J
AF Hutcheon, Deborah A.
   Ziegler, Jane
TI Green Tea Should It Be Used As a Dietary Aid for Weight Loss?
SO TOPICS IN CLINICAL NUTRITION
LA English
DT Review
DE caffeine; dietary supplements; epigallocatechin-3-gallate; functional food; green tea; obesity; weight loss
ID epigallocatechin-gallate egcg; fat oxidation; catechin-polyphenols; energy-expenditure; body-weight; caffeine; extract; supplements; safety
AB Dietary weight loss supplements include a wide range of ingredients. Many ingredients are derived from natural food sources such as green tea. This article presents the composition, mechanisms of action, efficacy, and safety of green tea as a dietary aid to weight loss in overweight and obese adults. While green tea appears to promote energy expenditure and fat oxidation, safety concerns exist when it is consumed as a dietary supplement. Until more evidence-based research is conducted to determine which formulations and dosages are the safest and most effective, green tea should be used with caution as an aid for weight loss.
C1 [Hutcheon, Deborah A.; Ziegler, Jane] Rutgers State Univ, Sch Hlth Related Profess, Newark, NJ 07107 USA.
C3 Rutgers University System; Rutgers University New Brunswick; Rutgers University Newark
RP Hutcheon, DA (corresponding author), Rutgers State Univ, Sch Hlth Related Profess, 65 Bergen St, Newark, NJ 07107 USA.
EM hutcheda@shrp.rutgers.edu
CR Unknown -, 2009, J AM DIET ASSOC, V109, P330, DOI 10.1016/j.jada.2008.11.041
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   B√©rub√©-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bhagwat S, 2012, USDA DATABASE FLAVON, V0, P0
   Boehm K, 2009, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD005004.pub2
   Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518
   Chin JM, 2008, J ANAL TOXICOL, V32, P702, DOI 10.1093/jat/32.8.702
   Diepvens K, 2006, PHYSIOL BEHAV, V87, P185, DOI 10.1016/j.physbeh.2005.09.013
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Heckman MA, 2010, J FOOD SCI, V75, PR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Henning SM, 2004, AM J CLIN NUTR, V80, P1558
   Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hursel R, 2011, OBES REV, V12, PE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P636, DOI 10.1016/j.fct.2005.11.003
   Jeukendrup AE, 2011, OBES REV, V12, P841, DOI 10.1111/j.1467-789X.2011.00908.x
   Jurgens TM, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD008650.pub2
   Lin YS, 2003, J AGR FOOD CHEM, V51, P1864, DOI 10.1021/jf021066b
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Navarro VJ, 2013, DIGEST DIS SCI, V58, P2682, DOI 10.1007/s10620-013-2687-9
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Pillitteri JL, 2008, OBESITY, V16, P790, DOI 10.1038/oby.2007.136
   Sarma DN, 2008, DRUG SAFETY, V31, P469, DOI 10.2165/00002018-200831060-00003
   Thielecke F, 2010, EUR J CLIN NUTR, V64, P704, DOI 10.1038/ejcn.2010.47
   Ullmann U, 2004, INT J VITAM NUTR RES, V74, P269, DOI 10.1024/0300-9831.74.4.269
   Ullmann U, 2003, J INT MED RES, V31, P88, DOI 10.1177/147323000303100205
   Unachukwu UJ, 2010, J FOOD SCI, V75, PC541, DOI 10.1111/j.1750-3841.2010.01705.x
   US Food and Drug Administration, 2012, WHAT IS MEAN NAT LAB, V0, P0
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Wang ZM, 2011, AM J CLIN NUTR, V93, P506, DOI 10.3945/ajcn.110.005363
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
NR 35
TC 0
Z9 0
U1 2
U2 56
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0883-5691
EI 1550-5146
J9 TOP CLIN NUTR
JI Top. Clin. Nutr.
PD JUL-SEP 15
PY 2014
VL 29
IS 3
BP 268
EP 277
DI 10.1097/TIN.0000000000000004
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA CZ6QU
UT WOS:000367226600008
DA 2025-04-28
ER

PT J
AU Zheng, GD
   Qiu, YY
   Zhang, QF
   Li, DM
AF Zheng, Guodong
   Qiu, Yangyang
   Zhang, Qing-Feng
   Li, Dongming
TI Chlorogenic acid and caffeine in combination inhibit fat accumulation by regulating hepatic lipid metabolism-related enzymes in mice
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Chlorogenic acid; Caffeine; Fat accumulation; Lipid metabolism-related enzymes
ID green tea; coffee; differentiation; proliferation; thermogenesis; catechins; alpha; cells; liver
AB Obesity has become a public health concern due to its positive association with the incidence of many diseases, and coffee components including chlorogenic acid (CGA) and caffeine have been demonstrated to play roles in the suppression of fat accumulation. To investigate the mechanism by which CGA and caffeine regulate lipid metabolism, in the present study, forty mice were randomly assigned to four groups and fed diets containing no CGA or caffeine, CGA, caffeine, or CGA + caffeine for 24 weeks. Body weight, intraperitoneal adipose tissue (IPAT) weight, and serum biochemical parameters were measured, and the activities and mRNA and protein expression of lipid metabolism-related enzymes were analysed. There was a decrease in the body weight and IPAT weight of mice fed the CGA + caffeine diet. There was a significant decrease in the serum and hepatic concentrations of total cholesterol, TAG and leptin of mice fed the CGA + caffeine diet. The activities of carnitine acyltransferase (CAT) and acyl-CoA oxidase (ACO) were increased in mice fed the caffeine and CGA + caffeine diets, while the activity of fatty acid synthase (FAS) was suppressed in those fed the CGA + caffeine diet. The mRNA expression levels of AMP-activated protein kinase (AMPK), CAT and ACO were considerably up-regulated in mice fed the CGA + caffeine diet, while those of PPAR gamma 2 were down-regulated. The protein expression levels of AMPK were increased and those of FAS were decreased in mice fed the CGA + caffeine diet. These results indicate that CGA + caffeine suppresses fat accumulation and body weight gain by regulating the activities and mRNA and protein expression levels of hepatic lipid metabolism-related enzymes and that these effects are stronger than those exerted by CGA and caffeine individually.
C1 [Zheng, Guodong; Qiu, Yangyang; Zhang, Qing-Feng; Li, Dongming] Jiangxi Agr Univ, Coll Food Sci & Engn, Jiangxi Key Lab Nat Prod & Funct Food, Nanchang 330045, Peoples R China.
C3 Jiangxi Agricultural University
RP Zheng, GD (corresponding author), Jiangxi Agr Univ, Coll Food Sci & Engn, Jiangxi Key Lab Nat Prod & Funct Food, Nanchang 330045, Peoples R China.
EM zrs150716@aliyun.com
FU National Natural Science Foundation of China [31160320]; Scientific Research Foundation for the Returned Overseas Chinese Scholar, State Education Ministry
CR BARTLETT GR, 1959, J BIOL CHEM, V234, P469
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Farmer SR, 2005, INT J OBESITY, V29, PS13, DOI 10.1038/sj.ijo.0802907
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200
   Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965
   Hirata T, 2011, BIOORG MED CHEM LETT, V21, P1786, DOI 10.1016/j.bmcl.2011.01.060
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   Janeckov√° R, 2001, PHYSIOL RES, V50, P443
   KELLEY DS, 1986, BIOCHEM J, V235, P87, DOI 10.1042/bj2350087
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Lee CE, 2012, EVID-BASED COMPL ALT, V2012, P0, DOI 10.1155/2012/759143
   Li BH, 2006, IUBMB LIFE, V58, P39, DOI 10.1080/15216540500507408
   Li M, 1999, BIOCHEM MOL BIOL INT, V47, P63
   Lord CC, 2012, ADIPOCYTE, V1, P123, DOI 10.4161/adip.20035
   MARKWELL MA, 1973, J BIOL CHEM, V248, P3426
   Miura D, 2007, BIOSCI BIOTECH BIOCH, V71, P2743, DOI 10.1271/bbb.70359
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   Moriyama T, 2004, BIOSCI BIOTECH BIOCH, V68, P352, DOI 10.1271/bbb.68.352
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Narita Y, 2013, J AGR FOOD CHEM, V61, P966, DOI 10.1021/jf304105w
   Niseteo T, 2012, FOOD CHEM, V134, P1870, DOI 10.1016/j.foodchem.2012.03.095
   Ong KW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032718
   Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006
   OSUMI T, 1978, BIOCHEM BIOPH RES CO, V83, P479, DOI 10.1016/0006-291X(78)91015-X
   Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189
   Peng CH, 2011, J AGR FOOD CHEM, V59, P2663, DOI 10.1021/jf1043508
   Riedel A, 2012, FOOD FUNCT, V3, P955, DOI 10.1039/c2fo30053b
   Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520
   Su SJ, 2013, INT J FOOD SCI NUTR, V64, P429, DOI 10.3109/09637486.2012.759184
   Tanaka K, 2010, BIOSCI BIOTECH BIOCH, V74, P1606, DOI 10.1271/bbb.100197
   Tauler P, 2013, MED SCI SPORT EXER, V45, P1269, DOI 10.1249/MSS.0b013e3182857c8a
   Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8
   YOSHIOKA K, 1990, J NUTR SCI VITAMINOL, V36, P173, DOI 10.3177/jnsv.36.173
   Zhang A, 2013, OBES REV, V14, P344, DOI 10.1111/obr.12011
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
   Zheng GD, 2004, IN VIVO, V18, P55
NR 38
TC 55
Z9 58
U1 0
U2 43
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD SEP 28
PY 2014
VL 112
IS 6
BP 1034
EP 1040
DI 10.1017/S0007114514001652
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA AP3JD
UT WOS:000341970800019
PM 25201308
DA 2025-04-28
ER

PT J
AU Kim, J
   Kim, J
   Shim, J
   Lee, CY
   Lee, KW
   Lee, HJ
AF Kim, Jiyoung
   Kim, Jaekyoon
   Shim, Jaesung
   Lee, Chang Yong
   Lee, Ki Won
   Lee, Hyong Joo
TI Cocoa Phytochemicals: Recent Advances in Molecular Mechanisms on Health
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Cocoa; cardiovascular diseases; cancer; neurodegeneration; obesity and diabetes; skin aging
ID flavanol-rich cocoa; cacao liquor proanthocyanidins; low-density-lipoprotein; improves endothelial function; ldl oxidative susceptibility; coronary-heart-disease; nf-kappa-b; dark chocolate; theobroma-cacao; blood-pressure
AB Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health. Cocoa consumption is correlated with reduced health risks of cardiovascular diseases, hypertension, atherosclerosis, and cancer, and the health-promoting effects of cocoa are mediated by cocoa-driven phytochemicals. Cocoa is rich in procyanidins, theobromine, (-)-epicatechin, catechins, and caffeine. Among the phytochemicals present in consumed cocoa, theobromine is most available in human plasma, followed by caffeine, (-)-epicatechin, catechin, and procyanidins. It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases, including cardiovascular diseases, cancer, neurodegenerative diseases, obesity, diabetes, and skin aging. This review summarizes comprehensive recent findings on the beneficial actions of cocoa-driven phytochemicals in molecular mechanisms of human health.
C1 [Kim, Jiyoung; Kim, Jaekyoon; Shim, Jaesung; Lee, Ki Won; Lee, Hyong Joo] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151742, South Korea.
   [Kim, Jiyoung; Lee, Ki Won; Lee, Hyong Joo] Seoul Natl Univ, Ctr Food & Bioconvergence Technol, Seoul 151921, South Korea.
   [Kim, Jiyoung; Lee, Ki Won; Lee, Hyong Joo] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 443270, Gyeonggi Do, South Korea.
   [Lee, Chang Yong] Cornell Univ, Dept Food Sci, Geneva, NY 14456 USA.
   [Lee, Ki Won] Seoul Natl Univ, Inst Green Bio Sci & Technol, Res Inst Bio Food Ind, Pyeongchang 232916, South Korea.
C3 Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Cornell University; Seoul National University (SNU)
RP Lee, HJ (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, 1 Gwanak Ro, Seoul 151742, South Korea.
EM kiwon@snu.ac.kr; leehyjo@snu.ac.kr
FU National Research Foundation, Ministry of Education, Science and Technology, Republic of Korea [2010-0029233]; Ministry of Trade, Industry and Energy/Korea Institute for the Advancement of Technology, Republic of Korea [N0000697]
CR Abd El Mohsen MM, 2002, FREE RADICAL BIO MED, V33, P1693, DOI 10.1016/S0891-5849(02)01137-1
   Andres-Lacueva C, 2008, J AGR FOOD CHEM, V56, P3111, DOI 10.1021/jf0728754
   Arteel GE, 2000, J NUTR, V130, P2100S, DOI 10.1093/jn/130.8.2100S
   Baba S, 2000, FREE RADICAL RES, V33, P635, DOI 10.1080/10715760000301151
   Baba S, 2007, J NUTR, V137, P1436, DOI 10.1093/jn/137.6.1436
   Baba S, 2007, AM J CLIN NUTR, V85, P709, DOI 10.1093/ajcn/85.3.709
   Barcz E, 1998, ONCOL REP, V5, P517
   Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6
   Biessels GJ, 2010, J ALZHEIMERS DIS, V20, PS143, DOI 10.3233/JAD-2010-091228
   Bisson JF, 2008, BRIT J NUTR, V100, P94, DOI 10.1017/S0007114507886375
   Brothers HM, 2010, NEUROSCI LETT, V480, P97, DOI 10.1016/j.neulet.2010.06.013
   Buijsse B, 2006, ARCH INTERN MED, V166, P411, DOI 10.1001/.411
   Caligiani A, 2007, CHIRALITY, V19, P329, DOI 10.1002/chir.20380
   Carn√©secchi S, 2002, CANCER LETT, V175, P147, DOI 10.1016/S0304-3835(01)00731-5
   Chavez-Valdez R, 2009, PEDIATR RES, V65, P203, DOI 10.1203/PDR.0b013e31818d66b1
   Chen XS, 2010, J ALZHEIMERS DIS, V20, PS127, DOI 10.3233/JAD-2010-1376
   Cho ES, 2008, MUTAT RES-FUND MOL M, V640, P123, DOI 10.1016/j.mrfmmm.2007.12.012
   Cho ES, 2009, FREE RADICAL BIO MED, V46, P1319, DOI 10.1016/j.freeradbiomed.2009.02.010
   Cooper KA, 2008, BRIT J NUTR, V99, P1, DOI 10.1017/S0007114507795296
   Cooper KA, 2007, J AGR FOOD CHEM, V55, P2841, DOI 10.1021/jf063277c
   Corti R, 2009, CIRCULATION, V119, P1433, DOI 10.1161/CIRCULATIONAHA.108.827022
   Counet C, 2006, FOOD CHEM, V98, P649, DOI 10.1016/j.foodchem.2005.06.030
   Cuevas E, 2009, EUR J PHARMACOL, V616, P122, DOI 10.1016/j.ejphar.2009.06.013
   de Mendon√ßa A, 2010, J ALZHEIMERS DIS, V20, PS1, DOI 10.3233/JAD-2010-1420
   D√©prez S, 2000, J NUTR, V130, P2733, DOI 10.1093/jn/130.11.2733
   Deprez S, 2001, ANTIOXID REDOX SIGN, V3, P957, DOI 10.1089/152308601317203503
   Dillinger TL, 2000, J NUTR, V130, P2057S, DOI 10.1093/jn/130.8.2057S
   Donovan JL, 2002, BRIT J NUTR, V87, P299, DOI 10.1079/BJN2001517
   Dray C, 2007, J PHYSIOL BIOCHEM, V63, P329, DOI 10.1007/BF03165764
   Echeverri D, 2010, INT J VASC MED, V2010, P0, DOI 10.1155/2010/834060
   Engler MB, 2004, J AM COLL NUTR, V23, P197, DOI 10.1080/07315724.2004.10719361
   Engler MB, 2006, NUTR REV, V64, P109, DOI 10.1111/j.1753-4887.2006.tb00194.x
   Eskelinen MH, 2010, J ALZHEIMERS DIS, V20, PS167, DOI 10.3233/JAD-2010-1404
   Fisher NDL, 2006, J HYPERTENS, V24, P1575, DOI 10.1097/01.hjh.0000239293.40507.2a
   Fisher NDL, 2003, J HYPERTENS, V21, P2281, DOI 10.1097/00004872-200312000-00016
   FORSYTH WGC, 1952, BIOCHEM J, V51, P511, DOI 10.1042/bj0510511
   Fraga Cesar G, 2005, CLIN DEV IMMUNOL, V12, P11, DOI 10.1080/10446670410001722159
   Francis ST, 2006, J CARDIOVASC PHARM, V47, PS215, DOI 10.1097/00005344-200606001-00018
   Gasser P, 2008, INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, V30, P339, DOI 10.1111/j.1468-2494.2008.00457.x
   GIL M, 1993, FOLIA BIOL-PRAGUE, V39, P63
   GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8
   Gotti R, 2006, J CHROMATOGR A, V1112, P345, DOI 10.1016/j.chroma.2005.11.058
   Grassi D, 2005, AM J CLIN NUTR, V81, P611
   Gu LW, 2006, J AGR FOOD CHEM, V54, P4057, DOI 10.1021/jf060360r
   Heinrich U, 2006, J NUTR, V136, P1565, DOI 10.1093/jn/136.6.1565
   Heiss C, 2005, J AM COLL CARDIOL, V46, P1276, DOI 10.1016/j.jacc.2005.06.055
   Heiss C, 2003, JAMA-J AM MED ASSOC, V290, P1030, DOI 10.1001/jama.290.8.1030
   Heiss C, 2006, J CARDIOVASC PHARM, V47, P0
   Heiss C, 2007, J CARDIOVASC PHARM, V49, P74, DOI 10.1097/FJC.0b013e31802d0001
   Heiss C, 2006, J CARDIOVASC PHARM, V47, PS128, DOI 10.1097/00005344-200606001-00007
   Heptinstall S, 2006, J CARDIOVASC PHARM, V47, PS197, DOI 10.1097/00005344-200606001-00015
   Hermann F, 2006, HEART, V92, P119, DOI 10.1136/hrt.2005.063362
   Hollenberg NK, 1997, HYPERTENSION, V29, P171, DOI 10.1161/01.HYP.29.1.171
   Holt RR, 2002, AM J CLIN NUTR, V76, P798, DOI 10.1093/ajcn/76.4.798
   Innes AJ, 2003, PLATELETS, V14, P325, DOI 10.1080/0953710031000123681
   Jourdain C, 2006, EUR J CANCER PREV, V15, P353, DOI 10.1097/00008469-200608000-00009
   Kang NJ, 2008, J BIOL CHEM, V283, P20664, DOI 10.1074/jbc.M800263200
   Kang SS, 2010, CANCER RES, V70, P1173, DOI 10.1158/0008-5472.CAN-09-2886
   KENNY D, 1994, AM HEART J, V127, P1456, DOI 10.1016/0002-8703(94)90370-0
   Kenny TP, 2004, EXP BIOL MED, V229, P255, DOI 10.1177/153537020422900306
   Kim JE, 2010, BRIT J NUTR, V104, P957, DOI 10.1017/S0007114510001704
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Kostyuk VA, 2003, FEBS LETT, V537, P146, DOI 10.1016/S0014-5793(03)00113-3
   Kraemer T, 2004, BIOL CHEM, V385, P809, DOI 10.1515/BC.2004.106
   Ku BM, 2011, MOL CELLS, V31, P275, DOI 10.1007/s10059-011-0027-5
   Lee C, 2000, CLIN CHIM ACTA, V295, P141, DOI 10.1016/S0009-8981(00)00201-1
   Lee DE, 2010, J NUTR BIOCHEM, V21, P680, DOI 10.1016/j.jnutbio.2009.03.014
   Lee KW, 2008, CARDIOVASC RES, V79, P34, DOI 10.1093/cvr/cvn056
   Lee KW, 2003, J AGR FOOD CHEM, V51, P7292, DOI 10.1021/jf0344385
   Lee KW, 2006, J NUTR, V136, P1150, DOI 10.1093/jn/136.5.1150
   Lijnen PJ, 2000, MOL GENET METAB, V71, P418, DOI 10.1006/mgme.2000.3032
   Liuzzo G, 2001, RAYS, V26, P221
   Loke WM, 2008, AM J CLIN NUTR, V88, P1018, DOI 10.1093/ajcn/88.4.1018
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Lv XW, 2010, INFLAMM RES, V59, P635, DOI 10.1007/s00011-010-0176-6
   Mackenzie GG, 2006, FREE RADICAL RES, V40, P1086, DOI 10.1080/10715760600788396
   Mackenzie GG, 2004, FASEB J, V18, P167, DOI 10.1096/fj.03-0402fje
   Manach C, 2005, AM J CLIN NUTR, V81, P230S, DOI 10.1093/ajcn/81.1.230S
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Mao T, 2000, J NUTR, V130, P2093S, DOI 10.1093/jn/130.8.2093S
   Mao T K, 2002, DEV IMMUNOL, V9, P135
   Mao TK, 2003, EXP BIOL MED, V228, P93, DOI 10.1177/153537020322800113
   Merighi S, 2007, MOL PHARMACOL, V72, P395, DOI 10.1124/mol.106.032920
   Miller KB, 2006, J AGR FOOD CHEM, V54, P4062, DOI 10.1021/jf060290o
   Miller KB, 2009, J AGR FOOD CHEM, V57, P9169, DOI 10.1021/jf901821x
   Mumford GK, 1996, EUR J CLIN PHARMACOL, V51, P319, DOI 10.1007/s002280050205
   Muniyappa R, 2008, AM J CLIN NUTR, V88, P1685, DOI 10.3945/ajcn.2008.26457
   Murphy KJ, 2003, AM J CLIN NUTR, V77, P1466, DOI 10.1093/ajcn/77.6.1466
   Mursu J, 2004, FREE RADICAL BIO MED, V37, P1351, DOI 10.1016/j.freeradbiomed.2004.06.002
   Naik JP, 2001, J AGR FOOD CHEM, V49, P3579, DOI 10.1021/jf000728z
   Nakabayashi H, 2008, BIOFACTORS, V34, P293, DOI 10.3233/BIO-2009-1083
   Natsume M, 2003, FREE RADICAL BIO MED, V34, P840, DOI 10.1016/S0891-5849(02)01434-X
   Nazaruddin R, 2006, IND CROP PROD, V24, P87, DOI 10.1016/j.indcrop.2006.03.013
   NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B
   Okano JI, 2008, BASIC CLIN PHARMACOL, V102, P543, DOI 10.1111/j.1742-7843.2008.00231.x
   Osakabe N, 2001, FREE RADICAL RES, V34, P93, DOI 10.1080/10715760100300091
   Osakabe N, 1998, J NUTR SCI VITAMINOL, V44, P313, DOI 10.3177/jnsv.44.313
   Ottaviani JI, 2002, ARCH BIOCHEM BIOPHYS, V406, P203, DOI 10.1016/S0003-9861(02)00455-1
   Pan TH, 2003, DRUG AGING, V20, P711, DOI 10.2165/00002512-200320100-00001
   Pearson DA, 2002, THROMB RES, V106, P191, DOI 10.1016/S0049-3848(02)00128-7
   Peng L, 2010, PHARM RES-DORDR, V27, P1128, DOI 10.1007/s11095-010-0052-7
   PETTIPHER GL, 1986, J SCI FOOD AGR, V37, P289, DOI 10.1002/jsfa.2740370314
   Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X
   Prediger RDS, 2010, J ALZHEIMERS DIS, V20, PS205, DOI 10.3233/JAD-2010-091459
   Ptolemy AS, 2010, J CHROMATOGR B, V878, P409, DOI 10.1016/j.jchromb.2009.12.019
   Ramiro E, 2005, J AGR FOOD CHEM, V53, P8506, DOI 10.1021/jf0511042
   Ramiro-Puig E, 2009, BRIT J NUTR, V101, P931, DOI 10.1017/S0007114508169896
   Rein D, 2000, J NUTR, V130, P2109S, DOI 10.1093/jn/130.8.2109S
   Richelle M, 1999, EUR J CLIN NUTR, V53, P22, DOI 10.1038/sj.ejcn.1600673
   Rios LY, 2003, AM J CLIN NUTR, V77, P912, DOI 10.1093/ajcn/77.4.912
   Ritchie K, 2007, NEUROLOGY, V69, P536, DOI 10.1212/01.wnl.0000266670.35219.0c
   Ruzaidi A, 2005, J ETHNOPHARMACOL, V98, P55, DOI 10.1016/j.jep.2004.12.018
   Schewe T, 2008, ARCH BIOCHEM BIOPHYS, V476, P102, DOI 10.1016/j.abb.2008.03.004
   Scholey AB, 2010, J PSYCHOPHARMACOL, V24, P1505, DOI 10.1177/0269881109106923
   Schramm DD, 2003, LIFE SCI, V73, P857, DOI 10.1016/S0024-3205(03)00373-4
   Schroeter H, 2006, P NATL ACAD SCI USA, V103, P1024, DOI 10.1073/pnas.0510168103
   Schroeter H, 2000, FREE RADICAL BIO MED, V29, P1222, DOI 10.1016/S0891-5849(00)00415-9
   Seimi C, 2008, MOL NUTR FOOD RES, V52, P1340, DOI 10.1002/mnfr.200700435
   Selmi C, 2006, J CARDIOVASC PHARM, V47, PS163, DOI 10.1097/00005344-200606001-00010
   SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001
   Sies H, 2005, AM J CLIN NUTR, V81, P304S, DOI 10.1093/ajcn/81.1.304S
   Skopinska-R√≥zewska E, 1998, INT J MOL MED, V2, P649
   Smit HJ, 2000, PSYCHOPHARMACOLOGY, V152, P167, DOI 10.1007/s002130000506
   Smit HJ, 2005, PSYCHOPHARMACOLOGY, V181, P101, DOI 10.1007/s00213-005-2209-3
   Smit HJ, 2004, PSYCHOPHARMACOLOGY, V176, P412, DOI 10.1007/s00213-004-1898-3
   Spencer JPE, 2009, GENES NUTR, V4, P243, DOI 10.1007/s12263-009-0136-3
   STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823
   Steinberg FM, 2003, J AM DIET ASSOC, V103, P215, DOI 10.1053/jada.2003.50028
   TARKA SM, 1982, CRC CR REV TOXICOL, V9, P275, DOI 10.3109/10408448209037495
   Taubert D, 2007, ARCH INTERN MED, V167, P626, DOI 10.1001/archinte.167.7.626
   Tomaru M, 2007, NUTRITION, V23, P351, DOI 10.1016/j.nut.2007.01.007
   Umemura T, 2006, AM J CARDIOL, V98, P1538, DOI 10.1016/j.amjcard.2006.06.058
   van Praag H, 2007, J NEUROSCI, V27, P5869, DOI 10.1523/JNEUROSCI.0914-07.2007
   Vlachopoulos C, 2005, AM J HYPERTENS, V18, P785, DOI 10.1016/j.amjhyper.2004.12.008
   Wan Y, 2001, AM J CLIN NUTR, V74, P596
   Wang JF, 2000, J NUTR, V130, P2115S, DOI 10.1093/jn/130.8.2115S
   Wang-Polagruto JF, 2006, J CARDIOVASC PHARM, V47, PS177, DOI 10.1097/00005344-200606001-00013
   Waterhouse AL, 1996, LANCET, V348, P834, DOI 10.1016/S0140-6736(05)65262-2
   Weisburger JH, 2001, EXP BIOL MED, V226, P891, DOI 10.1177/153537020122601003
   Wollgast J, 2000, FOOD RES INT, V33, P423, DOI 10.1016/S0963-9969(00)00068-5
   Yamade T, 2009, J NUTR BIOCHEM, V20, P948, DOI 10.1016/j.jnutbio.2008.08.007
   Yamagishi M, 2003, CANCER LETT, V191, P49, DOI 10.1016/S0304-3835(02)00629-8
   Yamagishi M, 2002, CANCER LETT, V185, P123, DOI 10.1016/S0304-3835(02)00276-8
   Yamagishi M, 2001, LIPIDS, V36, P67, DOI 10.1007/s11745-001-0669-9
   Yang HY, 2004, CLIN EXP METASTAS, V21, P719, DOI 10.1007/s10585-004-8251-4
   Yasuda A, 2008, BIOFACTORS, V33, P211, DOI 10.1002/biof.5520330307
NR 146
TC 67
Z9 71
U1 1
U2 368
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD NOV 2
PY 2014
VL 54
IS 11
BP 1458
EP 1472
DI 10.1080/10408398.2011.641041
PG 15
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA AH2DS
UT WOS:000335931500004
PM 24580540
DA 2025-04-28
ER

PT J
AU Otake, T
   Fukumoto, J
   Abe, M
   Takemura, S
   Mihn, PN
   Mizoue, T
   Kiyohara, C
AF Otake, Toshie
   Fukumoto, Jin
   Abe, Masao
   Takemura, Shigeki
   Pham Ngoc Mihn
   Mizoue, Tetsuya
   Kiyohara, Chikako
TI Linking lifestyle factors and insulin resistance, based on fasting plasma insulin and HOMA-IR in middle-aged Japanese men: A cross-sectional study
SO SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
LA English
DT Article
DE Insulin resistance (IR); homeostasis model assessment-estimated insulin resistance (HOMA-IR); fasting plasma insulin; lifestyle; obesity; alcohol; physical activity; coffee; green tea
ID homeostasis model assessment; randomized controlled-trial; alcohol-consumption; cardiovascular-disease; glucose-metabolism; tea consumption; global burden; sensitivity; population; smoking
AB Objective. Insulin resistance (IR) is regarded as one of the earliest features of many metabolic diseases, and major efforts are aimed at improving insulin function to confront this issue. The aim of this study was to investigate the relationship of body mass index (BMI), cigarette smoking, alcohol intake, physical activity, green tea and coffee consumption to IR. Methods. We performed a cross-sectional study of 1542 male self defense officials. IR was defined as the highest quartile of the fasting plasma insulin (>= 50 pmol/L) or the homeostasis model assessment-estimated IR (HOMA-IR >= 1.81). An unconditional logistic model was used to estimate the odds ratio (OR) and 95% confidence interval (CI) for the association between IR and influential factors. Stratified analysis by obesity status (BMI < 25 kg/m(2), non-obese; >= 25 kg/m(2), obese) was performed. Results. IR was significantly positively related to BMI and glucose tolerance, negatively related to alcohol use. Independent of obesity status, significant trends were observed between IR and alcohol use. Drinking 30 mL or more of ethanol per day reduced IR by less than 40%. Strong physical activity was associated with decreased risk of IR based on fasting plasma insulin only in the obese. Coffee consumption was inversely associated with the risk of IR based on HOMA-IR in the non-obese group. Conclusion. Higher coffee consumption may be protective against IR among only the non-obese. Further studies are warranted to examine the effect modification of the obesity status on the coffee-IR association.
C1 [Otake, Toshie; Abe, Masao] Self Def Forces Fukuoka Hosp, Kasuga, Fukuoka, Japan.
   [Otake, Toshie; Fukumoto, Jin; Abe, Masao; Kiyohara, Chikako] Kyushu Univ, Grad Sch Med Sci, Dept Prevent Med, Higashi Ku, Fukuoka 8128582, Japan.
   [Fukumoto, Jin; Takemura, Shigeki] Wakayama Med Univ, Sch Med, Dept Hyg, Wakayama, Japan.
   [Pham Ngoc Mihn; Mizoue, Tetsuya] Int Med Ctr Japan, Res Inst, Dept Epidemiol & Int Hlth, Shinjuku Ku, Tokyo, Japan.
C3 Kyushu University; Wakayama Medical University; Japan Institute for Health Security (JIHS); National Center for Global Health & Medicine - Japan
RP Kiyohara, C (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Prevent Med, Higashi Ku, Fukuoka 8128582, Japan.
EM chikako@phealth.med.kyushu-u.ac.jp
CR AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011
   Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320
   Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57
   Carrieri P, 2012, HEPATOLOGY, V56, P2010, DOI 10.1002/hep.25813
   Das UN, 2002, PROSTAG LEUKOTR ESS, V67, P1, DOI 10.1054/plef.2002.0374
   Eliasson B, 1996, CIRCULATION, V94, P878, DOI 10.1161/01.CIR.94.5.878
   ELIASSON B, 1994, ARTERIOSCLER THROMB, V14, P1946, DOI 10.1161/01.ATV.14.12.1946
   Esteghamati A, 2009, PREV MED, V49, P402, DOI 10.1016/j.ypmed.2009.09.005
   Fueki Y, 2007, CLIN CHIM ACTA, V382, P71, DOI 10.1016/j.cca.2007.03.027
   Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806
   Fukino Y, 2005, J NUTR SCI VITAMINOL, V51, P335, DOI 10.3177/jnsv.51.335
   Fukumoto J, 2008, CANCER SCI, V99, P781, DOI 10.1111/j.1349-7006.2008.00745.x
   Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177
   Howard G, 1996, CIRCULATION, V93, P1809, DOI 10.1161/01.CIR.93.10.1809
   Kawamoto R, 2009, TOHOKU J EXP MED, V218, P331, DOI 10.1620/tjem.218.331
   Kiechl S, 1996, BRIT MED J, V313, P1040
   King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414
   Komiya H, 2006, TOHOKU J EXP MED, V208, P123, DOI 10.1620/tjem.208.123
   Kono S, 1999, JPN J CANCER RES, V90, P805, DOI 10.1111/j.1349-7006.1999.tb00819.x
   Lazarus R, 1997, AM J EPIDEMIOL, V145, P909, DOI 10.1093/oxfordjournals.aje.a009050
   Lee KY, 2002, J NUTR SCI VITAMINOL, V48, P467, DOI 10.3177/jnsv.48.467
   Lee S, 2006, J KOREAN MED SCI, V21, P695
   Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191
   MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McAuley KA, 2001, DIABETES CARE, V24, P460, DOI 10.2337/diacare.24.3.460
   Molloy JW, 2012, HEPATOLOGY, V55, P429, DOI 10.1002/hep.24731
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Perry IJ, 2002, P NUTR SOC, V61, P543, DOI 10.1079/PNS2002196
   Radikova Z, 2006, EXP CLIN ENDOCR DIAB, V114, P249, DOI 10.1055/s-2006-924233
   Reaven G, 2005, PANMINERVA MED, V47, P201
   Rebello SA, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-61
   Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7
   Riegelman RK, 2004, INTERPRETATION STUDY, V0, P50
   Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X
   Taniyama M, 2008, NIPPON RINSHO, V66, P208
   Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487
   Wise S, 2006, DIABETIC MED, V23, P510, DOI 10.1111/j.1464-5491.2006.01836.x
   World Health Organization International Diabetes Federation, 2006, DEFINITION AND DIAGNOSIS OF DIABETES MELLITUS AND INTERMEDIATE HYPERGLYCAEMIA: REPORT OF A WHO/IDF CONSULTATION, V0, P0
   Yang JY, 2012, DIABETES, V61, P1888, DOI 10.2337/db11-1393
   Zampelas A, 2004, AM J CLIN NUTR, V80, P862, DOI 10.1093/ajcn/80.4.862
NR 41
TC 6
Z9 6
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0036-5513
EI 1502-7686
J9 SCAND J CLIN LAB INV
JI Scand. J. Clin. Lab. Invest.
PD SEP 15
PY 2014
VL 74
IS 6
BP 536
EP 545
DI 10.3109/00365513.2014.913304
PG 10
WC Medical Laboratory Technology; Medicine, Research & Experimental
SC Medical Laboratory Technology; Research & Experimental Medicine
GA AP4OE
UT WOS:000342056100011
PM 24830843
DA 2025-04-28
ER

PT J
AU Jeszka-Skowron, M
   Flaczyk, E
   Jeszka, J
   Krejpcio, Z
   Kr√≥l, E
   Buchowski, MS
AF Jeszka-Skowron, Magdalena
   Flaczyk, Ewa
   Jeszka, Jan
   Krejpcio, Zbigniew
   Krol, Ewelina
   Buchowski, Maciej S.
TI Mulberry leaf extract intake reduces hyperglycaemia in streptozotocin (STZ)-induced diabetic rats fed high-fat diet
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Mulberry; Diabetic rats; Carbohydrate metabolism; Antioxidant activity; Phenolics; High-fat diet
ID morus-alba l.; postprandial blood-glucose; antioxidant activity; flavonol glycosides; oxidative stress; phenolic-acids; leaves; 1-deoxynojirimycin; metabolism; inhibition
AB This study evaluated the antioxidant activity and anti-diabetic effect of mulberry (Morus alba L. wielkolistna zolwinska) leaf extracts in diabetic rats fed a high-fat diet. After initial 4-week high-fat diet, streptozotocin was injected in Wistar rats to induce non-obese type 2 diabetes. After confirmation of diabetes, animals were treated with mulberry dried leaves, leaf-derived ethanol or acetone extracts added to high-fat diet for 4 weeks. Mulberry ethanol extract with higher level of phenolics - chlorogenic acid and flavonol glucosides was more effective than acetone extract or dry leaves in the lowering of blood glucose, increasing insulin level and markers of antioxidant activity. The results confirm key mechanisms related to the effect of mulberry and its bioactive components on modulation of glucose metabolism through correcting hyperglycaemia, increasing insulin secretion, and improving antioxidant status in STZ-induced non-obese diabetic rat model. Antidiabetic effects exerted by mulberry leaves might depend on the extraction process. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Jeszka-Skowron, Magdalena] Poznan Univ Tech, Dept Chem & Tech Electrochem, PL-60965 Poznan, Poland.
   [Flaczyk, Ewa] Poznan Univ Life Sci, Dept Food Serv & Catering, PL-60624 Poznan, Poland.
   [Jeszka, Jan; Krejpcio, Zbigniew; Krol, Ewelina] Poznan Univ Life Sci, Dept Human Nutr & Hyg, PL-60624 Poznan, Poland.
   [Buchowski, Maciej S.] Vanderbilt Univ, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37072 USA.
C3 Poznan University of Technology; Poznan University of Life Sciences; Poznan University of Life Sciences; Vanderbilt University
RP Jeszka-Skowron, M (corresponding author), Poznan Univ Tech, Dept Chem & Tech Electrochem, Piotrowo 3, PL-60965 Poznan, Poland.
EM magdalena.jeszka-skowron@put.poznan.pl
FU EU Project POIG [01.01.02.-00-061/09]; Polish Ministry of Science and Higher Education [NN312209138]
CR Ainsworth EA, 2007, NAT PROTOC, V2, P875, DOI 10.1038/nprot.2007.102
   Amarowicz R, 2000, NAHRUNG, V44, P60, DOI 10.1002/(SICI)1521-3803(20000101)44:1<60::AID-FOOD60>3.3.CO;2-C
   Unknown -, 2011, PROGRAM PREVENTION T, V0, P0
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Buege J A, 1978, METHODS ENZYMOL, V52, P302
   Ceriello A, 2012, VASC PHARMACOL, V57, P133, DOI 10.1016/j.vph.2012.05.005
   Chan YK, 2012, LAB ANIM-UK, V46, P142, DOI 10.1258/la.2011.011136
   Cheung LM, 2003, FOOD CHEM, V81, P249, DOI 10.1016/S0308-8146(02)00419-3
   Chung HI, 2013, J FUNCT FOODS, V5, P1502, DOI 10.1016/j.jff.2013.04.015
   Davis N, 2009, MT SINAI J MED, V76, P257, DOI 10.1002/msj.20118
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   HANOZET G, 1981, J BIOL CHEM, V256, P3703
   Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359
   Janaszewska A, 2002, SCAND J CLIN LAB INV, V62, P231, DOI 10.1080/003655102317475498
   Jeszka-Skowron M, 2009, BROMATOLOGIA CHEM TO, V42, P2791
   Jeszka-Skowron M, 2014, FOOD SCI TECHNOLOGY, V91, P15
   Katsube T, 2006, FOOD CHEM, V97, P25, DOI 10.1016/j.foodchem.2005.03.019
   Katsube T, 2009, FOOD CHEM, V113, P964, DOI 10.1016/j.foodchem.2008.08.041
   Katsube T, 2010, J SCI FOOD AGR, V90, P2386, DOI 10.1002/jsfa.4096
   Khan Muhammad Ali, 2013, BMC RES NOTES, V6, P24, DOI 10.1186/1756-0500-6-24
   Kimura T, 2004, BIOFACTORS, V22, P341, DOI 10.1002/biof.5520220167
   Kimura T, 2007, J AGR FOOD CHEM, V55, P5869, DOI 10.1021/jf062680g
   Kobayashi Y, 2010, BIOSCI BIOTECH BIOCH, V74, P2385, DOI 10.1271/bbb.100392
   Kr√≥l E, 2010, FOOD CHEM TOXICOL, V48, P2791, DOI 10.1016/j.fct.2010.07.008
   Kwon HJ, 2011, J AGR FOOD CHEM, V59, P3014, DOI 10.1021/jf103463f
   Lee CY, 2007, NUTR RES, V27, P492, DOI 10.1016/j.nutres.2007.06.004
   Lee J, 2008, J ETHNOPHARMACOL, V115, P263, DOI 10.1016/j.jep.2007.09.029
   Meda A, 2005, FOOD CHEM, V91, P571, DOI 10.1016/j.foodchem.2004.10.006
   Memon Ayaz Ali, 2010, POLISH JOURNAL OF FOOD AND NUTRITION SCIENCES, V60, P25
   Misra A, 2010, J AM COLL NUTR, V29, P289S, DOI 10.1080/07315724.2010.10719844
   Mohammadi J, 2008, INDIAN J PHARMACOL, V40, P15, DOI 10.4103/0253-7613.40483
   Nakamura M, 2009, NUTR METAB, V6, P0, DOI 10.1186/1743-7075-6-29
   Naowaboot J, 2009, PLANT FOOD HUM NUTR, V64, P116, DOI 10.1007/s11130-009-0112-5
   Ong KW, 2011, J ETHNOPHARMACOL, V133, P598, DOI 10.1016/j.jep.2010.10.046
   Park E, 2013, J FUNCT FOODS, V5, P178, DOI 10.1016/j.jff.2012.10.002
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Reuter T, 2007, DRUG DISCOV TODAY, V4, P1
   Rodr√≠guez-S√°nchez S, 2013, J AGR FOOD CHEM, V61, P4539, DOI 10.1021/jf305049k
   Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   Singa ANB, 2005, J ETHNOPHARMACOL, V100, P333, DOI 10.1016/j.jep.2005.03.013
   Song W, 2009, J AGR FOOD CHEM, V57, P9133, DOI 10.1021/jf9022228
   Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004
   Srivastava S, 2006, INT J FOOD SCI NUTR, V57, P305, DOI 10.1080/09637480600801837
   Sunil C, 2011, J ETHNOPHARMACOL, V134, P298, DOI 10.1016/j.jep.2010.12.018
   Thabti I, 2012, J FUNCT FOODS, V4, P367, DOI 10.1016/j.jff.2012.01.006
   Voss AA, 2007, MOL PHARMACOL, V71, P628, DOI 10.1124/mol.106.030288
   Wu CH, 2013, J FUNCT FOODS, V5, P1620, DOI 10.1016/j.jff.2013.07.004
   Zeni ALB, 2010, REV BRAS FARMACOGN, V20, P130, DOI 10.1590/S0102-695X2010000100025
   Zhang L, 2010, J ETHNOPHARMACOL, V132, P518, DOI 10.1016/j.jep.2010.08.053
NR 51
TC 93
Z9 102
U1 3
U2 115
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 
J9 J FUNCT FOODS
JI J. Funct. Food.
PD MAY 15
PY 2014
VL 8
IS 
BP 9
EP 17
DI 10.1016/j.jff.2014.02.018
PG 9
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA AI5DH
UT WOS:000336885100002
DA 2025-04-28
ER

PT J
AU Yamamoto, T
   Takahashi, H
   Suzuki, K
   Hirano, A
   Kamei, M
   Goto, T
   Takahashi, N
   Kawada, T
AF Yamamoto, Takayuki
   Takahashi, Haruya
   Suzuki, Koichiro
   Hirano, Akira
   Kamei, Masanori
   Goto, Tsuyoshi
   Takahashi, Nobuyuki
   Kawada, Teruo
TI Theobromine enhances absorption of cacao polyphenol in rats
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE absorption; rat; theobromine; Caco-2; cacao polyphenol
ID (-)-epicatechin metabolites; mass-spectrometry; oral ingestion; cocoa; transport; humans; plasma; caffeine; obesity; cells
AB Several concentrations of theobromine (TB) and (-)-epicatechin (EC) were coadministered to rats, and plasma EC and its metabolites were determined using ultra-high-performance liquid chromatography-tandem mass spectrometry. It has been demonstrated that TB increases the absorption of EC in a dose-dependent manner. Cocoa powder had a similar effect, and the mechanism involved is not thought to depend on tight junctions.
C1 [Yamamoto, Takayuki; Takahashi, Haruya; Goto, Tsuyoshi; Takahashi, Nobuyuki; Kawada, Teruo] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Mol Funct Food, Uji, Kyoto, Japan.
   [Yamamoto, Takayuki; Suzuki, Koichiro; Hirano, Akira; Kamei, Masanori] Morinaga & Co Ltd, Res Inst, Yokohama, Kanagawa, Japan.
C3 Kyoto University; Morinaga & Company, Ltd.
RP Yamamoto, T (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Mol Funct Food, Uji, Kyoto, Japan.
EM t-yamamoto-jc@morinaga.co.jp
CR Abd El Mohsen MM, 2002, FREE RADICAL BIO MED, V33, P1693, DOI 10.1016/S0891-5849(02)01137-1
   CEREIJIDO M, 1993, J CELL SCI, V0, P127
   CRAIG WJ, 1984, J FOOD SCI, V49, P302, DOI 10.1111/j.1365-2621.1984.tb13737.x
   Deprez S, 2001, ANTIOXID REDOX SIGN, V3, P957, DOI 10.1089/152308601317203503
   Donovan JL, 2001, J NUTR, V131, P1753, DOI 10.1093/jn/131.6.1753
   GANS JH, 1980, TOXICOL APPL PHARM, V53, P481, DOI 10.1016/0041-008X(80)90360-9
   Hammerstone JF, 1999, J AGR FOOD CHEM, V47, P490, DOI 10.1021/jf980760h
   Kadowaki M, 2008, J PHARM PHARMACOL, V60, P1189, DOI 10.1211/jpp.60.9.0011
   Kosinska A, 2012, FOOD CHEM, V135, P999, DOI 10.1016/j.foodchem.2012.05.101
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Matsui N, 2005, NUTRITION, V21, P594, DOI 10.1016/j.nut.2004.10.008
   Nakagawa K, 2009, BIOSCI BIOTECH BIOCH, V73, P2014, DOI 10.1271/bbb.90195
   Natsume M, 2003, FREE RADICAL BIO MED, V34, P840, DOI 10.1016/S0891-5849(02)01434-X
   Ortega N, 2008, J AGR FOOD CHEM, V56, P9621, DOI 10.1021/jf8014415
   Ottaviani JI, 2012, FREE RADICAL BIO MED, V52, P1403, DOI 10.1016/j.freeradbiomed.2011.12.010
   Piskula MK, 1998, J NUTR, V128, P1172, DOI 10.1093/jn/128.7.1172
   Roelofsen H, 1998, J CELL SCI, V111, P1137
   Roura E, 2005, J AGR FOOD CHEM, V53, P6190, DOI 10.1021/jf050377u
   Salucci M, 2002, BRIT J CANCER, V86, P1645, DOI 10.1038/sj.bjc.6600295
   S√°nchez-Rabaneda F, 2003, J MASS SPECTROM, V38, P35, DOI 10.1002/jms.395
   Suzuki K, 2013, BIOSCI BIOTECH BIOCH, V77, P1792, DOI 10.1271/bbb.130380
   Vaidyanathan JB, 2001, PHARMACEUT RES, V18, P1420, DOI 10.1023/A:1012200805593
   Yamashita Y, 2012, ARCH BIOCHEM BIOPHYS, V527, P95, DOI 10.1016/j.abb.2012.03.018
   Zomer E, 2012, BMJ-BRIT MED J, V344, P0, DOI 10.1136/bmj.e3657
NR 24
TC 9
Z9 9
U1 0
U2 23
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PD DEC 2
PY 2014
VL 78
IS 12
BP 2059
EP 2063
DI 10.1080/09168451.2014.942252
PG 5
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology
GA AU3HZ
UT WOS:000345504400012
PM 25079983
DA 2025-04-28
ER

PT J
AU Kim, HJ
   Cho, S
   Jacobs, DR
   Park, K
AF Kim, Hyo-Jin
   Cho, Seongbeom
   Jacobs, David R., Jr.
   Park, Kyong
TI Instant coffee consumption may be associated with higher risk of metabolic syndrome in Korean adults
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Instant coffee; Metabolic syndrome; Korean adults
ID type-2 diabetes-mellitus; tea consumption; habitual coffee; blood-pressure; amsterdam growth; green tea; prevalence; health; men
AB Aims: Cumulative evidence suggests that coffee consumption may have beneficial effects on metabolic diseases; however, few previous studies have considered the types of coffee consumed and the additives used. We investigated the relationship between coffee consumption and metabolic syndrome (MetSyn) and its components. Methods: We analyzed 17,953 Korean adults, aged 19-65 years, using cross-sectional data from the Korean National Health and Nutrition Examination Survey (KNHANES, 2007-2011). Coffee consumption level, types of coffee consumed, and the additives used were assessed based on a food frequency questionnaire and 24-h recall. Demographic and lifestyle factors were assessed using self-administered questionnaires. Data on metabolic biomarkers were obtained from a health examination. Multivariable logistic regression was used to determine the odds ratios of prevalent metabolic syndrome and its components according to frequency and type of coffee consumption. Results: We found that 76% of the subjects were habitual coffee drinkers, most of whom consumed instant coffee mix containing sugar and powder creamer. After multivariable adjustment, the odds ratios (95% CI) comparing those who consumed coffee >= 3 times/day with those who consumed coffee <1 time/week were 1.37 (1.15-1.63) for obesity, 1.33 (1.11-1.59) for abdominal obesity, 1.28 (1.09-1.51) for hypo-HDL cholesterolemia, and 1.37 (1.10-1.72) for metabolic syndrome. Instant-coffee drinkers were observed to have elevated risks of these metabolic conditions. Conclusions: Consumption of coffee, particularly instant coffee mix, may have harmful effects on MetSyn, perhaps partly deriving from excessive intake of sugar and powder creamer. (C) 2014 Elsevier Ireland Ltd. All rights reserved.D
C1 [Kim, Hyo-Jin; Park, Kyong] Yeungnam Univ, Dept Food & Nutr, Gyongsan 712749, Gyeongbuk, South Korea.
   [Cho, Seongbeom] Seoul Natl Univ, Coll Vet Med, Seoul, South Korea.
   [Cho, Seongbeom] Seoul Natl Univ, Res Inst Vet Sci, Seoul, South Korea.
   [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA.
C3 Yeungnam University; Seoul National University (SNU); Seoul National University (SNU); University of Minnesota System; University of Minnesota Twin Cities
RP Park, K (corresponding author), Yeungnam Univ, Dept Food & Nutr, 280 Daehak Ro, Gyongsan 712749, Gyeongbuk, South Korea.
EM kypark@ynu.ac.kr
FU Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2012R1A1A1009214]
CR AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011
   Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Cheung BMY, 2005, J CARDIOVASC PHARM, V46, P125, DOI 10.1097/01.fjc.0000171752.43564.35
   Choi Mi-Kyeong, 2007, THE KOREAN JOURNAL OF FOOD AND NUTRITION ÌïúÍµ≠ÏãùÌíàÏòÅÏñëÌïôÌöåÏßÄ, V20, P460
   Choi Soyeong, 2010, JOURNAL OF THE KOREAN SOCIETY OF FOOD SCIENCE AND NUTRITION ÌïúÍµ≠ÏãùÌíàÏòÅÏñëÍ≥ºÌïôÌöåÏßÄ, V39, P1279
   Driessen MT, 2009, EUR J CLIN NUTR, V63, P536, DOI 10.1038/ejcn.2008.6
   Frost G, 1999, LANCET, V353, P1045, DOI 10.1016/S0140-6736(98)07164-5
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   International Coffee Organization, 2012, MONTHL COFF MARK REP, V0, P0
   Jee SH, 2001, AM J EPIDEMIOL, V153, P353, DOI 10.1093/aje/153.4.353
   Ïù¥Î¥ÑÏù¥, 2012, JOURNAL OF THE KOREAN SOCIETY OF FOOD SCIENCE AND NUTRITION ÌïúÍµ≠ÏãùÌíàÏòÅÏñëÍ≥ºÌïôÌöåÏßÄ, V41, P362
   Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109
   Lin WY, 2011, EUR J CLIN INVEST, V41, P659, DOI 10.1111/j.1365-2362.2010.02455.x
   Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   Ministry of Health and Welfare Korea Centers for Disease Control and Prevention, 2011, KOR HLTH STAT 2010 K, V0, P0
   Nicholls SJ, 2006, J AM COLL CARDIOL, V48, P715, DOI 10.1016/j.jacc.2006.04.080
   Oba S, 2010, BRIT J NUTR, V103, P453, DOI 10.1017/S0007114509991966
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   SALVAGGIO A, 1990, J HYPERTENS, V8, P585, DOI 10.1097/00004872-199006000-00013
   Schaefer B, 2004, ANN INTERN MED, V141, P321, DOI 10.7326/0003-4819-141-4-200408170-00016
   Shin MH, 1994, KOREAN J PREV MED, V27, P200
   Steffen M, 2012, J HYPERTENS, V30, P2245, DOI 10.1097/HJH.0b013e3283588d73
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   United States Department of Agriculture Foreign Agricultural Service, 2011, GLOB AGR INF NETW RE, V0, P0
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   van Dam RM, 2008, APPL PHYSIOL NUTR ME, V33, P1269, DOI 10.1139/H08-120
   van Dieren S, 2009, DIABETOLOGIA, V52, P2561, DOI 10.1007/s00125-009-1516-3
   Wakabayashi K, 1998, EUR J EPIDEMIOL, V14, P669, DOI 10.1023/A:1007478522638
   WHO/IASO/IOTF, 2000, AS PAC PERSP RED OB, V0, P0
   Yamaji T, 2004, DIABETOLOGIA, V47, P2145, DOI 10.1007/s00125-004-1590-5
NR 39
TC 62
Z9 65
U1 1
U2 22
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD OCT 15
PY 2014
VL 106
IS 1
BP 145
EP 153
DI 10.1016/j.diabres.2014.07.007
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AP9DE
UT WOS:000342377800022
PM 25112922
DA 2025-04-28
ER

PT J
AU Mostad, IL
   Langaas, M
   Grill, V
AF Mostad, Ingrid Lovold
   Langaas, Mette
   Grill, Valdemar
TI Central obesity is associated with lower intake of whole-grain bread and less frequent breakfast and lunch: results from the HUNT study, an adult all-population survey
SO APPLIED PHYSIOLOGY NUTRITION AND METABOLISM
LA English
DT Article
DE HUNT; central obesity; waist/hip ratio; dietary intake; whole-grain bread; meal frequency; all-population survey; nutrition epidemiology
ID body-mass index; doubly labeled water; food-intake patterns; waist circumference; dietary patterns; abdominal obesity; risk-factors; weight-gain; cardiovascular-disease; artificial sweeteners
AB All-population and area-based investigations of diet in central obesity are scarce. We used cross-sectional data from 50 339 individuals who responded to the HUNT3 survey of 2006-2008, which recruited from all county-residing adults 20 years and older, to investigate whether those with central obesity eat and drink differently than others. Answers to dietary questions were recoded and analyzed with multiple linear regression, using waist/hip ratio (WHR), age, and sex as explanatory variables. Frequencies of consumption or amounts of food, beverages, and meals were compared among WHR quartiles. Central obesity was present in the quartile with the highest WHR, WHR4(WHR >= 0.917 for women and 0.981 for men) but not in the quartile with the lowest WHR, WHR1 (WHR<0.817 for women and 0.895 for men). Dietary variables differed markedly by age and sex. After adjustment for these factors and for multiple testing, we found significant differences between WHR4 and WHR1 for 19 of 30 dietary variables. Central obesity was associated with a lower intake of any bread, and of whole-grain bread in particular. Intake of fruits and berries, vegetables, and pasta and rice was less, and intake of sausages and hamburgers and boiled potatoes was more frequent. Intake of alcohol, tea, and fruit juice was lower in those with central obesity, whereas intake of sugar-free soft drinks and coffee was higher. The frequency of breakfast and lunch was lower and of nightly meals was higher in those with central obesity. In conclusion, in this large area-based population, central obesity was associated with differences in dietary habits, some of which (such as decreased consumption of whole-grain bread and increased intake of sugar-free drinks) are of possible clinical significance.
C1 [Mostad, Ingrid Lovold] Univ Trondheim Hosp, St Olavs Hosp, Clin Clin Serv, Dept Clin Nutr, NO-7006 Trondheim, Norway.
   [Mostad, Ingrid Lovold; Grill, Valdemar] NTNU, Fac Med, Dept Canc Res & Mol Med, NO-7491 Trondheim, Norway.
   [Langaas, Mette] NTNU, Fac Informat Technol Math & Elect Engn, Dept Math Sci, NO-7491 Trondheim, Norway.
C3 Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)
RP Mostad, IL (corresponding author), Univ Trondheim Hosp, St Olavs Hosp, Clin Clin Serv, Dept Clin Nutr, Box 3250 Sluppen, NO-7006 Trondheim, Norway.
EM ingrid.l.mostad@ntnu.no
FU Central Norway Regional Health Authority; Norwegian University of Science and Technology
CR Alinia S, 2009, OBES REV, V10, P639, DOI 10.1111/j.1467-789X.2009.00582.x
   Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x
   Unknown -, 2008, J AM DIET ASSOC, V108, P1716, DOI 10.1016/j.jada.2008.08.007
   Unknown -, 2010, R LANG ENV STAT COMP, V0, P0
   Bautista-Casta√±o I, 2012, NUTR REV, V70, P218, DOI 10.1111/j.1753-4887.2012.00454.x
   Berg C, 2009, APPETITE, V52, P21, DOI 10.1016/j.appet.2008.07.008
   Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976
   Brown RJ, 2010, INT J PEDIATR OBES, V5, P305, DOI 10.3109/17477160903497027
   Cunha DB, 2010, BRIT J NUTR, V104, P908, DOI 10.1017/S0007114510001479
   DeCaria JE, 2012, INT J OBESITY, V36, P1141, DOI 10.1038/ijo.2012.29
   Droyvold WB, 2006, INT J OBESITY, V30, P935, DOI 10.1038/sj.ijo.0803178
   Du HD, 2010, AM J CLIN NUTR, V91, P329, DOI 10.3945/ajcn.2009.28191
   Forslund HB, 2002, EUR J CLIN NUTR, V56, P740, DOI 10.1038/sj.ejcn.1601387
   Halkj√¶r J, 2006, AM J CLIN NUTR, V84, P789, DOI 10.1093/ajcn/84.4.789
   Halkjer J, 2009, J AM DIET ASSOC, V109, P1356, DOI 10.1016/j.jada.2009.05.015
   Harland JI, 2008, PUBLIC HEALTH NUTR, V11, P554, DOI 10.1017/S1368980007001279
   Hill RJ, 2001, BRIT J NUTR, V85, P415, DOI 10.1079/BJN2000281
   Hostmark AT, 2010, APPL PHYSIOL NUTR ME, V35, P816, DOI 10.1139/H10-080
   Hsiao Pao Ying, 2011, JOURNAL OF NUTRITION IN GERONTOLOGY AND GERIATRICS, V30, P204, DOI 10.1080/21551197.2011.591266
   Hu FB, 1999, AM J CLIN NUTR, V69, P243
   JACOBSEN BK, 1987, J CHRON DIS, V40, P795, DOI 10.1016/0021-9681(87)90131-7
   Kahn HS, 1997, INT J OBESITY, V21, P903, DOI 10.1038/sj.ijo.0800490
   Kjollesdal MR, 2010, BRIT J NUTR, V104, P1230, DOI 10.1017/S0007114510001868
   Koh-Banerjee P, 2004, AM J CLIN NUTR, V80, P1237, DOI 10.1093/ajcn/80.5.1237
   Koh-Banerjee P, 2003, P NUTR SOC, V62, P25, DOI 10.1079/PNS2002232
   Koh-Banerjee P, 2003, AM J CLIN NUTR, V78, P719, DOI 10.1093/ajcn/78.4.719
   Krachler B, 2006, NUTR J, V5, P0, DOI 10.1186/1475-2891-5-34
   Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095
   Laitinen J, 2004, EUR J CLIN NUTR, V58, P180, DOI 10.1038/sj.ejcn.1601765
   Langhammer A, 2012, BMC MED RES METHODOL, V12, P0, DOI 10.1186/1471-2288-12-143
   Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012
   Lin BH, 2002, FOODREVIEW, V25, P28
   Lissner L, 2002, PUBLIC HEALTH NUTR, V5, P889, DOI 10.1079/PHN2002388
   Lissner L, 2007, INT J OBESITY, V31, P956, DOI 10.1038/sj.ijo.0803527
   Lissner L, 2000, BRIT J NUTR, V83, P0
   Liu SM, 2003, AM J CLIN NUTR, V78, P920, DOI 10.1093/ajcn/78.5.920
   McKeown NM, 2010, AM J CLIN NUTR, V92, P1165, DOI 10.3945/ajcn.2009.29106
   Midthjell K, 2013, CLIN OBES, V3, P12, DOI 10.1111/cob.12009
   Moreira Pedro, 2006, EAT BEHAV, V7, P220, DOI 10.1016/j.eatbeh.2005.08.008
   Mosdol A, 2004, THESIS U OSLO OSLO, V0, P0
   Nasjonalt rad for ernaering (National Nutrition Council), 2011, KOSTR FREMM FOLK FOR, V0, P0
   Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417
   ONeil CE, 2011, NUTR RES, V31, P122, DOI 10.1016/j.nutres.2011.01.007
   Price GM, 2006, AM J CLIN NUTR, V84, P449
   Romaguera D, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0023384
   Rossi M, 2008, PUBLIC HEALTH NUTR, V11, P214, DOI 10.1017/S1368980007000833
   Shi Z, 2008, INT J OBESITY, V32, P975, DOI 10.1038/ijo.2008.21
   Srikanthan P, 2009, ANN EPIDEMIOL, V19, P724, DOI 10.1016/j.annepidem.2009.05.003
   Thane CW, 2009, EUR J CLIN NUTR, V63, P229, DOI 10.1038/sj.ejcn.1602911
   Togo P, 2001, INT J OBESITY, V25, P1741, DOI 10.1038/sj.ijo.0801819
   Trabulsi J, 2001, AM J PHYSIOL-ENDOC M, V281, PE891, DOI 10.1152/ajpendo.2001.281.5.E891
   van Dijk SB, 2012, NETH HEART J, V20, P208, DOI 10.1007/s12471-011-0237-7
   Walker SP, 1996, AM J EPIDEMIOL, V144, P1143, DOI 10.1093/oxfordjournals.aje.a008892
   Wei M, 1997, OBES RES, V5, P16, DOI 10.1002/j.1550-8528.1997.tb00278.x
   WILLETT WC, 1987, J AM DIET ASSOC, V87, P43
   Wolongevicz DM, 2010, J OBES, V2010, P0, DOI 10.1155/2010/945987
   Yang Qing, 2010, YALE JOURNAL OF BIOLOGY AND MEDICINE, V83, P101
   Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714
NR 60
TC 12
Z9 12
U1 1
U2 25
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 1715-5312
EI 1715-5320
J9 APPL PHYSIOL NUTR ME
JI Appl. Physiol. Nutr. Metab.
PD JUL 15
PY 2014
VL 39
IS 7
BP 819
EP 828
DI 10.1139/apnm-2013-0356
PG 10
WC Nutrition & Dietetics; Physiology; Sport Sciences
SC Nutrition & Dietetics; Physiology; Sport Sciences
GA AO7GE
UT WOS:000341519700010
PM 24833275
DA 2025-04-28
ER

PT J
AU Saldiva, SRDM
   Venancio, SI
   de Santana, AC
   Castro, ALD
   Escuder, MML
   Giugliani, ERJ
AF Dias Medici Saldiva, Silvia Regina
   Venancio, Sonia Isoyama
   de Santana, Andreia Cardoso
   da Silva Castro, Ana Lucia
   Loureiro Escuder, Maria Mercedes
   Justo Giugliani, Elsa Regina
TI The consumption of unhealthy foods by Brazilian children is influenced by their mother's educational level
SO NUTRITION JOURNAL
LA English
DT Article
DE Supplementary feeding; Food habits; Infant; Cross-sectional study
ID sugar-sweetened beverages; childhood obesity; feeding practices; weight-gain; impact; diet; association; disparity; variety; infancy
AB Objective: To evaluate the association between the consumption of unhealthy foods in children under one year and the education level of the mothers, data obtained from participants of the II Survey on the prevalence of breastfeeding in the Brazilian capitals and the Federal District in 2008 was analyzed. Methods: During the second stage of the campaign for multi-vaccination, a questionnaire on food consumption in the last 24 hours was given to mothers or guardians of children under one year old. We analyzed the consumption of unhealthy foods according to age group, maternal education, region of residence and breastfeeding status. The state capitals and the Federal District were grouped according to the five macro-regions of the country (North, Northeast, Southeast, South and West). Processed juice, soda, coffee, cookies/salted snacks and sugar and/or honey were defined as unhealthy foods. Prevalence ratios (RP) for the association between the consumption of unhealthy foods and maternal education were estimated using Poisson regression models. Results: The study included 34,366 children. The consumption of sweet foods started early and was predominant until the age of six months; after this age, the consumption of biscuits and/or snacks became more prevalent. The consumption of these foods also differs in relation to the macro-region of residence. Consumption of unhealthy foods was higher among mothers with lower education levels. Conclusions: The consumption of unhealthy foods by Brazilian children under one year old was high, indicating a need for developing effective strategies to combat the consumption of unhealthy foods in Brazilian children as a way of preventing obesity and other future disorders.
C1 [Dias Medici Saldiva, Silvia Regina; Venancio, Sonia Isoyama; de Santana, Andreia Cardoso; da Silva Castro, Ana Lucia; Loureiro Escuder, Maria Mercedes] Secretaria Estado Saude Sao Paulo, Inst Saude, BR-01314000 Sao Paulo, Brazil.
   [Justo Giugliani, Elsa Regina] Univ Fed Rio Grande do Sul, Fac Med, Dept Pediat & Puericultura, BR-90035003 Porto Alegre, RS, Brazil.
C3 Universidade Federal do Rio Grande do Sul
RP Saldiva, SRDM (corresponding author), Secretaria Estado Saude Sao Paulo, Inst Saude, Rua Santo Antonio,590,Bela Vista, BR-01314000 Sao Paulo, Brazil.
EM smsaldiva@isaude.sp.gov.br
FU Brazilian Ministry of Health - Brazil
CR Agostoni C, 2005, ACTA PAEDIATR, V94, P523, DOI 10.1080/08035320510031054
   Unknown -, 2011, PESQ ORC FAM 2008 20, V0, P0
   Unknown -, 2009, INF YOUNG CHILD FEED, V0, P0
   Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0
   Barros Aluisio J D, 2003, BMC MED RES METHODOL, V3, P21, DOI 10.1186/1471-2288-3-21
   Bernardi JR, 2011, CAD SAUDE PUBLICA, V27, P1213, DOI 10.1590/S0102-311X2011000600018
   Birch LL, 2009, INT J OBESITY, V33, PS74, DOI 10.1038/ijo.2009.22
   Buyken AE, 2008, AM J CLIN NUTR, V88, P755, DOI 10.1093/ajcn/88.3.755
   Caldeira Ant√¥nio Prates, 2008, REV. SA√öDE P√öBLICA, V42, P1027, DOI 10.1590/S0034-89102008005000057
   Carvalhaes MABL, 1998, REV SAUDE PUBL, V32, P430, DOI 10.1590/S0034-89101998000500005
   de Aquino RD, 2002, REV SAUDE PUBL, V36, P655, DOI 10.1590/S0034-89102002000700001
   Bernardi JLD, 2009, REV PANAM SALUD PUBL, V26, P405, DOI 10.1590/S1020-49892009001100004
   Saldiva SRDM, 2010, REV NUTR, V23, P221, DOI 10.1590/S1415-52732010000200005
   Dixon B, 2012, ADV NUTR, V3, P73, DOI 10.3945/an.111.000919
   Erkkola M, 2009, BRIT J NUTR, V101, P1209, DOI 10.1017/S0007114508057619
   Feldens CA, 2010, CARIES RES, V44, P445, DOI 10.1159/000319898
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5
   Fox MK, 2006, J AM DIET ASSOC, V106, PS77, DOI 10.1016/j.jada.2005.09.039
   Geleijnse JM, 1997, HYPERTENSION, V29, P913, DOI 10.1161/01.HYP.29.4.913
   Gibson S, 2009, BRIT J NUTR, V101, P100, DOI 10.1017/S0007114508981484
   HOFMAN A, 1983, JAMA-J AM MED ASSOC, V250, P370, DOI 10.1001/jama.250.3.370
   Imdad A, 2011, BMC PUBLIC HEALTH, V11, P0, DOI 10.1186/1471-2458-11-S3-S25
   Instituto Brasileiro de Geografia e Estatistica, 2010, PESQUISA DE ORCAMENTOS FAMILIARES 2008-2009: ANTROPOMETRIA E ESTADO NUTRICIONAL DE CRIANCAS, V0, P0
   Kim J, 2008, ARCH PEDIAT ADOL MED, V162, P627, DOI 10.1001/archpedi.162.7.627
   Kranz S, 2005, J PEDIATR-US, V146, P105, DOI 10.1016/j.jpeds.2004.08.077
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Fernandez-Alvira JM, 2013, PUBLIC HEALTH NUTR, V16, P487, DOI 10.1017/S136898001200290X
   Monteiro CA, 2010, CAD SAUDE PUBLICA, V26, P2039, DOI 10.1590/S0102-311X2010001100005
   Moorcroft KE, 2011, MATERN CHILD NUTR, V7, P3, DOI 10.1111/j.1740-8709.2010.00284.x
   Nicklaus S, 2005, APPETITE, V44, P289, DOI 10.1016/j.appet.2005.01.006
   Pearce J, 2013, INT J OBESITY, V37, P477, DOI 10.1038/ijo.2013.8
   Pereira MA, 2006, INT J OBESITY, V30, PS28, DOI 10.1038/sj.ijo.0803489
   Ruottinen S, 2008, PEDIATRICS, V121, PE1676, DOI 10.1542/peds.2007-1642
   Saldiva SRDM, 2007, J PEDIAT-BRAZIL, V83, P53, DOI 10.2223/JPED.1588
   Skinner JD, 2002, J NUTR EDUC BEHAV, V34, P310, DOI 10.1016/S1499-4046(06)60113-9
   Thompson AL, 2013, SOC SCI MED, V97, P288, DOI 10.1016/j.socscimed.2012.12.007
   VICTORA CG, 1992, SOC SCI MED, V34, P899, DOI 10.1016/0277-9536(92)90258-R
   WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA, V0, P0
   Wilson TA, 2009, J AM DIET ASSOC, V109, P1012, DOI 10.1016/j.jada.2009.03.007
   World Health Organization, 2008, GUID DRINK WAT QUAL, V0, P0, DOI DOI 10.1007/S12403-018-0288-8
NR 50
TC 42
Z9 48
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1475-2891
J9 NUTR J
JI Nutr. J.
PD APR 3
PY 2014
VL 13
IS 
BP 
EP 
DI 10.1186/1475-2891-13-33
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA AG4QD
UT WOS:000335404300001
PM 24708610
DA 2025-04-28
ER

PT J
AU Moubarac, JC
   Receveur, O
   Cargo, M
   Daniel, M
AF Moubarac, Jean-Claude
   Receveur, Olivier
   Cargo, Margaret
   Daniel, Mark
TI Consumption patterns of sweetened food and drink products in a Catholic Middle Eastern Canadian community
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Sweet products; Ultra-processed; Public health nutrition; Middle Eastern Canadian; Arab Canadian
ID weight-gain; life-style; processed foods; obesity; beverages; health; schoolchildren; overweight; nutrition; impact
AB Objective: The present study describes the consumption patterns of sweetened food and drink products in a Catholic Middle Eastern Canadian community and examines its associations with physical activity, sedentary behaviours and BMI. Design: A two-stage cross-sectional design was used. In Stage 1 (n 42), 24 h recalls enabled the identification of sweetened products. In Stage 2 (n 192), an FFQ was administered to measure the daily consumption of these products and to collect sociodemographic and behavioural data. Sweetened products were defined as processed culinary ingredients and ultra-processed products for which total sugar content exceeded 20 % of total energy. Setting: Three Catholic Middle Eastern churches located in Montreal, Canada. Subjects: Normoglycaemic men and women (18-60 years old). Results: Twenty-six sweetened products represented an average consumption of 75.4 g total sugars/d or 15.1 % of daily energy intake (n 190, 56 % women). Soft drinks, juices, sweetened coffee, chocolate, cookies, cakes and muffins were the main sources of consumption and mostly consumed between meals. Age (exp (beta) = 0.99; P < 0.01), physical activity (exp (beta) = 1.08; P < 0.01) and recreational computer use (exp (beta) = 1.17; P < 0.01) were independently associated with sweetened product consumption. The association between sweetened product consumption and physical activity was U-shaped. BMI was not significantly associated with sweetened product consumption but all participants regardless of BMI were above the WHO recommendation for free sugars. Conclusions: Being physically active and spending less time using a computer may favour a reduced consumption of sweetened products. Very active individuals may, however, overconsume such products.
C1 [Moubarac, Jean-Claude] Univ Sao Paulo, Nucleo Pesquisas Epidemiol Nutr & Saude, BR-01255000 Sao Paulo, Brazil.
   [Moubarac, Jean-Claude] Univ Montreal, Ecole Sante Publ, Montreal, PQ, Canada.
   [Receveur, Olivier] Univ Montreal, Dept Nutr, Montreal, PQ, Canada.
   [Cargo, Margaret; Daniel, Mark] Univ S Australia, Sch Hlth Sci, Adelaide, SA 5001, Australia.
C3 Universidade de Sao Paulo; Universite de Montreal; Universite de Montreal; University of South Australia
RP Moubarac, JC (corresponding author), Univ Sao Paulo, Nucleo Pesquisas Epidemiol Nutr & Saude, Av Dr Arnaldo 715, BR-01255000 Sao Paulo, Brazil.
EM jcmoubarac@gmail.com
CR Amer Diabet Assoc, 2010, DIABETES CARE, V33, PS11, DOI 10.2337/dc11-S011
   Andersen LF, 2005, SCAND J PUBLIC HEALT, V33, P99, DOI 10.1080/140349404100410019172
   Unknown -, 2012, CAN NUTR FIL, V0, P0
   Asfaw A, 2011, HEALTH ECON, V20, P184, DOI 10.1002/hec.1579
   Bandini LG, 1999, OBES RES, V7, P438, DOI 10.1002/j.1550-8528.1999.tb00431.x
   Blanchet C, 2009, LA CONSOMMATION ALIMENTAIRE ET LES APPORTS NUTRITIONNELS DES ADULTES QUEBECOIS. RAPPORT DE LENQUETE SUR LA SANTE DANS LES COLLECTIVITES CANADIENNES (CYCLE 2.2), V0, P0
   Bray GA, 2010, CURR OPIN LIPIDOL, V21, P51, DOI 10.1097/MOL.0b013e3283346ca2
   Bryan SN, 2006, CAN J PUBLIC HEALTH, V97, P271, DOI 10.1007/BF03405602
   Chapelot D, 2011, J NUTR, V141, P158, DOI 10.3945/jn.109.114330
   Cummings JH, 2007, EUR J CLIN NUTR, V61, PS5, DOI 10.1038/sj.ejcn.1602936
   Deldicque L, 2008, CURR OPIN CLIN NUTR, V11, P774, DOI 10.1097/MCO.0b013e3283139489
   Dogra Shilpa, 2010, INT J BEHAV NUTR PHYS ACT, V7, P75, DOI 10.1186/1479-5868-7-75
   Galal OM, 2002, PUBLIC HEALTH NUTR, V5, P141, DOI 10.1079/PHN2001286
   Guthrie JF, 2000, J AM DIET ASSOC, V100, P43, DOI 10.1016/S0002-8223(00)00018-3
   Hassan-Wassef H, 2004, EAST MEDITERR HEALTH J, V10, P898
   Hetherington MM, 2006, PHYSIOL BEHAV, V88, P498, DOI 10.1016/j.physbeh.2006.04.025
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   Issa C, 2009, INT J FOOD SCI NUTR, V60, P285, DOI 10.1080/09637480903107700
   Jaghasi I, 2012, EASTERN MEDITERRANEAN HEALTH JOURNAL, V18, P358
   Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627
   Liu Richard, 2010, OPEN MED, V4, P0
   Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a
   Lustig RH, 2010, J AM DIET ASSOC, V110, P1307, DOI 10.1016/j.jada.2010.06.008
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   McDonald JT, 2005, SOC SCI MED, V61, P2469, DOI 10.1016/j.socscimed.2005.05.004
   Monteiro CA, 2012, PLOS MED, V9, P0, DOI 10.1371/journal.pmed.1001252
   Monteiro CA, 2010, AM J PUBLIC HEALTH, V100, P975, DOI 10.2105/AJPH.2009.187666
   Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241
   Monteiro CA, 2010, CAD SAUDE PUBLICA, V26, P2039, DOI 10.1590/S0102-311X2010001100005
   Moubarac JC, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044738
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Mullie P, 2012, EUR J CLIN NUTR, V66, P150, DOI 10.1038/ejcn.2011.138
   Musaiger AO, 2012, INT J GEN MED, V5, P199, DOI 10.2147/IJGM.S29663
   Must A, 2005, INT J OBESITY, V29, PS84, DOI 10.1038/sj.ijo.0803064
   Nakanishi S, 2004, BIOMED PHARMACOTHER, V58, P571, DOI 10.1016/j.biopha.2004.10.001
   Nasreddine L, 2006, PUBLIC HEALTH NUTR, V9, P194, DOI 10.1079/PHN2005855
   Nickles HG, 1975, LA CUISINE AU MOYEN-ORIENT, V0, P0
   OLoughlin J, 2007, ETHNIC DIS, V17, P657
   Pi-Sunyer FX, 2000, P NUTR SOC, V59, P505, DOI 10.1017/S0029665100000732
   Rehm CD, 2008, J URBAN HEALTH, V85, P375, DOI 10.1007/s11524-008-9269-8
   Sabat√© J, 2004, BRIT J NUTR, V92, P199, DOI 10.1079/BJN20041229
   Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927
   Shi L, 2010, ITAL J PEDIATR, V36, P0, DOI 10.1186/1824-7288-36-52
   Tremblay Mark S, 2005, HEALTH REP, V16, P23
   Vallianatos H, 2008, FOOD, V0, P0
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   WHO, 2003, WHO TECHN REP SER, V0, P0
NR 54
TC 4
Z9 5
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD FEB 15
PY 2014
VL 17
IS 2
BP 471
EP 478
DI 10.1017/S1368980012005460
PG 8
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA AD0XN
UT WOS:000332957800027
PM 23286218
DA 2025-04-28
ER

PT J
AU Hamilton, D
   Beall, C
   Jeromson, S
   Chevtzoff, C
   Cuthbertson, D
   Ashford, M
AF Hamilton, D. Lee
   Beall, Craig
   Jeromson, Stewart
   Chevtzoff, Cyrille
   Cuthbertson, Daniel J.
   Ashford, Michael L. J.
TI Kv1.3 inhibitors have differential effects on glucose uptake and AMPK activity in skeletal muscle cell lines and mouse ex vivo skeletal muscle
SO JOURNAL OF PHYSIOLOGICAL SCIENCES
LA English
DT Article
DE AMPK; Kv1.3; Skeletal muscle; Glucose uptake
ID glut4 translocation; hexose-transport; insulin; channel; stimulation; contraction; activation; phosphorylation; homeostasis; caffeine
AB Knockout of Kv1.3 improves glucose homeostasis and confers resistance to obesity. Additionally, Kv1.3 inhibition enhances glucose uptake. This is thought to occur through calcium release. Kv1.3 inhibition in T-lymphocytes alters mitochondrial membrane potential, and, as many agents that induce Ca2+ release or inhibit mitochondrial function activate AMPK, we hypothesised that Kv1.3 inhibition would activate AMPK and increase glucose uptake. We screened cultured muscle with a range of Kv1.3 inhibitors for their ability to alter glucose uptake. Only Psora4 increased glucose uptake in C2C12 myotubes. None of the inhibitors had any impact on L6 myotubes. Magratoxin activated AMPK in C2C12 myotubes and only Pap1 activated AMPK in the SOL. Kv1.3 inhibitors did not alter cellular respiration, indicating a lack of effect on mitochondrial function. In conclusion, AMPK does not mediate the effects of Kv1.3 inhibitors and they display differential effects in different skeletal muscle cell lines without impairing mitochondrial function.
C1 [Hamilton, D. Lee; Beall, Craig; Ashford, Michael L. J.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Div Cardiovasc & Diabet Med, Dundee DD1 9SY, Scotland.
   [Beall, Craig; Cuthbertson, Daniel J.] Aintree Univ Hosp NHS Fdn Trust, Obes & Endocrinol Clin Res Unit, Liverpool L9 7AL, Merseyside, England.
   [Jeromson, Stewart] Univ Stirling, Sch Sport, Hlth & Exercise Sci Res Grp, Stirling FK9 4LA, Scotland.
   [Chevtzoff, Cyrille] Univ Dundee, Coll Life Sci, Div Cell Sci & Immunol, Dundee DD1 5EH, Scotland.
C3 University of Dundee; Aintree University Hospitals NHS Foundation Trust; University of Stirling; University of Dundee
RP Ashford, M (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Div Cardiovasc & Diabet Med, Dundee DD1 9SY, Scotland.
EM d.l.hamilton@stir.ac.uk; m.l.j.ashford@dundee.ac.uk
FU Tenovous Tayside (award); Diabetes UK; Anonymous Trust
CR Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782
   Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x
   Cook KK, 2002, J BIOL CHEM, V277, P13268, DOI 10.1074/jbc.M108898200
   Dzamko NL, 2009, ACTA PHYSIOL, V196, P115, DOI 10.1111/j.1748-1716.2009.01969.x
   Fadool DA, 2000, J NEUROPHYSIOL, V83, P2332, DOI 10.1152/jn.2000.83.4.2332
   Freymond D, 2002, ACTA PHYSIOL SCAND, V176, P283, DOI 10.1046/j.1365-201X.2002.01039.x
   Gulbins E, 2012, BIOCHIM BIOPHYS ACTA, V1797, P1251
   Hamilton DL, 2010, BMC CELL BIOL, V11, P0, DOI 10.1186/1471-2121-11-37
   JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0
   Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V293, PE286, DOI 10.1152/ajpendo.00693.2006
   Jensen TE, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0002102
   Kanzaki M, 2006, ENDOCR J, V53, P267, DOI 10.1507/endocrj.KR-65
   Khayat ZA, 1998, AM J PHYSIOL-CELL PH, V275, PC1487, DOI 10.1152/ajpcell.1998.275.6.C1487
   KLIP A, 1984, AM J PHYSIOL, V247, PE297, DOI 10.1152/ajpendo.1984.247.3.E297
   KLIP A, 1992, ENDOCRINOLOGY, V130, P2535, DOI 10.1210/en.130.5.2535
   Klip A, 2009, APPL PHYSIOL NUTR ME, V34, P481, DOI 10.1139/H09-047
   Li YY, 2006, AM J PHYSIOL-CELL PH, V290, PC345, DOI 10.1152/ajpcell.00091.2005
   Mcgee SL, 2008, J PHYSIOL-LONDON, V586, P1731, DOI 10.1113/jphysiol.2007.143685
   Niu WY, 2010, AM J PHYSIOL-ENDOC M, V298, PE1058, DOI 10.1152/ajpendo.00773.2009
   Philp A, 2010, AM J PHYSIOL-CELL PH, V299, PC240, DOI 10.1152/ajpcell.00438.2009
   Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006
   Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, PE29, DOI 10.1152/ajpendo.90331.2008
   Santos JM, 2008, INT J SPORTS MED, V29, P785, DOI 10.1055/s-2008-1038404
   SARABIA V, 1990, BIOCHEM CELL BIOL, V68, P536, DOI 10.1139/o90-076
   Straub SV, 2013, AM J PHYSL IN PRESS, V0, P0
   Szab√≥ I, 2008, P NATL ACAD SCI USA, V105, P14861, DOI 10.1073/pnas.0804236105
   Tschritter O, 2006, J CLIN ENDOCR METAB, V91, P654, DOI 10.1210/jc.2005-0725
   Tucker K, 2008, INT J OBESITY, V32, P1222, DOI 10.1038/ijo.2008.77
   Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2
   Wijesekara N, 2006, AM J PHYSIOL-ENDOC M, V290, PE1276, DOI 10.1152/ajpendo.00573.2005
   Xu JC, 2004, P NATL ACAD SCI USA, V101, P3112, DOI 10.1073/pnas.0308450100
   Xu JC, 2003, HUM MOL GENET, V12, P551, DOI 10.1093/hmg/ddg049
   YOUN JH, 1991, AM J PHYSIOL, V260, PC555, DOI 10.1152/ajpcell.1991.260.3.C555
NR 33
TC 7
Z9 8
U1 1
U2 5
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN
SN 1880-6546
EI 1880-6562
J9 J PHYSIOL SCI
JI J. Physiol. Sci.
PD JAN 15
PY 2014
VL 64
IS 1
BP 13
EP 20
DI 10.1007/s12576-013-0285-4
PG 8
WC Physiology
SC Physiology
GA 280XN
UT WOS:000329064200002
PM 24043354
DA 2025-04-28
ER

PT J
AU Davoodi, SH
   Hajimiresmaiel, SJ
   Ajami, M
   Mohseni-Bandpei, A
   Ayatollahi, SA
   Dowlatshahi, K
   Javedan, G
   Pazoki-Toroudi, H
AF Davoodi, Sayed Hossein
   Hajimiresmaiel, Seyed Javad
   Ajami, Marjan
   Mohseni-Bandpei, Anoushiravan
   Ayatollahi, Seyyed Abdulmajid
   Dowlatshahi, Kamran
   Javedan, Gholamali
   Pazoki-Toroudi, Hamidreza
TI Caffeine Treatment Prevented from Weight Regain after Calorie Shifting Diet Induced Weight Loss
SO IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH
LA English
DT Article
DE Caffeine; Calorie shifting diet; Diet; Obesity; Resting metabolic rate; Weight loss
ID appetite sensations; energy-expenditure; physical-activity; oxidative stress; restriction; determinants; adherence; obesity; impact
AB Low calorie diets are always difficult for obese subjects to follow and lead to metabolic and behavioral adaptation. Therefore, we evaluated the effect of caffeine treatment with calorie shifting diet (CSD) on weight loss. Female subjects (n=60; BMI > 25) completed 4-weeks control diet, 6-weeks CSD (3 repeated phases; each 2-weeks) and 4-weeks follow-up diet, with or without caffeine treatment (5 mg/Kg/day). The first 11 days of each phase included calorie restriction with four meals every day and 4 hours intervals. Significant weight and fat loss were observed after 4-weeks of CSD (5.7 +/- 1.24 Kg and 4.84 +/- 1.53 Kg) or CSD+Caffeine (7.57 +/- 2.33 Kg and 5.24 +/- 2.07 Kg) which was consistent for one month of the follow-up (CSD: 5.24 +/- 1.83 Kg and 4.3 +/- 1.62 Kg, CSD+ Caffeine: 12.11 +/- 2.31 Kg and 9.85 +/- 1.6 Kg, p < 0.05 vs CSD group) and correlated to the restricted energy intake (p < 0.05). During three CSD phases, RMR tended to remain unchanged in both groups. While, CSD or CSD + Caffeine treatments, significantly decreased plasma glucose, total-cholesterol, and triacylglycerol (p < 0.05), even during follow-up period (p < 0.05). HDL-cholesterol was not changed by CSD. Feeling of hunger decreased and subject's satisfaction increased after 4-weeks of CSD (p < 0.05) and remained low to the end of study, while satiety was not affected. Coffeine increased the effect of CSD on feeling of hunger and subject's satisfaction after week 7 (p < 0.05 vs. CSD). These findings indicated that combination of caffeine treatment with CSD could be an effective alternative approach to weight and fat loss with small changes in RMR and improved tolerance of subjects to the new diet.
C1 [Davoodi, Sayed Hossein] Shahid Beheshti Univ Med Sci, Fac Nutr & Food Technol, Natl Nutr & Food Technol Res Inst, Tehran, Iran.
   [Hajimiresmaiel, Seyed Javad] Iran Univ Med Sci, Dept Cardiol, Tehran, Iran.
   [Ajami, Marjan] Shahid Beheshti Univ Med Sci, Fac Nutr & Food Technol, Natl Nutr & Food Technol Res Inst, Dept Food & Nutr Policy & Planning Res, Tehran, Iran.
   [Mohseni-Bandpei, Anoushiravan] Shahid Beheshti Univ Med Sci, Sch Hlth, Tehran, Iran.
   [Ayatollahi, Seyyed Abdulmajid] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmacognosy, Phytochem Res Ctr, Tehran, Iran.
   [Javedan, Gholamali] Iran Univ Med Sci, Dept Nutr, Tehran, Iran.
   [Pazoki-Toroudi, Hamidreza] Iran Univ Med Sci, Physiol Res Ctr, Tehran, Iran.
C3 Shahid Beheshti University Medical Sciences; Iran University of Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences
RP Ajami, M (corresponding author), Shahid Beheshti Univ Med Sci, Fac Nutr & Food Technol, Natl Nutr & Food Technol Res Inst, Dept Food & Nutr Policy & Planning Res, Tehran, Iran.
EM nutritionist80@gmail.com
CR Anton SD, 2009, J HUM NUTR DIET, V22, P141, DOI 10.1111/j.1365-277X.2008.00943.x
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Avenell A, 2004, HEALTH TECHNOL ASSES, V8, P1
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, PE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Chaston TB, 2008, INT J OBESITY, V32, P619, DOI 10.1038/sj.ijo.0803761
   Das SK, 2007, AM J CLIN NUTR, V85, P1023, DOI 10.1093/ajcn/85.4.1023
   DATTILO AM, 1992, AM J CLIN NUTR, V56, P320, DOI 10.1093/ajcn/56.2.320
   Drapeau V, 2005, BRIT J NUTR, V93, P273, DOI 10.1079/BJN20041312
   Drapeau V, 2007, APPETITE, V48, P159, DOI 10.1016/j.appet.2006.08.002
   Drolet B, 2007, AM J CARDIOVASC DRUG, V7, P273, DOI 10.2165/00129784-200707040-00005
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Ellison RC, 2004, AM HEART J, V147, P529, DOI 10.1016/j.ahj.2003.10.033
   Eshghinia S, 2013, J DIABETES METAB DIS, V12, P0, DOI 10.1186/2251-6581-12-4
   Fardet L, 2007, REV MED INTERNE, V28, P284, DOI 10.1016/j.revmed.2006.12.013
   Harp JB, 2002, OBES RES, V10, P985, DOI 10.1038/oby.2002.134
   Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539
   Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005
   Klempel MC, 2010, NUTR J, V9, P0, DOI 10.1186/1475-2891-9-35
   Kouda Katsuyasu, 2006, ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE, V11, P89, DOI 10.1007/BF02898148
   Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068
   Lee HO, 2013, NUTR RES PRACT, V7, P43, DOI 10.4162/nrp.2013.7.1.43
   Malik VS, 2007, NAT CLIN PRACT CARD, V4, P34, DOI 10.1038/ncpcardio0726
   Martin CK, 2007, OBESITY, V15, P2964, DOI 10.1038/oby.2007.354
   Martins C, 2008, P NUTR SOC, V67, P28, DOI 10.1017/S0029665108005995
   National Institutes of Health, 1996, THE AMERICAN JOURNAL OF CLINICAL NUTRITION, V64, P524S, DOI 10.1093/ajcn/64.3.524S
   RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749
   Redman LM, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0004377
   Tapsell L, 2010, NUTR METAB CARDIOVAS, V20, P317, DOI 10.1016/j.numecd.2009.04.007
   Varady KA, 2007, AM J CLIN NUTR, V86, P7, DOI 10.1093/ajcn/86.1.7
   Varady KA, 2009, AM J CLIN NUTR, V90, P1138, DOI 10.3945/ajcn.2009.28380
   Varma JL, 2007, AM J CLIN NUTR, V85, P1127, DOI 10.1093/ajcn/85.4.1127
   Varo JJ, 2003, INT J EPIDEMIOL, V32, P138, DOI 10.1093/ije/dyg116
   Westerterp KR, 2003, OBES RES, V11, P865, DOI 10.1038/oby.2003.119
   Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323
NR 35
TC 22
Z9 25
U1 1
U2 26
PU SHAHEED BEHESHTI UNIV, SCH PHARMACY
PI TEHRAN
PA NO 10 SHAMS ALLEY, VALI-E ASR ST, TEHRAN, 00000, IRAN
SN 1735-0328
EI 1726-6890
J9 IRAN J PHARM RES
JI Iran. J. Pharm. Res.
PD SPR 15
PY 2014
VL 13
IS 2
BP 707
EP 718
DI 
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AI3AP
UT WOS:000336731100038
PM 25237367
DA 2025-04-28
ER

PT J
AU Stern, D
   Piernas, C
   Barquera, S
   Rivera, JA
   Popkin, BM
AF Stern, Dalia
   Piernas, Carmen
   Barquera, Simon
   Rivera, Juan A.
   Popkin, Barry M.
TI Caloric Beverages Were Major Sources of Energy among Children and Adults in Mexico, 1999-2012
SO JOURNAL OF NUTRITION
LA English
DT Article
ID sugar-sweetened beverages; national-health; body-weight; food; consumption; obesity; carbohydrate; demand; prices; trends
AB Mexico, with 1 of the highest obesity prevalences in the world, instituted a 10% excise tax for any sugar-sweetened beverage (SSB) starting on 1 January 2014. Understanding the recent patterns and trends in beverage intake and sales in Mexico provides both background and baseline data for the importance of SSBs and other beverages in the Mexican diet. We analyzed a single 24-h dietary recall from 2 nationally representative surveys: the Mexican Nutrition Survey 1999 (n = 6049) and the National Health and Nutrition Survey 2012 (n = 10,343). To describe trends and patterns in beverages, we calculated the volume and energy intake per capita and per consumer and the proportion of consumers of each beverage group in each survey. A commercial sales dataset was used to describe beverage sales trends from 1999 to 2012. From 1999 to 2012, total daily energy from beverages increased among children aged 5-11 y (+45.3 kcal), females aged 12-19 y (+57.3 kcal), and adult females aged 20-49 y (+96.4 kcal) (P < 0.05). Over the same period, intake of beverages with added sugars increased, specifically flavored milk, agua fresca (fruit water made in stalls or at home, usually with added sugars), and fruit drinks among children aged 5-11 y and females aged 12-19 y and caloric coffee/tea, soda, and agua fresca among adult females aged 20-49 y. In 2012, beverages represented 17.5% (325 kcal) and 19.0% (382 kcal) of the total daily energy intake per capita in children aged 1-19 y and adults aged >= 20 y, respectively. In 2012, flavored milk beverages, caloric soda, and high-fat milk were the top 3 major contributors to total daily energy intake per capita in all children aged 1-19 y. Caloric soda, caloric coffee/tea, and agua fresca were the top 3 major energy contributors in adults aged >= 20 y. From 1999 to 2012, sales of soda, fruit-flavored drinks, and flavored waters increased. In conclusion, consumption of several beverages with added sugars increased among children and adult females in Mexico. Because caloric soda is currently 1 of the top beverages consumed, a 10% tax on SSBs might help to significantly reduce added sugars intake in Mexico.
C1 [Stern, Dalia; Piernas, Carmen; Popkin, Barry M.] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA.
   [Barquera, Simon; Rivera, Juan A.] Natl Inst Publ Hlth, Nutr & Hlth Res Ctr, Cuernavaca, Morelos, Mexico.
C3 University of North Carolina; University of North Carolina Chapel Hill; Instituto Nacional de Salud Publica
RP Popkin, BM (corresponding author), Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA.
EM popkin@unc.edu
FU Mexican National Council of Science and Technology Scholarship (CONACyT) [309902]; Carolina Population Center [5 R24 HD050924]
CR Andreyeva T, 2011, PREV MED, V52, P413, DOI 10.1016/j.ypmed.2011.03.013
   Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415
   Unknown -, 2008, USDA NAT NUTR DAT ST, V0, P0
   Barquera S, 2008, J NUTR, V138, P2454, DOI 10.3945/jn.108.092163
   Barquera S, 2010, NUTR J, V9, P0, DOI 10.1186/1475-2891-9-47
   Batis C, 2011, J NUTR, V141, P1898, DOI 10.3945/jn.111.141473
   Block JP, 2013, BMJ-BRIT MED J, V347, P0, DOI 10.1136/bmj.f5947
   Briggs ADM, 2013, BMJ-BRIT MED J, V347, P0, DOI 10.1136/bmj.f6189
   BRONFMAN M, 1988, ARCH INVEST MED, V19, P351
   de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034
   DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229
   Drewnowski A, 2013, NUTR J, V12, P0, DOI 10.1186/1475-2891-12-85
   Duffey KJ, 2008, AM J CLIN NUTR, V88, P1722S, DOI 10.3945/ajcn.2008.25825C
   Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388
   Ford ES, 2013, AM J CLIN NUTR, V97, P848, DOI 10.3945/ajcn.112.052662
   Gibson RS, 2005, PRINCIPLES NUTR ASSE, V0, P0
   Gutierrez JP, 2012, NATL HLTH NUTR SURVE, V0, P0
   Igumbor EU, 2012, PLOS MED, V9, P0, DOI 10.1371/journal.pmed.1001253
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Mattes Richard D, 1996, PHYSIOLOGY AND BEHAVIOR, V59, P179, DOI 10.1016/0031-9384(95)02007-1
   Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3
   Mourao DM, 2007, INT J OBESITY, V31, P1688, DOI 10.1038/sj.ijo.0803667
   Ng SW, 2014, AM J CLIN NUTR, V99, P609, DOI 10.3945/ajcn.113.072892
   Guti√©rrez JP, 2013, SALUD PUBLICA MEXICO, V55, PS341, DOI 10.21149/spm.v55s2.5133
   Piernas C, 2013, PEDIATR OBES, V8, P294, DOI 10.1111/j.2047-6310.2013.00153.x
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529
   Powell LM, 2013, OBES REV, V14, P110, DOI 10.1111/obr.12002
   Resano-P√©rez E, 2003, SALUD PUBLICA MEXICO, V45, P0
   Rivera Juan A, 2008, SALUD P√öBLICA M√âX, V50, P173
   Rivera-Dommarco J, 2001, NATL HLTH NUTR SURVE, V0, P0
   Romero-Mart√≠nez M, 2013, SALUD PUBLICA MEXICO, V55, PS332, DOI 10.21149/spm.v55s2.5132
   Stuckler D, 2012, PLOS MED, V9, P0, DOI 10.1371/journal.pmed.1001235
NR 35
TC 126
Z9 143
U1 0
U2 58
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD JUN 15
PY 2014
VL 144
IS 6
BP 949
EP 956
DI 10.3945/jn.114.190652
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA AH9LZ
UT WOS:000336465200023
PM 24744311
DA 2025-04-28
ER

PT J
AU Kubow, S
   Hobson, L
   Iskandar, MM
   Sabally, K
   Donnelly, DJ
   Agellon, LB
AF Kubow, Stan
   Hobson, Luc
   Iskandar, Michele M.
   Sabally, Kebba
   Donnelly, Danielle J.
   Agellon, Luis B.
TI Extract of Irish potatoes (Solanum tuberosum L.) decreases body weight gain and adiposity and improves glucose control in the mouse model of diet-induced obesity
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article
DE Glucose tolerance; Polyphenols; Potato; Sex differences
ID high-fat diet; lipid-metabolism; ferulic acid; chlorogenic acid; resistance; pathways; mice
AB Both sexes of mice were fed a high fat diet (HFD) for 10 weeks without and with polyphenolic-rich potato extracts (PRPE) of cultivars Onaway and Russet Burbank. PRPE attenuated weight gain in male and female mice by as much as 63.2%, which was associated mostly with a reduction in adiposity. Mice receiving PRPE showed enhanced capacity for blood glucose clearance. Sex differences regarding the impact of HFD and PRPE on plasma levels of insulin, ghrelin, leptin, gastric inhibitory peptide, and resistin were noted. PRPE may serve as part of a preventative dietary strategy against the development of obesity and type 2 diabetes.
C1 [Kubow, Stan; Hobson, Luc; Iskandar, Michele M.; Sabally, Kebba; Agellon, Luis B.] McGill Univ, Sch Dietet & Human Nutr, Ste Anne De Bellevue, PQ H9X 3V9, Canada.
   [Donnelly, Danielle J.] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ H9X 3V9, Canada.
C3 McGill University; McGill University
RP Kubow, S (corresponding author), McGill Univ, Sch Dietet & Human Nutr, 21,111 Lakeshore, Ste Anne De Bellevue, PQ H9X 3V9, Canada.
EM stan.kubow@mcgill.ca
FU Natural Sciences and Engineering Council of Canada; Canadian Institutes of Health Research; Canada Foundation for Innovation
CR Andallu B, 2003, CLIN CHIM ACTA, V338, P3, DOI 10.1016/S0009-8981(03)00322-X
   Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, PE1323, DOI 10.1152/ajpendo.90617.2008
   Unknown -, 2006, BMC COMPLEM ALTERN M, V0, P0
   Bolkent S, 2000, J ETHNOPHARMACOL, V73, P251, DOI 10.1016/S0378-8741(00)00328-7
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cox LM, 2013, CELL METAB, V17, P883, DOI 10.1016/j.cmet.2013.05.004
   Crandall JP, 2012, J GERONTOL A-BIOL, V67, P1307, DOI 10.1093/gerona/glr235
   FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311
   Gomez G, 2012, REGUL PEPTIDES, V173, P60, DOI 10.1016/j.regpep.2011.09.006
   Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878
   Kamalakkannan N, 2003, J ETHNOPHARMACOL, V87, P207, DOI 10.1016/S0378-8741(03)00148-X
   Lin HV, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0035240
   Liu QO, 2010, BBA-GENE REGUL MECH, V1799, P854, DOI 10.1016/j.bbagrm.2010.06.004
   Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Ohnishi M, 2004, BIOFACTORS, V21, P315, DOI 10.1002/biof.552210161
   Park HJ, 2013, MOL NUTR FOOD RES, V57, P360, DOI 10.1002/mnfr.201200447
   Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214
   Romo-Vaquero M, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0094687
   Rondini L, 2004, J AGR FOOD CHEM, V52, P4338, DOI 10.1021/jf0348323
   Seeram NP, 2004, J AGR FOOD CHEM, V52, P2512, DOI 10.1021/jf0352778
   Shehzad A, 2011, EUR J NUTR, V50, P151, DOI 10.1007/s00394-011-0188-1
   Singh N, 2005, PLANT FOOD HUM NUTR, V60, P49, DOI 10.1007/s11130-005-5099-y
   Son MJ, 2010, J CLIN BIOCHEM NUTR, V46, P150, DOI 10.3164/jcbn.09-98
   Sugiyama MG, 2012, BIOCHEM CELL BIOL, V90, P124, DOI 10.1139/O11-067
   Tunnicliffe JM, 2011, APPL PHYSIOL NUTR ME, V36, P650, DOI 10.1139/H11-072
   Wang CY, 2012, METHODS MOL BIOL, V821, P421, DOI 10.1007/978-1-61779-430-8_27
   Yang ZH, 2012, DIABETOL METAB SYNDR, V4, P0, DOI 10.1186/1758-5996-4-32
   Yoon SS, 2008, J ETHNOPHARMACOL, V118, P396, DOI 10.1016/j.jep.2008.05.014
NR 29
TC 24
Z9 29
U1 1
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD NOV 15
PY 2014
VL 58
IS 11
BP 2235
EP 2238
DI 10.1002/mnfr.201400013
PG 4
WC Food Science & Technology
SC Food Science & Technology
GA AT8XK
UT WOS:000345212200014
PM 25066548
DA 2025-04-28
ER

PT J
AU Jacobs, DM
   Hodgson, AB
   Randell, RK
   Mahabir-Jagessar-T, K
   Garczarek, U
   Jeukendrup, AE
   Mela, DJ
   Lotito, S
AF Jacobs, Doris M.
   Hodgson, Adrian B.
   Randell, Rebecca K.
   Mahabir-Jagessar-T, Krishna
   Garczarek, Ursula
   Jeukendrup, Asker E.
   Mela, David J.
   Lotito, Silvina
TI Metabolic Response to Decaffeinated Green Tea Extract during Rest and Moderate-Intensity Exercise
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE green tea; catechin; caffeine; metabolomics; exercise; fat oxidation
ID fat oxidation; energy-expenditure; catechin-polyphenols; body-weight; caffeine; ingestion; consumption; thermogenesis; overweight; efficacy
AB We previously reported that a 7 day ingestion of caffeinated green tea extract (cGTE) induced marked metabolic differences during rest and exercise. Here, we report the metabolic effects of 1, 7, and 28 day ingestions of decaffeinated GTE (dGTE). In this crossover placebo-controlled study, 19 healthy males ingested dGTE or placebo (PLA) for 28 days, separated by a 28 day wash-out period. On days 1, 7, and 28, participants completed a 30 min cycling exercise 2 h after the ingestion of dGTE or PLA. Blood samples were collected at rest (t = 0 and 120 min) and during exercise (t = 150 min). Plasma was analyzed using untargeted four-phase metabolite profiling and targeted profiling of catecholamines and catechins. dGTE abolished several metabolic effects when compared to our previous study with cGTE. However, following 7 and 28 day dGTE ingestions, increases in 3-hydroxybutyrate, a metabolic marker of fat oxidation, were observed at t = 0 min. dGTE ingestion did not induce significant acute or acute-on-chronic effects on endogenous metabolites just prior to and during exercise.
C1 [Hodgson, Adrian B.; Randell, Rebecca K.; Jeukendrup, Asker E.] Univ Birmingham, Sch Sport & Exercise Sci, Birmingham B15 2TT, W Midlands, England.
   [Jacobs, Doris M.; Mahabir-Jagessar-T, Krishna; Garczarek, Ursula; Mela, David J.] Unilever R&D, NL-3130 AC Vlaardingen, Netherlands.
   [Lotito, Silvina] Unilever R&D, Sharnbrook MK44 1LQ, Beds, England.
C3 University of Birmingham; Unilever; Unilever
RP Jacobs, DM (corresponding author), Unilever R&D, Olivier van Noortlaan 120, NL-3130 AC Vlaardingen, Netherlands.
EM doris.jacobs@unilever.com
FU Unilever RD
CR Achten J, 2004, INT J SPORTS MED, V25, P32, DOI 10.1055/s-2003-45231
   Unknown -, 2008, A LANGUAGE AND ENVIRONMENT FOR STATISTICAL COMPUTING, V0, P0
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   B√©rub√©-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bohn SK, 2012, FOOD FUNCT, V3, P575, DOI 10.1039/c2fo10288a
   Brugnara L, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0040600
   Chorell E, 2009, J PROTEOME RES, V8, P2966, DOI 10.1021/pr900081q
   Crane FL, 2001, J AM COLL NUTR, V20, P591, DOI 10.1080/07315724.2001.10719063
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Eichenberger P, 2009, INT J VITAM NUTR RES, V79, P24, DOI 10.1024/0300-9831.79.1.24
   Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4
   Glube Natalie, 2013, RESULTS PHARMA SCI, V3, P1, DOI 10.1016/j.rinphs.2013.08.002
   Graham TE, 2000, J PHYSIOL-LONDON, V529, P837, DOI 10.1111/j.1469-7793.2000.00837.x
   Gruz J, 2008, FOOD CHEM, V111, P789, DOI 10.1016/j.foodchem.2008.05.014
   Harada U, 2005, J HEALTH SCI, V51, P248, DOI 10.1248/jhs.51.248
   Hodgson AB, 2014, J AGR FOOD CHEM, V62, P1198, DOI 10.1021/jf404872y
   Hodgson AB, 2013, ADV NUTR, V4, P129, DOI 10.3945/an.112.003269
   Hodgson AB, 2013, J NUTR BIOCHEM, V24, P325, DOI 10.1016/j.jnutbio.2012.06.017
   Hursel R, 2011, OBES REV, V12, PE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Hursel R, 2013, AM J CLIN NUTR, V98, P1682S, DOI 10.3945/ajcn.113.058396
   Ichinose T, 2011, SCAND J MED SCI SPOR, V21, P598, DOI 10.1111/j.1600-0838.2009.01077.x
   Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022
   Kovacs EMR, 2006, OBES REV, V7, P59, DOI 10.1111/j.1467-789X.2006.00203.x
   Lehmann R, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011519
   Lewis GD, 2010, SCI TRANSL MED, V2, P0, DOI 10.1126/scitranslmed.3001006
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Moore RJ, 2009, BRIT J NUTR, V102, P1790, DOI 10.1017/S0007114509991218
   Morris C, 2013, MOL NUTR FOOD RES, V57, P1246, DOI 10.1002/mnfr.201200629
   Pinheiro J, 2009, AND THE R CORE TEAM NLME: LINEAR AND NONLINEAR MIXED EFFECTS MODELS, V0, P0
   Pohjanen E, 2007, J PROTEOME RES, V6, P2113, DOI 10.1021/pr070007g
   Randell RK, 2014, MED SCI SPORT EXER, V46, P1185, DOI 10.1249/MSS.0000000000000205
   Randell RK, 2013, MED SCI SPORT EXER, V45, P883, DOI 10.1249/MSS.0b013e31827dd9d4
   Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x
   Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013
   STOCKER R, 1991, P NATL ACAD SCI USA, V88, P1646, DOI 10.1073/pnas.88.5.1646
   van Ravenzwaay B, 2007, TOXICOL LETT, V172, P21, DOI 10.1016/j.toxlet.2007.05.021
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Yamada H, 2002, J ANAL TOXICOL, V26, P17, DOI 10.1093/jat/26.1.17
NR 46
TC 16
Z9 18
U1 1
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD OCT 8
PY 2014
VL 62
IS 40
BP 9936
EP 9943
DI 10.1021/jf502764r
PG 8
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology
SC Agriculture; Chemistry; Food Science & Technology
GA AQ7RF
UT WOS:000343016200037
PM 25195522
DA 2025-04-28
ER

